
<html lang="en"     class="pb-page"  data-request-id="a8c943c1-e187-46b0-a407-59e50899f458"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2015.58.issue-21;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.5b00963"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999): A Highly Selective Mechanism-Based Myeloperoxidase Inhibitor for the Treatment of Cardiovascular Diseases" /></meta><meta name="dc.Creator" content="Roger B.  Ruggeri" /></meta><meta name="dc.Creator" content="Leonard  Buckbinder" /></meta><meta name="dc.Creator" content="Scott W.  Bagley" /></meta><meta name="dc.Creator" content="Philip A.  Carpino" /></meta><meta name="dc.Creator" content="Edward L.  Conn" /></meta><meta name="dc.Creator" content="Matthew S.  Dowling" /></meta><meta name="dc.Creator" content="Dilinie P.  Fernando" /></meta><meta name="dc.Creator" content="Wenhua  Jiao" /></meta><meta name="dc.Creator" content="Daniel W.  Kung" /></meta><meta name="dc.Creator" content="Suvi T. M.  Orr" /></meta><meta name="dc.Creator" content="Yingmei  Qi" /></meta><meta name="dc.Creator" content="Benjamin N.  Rocke" /></meta><meta name="dc.Creator" content="Aaron  Smith" /></meta><meta name="dc.Creator" content="Joseph S.  Warmus" /></meta><meta name="dc.Creator" content="Yan  Zhang" /></meta><meta name="dc.Creator" content="Daniel  Bowles" /></meta><meta name="dc.Creator" content="Daniel W.  Widlicka" /></meta><meta name="dc.Creator" content="Heather  Eng" /></meta><meta name="dc.Creator" content="Tim  Ryder" /></meta><meta name="dc.Creator" content="Raman  Sharma" /></meta><meta name="dc.Creator" content="Angela  Wolford" /></meta><meta name="dc.Creator" content="Carlin  Okerberg" /></meta><meta name="dc.Creator" content="Karen  Walters" /></meta><meta name="dc.Creator" content="Tristan S.  Maurer" /></meta><meta name="dc.Creator" content="Yanwei  Zhang" /></meta><meta name="dc.Creator" content="Paul D.  Bonin" /></meta><meta name="dc.Creator" content="Samantha N.  Spath" /></meta><meta name="dc.Creator" content="Gang  Xing" /></meta><meta name="dc.Creator" content="David  Hepworth" /></meta><meta name="dc.Creator" content="Kay  Ahn" /></meta><meta name="dc.Creator" content="Amit S.  Kalgutkar" /></meta><meta name="dc.Description" content="Myeloperoxidase (MPO) is a heme peroxidase that catalyzes the production of hypochlorous acid. Clinical evidence suggests a causal role for MPO in various autoimmune and inflammatory disorders incl..." /></meta><meta name="Description" content="Myeloperoxidase (MPO) is a heme peroxidase that catalyzes the production of hypochlorous acid. Clinical evidence suggests a causal role for MPO in various autoimmune and inflammatory disorders incl..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 28, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00963" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00963" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00963" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00963" /></link>
        
    
    

<title>Discovery of 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999): A Highly Selective Mechanism-Based Myeloperoxidase Inhibitor for the Treatment of Cardiovascular Diseases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00963" /></meta><meta property="og:title" content="Discovery of 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999): A Highly Selective Mechanism-Based Myeloperoxidase Inhibitor for the Treatment of Cardiovascular Diseases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0012.jpeg" /></meta><meta property="og:description" content="Myeloperoxidase (MPO) is a heme peroxidase that catalyzes the production of hypochlorous acid. Clinical evidence suggests a causal role for MPO in various autoimmune and inflammatory disorders including vasculitis and cardiovascular and Parkinson’s diseases, implying that MPO inhibitors may represent a therapeutic treatment option. Herein, we present the design, synthesis, and preclinical evaluation of N1-substituted-6-arylthiouracils as potent and selective inhibitors of MPO. Inhibition proceeded in a time-dependent manner by a covalent, irreversible mechanism, which was dependent upon MPO catalysis, consistent with mechanism-based inactivation. N1-Substituted-6-arylthiouracils exhibited low partition ratios and high selectivity for MPO over thyroid peroxidase and cytochrome P450 isoforms. N1-Substituted-6-arylthiouracils also demonstrated inhibition of MPO activity in lipopolysaccharide-stimulated human whole blood. Robust inhibition of plasma MPO activity was demonstrated with the lead compound 2-(6-(5-chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999, 8) upon oral administration to lipopolysaccharide-treated cynomolgus monkeys. On the basis of its pharmacological and pharmacokinetic profile, PF-06282999 has been advanced to first-in-human pharmacokinetic and safety studies." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00963"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00963">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00963&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00963&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00963&amp;href=/doi/10.1021/acs.jmedchem.5b00963" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 8513-8528</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00961" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01024" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)acetamide (PF-06282999): A Highly Selective Mechanism-Based Myeloperoxidase Inhibitor for the Treatment of Cardiovascular Diseases</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roger+B.++Ruggeri">Roger B. Ruggeri</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leonard++Buckbinder">Leonard Buckbinder</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott+W.++Bagley">Scott W. Bagley</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philip+A.++Carpino">Philip A. Carpino</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edward+L.++Conn">Edward L. Conn</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+S.++Dowling">Matthew S. Dowling</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dilinie+P.++Fernando">Dilinie P. Fernando</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wenhua++Jiao">Wenhua Jiao</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+W.++Kung">Daniel W. Kung</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Suvi+T.+M.++Orr">Suvi T. M. Orr</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yingmei++Qi">Yingmei Qi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin+N.++Rocke">Benjamin N. Rocke</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aaron++Smith">Aaron Smith</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+S.++Warmus">Joseph S. Warmus</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Zhang">Yan Zhang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Bowles">Daniel Bowles</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+W.++Widlicka">Daniel W. Widlicka</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Heather++Eng">Heather Eng</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tim++Ryder">Tim Ryder</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raman++Sharma">Raman Sharma</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angela++Wolford">Angela Wolford</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carlin++Okerberg">Carlin Okerberg</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karen++Walters">Karen Walters</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tristan+S.++Maurer">Tristan S. Maurer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yanwei++Zhang">Yanwei Zhang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+D.++Bonin">Paul D. Bonin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Samantha+N.++Spath">Samantha N. Spath</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gang++Xing">Gang Xing</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Hepworth">David Hepworth</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kay++Ahn">Kay Ahn</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amit+S.++Kalgutkar">Amit S. Kalgutkar</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Worldwide Research and Development, Pfizer, Inc., Groton, Connecticut 06340, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 860-441-3535. E-mail: <a href="/cdn-cgi/l/email-protection#3e6c51595b4c107c106c4b59595b4c577e4e5857445b4c105d5153"><span class="__cf_email__" data-cfemail="f9ab969e9c8bd7bbd7ab8c9e9e9c8b90b9899f90839c8bd79a9694">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00963&amp;href=/doi/10.1021%2Facs.jmedchem.5b00963" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 8513–8528</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 28, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 June 2015</li><li><span class="item_label"><b>Published</b> online</span>28 October 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 November 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00963" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00963</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8513%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRoger%2BB.%2BRuggeri%252C%2BLeonard%2BBuckbinder%252C%2BScott%2BW.%2BBagley%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D21%26contentID%3Dacs.jmedchem.5b00963%26title%3DDiscovery%2Bof%2B2-%25286-%25285-Chloro-2-methoxyphenyl%2529-4-oxo-2-thioxo-3%252C4-dihydropyrimidin-1%25282H%2529-yl%2529acetamide%2B%2528PF-06282999%2529%253A%2BA%2BHighly%2BSelective%2BMechanism-Based%2BMyeloperoxidase%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BCardiovascular%2BDiseases%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8528%26publicationDate%3DNovember%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00963"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2139</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">35</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00963" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999): A Highly Selective Mechanism-Based Myeloperoxidase Inhibitor for the Treatment of Cardiovascular Diseases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Roger&quot;,&quot;last_name&quot;:&quot;B. Ruggeri&quot;},{&quot;first_name&quot;:&quot;Leonard&quot;,&quot;last_name&quot;:&quot;Buckbinder&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;W. Bagley&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;A. Carpino&quot;},{&quot;first_name&quot;:&quot;Edward&quot;,&quot;last_name&quot;:&quot;L. Conn&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;S. Dowling&quot;},{&quot;first_name&quot;:&quot;Dilinie&quot;,&quot;last_name&quot;:&quot;P. Fernando&quot;},{&quot;first_name&quot;:&quot;Wenhua&quot;,&quot;last_name&quot;:&quot;Jiao&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;W. Kung&quot;},{&quot;first_name&quot;:&quot;Suvi&quot;,&quot;last_name&quot;:&quot;T. M. Orr&quot;},{&quot;first_name&quot;:&quot;Yingmei&quot;,&quot;last_name&quot;:&quot;Qi&quot;},{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;N. Rocke&quot;},{&quot;first_name&quot;:&quot;Aaron&quot;,&quot;last_name&quot;:&quot;Smith&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;S. Warmus&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Bowles&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;W. Widlicka&quot;},{&quot;first_name&quot;:&quot;Heather&quot;,&quot;last_name&quot;:&quot;Eng&quot;},{&quot;first_name&quot;:&quot;Tim&quot;,&quot;last_name&quot;:&quot;Ryder&quot;},{&quot;first_name&quot;:&quot;Raman&quot;,&quot;last_name&quot;:&quot;Sharma&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;Wolford&quot;},{&quot;first_name&quot;:&quot;Carlin&quot;,&quot;last_name&quot;:&quot;Okerberg&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;Walters&quot;},{&quot;first_name&quot;:&quot;Tristan&quot;,&quot;last_name&quot;:&quot;S. Maurer&quot;},{&quot;first_name&quot;:&quot;Yanwei&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;D. Bonin&quot;},{&quot;first_name&quot;:&quot;Samantha&quot;,&quot;last_name&quot;:&quot;N. Spath&quot;},{&quot;first_name&quot;:&quot;Gang&quot;,&quot;last_name&quot;:&quot;Xing&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Hepworth&quot;},{&quot;first_name&quot;:&quot;Kay&quot;,&quot;last_name&quot;:&quot;Ahn&quot;},{&quot;first_name&quot;:&quot;Amit&quot;,&quot;last_name&quot;:&quot;S. Kalgutkar&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;8513-8528&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00963&quot;},&quot;abstract&quot;:&quot;Myeloperoxidase (MPO) is a heme peroxidase that catalyzes the production of hypochlorous acid. Clinical evidence suggests a causal role for MPO in various autoimmune and inflammatory disorders including vasculitis and cardiovascular and Parkinson’s diseases, implying that MPO inhibitors may represent a therapeutic treatment option. Herein, we present the design, synthesis, and preclinical evaluation of N1-substituted-6-arylthiouracils as potent and selective inhibitors of MPO. Inhibition proceeded in a time-dependent manner by a covalent, irreversible mechanism, which was dependent upon MPO catalysis, consistent with mechanism-based inactivation. N1-Substituted-6-arylthiouracils exhibited low partition ratios and high selectivity for MPO over thyroid peroxidase and cytochrome P450 isoforms. N1-Substituted-6-arylthiouracils also demonstrated inhibition of MPO activity in lipopolysaccharide-stimulated human whole blood. Robust inhibition of plasma MPO activity was demonstrated with the lead compound 2-(6-(5-chl&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00963&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00963" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00963&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00963" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00963&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00963" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00963&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00963&amp;href=/doi/10.1021/acs.jmedchem.5b00963" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00963" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00963" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00963%26sid%3Dliteratum%253Aachs%26pmid%3D26509551%26genre%3Darticle%26aulast%3DRuggeri%26date%3D2015%26atitle%3DDiscovery%2Bof%2B2-%25286-%25285-Chloro-2-methoxyphenyl%2529-4-oxo-2-thioxo-3%252C4-dihydropyrimidin-1%25282H%2529-yl%2529acetamide%2B%2528PF-06282999%2529%253A%2BA%2BHighly%2BSelective%2BMechanism-Based%2BMyeloperoxidase%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BCardiovascular%2BDiseases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D21%26spage%3D8513%26epage%3D8528%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/jmcmar.2015.58.issue-21/20151112/jmcmar.2015.58.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00963&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Myeloperoxidase (MPO) is a heme peroxidase that catalyzes the production of hypochlorous acid. Clinical evidence suggests a causal role for MPO in various autoimmune and inflammatory disorders including vasculitis and cardiovascular and Parkinson’s diseases, implying that MPO inhibitors may represent a therapeutic treatment option. Herein, we present the design, synthesis, and preclinical evaluation of <i>N</i>1-substituted-6-arylthiouracils as potent and selective inhibitors of MPO. Inhibition proceeded in a time-dependent manner by a covalent, irreversible mechanism, which was dependent upon MPO catalysis, consistent with mechanism-based inactivation. <i>N</i>1-Substituted-6-arylthiouracils exhibited low partition ratios and high selectivity for MPO over thyroid peroxidase and cytochrome P450 isoforms. <i>N</i>1-Substituted-6-arylthiouracils also demonstrated inhibition of MPO activity in lipopolysaccharide-stimulated human whole blood. Robust inhibition of plasma MPO activity was demonstrated with the lead compound 2-(6-(5-chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)acetamide (PF-06282999, <b>8</b>) upon oral administration to lipopolysaccharide-treated cynomolgus monkeys. On the basis of its pharmacological and pharmacokinetic profile, PF-06282999 has been advanced to first-in-human pharmacokinetic and safety studies.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16566" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16566" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Myeloperoxidase (MPO, EC 1.11.2.2) is a member of the heme peroxidase family of enzymes and catalyzes the production of hypochlorous acid (HOCl) from hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) and chloride ion (Cl<sup>–</sup>). MPO is produced in the bone marrow and stored in the azurophilic granules of neutrophils, where it constitutes up to 5% of the cellular protein; it is also found, albeit to a lesser extent, in some human monocytes and macrophages.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Upon phagocyte activation, MPO activity appears within the phagolysosome and extracellularly. The main function of MPO is considered to be microbicidal; however, MPO deficiency occurs in ∼1/2000 individuals<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and is not usually associated with increased risk of infections.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Compelling human data implicate MPO in the pathogenesis of a number of acute and chronic inflammatory diseases such as chronic obstructive pulmonary disease (COPD),<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> rheumatoid arthritis,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> acute kidney injury,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and Parkinson’s<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and cardiovascular diseases.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The role of MPO in cardiovascular diseases has been particularly well studied in humans; high levels of MPO are found in atherosclerotic plaques, and elevated plasma MPO levels are associated with risk of major adverse cardiovascular events in otherwise apparently healthy individuals. In addition, elevated MPO levels are also associated with risk of secondary adverse events in stable coronary artery disease subjects, as well as those with recent acute coronary syndrome.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Mechanisms by which MPO may contribute to the pathogenesis of diseases include (1) MPO-specific oxidation of lipids and proteins including those in low-density and high-density lipoproteins, contributing to oxidative tissue damage and atherosclerosis;<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> (2) consumption of nitric oxide, thereby impairing nitric oxide-dependent vasodilation, leading to endothelial/vasomotor dysfunction in humans;<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> and (3) microvascular occlusion resulting from the MPO-dependent formation of neutrophil extracellular traps in response to certain stimuli (e.g., phorbol myristate acetate).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Studies in MPO deficient mice have demonstrated protection from cardiac remodeling and impaired left ventricular function following surgically induced myocardial infarction.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> More recently, Churg et al.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> have also demonstrated that the MPO inhibitor 3-[[(2<i>S</i>)-tetrahydrofuran-2-yl]methyl]-2-thioxo-7<i>H</i>-purin-6-one (AZD-5904,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> AZ1, or TX4, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) is able to halt the progression of emphysema and small airway remodeling in a guinea pig model of COPD. In addition, a further MPO inhibitor (AZD-3241) is reported to be currently undergoing clinical trials for the treatment of multiple system atrophy.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of previously reported MPO irreversible inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00963&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">MPO is a complex hemoprotein with multiple intermediate states (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). The peroxidation reaction (reaction 1 in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) involves the native ferric enzyme, which undergoes a two-electron oxidation reaction with H<sub>2</sub>O<sub>2</sub> producing the highly reactive form of the enzyme, compound <b>I</b>. In the chlorination (or halogenation) cycle, compound <b>I</b> reacts with chloride (or other halides) through a two-electron reduction reaction to be reduced back to the native enzyme, generating HOCl (or HOX, reaction 2 in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Alternatively, in the peroxidation cycle, compound <b>I</b> may oxidize various electron-rich organic substrates including phenols,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> anilines,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and thiols<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (AH) via a one-electron transfer reaction generating the compound <b>II</b> form of the enzyme (reaction 3 in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Transfer of an additional electron to compound <b>II</b> from another molecule of the organic substrate, or an alternative source, regenerates native MPO (reaction 4 in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Enzymatic cycle for myeloperoxidase. Oxidation of native MPO by hydrogen peroxide (reaction 1) gives rise to compound <b>I</b>, the most oxidatively reactive state for MPO. In the halogenation cycle (reaction 2) a substrate, typically chloride, undergoes oxidation to afford a reactive species (e.g., hypochlorous acid) that can contribute to tissue damage under inflammatory conditions. In the peroxidation cycle, compound <b>I</b> reacts with an electron-rich organic substrate (reaction 3) to provide a radical species and compound <b>II</b>. For certain substrates such as those described in this article, the resulting radical species may then react with MPO to form a covalent adduct, rendering it irreversibly inhibited. Compound <b>II</b> may also react with another readily oxidized species (reaction 4) to return to the native state of the enzyme and complete the peroxidation cycle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00963&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While MPO inhibitors hold much promise as therapeutic agents, their development has been challenging. Many known MPO inhibitors<a onclick="showRef(event, 'ref20 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref23">(20, 23)</a> such as hydroxamic acid, indole, hydrazine, aniline, and tryptamine derivatives inhibit the chlorinating activity of MPO in vitro by acting as peroxidase substrates and diverting the enzyme from the chlorinating cycle to the peroxidation cycle. Such compounds promote the formation of compound <b>II</b> by being readily oxidized by compound <b>I</b> (i.e., reaction 3 in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), one of the strongest oxidizing enzyme intermediates found in vivo, but they do not then react with compound <b>II</b>. Accumulated compound <b>II</b> can be easily reduced back to the native enzyme form by many other electron donors such as urate, ascorbate, tyrosine, or superoxide anion readily found in vivo (i.e., reaction 4 in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref24 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27 ref28">(24-28)</a> Thus, in vivo the mode of inhibition by these inhibitors is reversible and likely to be ineffective against HOCl-mediated tissue damage.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> More recently, 2-thioxanthines represented by AZD-5904 (also reported as AZ1 or TX4) and compound <b>A</b> were reported to be mechanism-based inactivators of MPO (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref4 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref4 ref30 ref31 ref32">(4, 30-32)</a> AZD-5904 and <b>A</b> are suicide substrates of MPO, acting as substrates in reaction 3 in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> via the one-electron reduction of compound <b>I</b> to compound <b>II</b> followed by covalent modification of the heme moiety by a thiyl radical species generated from AZD-5904 and <b>A</b> in the course of catalysis.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30-32)</a> The resulting covalent modification of the MPO heme “traps” MPO in an unreactive state, which cannot readily be converted back to the native form, in contrast to the reversible single electron transfer mechanism of inhibition.</div><div class="NLM_p last">In the present manuscript, we describe the design, synthesis, and preclinical characterization of <i>N</i>1-substituted-6-aryl-2-thiouracil analogs as novel mechanism-based inhibitors of MPO with high selectivity over thyroid peroxidase (TPO) and over heme-containing cytochrome P450 (CYP) isoforms. The lead compound 2-(6-(5-chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)acetamide (PF-06282999, <b>8</b>) displayed excellent oral pharmacokinetics in preclinical species and robust irreversible inhibition of plasma MPO activity both in human blood stimulated exogenously and in plasma collected after oral (po) administration to lipopolysaccharide (LPS)-treated cynomolgus monkeys. PF-06282999 has been advanced into first-in-human pharmacokinetics and safety studies.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85203" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85203" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Selection of in Vitro Assays To Guide Structure–Activity Relationship (SAR) Studies</h3><div class="NLM_p">Propylthiouracil (PTU, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) is an inhibitor of TPO used clinically for the treatment of hyperthyroidism.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Reports on the MPO substrate and inhibitory properties of PTU have been published;<a onclick="showRef(event, 'ref34 ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36 ref37">(34-37)</a> however, a detailed kinetic investigation providing evidence for mechanism-based inactivation of MPO has not been reported. To assess the feasibility of PTU as a potential chemical lead for the de novo design of selective MPO inhibitors, we examined the mechanism of MPO inhibition by PTU in greater detail by measuring MPO peroxidase activity with Amplex Red (10-acetyl-3,7-dihydroxyphenoxazine) as a substrate.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p">As shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A, the MPO reaction with H<sub>2</sub>O<sub>2</sub> and Amplex Red was linear over ∼500 s in the absence of PTU. However, in the presence of PTU, the progressive curves exhibited curvature and time-dependent inhibition, as typically observed with an irreversible mechanism of inhibition. The data were fit to <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>, and the rate of MPO inactivation at each inhibitor concentration (<i>k</i><sub>obs</sub>) was determined as described in the <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>. Plotting these <i>k</i><sub>obs</sub> values as a function of PTU concentration revealed a linear line that passed through near the origin, which was consistent with a two-step inactivation kinetics process when the concentration of inhibitor is far below <i>K</i><sub>I</sub> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). On the basis of this model (<a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a>), the slope of the line (which is equal to <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub>, the second-order rate constant and the overall inactivation potency) was determined to be 360 M<sup>–1</sup> s<sup>–1</sup> for PTU. An IC<sub>50</sub> value of 2.81 μM for MPO inhibition was also obtained by using initial rates from the first 300 s of the reaction at each inhibitor concentration (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C). To verify that the inhibition of MPO by PTU was irreversible and required H<sub>2</sub>O<sub>2</sub>, we performed rapid dilution experiments in the presence and absence of H<sub>2</sub>O<sub>2</sub>. After preincubation of MPO with PTU for 15 min, the reaction mixture was rapidly diluted 300-fold into the assay buffer containing both H<sub>2</sub>O<sub>2</sub> and Amplex Red substrates, and the resulting recovery of MPO activity was immediately monitored. As shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, no recovery of MPO activity was observed with PTU when H<sub>2</sub>O<sub>2</sub> was included in the preincubation mixture, confirming that PTU is an irreversible inhibitor. However, when the rapid dilution experiment was performed in the absence of H<sub>2</sub>O<sub>2</sub> substrate during preincubation, MPO activity was recovered to a similar level as that of the DMSO control, indicating MPO catalysis by the substrate H<sub>2</sub>O<sub>2</sub> was required for inhibition by PTU. Taken together, these data indicated that PTU is a mechanism-based inhibitor of MPO. TPO inhibition by PTU was evaluated using methods analogous to those above for MPO and the <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> ratio and IC<sub>50</sub> values were determined to be 442 M<sup>–1</sup> s<sup>–1</sup> and 3.38 μM, respectively, thus demonstrating that PTU is not selective as it inhibits both TPO and MPO with comparable potency.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of MPO by propylthiouracil. The MPO reactions were performed as described in <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>. Data are averages, and error bars represent the SD from two separate experiments. (A) Progress curves for MPO inhibition by PTU varied at 0.47–30 μM. The <i>k</i><sub>obs</sub> values were obtained by fitting the time course as described in <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>. (B) The <i>k</i><sub>obs</sub> values were fit to <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a> to determine the overall potency <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> ratio. (C) The initial rates from the first linear ∼300 s of each reaction progress curve in (A) were used to calculate percent inhibition. The data were fit to equation, <i>y</i> = 100/[1 + (<i>x</i>/IC<sub>50</sub>)<sup><i>z</i></sup>], where IC<sub>50</sub> is the inhibitor concentration at 50% inhibition and <i>z</i> is the Hill slope.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00963&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Reversibility of MPO inhibition by PTU. MPO was incubated with 24 μM PTU with (▲) or without (●) 2 μM H<sub>2</sub>O<sub>2</sub>, or DMSO for control with (■) or without (◆) 2 μM H<sub>2</sub>O<sub>2</sub>. After 15 min, an aliquot of the preincubation mixture was rapidly diluted 300-fold into the MPO reaction buffer containing 2 μM H<sub>2</sub>O<sub>2</sub> and 30 μM Amplex Red substrates and the MPO activity was immediately monitored.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00963&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although PTU was not selective for inhibition between TPO and MPO, its mechanism-based inhibition profile was deemed suitable for a chemical starting point to identify selective inhibitors, and the assays used in its characterization were adapted for use as primary in vitro screens for inactivation of MPO and for selectivity versus TPO. SAR studies were carried out using the second-order rate constant <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> ratio as the measure of potency. Unlike IC<sub>50</sub> values, <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> ratios are independent of incubation times and substrate concentrations and are generally considered the best measure of potency for irreversible inhibitors.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_p">Partition ratio is a quantitative assessment of the efficiency with which mechanism-based inhibitors inactivate their targets. The reactive intermediate that is formed by reaction of an enzyme with a potential mechanism-based inhibitor may either (a) directly form a covalent adduct in the enzyme active site (resulting in inactivation) or (b) escape from the active site (leaving enzyme activity intact). PTU was found to have a high partition ratio of 75 for inhibition of MPO, meaning that the activated inhibitory species proceeded to form a covalently inactivated MPO–PTU adduct only one time for every 76 turnover events of the MPO reaction with PTU. To determine the partition ratio, the percentage of control activity after rapid dilution was plotted as a function of the ratio of PTU versus MPO ([PTU]/[MPO]). As shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, the remaining fractional activity decreased as a linear function of [PTU]/[MPO] until there was no activity remaining. The point at which this straight line intersected the <i>x</i>-axis was determined to be 76, which is equal to the partition ratio plus 1. For SAR purposes, the assay to determine partition ratios provided a measure of progress in the design of more efficient inhibitors (lower partition ratio). Higher efficiency inactivation was expected to be advantageous for in vivo efficacy and for safety (by minimizing the frequency of reactive intermediates escaping the MPO active site).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Determination of the partition ratio for mechanism-based inactivation of MPO by PTU. MPO was incubated with 2 μM H<sub>2</sub>O<sub>2</sub> and PTU at concentrations varying by 1.5-fold between 0.026 and 12 μM (or DMSO for control). After 15 min, an aliquot of the preincubation mixture was rapidly diluted 300-fold into the assay buffer containing 2 μM H<sub>2</sub>O<sub>2</sub> and 30 μM Amplex Red substrates and the MPO activity was immediately monitored. The initial rate of each progress curve was determined, and the fractional MPO activity of each inhibited reaction was plotted as a function of the ratio of PTU to MPO ([PTU]/[MPO]). Data are averages, and error bars represent the SD from two separate experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00963&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Concurrent with evaluation of compound potency utilizing biochemical assays, inhibition of MPO in a cell-based assay employing human whole blood stimulated with bacterial lipopolysaccharide was also assessed.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The human whole blood assay provided a time-averaged inhibition of enzyme activity in the presence of potentially confounding factors (e.g., blood-borne electron donors, plasma protein binding, compartmental partitioning). While it remains to be established, it was assumed that the IC<sub>50</sub> values obtained in human whole blood would correlate with the relative efficacious plasma concentrations in humans. Also uncertain at the outset was how well the human MPO biochemical assay (<i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> ratio) would predict improvements in partition ratio or the human whole blood assay.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p last"><i>N</i>1-Substituted-2-thiouracils have been previously synthesized via the condensation of appropriate mono-<i>N</i>-substituted-thiourea and β-ketoester derivatives to afford the corresponding <i>N</i>1<i>-</i> and <i>N</i>3-substituted-thiouracils as a mixture of regioisomers.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> In the present work, the synthesis of the targeted <i>N</i>1-substituted-6-aryl-2-thiouracils was achieved by employing a regioselective two-step route (<a class="ref internalNav" href="#sch2" aria-label="Scheme 1">Scheme 1</a>) involving the condensation of the appropriate β-ketoester intermediates (<b>9</b>–<b>12</b>) with the requisite primary amines (<b>13</b>–<b>17</b>) to yield the corresponding β-aminoacrylates (<b>18</b>–<b>24</b>). The β-ketoesters <b>11</b> and <b>12</b> were obtained via the reaction of ethyl hydrogen malonate (<b>29</b>) and the appropriate benzoic acid derivatives (intermediates <b>30</b> and <b>31</b>) in the presence of magnesium ethoxide and 1,1′-carbonyldiimidazole. The corresponding <i>N</i>1-substituted-thioruracil analogs (<b>2</b>, <b>3</b>, <b>5</b>, <b>7</b>, <b>8</b>, <b>25</b>, and <b>26</b>) were thus obtained in a regiospecific manner by treatment of the β-aminoacrylates with isothiocyanatotrimethylsilane.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Amine-containing side chain analogs were obtained by postcyclization modifications. Hydrochloric acid-catalyzed cleavage of the <i>tert</i>-butyloxycarbonyl protecting group in thiouracil <b>25</b> yielded <b>4</b> as the hydrochloride salt. Alternatively, hydrolysis of the thiouracil ester <b>26</b> yielded the carboxylic acid <b>27</b>, which was then transformed to <b>28</b> by amide coupling with <i>tert</i>-butyloxycarbonylethylenediamine. Acid-catalyzed cleavage of the <i>tert</i>-butyloxycarbonyl protecting group in <b>28</b> generated amine <b>6</b> as the corresponding hydrochloride salt.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> SAR Studies</h3><div class="NLM_p">Having established assays for the characterization of PTU inhibition of MPO and TPO, we utilized this compound as our starting point to seek thiouracil-based inhibitors with increased selectivity for MPO and decreased partition ratio. Initial SAR studies focused on replacement of the C6-propyl group and on introduction of an N1-substituent. Concurrently, considerations of the thiourea substructure contained within the thiouracil (see below) also led to a focus on a narrowly constrained target physicochemical properties space (roughly log <i>D</i> < 1.5 to minimize CYP oxidative metabolism and nonproductive reactive metabolite formation while keeping PSA < 100 to maintain favorable membrane permeability and oral absorption) and the incorporation of specific polar functional groups in the N1-substituent.</div><div class="NLM_p">In the course of our present SAR studies (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), it was observed that replacement of the propyl group in PTU with an electron-rich aromatic functionality, such as the 2-methoxyphenyl group in <b>1</b>, improved <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> ratio by 6-fold for MPO inhibition, although with only a modest improvement in inhibitory selectivity for MPO relative to TPO. However, far greater improvements in selectivity were obtained (>3000-fold) by substitution of the <i>N</i>1-position on the thiouracil ring, as shown in <b>2</b>, which nearly abolished TPO inhibitory activity (<i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> < 3 M<sup>–1</sup> s<sup>–1</sup>, IC<sub>50</sub> > 100 μM) while significantly increasing MPO <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> ratio by 21-fold from PTU.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Representative Set of in Vitro Pharmacology Data for <i>N</i>1-Substituted-6-arylthiouracil Analogs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0011.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">log <i>D</i> was measured at pH 7.4 using the previously described shake-flask method.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last"><i>k</i><sub>inact</sub> and <i>K</i><sub>I</sub> values were determined as described in <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>. Values are the geometric mean [90% CI] of at least two independent experiments. The overall potency (<i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub>) was calculated using these mean values. When <i>k</i><sub>inact</sub> and <i>K</i><sub>I</sub> values could not be determined separately (i.e., <i>K</i><sub>I</sub> ≫ [I]), the <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> ratios were obtained from the slopes, similar to <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B, and values listed are the geometric mean values (±90% CI) of at least two independent experiments. The <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> ratios given for TPO inhibition are geometric mean values [90% CI] that when measurable were obtained by using initial rates from the first 300 s of the reaction at each inhibitor concentration.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Partition ratios were generated from two to four separate experiments.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">IC<sub>50</sub> values shown are geometric mean values [90% CI] of individual determinations for inhibition of MPO activity in LPS-stimulated human whole blood.</p></div></div><div></div></div><div class="NLM_p">While these initial improvements in MPO inhibitory potency leading from PTU to <b>1</b> and <b>2</b> were observed employing the biochemical assay, similar improvements were not seen in the human whole blood assay (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Ongoing optimization of the N1- and C6-substituents showed that both made significant contributions to potency, and the combination ultimately led to compounds with improved whole blood potency. The preferred C6-ring system was found to be disubstituted phenyl, with the second substituent (methoxy or chloro) at the para (e.g., <b>2</b>-<b>6</b>) or meta (e.g., <b>7</b> and <b>8</b>) positions, providing a significant increase in potency; we concluded that MPO inhibitory potency was more dependent on the electron-density and substitution pattern on the C6-phenyl ring than on its overall hydrophobicity. Significant reductions in whole blood IC<sub>50</sub> were not afforded until <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> values were increased to >10 000 M<sup>–1</sup> s<sup>–1</sup>, although improvements in <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> values did not then strictly correlate with lower IC<sub>50</sub> values in the human whole blood assay (e.g., alcohol <b>3</b> vs amine <b>4</b>). Factors diminishing the direct correlation of potencies between the biochemical and whole blood assays may include differences in the unbound plasma concentrations (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), distribution between compartments within whole blood, and/or varying contributions of the nonproductive single electron transfer (compound <b>II</b>) pathway in the biochemical assay. As such, potency improvement in the whole blood assay below 0.5 μM proved to be highly challenging, especially while operating within a constrained physiochemical property space (see below for additional discussion). This may be due to modest affinity of the inhibitor for the active site (as reflected by the >100 nM <i>K</i><sub>I</sub> values from the Amplex Red assay), competition with high concentration of native endogenous substrates (e.g., chloride and H<sub>2</sub>O<sub>2</sub>), dynamics of MPO activation in the assay, and/or efficiency of capture by the activated inhibitor species (partition ratio).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Representative in Vitro ADME Data for <i>N</i>1-Substituted-6-arylthiouracil Analogs</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">PSA (Å<sup>2</sup>)</th><th class="colsep0 rowsep0" align="center">permeability RRCK <i>P</i><sub>app</sub> (10<sup>–6</sup> cm/s)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">human PPB <i>f</i><sub>u</sub> <a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">HLM CL<sub>int,app</sub> (μL min<sup>–1</sup> mg<sup>–1</sup>)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">HHEP CL<sub>int,app</sub> (μL min<sup>–1</sup> per 10<sup>6</sup> cells) <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">65</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">76</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left"><8.0</td><td class="colsep0 rowsep0" align="left"><6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">82</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">8.8</td><td class="colsep0 rowsep0" align="left">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">99</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left"><8.0</td><td class="colsep0 rowsep0" align="left"><6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">111</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left"><8.0</td><td class="colsep0 rowsep0" align="left"><6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">99</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left"><8.0</td><td class="colsep0 rowsep0" align="left"><6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">90</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left"><8.0</td><td class="colsep0 rowsep0" align="left"><6.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Passive permeability was determined in Ralph–Russ canine kidney cells, which are a low transporter cell line, isolated from Madine–Darby canine kidney cells.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Fraction unbound (<i>f</i><sub>u</sub>) in human plasma was determined from equilibrium dialysis method and is a mean value from three individual determinations.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">CL<sub>int,app</sub> refers to total apparent intrinsic clearance obtained from scaling in vitro half-lives in HLM and HHEP as previously described.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">ND = not determined.</p></div></div></div><div class="NLM_p">Concurrent with the development of SAR around substituents on the thiouracil ring, we initiated planning and experiments to better understand the risks associated with the thiouracil functionality. The thiouracil motif is considered a “structural alert” (analogous to the thiourea functionality) because of its propensity toward bioactivation to reactive species.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> For example, cases of immune-mediated hepatotoxicity and agranulocytosis have been reported in patients receiving chronic PTU treatment.<a onclick="showRef(event, 'ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45">(43-45)</a> There is causal evidence linking the immune-mediated toxicity to the oxidative bioactivation of PTU by MPO.<a onclick="showRef(event, 'ref34 ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36 ref37">(34-37)</a> In activated human polymorphonuclear leukocytes and/or human MPO/H<sub>2</sub>O<sub>2</sub>/Cl<sup>–</sup>, PTU undergoes oxidative metabolism on its thiocarbonyl motif (<a class="ref internalNav" href="#sch1" aria-label="Scheme 2">Scheme 2</a>) to yield PTU-disulfide, PTU-SO<sub>2</sub><sup>–</sup>, and the protein- and thiol-reactive PTU-SO<sub>3</sub><sup>–</sup> as metabolites. It has been proposed that modification of neutrophil proteins, including MPO, may induce the formation of the antineutrophil antibodies that have been detected in patients with PTU-induced agranulocytosis<a onclick="showRef(event, 'ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48">(46-48)</a> and lupus-like syndrome.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> In our present studies, liquid chromatography–tandem mass spectrometry (LC–MS/MS) analysis of an incubation of arylthiouracil <b>2</b> (exact mass (MH<sup>+</sup>) of 351.1367) with human MPO/H<sub>2</sub>O<sub>2</sub>/Cl<sup>–</sup> in the presence of excess glutathione (GSH) (1 mM) indicated the formation of a GSH conjugate (MH<sup>+</sup> = 624.2334), which can be obtained via oxidation of the thiocarbonyl group in <b>2</b> to the putative sulfonate species followed by nucleophilic displacement in the presence of exogenously added GSH (<a class="ref internalNav" href="#sch1" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>N</i>1-Substituted-6-arylthiouracil Derivatives Described in This Study<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00963&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Mg ethoxide, CDI; (b) AcOH, 80 °C; (c) TMSNCS; (d) HCl; (e) NaOH; (f) NH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHBoc, T3P.</p></p></figure><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Oxidative Bioactivation of the Thiouracil Motif in PTU and Compound <b>2</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00963&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With awareness of the high partition ratio of PTU, we speculated that systemic exposure to reactive species derived from oxidative bioactivation of the thiocarbonyl motif (e.g., the corresponding sulfonate) could be minimized if a pendent nucleophilic group were tethered to the N1-substituent such that potential thiocarbonyl reactive species in solution could be rapidly quenched in an intramolecular fashion. At the outset it was not obvious whether such a tactic would compromise the ability of the compound(s) to inhibit MPO in the desired irreversible and selective manner. However, optimization of the N1-substituent demonstrated that small polar groups such as a hydroxyl (<b>3</b>), amino (<b>4</b>), or amidoyl (<b>5</b>) not only were tolerated for MPO inhibition but also enhanced the effectiveness of the arylthiouracil to act as an irreversible inhibitor, as evidenced by their increased <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> and their lower IC<sub>50</sub> in the human whole blood assay (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Higher potencies in the biochemical assay were observed with alcohols (e.g., <b>3</b>, <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> = 29 800), while greater inhibitory potencies in the human whole blood assay were obtained with the amines (e.g., <b>4</b> and <b>6</b>, human whole blood IC<sub>50</sub> of 0.50 and 0.60 μM, respectively). Although not as robust an MPO potency improvement when compared with the alcohol and amine variants, the primary carboxamide functionality (e.g., <b>5</b>) also provided another viable alternative for modulating physical properties in the balance of efficacy and safety. Gratifyingly, compounds <b>3</b>–<b>5</b> also displayed a greatly improved MPO inactivation efficiency (partition ratio) with <b>4</b> possessing the highest inactivation efficiency (lowest partition ratio) of 4.7 (versus 75 for PTU), which suggested that MPO inactivation efficiency may be a key determinant of inhibitory activity in the human whole blood assay.</div><div class="NLM_p">Oxidative desulfurization of thioureas to ureas by H<sub>2</sub>O<sub>2</sub> is a well-studied reaction.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a> Therefore, an initial assessment of the viability of the intramolecular trapping of reactive species with the pendent nucleophile was conducted via reacting alcohol <b>3</b> (10 μM) with H<sub>2</sub>O<sub>2</sub> (500 μM) in phosphate buffer (pH 7.4) for 60 min at 37 °C. While no sulfonic acid metabolite could be observed, its presence as an intermediate in the incubation was inferred from the quantitative conversion of <b>3</b> (<i>t</i><sub>R</sub> = 17.49 min, MH<sup>+</sup> = 309.0903) to the stable cyclic ether M1 (<i>t</i><sub>R</sub> = 14.99 min, MH<sup>+</sup> = 275.1026) as a metabolite (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>) upon analysis by LC–MS/MS. The formation of M1 was also noted in incubations of <b>3</b> (10 μM) in the MPO/H<sub>2</sub>O<sub>2</sub>/Cl<sup>–</sup> system in a H<sub>2</sub>O<sub>2</sub>-dependent fashion, although the reaction was not quantitative likely due to rapid inhibition of MPO activity. Importantly, no sulfhydryl conjugates of <b>3</b> were detected upon addition of excess GSH (1 mM) to the H<sub>2</sub>O<sub>2</sub> or MPO/H<sub>2</sub>O<sub>2</sub>/Cl<sup>–</sup> incubations. A similar analysis with thiouracils <b>4</b>, <b>6</b>, <b>7</b>, and <b>8</b> in the MPO/H<sub>2</sub>O<sub>2</sub>/Cl<sup>–</sup> system in the presence of excess GSH also failed to generate GSH adducts. Overall, these observations support the hypothesis that although an undesired reactive metabolite may be formed in the course of MPO catalysis, the intramolecular trapping mechanism provides the potential for decreasing exposure to the reactive metabolite(s) in vivo.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. LC–MS/MS analysis of the oxidative metabolism of alcohol <b>4</b> to cyclic ether <b>M1</b> in the presence of H<sub>2</sub>O<sub>2</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00963&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Besides peroxidases, heme-containing CYPs or other oxidative enzymes such as flavin monooxygenases in human hepatic tissues (e.g., human liver microsomes (HLM) and cryopreserved hepatocytes (HHEP)) are also capable of oxidizing the thiourea/thiouracil functionalities to reactive species capable of eliciting a toxicological response.<a onclick="showRef(event, 'ref42 ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref42 ref52 ref53 ref54">(42, 52-54)</a> In the present situation, minimization of oxidative metabolism/bioactivation of the thiouracil derivatives was largely driven through a reduction in lipophilicity as determined by log <i>D</i><sub>7.4</sub>.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55, 56)</a> Aiding in this endeavor was an only modest dependency between log <i>D</i> and MPO inhibitory potency as noted earlier. Virtually all compounds prepared with log <i>D</i> < 1.5 were resistant to metabolic turnover in prototypic stability studies in NADPH-supplemented HLM and HHEP, as reflected from their very low apparent intrinsic clearance (CL<sub>int,app</sub>) values (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). However, while potency and metabolic clearance tended to favor molecules at the lower ranges of hydrophobicity, the less-lipophilic analogs obtained with increasingly polar functionalities (e.g., <i>N</i>-ethylaminoamide <b>6</b>, PSA = 111) showed impairment in passive membrane permeability (<i>P</i><sub>app</sub>) as measured in the Ralph–Russ canine kidney (RRCK) assay<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> (<a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Fortunately, the range of physicochemical properties discovered to be tolerated within this series of thiouracils provided sufficient latitude to allow overall balance to be achieved with regard to absorption, distribution, metabolism, and excretion (ADME) properties discussed below.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Pharmacokinetics and in Vitro ADME Profiling</h3><div class="NLM_p">A subset of <i>N</i>1-substituted-6-arylthiouracils that met the MPO inhibitory potency and selectivity criteria were advanced to intravenous (iv) and po pharmacokinetic studies in preclinical species. The pharmacokinetic parameters describing the disposition are summarized in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>. Following iv administration to rats, compounds <b>5</b>–<b>7</b> demonstrated moderate plasma clearance (CL<sub>p</sub>) ranging from 35.1 to 38.6 mL min<sup>–1</sup> kg<sup>–1</sup>, while compounds <b>3</b> and <b>4</b> exhibited high CL<sub>p</sub> (59–70 mL min<sup>–1</sup> kg<sup>–1</sup>), which approached the rat hepatic blood flow of 70–80 mL min<sup>–1</sup> kg<sup>–1</sup>. In contrast, compounds <b>3</b>–<b>7</b> exhibited relatively low CL<sub>p</sub> (1.31–13.4 mL min<sup>–1</sup> kg<sup>–1</sup>) in dogs. Furthermore, with the exception of primary alcohol <b>3</b> and basic amine <b>6</b>, good oral bioavailability (<i>F</i>) was discerned with <b>4</b>, <b>5</b>, and <b>7</b> in rats and dogs (oral <i>F</i> of <b>3</b> and <b>6</b> was 8.0–16% in rats and dogs; oral <i>F</i> of <b>4</b>, <b>5</b>, and <b>7</b> was 31–100% in rats and dogs).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Preclinical Pharmacokinetics<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> of Selected <i>N</i>1-Substituted-6-arylthiouracil Derivatives</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">CL<sub>p</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>dss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> (h)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">oral <i>F</i> (%)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">59.3 ± 2.65</td><td class="colsep0 rowsep0" align="left">0.82 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.25 ± 0.01</td><td class="colsep0 rowsep0" align="left">1.3 ± 0.6</td><td class="colsep0 rowsep0" align="left">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">11.9 ± 2.87</td><td class="colsep0 rowsep0" align="left">1.33 ± 0.26</td><td class="colsep0 rowsep0" align="left">5.3 ± 0.7</td><td class="colsep0 rowsep0" align="left">1.17 ± 0.76</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">70.3 (79, 69.5)</td><td class="colsep0 rowsep0" align="left">3.71 (4.34, 3.08)</td><td class="colsep0 rowsep0" align="left">1.1 (0.9, 1.2)</td><td class="colsep0 rowsep0" align="left">0.38 (0.25, 0.50)</td><td class="colsep0 rowsep0" align="left">91</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">13.4 (12.3, 14.4)</td><td class="colsep0 rowsep0" align="left">3.66 (3.89, 3.43)</td><td class="colsep0 rowsep0" align="left">5.7 (5.8, 5.7)</td><td class="colsep0 rowsep0" align="left">1.3 (2.0, 0.5)</td><td class="colsep0 rowsep0" align="left">84</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">35.1 (35.8, 34.4)</td><td class="colsep0 rowsep0" align="left">1.23 (1.37, 1.09)</td><td class="colsep0 rowsep0" align="left">0.76 (1.02, 0.50)</td><td class="colsep0 rowsep0" align="left">0.5 (0.5, 0.5)</td><td class="colsep0 rowsep0" align="left">76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">1.31 (1.44, 1.17)</td><td class="colsep0 rowsep0" align="left">0.30 (0.29, 0.30)</td><td class="colsep0 rowsep0" align="left">3.4 (3.2, 3.6)</td><td class="colsep0 rowsep0" align="left">1.5 (2.0, 1.0)</td><td class="colsep0 rowsep0" align="left">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">38.6 ± 5.52</td><td class="colsep0 rowsep0" align="left">0.59 ± 0.17</td><td class="colsep0 rowsep0" align="left">0.81 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.75 (0.5, 1.0)</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">4.10 (3.81, 4.39)</td><td class="colsep0 rowsep0" align="left">0.86 (0.74, 0.97)</td><td class="colsep0 rowsep0" align="left">2.59 (2.50, 2.68)</td><td class="colsep0 rowsep0" align="left">1.0 (1.0, 1.0)</td><td class="colsep0 rowsep0" align="left">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">37.6 ± 1.36</td><td class="colsep0 rowsep0" align="left">0.83 ± 0.16</td><td class="colsep0 rowsep0" align="left">0.38 ± 0.19</td><td class="colsep0 rowsep0" align="left">0.67 ± 0.29</td><td class="colsep0 rowsep0" align="left">61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">7.07 (7.86, 6.27)</td><td class="colsep0 rowsep0" align="left">1.03 (0.92, 1.14)</td><td class="colsep0 rowsep0" align="left">2.80 (1.70, 3.90)</td><td class="colsep0 rowsep0" align="left">0.63 (1.0, 0.25)</td><td class="colsep0 rowsep0" align="left">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">41.8 ± 9.65</td><td class="colsep0 rowsep0" align="left">2.13 ± 1.08</td><td class="colsep0 rowsep0" align="left">0.75 ± 0.19</td><td class="colsep0 rowsep0" align="left">0.78 ± 1.10</td><td class="colsep0 rowsep0" align="left">86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">10.1 ± 0.83</td><td class="colsep0 rowsep0" align="left">0.90 ± 0.06</td><td class="colsep0 rowsep0" align="left">1.36 ± 0.12</td><td class="colsep0 rowsep0" align="left">1.0 ± 0.1</td><td class="colsep0 rowsep0" align="left">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">3.39 ± 1.13</td><td class="colsep0 rowsep0" align="left">0.54 ± 0.04</td><td class="colsep0 rowsep0" align="left">2.2 ± 0.5</td><td class="colsep0 rowsep0" align="left">0.7 ± 0.3</td><td class="colsep0 rowsep0" align="left">75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="left">10.3 (10.5,10.1)</td><td class="colsep0 rowsep0" align="left">1.09 (1.17, 1.01)</td><td class="colsep0 rowsep0" align="left">3.28 (3.31, 3.24)</td><td class="colsep0 rowsep0" align="left">1.5 (1.0, 2.0)</td><td class="colsep0 rowsep0" align="left">76</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">All experiments involving animals were conducted in our AAALAC-accredited facilities and were reviewed and approved by Pfizer Institutional Animal Care and Use Committee. Pharmacokinetic parameters were calculated from plasma concentration–time data and are reported as mean values (±SD for <i>n</i> = 3 and individual values for <i>n</i> = 2). All pharmacokinetics were conducted in male gender of each species (Wistar rats, CD-1 mice, beagle dogs, and/or cynomolgus monkey). Intravenous (iv) doses for the test compounds were 1 mg/kg, and compounds were administered in saline (compounds <b>4</b> and <b>6</b>) or 12% sulfobutyl ether β-cyclodextrin (compounds <b>3</b>, <b>4</b>, <b>5</b>, <b>7</b>, and <b>8</b>) solution. Oral (po) doses for the test compounds were either 3 or 5 mg/kg, and compounds were formulated in 0.5% methylcellulose.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Obtained from po dose.</p></div></div></div><div class="NLM_p">In the course of balancing MPO inhibitory potency, TPO selectivity, and in vivo pharmacokinetics, our focus was drawn to the series of acetylamides (compounds <b>6</b>, <b>7</b>, and <b>8</b>). At the lower end of the lipophilicity range, <i>N</i>-ethylaminoamide <b>6</b> demonstrated potent inhibition of MPO activity (IC<sub>50</sub> = 0.6 μM) in human whole blood. However, clinical viability of <b>6</b> was limited due to its low oral systemic bioavailability in preclinical species, which may be a consequence of its low membrane permeability due to its high polarity and PSA (log <i>D</i><sub>7.4</sub> = −1.4, PSA = 111). Each member of the pair of primary amides possessing a pendent 2,5-disubstituted phenyl group (compounds <b>7</b> and <b>8</b>) was considered for further investigations due to their improved MPO inhibitory potency relative to <b>5</b>, as well as the observed high oral bioavailability (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). While both compounds possessed desirable attributes, <b>8</b> was advanced into a preclinical pharmacology study in non-human primates due to advantages in thermodynamic solubility and predicted human bioavailability.</div><div class="NLM_p last">The in vivo pharmacokinetics of <b>8</b> were examined in greater detail in mice, rats, dogs, and monkeys, wherein it was demonstrated to have low CL<sub>p</sub> in mice (10.1 mL min<sup>–1</sup> kg<sup>–1</sup>), dogs (3.39 mL min<sup>–1</sup> kg<sup>–1</sup>), monkeys (10.3 mL min<sup>–1</sup> kg<sup>–1</sup>) and moderate CL<sub>p</sub> in rats (41.8 mL min<sup>–1</sup> kg<sup>–1</sup>). The terminal plasma elimination half-lives (<i>t</i><sub>1/2</sub>) ranged from 0.75 to 3.3 h in the four species. Approximately 26–32% of the iv dose of <b>8</b> was excreted in the unchanged form in rat, dog, and monkey urine, wherein it was also shown that it was well distributed with steady state distribution volumes (<i>V</i><sub>dss</sub>) ranging from 0.5–2.1 L/kg in mice, rats, dogs, and monkeys. Following oral administration, <b>8</b> was rapidly (<i>T</i><sub>max</sub> = 0.78–1.70 h) and well absorbed in mice, rats, dogs, and monkeys with oral bioavailability values of 100%, 86%, 75%, and 76%, respectively. The mean plasma free fraction (<i>f</i><sub>u</sub>) of <b>8</b> (2 μM), determined by equilibrium dialysis,<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> in mouse, rat, dog, monkey, and human was 0.451, 0.447, 0.460, 0.536, and 0.376, respectively. The ability of <b>8</b> to reversibly inhibit the major human CYP enzymes was investigated in human liver microsomes using established protocols.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Likewise, the potential of <b>8</b> to inhibit major human CYP enzymes in a time- and concentration-dependent manner was assessed using an IC<sub>50</sub> shift assay in human liver microsomes.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> In addition, <b>8</b> demonstrated no reversible inhibition and no change in time-dependent inhibitory potency (IC<sub>50</sub> > 100 μM) against CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 catalytic activities in human liver microsomes. Consistent with its low lipophilicity (log <i>D</i><sub>7.4</sub> = 0.81), <b>8</b> was resistant toward metabolic turnover in NADPH-supplemented HLM and cryopreserved HHEP and was devoid of GSH adduct formation in these biochemical matrices. On the basis of these observations and physicochemical properties (including low log <i>D</i> and low passive permeability), we speculate that metabolic elimination will be inconsequential as a clearance mechanism in humans and that <b>8</b> will be principally eliminated via renal excretion in the unchanged form.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> In addition, <b>8</b> was also devoid of mutagenic responses in the <i>Salmonella</i> Ames and in vitro micronucleus assays in the absence or presence of CYP activation (aroclor-induced rat liver S9 fraction/NADPH), and no significant off-target activity was discerned upon evaluation of <b>8</b> (at 100 μM) across a broad panel of receptors, ion channels, enzymes, and transporters.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> In Vivo Pharmacology</h3><div class="NLM_p">In order to ascertain whether the advances noted in the in vitro and ex vivo assays for candidate thiouracil derivatives translated to effective irreversible inhibition of MPO in vivo, <b>8</b> was also advanced to an in vivo pharmacology study in cynomolgus monkeys using iv endotoxin (LPS) challenge, a classic model of inflammatory leukocyte activation with corresponding MPO activation demonstrated in various species including human.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> In this randomized crossover study, cynomolgus monkeys were orally administered either vehicle or <b>8</b> (5, 20, and 80 mg/kg) 1 h after iv administration of LPS. Blood was sampled throughout the study and heparinized plasma prepared for MPO activity measurements as well as determination of <b>8</b> plasma concentrations. Total MPO was captured using anti-MPO antibody coated plates, and following exchange of plasma for drug-free assay media, the residual activity of the captured MPO was measured using the peroxidation of Amplex Red. A mixed effect sigmoid model was applied to study the relationship between plasma exposure of <b>8</b> and the MPO capture activity at 2 h after dose and 3 h after LPS administration, which corresponds to the peak of MPO activity. As shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>, the estimated EC<sub>50</sub> for total <b>8</b> concentration in plasma was 3.8 μM, which corresponds well with the IC<sub>50</sub> value obtained in the human whole blood assay of 1.9 μM.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Concentration–effect relationship for inhibition of MPO activity by <b>8</b> in a cynomolgous monkey LPS challenge study. Compound <b>8</b> was administered orally (5, 20, and 80 mg/kg) 1 h after iv administration of LPS. After 2 h (the peak in MPO activity) plasma samples were collected and concentrations of <b>8</b> as well as residual MPO activity determined. The plasma concentration of <b>8</b> that correlated with 50% of the maximum MPO inhibition achieved was 3.8 μM, approximately twice the IC<sub>50</sub> observed in the human whole blood assay (1.9 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00963&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Summary</h3><div class="NLM_p last">We have described the design, synthesis, and preclinical evaluation of <i>N</i>1-substituted-6-aryl-2-thiouracils as potent mechanism-based inactivators of MPO with great improvements in MPO inactivation efficiency (as evidenced by reduced partition ratio) over PTU. Furthermore, in contrast with PTU, the <i>N</i>1-substituted-6-aryl-2-thiouracil derivatives also demonstrated high selectivity over the related haloperoxidase TPO. Upon the basis of its potent and selective MPO inhibitory characteristics, lack of oxidative metabolism in HLM and HHEP, clean off-target profile including lack of measurable TPO activity, as well as favorable preclinical in vivo safety results, PF-06282999 (<b>8</b>) has been advanced to clinical trials for human pharmacokinetics, safety/tolerability, and MPO inhibition studies, which are currently underway and will be reported in due course.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22747" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22747" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> MPO Assay and Determination of Inhibitor Potency (<i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> Ratios)</h3><div class="NLM_p last">MPO was purified from human polynuclear leukocytes, and MPO peroxidase activity was measured by monitoring the formation of resorufin generated from the oxidation of Amplex Red by MPO as described previously.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Briefly, the assay mixture contained 50 mM sodium phosphate buffer, pH 7.4, 150 mM NaCl, 1 mM diethylenetriaminepentacetic acid, 2 μM H<sub>2</sub>O<sub>2</sub>, 30 μM Amplex Red, and the indicated concentrations of inhibitor (or DMSO). Reactions were initiated by the addition of 100 pM MPO, and the final concentration of DMSO was kept at 2%. The first ∼600 s of the reaction progress curves corresponding to the linear range of the DMSO control were fit to <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>.<span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/jm-2015-009634_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span>where <i>V</i><sub>0</sub> is the initial rate in RFU/s and <i>t</i> is time in seconds, to obtain the first order rate constant for enzyme inactivation (<i>k</i><sub>obs</sub>) at each inhibitor concentration. Each <i>k</i><sub>obs</sub> value was corrected for autoinactivation of the enzyme by subtracting the <i>k</i><sub>obs</sub> value for the uninhibited reaction. The corrected <i>k</i><sub>obs</sub> values were then plotted versus inhibitor concentration ([I]) and fit to <a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a>.<span class="NLM_disp-formula" id="eq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/jm-2015-009634_m002.gif" alt="" /></img><span class="labelSpan">(2)</span></span>where <i>k</i><sub>inact</sub> is the maximal rate of inactivation and <i>K</i><sub>I</sub> is the inhibitor concentration that yields half the rate of maximal inactivation. When [I] ≪ <i>K</i><sub>I</sub>, <a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a> is simplified to <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a>,<span class="NLM_disp-formula" id="eq3"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/jm-2015-009634_m003.gif" alt="" /></img><span class="labelSpan">(3)</span></span>where the <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> is calculated from the slope, which is obtained from the <i>k</i><sub>obs</sub> vs [I] linear lines.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> All assays were performed in 96-well, black, half-area, nonbinding surface, polystyrene plates (Corning, Tewksbury, MA). Fluorescent changes (relative fluorescent units/s, RFU/s) were monitored at room temperature every 20 s on a Spectramax M2 microplate spectrophotometer (Molecular Devices, Palo Alto, CA) equipped with Softmax Pro software (Molecular Devices, Palo Alto, CA) with excitation and emission filters set at 530 and 580 nm, respectively. All data were analyzed using nonlinear regression analysis in Microsoft Excel and Kaleidagraph (Synergy Software, Reading, PA).</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> TPO Assay</h3><div class="NLM_p last">TPO activity was measured by monitoring the formation of resorufin from the oxidation of Amplex Red using conditions similar to those in the described in the MPO assay.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Assay mixtures (100 μL) contained 50 mM sodium phosphate buffer, pH 7.4, 150 mM NaCl, 2 μM H<sub>2</sub>O<sub>2</sub>, 30 μM Amplex Red, 1 mM diethylenetriaminepentaacetic acid, and 2% DMSO. The reactions were initiated by the addition of TPO. Reaction mixtures to determine the background reaction rate consisted of all assay components and 4 μL of 500 unit/mL bovine catalase in 50 mM potassium phosphate buffer, pH 7.0. The background rate was subtracted from each reaction progress curve. All data were analyzed using nonlinear regression analysis in Microsoft Excel and Kaleidagraph (version 3.5, Synergy Software).</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Human Whole Blood Assay for Irreversible Inhibition of MPO</h3><div class="NLM_p last">MPO activity was determined using modifications to a described method,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> using human whole blood from healthy volunteers, collected in heparinized tubes. Test compound was incubated with human whole blood stimulated with bacterial LPS for 4 h, followed by capture of MPO on immobilized anti-MPO antibody coated plates. The captured MPO was washed and residual MPO activity was determined using Amplex Red and H<sub>2</sub>O<sub>2</sub> as described in our previous publication.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Compound Synthesis</h3><div class="NLM_p last">All chemicals, reagents, and solvents were purchased from commercial sources and were used without further purification. Except where otherwise noted, all reactions were run under an inert atmosphere of nitrogen gas using anhydrous solvents. Also, except where otherwise noted, all reactions were run at room temperature (∼23 °C). The term “concentrated” refers to the removal of solvent at reduced pressure on a rotary evaporator with a water bath temperature not exceeding 60 °C. Silica gel chromatography was performed using a medium pressure Biotage or ISCO system and columns prepackaged by various commercial vendors including Biotage and ISCO. PTU and 6-(2-methoxyphenyl)-2-thioxo-2,3-dihydropyrimidin-4(1<i>H</i>)-one (<b>1</b>) were purchased from commercial sources. Compound <b>7</b> (also known as PF-1355 or PF-06281355) is commercially available from Sigma-Aldrich (catalog no. PZ0277). NMR spectra were recorded on 400 or 500 MHz spectrometers and are reported relative to residual undeuterated solvent signals. Data for <sup>1</sup>H NMR spectra are reported as follows: chemical shift (δ), multiplicity, coupling constant (Hz), and integration. The peak shapes are denoted as follows: s, singlet; d, doublet; dd, doublet of doublets; t, triplet; q, quartet; spt, septet; m, multiplet; br s, broad singlet. Mass spectrometry (MS) was performed via atmospheric pressure chemical ionization (APCI) or electron scatter (ES) ionization sources. High-resolution mass spectrometry (HRMS) was performed via electrospray ionization (ESI) source. The system used was an Agilent 1200 DAD (G1315C), 190–400 nm scan, 4 nm slit, and Agilent 6220 MS (TOF). Where the intensity of single chlorine ions is described, the expected intensity ratio was observed (approximately 3:1 for <sup>35</sup>Cl/<sup>37</sup>Cl-containing ions) and the intensity of only the lower mass ion is given. Elemental analyses were performed by Intertek Pharmaceutical Services, Whitehouse, NJ. HPLC purity was determined using a Kinetex C18 column (100 mm × 3.0 mm, 2.6 μm), eluting with 95:5 water/acetonitrile (both solvents containing 0.1% formic acid), flow rate = 0.75 mL/min, detecting at 215 nm. HPLC purity is reported as >95% if no peaks other than the desired product were observed.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Ethyl (<i>Z</i>)-3-(2,4-Dimethoxyphenyl)-3-((2-isopropoxyethyl)amino)acrylate (<b>18</b>)</h3><div class="NLM_p last">A solution of ethyl 3-(2,4-dimethoxyphenyl)-3-oxopropanoate (<b>9</b>) (0.95 g, 4.0 mmol) and 2-isopropoxyethan-1-amine (<b>13</b>) (1.3 g, 12.0 mmol) in ethanol (4 mL) was treated with acetic acid (0.70 mL, 12.0 mmol) and then heated at reflux. After 64 h, the reaction mixture was allowed to cool to ambient temperature and concentrated under reduced pressure. The resulting residue was dissolved in dichloromethane (400 mL) and washed sequentially with an aqueous 1 M HCl solution (100 mL), a saturated aqueous sodium bicarbonate solution (100 mL), and brine (100 mL). The organic layer was dried over MgSO<sub>4</sub> and concentrated. The resulting crude product was purified by flash column chromatography on silica gel using a gradient of 5–10% ethyl acetate in heptane to afford the title compound <b>18</b> (0.75 g, 56%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.74 (t, <i>J</i> = 5.7 Hz, 1 H), 7.12 (d, <i>J</i> = 8.2 Hz, 1 H), 6.48 (dd, <i>J</i> = 8.2, 2.1 Hz, 1 H), 6.45 (d, <i>J</i> = 2.3 Hz, 1 H), 4.46 (s, 1 H), 4.13 (q, <i>J</i> = 7.0 Hz, 2 H), 3.82 (s, 3 H), 3.80 (s, 3 H), 3.55 (spt, <i>J</i> = 6.1 Hz, 1 H), 3.40 (t, <i>J</i> = 6.1 Hz, 2 H), 3.11 (m, 2 H), 1.26 (t, <i>J</i> = 7.1 Hz, 3 H), 1.14 (d, <i>J</i> = 6.3 Hz, 6 H). LCMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 338.2 [M + H]<sup>+</sup> (100%).</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 6-(2,4-Dimethoxyphenyl)-1-(2-isopropoxyethyl)-2-thioxo-2,3-dihydropyrimidin-4(1<i>H</i>)-one (<b>2</b>)</h3><div class="NLM_p last">A mixture of ethyl (<i>Z</i>)-3-(2,4-dimethoxyphenyl)-3-((2-isopropoxyethyl)amino)acrylate (<b>18</b>) (0.64 g, 1.9 mmol) and isothiocyanatotrimethylsilane (1.1 mL, 9.4 mmol) was heated at 110 °C by microwave irradiation for 1 h. After cooling to ambient temperature, the reaction mixture was directly purified by flash column chromatography on silica gel, eluting with a 5–10% gradient of ethyl acetate in heptane to afford <b>2</b> (0.54 g, 80%) as a pale yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.88 (br s, 1 H), 7.14 (d, <i>J</i> = 8.4 Hz, 1 H), 6.54 (dd, <i>J</i> = 8.4, 2.3 Hz, 1 H), 6.49 (d, <i>J</i> = 2.1 Hz, 1 H), 5.79 (s, 1 H), 4.63–4.71 (m, 1 H), 3.85 (s, 3 H), 3.81 (s, 3 H), 3.67–3.84 (m, 2 H), 3.48 (ddd, <i>J</i> = 9.8, 5.9, 3.1 Hz, 1 H), 3.45 (spt, <i>J</i> = 6.1 Hz, 1 H), 1.030 (d, <i>J</i> = 6.1 Hz, 3 H), 1.027 (d, <i>J</i> = 6.1 Hz, 3 H). LCMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 351.2 [M + H]<sup>+</sup> (100%). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 351.1379, found 351.1373. Anal. Calcd for C<sub>17</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub>S: C, 58.27; H, 6.33; N, 7.99; S, 9.15. Found: C, 57.81; H, 6.25; N, 7.81; S, 9.18. HPLC purity: >95%.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Methyl (<i>Z</i>)-3-(2,4-Dimethoxyphenyl)-3-((2-hydroxyethyl)amino)acrylate (<b>19</b>)</h3><div class="NLM_p last">A mixture of methyl 3-(2,4-dimethoxyphenyl)-3-oxopropanoate (<b>10</b>) (3.50 g, 14.69 mmol) and acetic acid (0.17 mL, 2.94 mmol) in isopropanol (70 mL) was combined with ethanolamine (0.88 mL, 14.69 mmol) and heated to 80 °C. After 2, 4, and 6 h, additional ethanolamine (0.88 mL, 14.69 mmol) was added to the reaction mixture. After 48 h, the reaction mixture was cooled to ambient temperature and then concentrated under reduced pressure. The resulting residue was suspended in equal parts of a saturated sodium bicarbonate solution and water under N<sub>2</sub>. After stirring overnight, the solids were filtered and dried in a vacuum oven at 30 °C overnight to afford <b>19</b> (2.72 g, 63%) as a beige colored power. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.77 (t, <i>J</i> = 5.4 Hz, 1 H), 7.13 (d, <i>J</i> = 8.3 Hz, 1 H), 6.47–6.52 (m, 2 H), 4.53 (s, 1 H), 3.84 (s, 3 H), 3.82 (s, 3 H), 3.66 (s, 3H), 3.61 (td, <i>J</i> = 5.5, 5.5 Hz, 2 H), 3.15 (td, <i>J</i> = 5.5, 5.5 Hz, 2 H).</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 6-(2,4-Dimethoxyphenyl)-1-(2-hydroxyethyl)-2-thioxo-2,3-dihydropyrimidin-4(1<i>H</i>)-one (<b>3</b>)</h3><div class="NLM_p last">A solution of methyl (<i>Z</i>)-3-(2,4-dimethoxyphenyl)-3-((2-hydroxyethyl)amino)acrylate (<b>19</b>) (9.50 g, 33.8 mmol) in 2-methyltetrahydrofuran (100 mL) was treated with isothiocyanatotrimethylsilane (23.80 mL, 168.79 mmol), and the resulting reaction mixture was heated at 85 °C. After stirring overnight, the reaction mixture was cooled to ambient temperature, extracted with an aqueous 1 N NaOH solution (1 × 250 mL, then 1 × 50 mL); the combined aqueous layers were washed with methylene chloride (2 × 50 mL), and the aqueous phase was acidified to pH 4 with concentrated HCl. The resulting solids were collected by filtration, washed with water (2 × 50 mL), and dried under N<sub>2</sub> overnight to afford a light yellow powder. This material was then dissolved in DMF (70 mL) at 90 °C before water (80 mL) was added to the hot solution. After allowing this solution to cool to ambient temperature and stirring overnight, the resulting solids were filtered, washed with water, and dried under high vacuum to provide <b>3</b> (6.7 g, 61%) as an off-white powder. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.68 (s, 1 H), 7.24 (d, <i>J</i> = 8.3 Hz, 1 H), 6.69 (d, <i>J</i> = 2.4 Hz, 1 H), 6.65 (dd, <i>J</i> = 8.4, 2.3 Hz, 1 H), 5.70 (d, <i>J</i> = 2.2 Hz, 1 H), 4.69 (t, <i>J</i> = 4.9 Hz, 1 H), 4.50 (ddd, <i>J</i> = 13.4, 7.1, 4.2 Hz, 1 H), 3.83 (s, 3 H), 3.82 (s, 3 H), 3.59 (dt, <i>J</i> = 13.4, 7.3 Hz, 1 H), 3.46–3.55 (m, 1 H), 3.38–3.46 (m, 1 H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 309.1 [M + H]<sup>+</sup>. HRMS: <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>17</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 309.0909, found 309.0906. Anal. Calcd for C<sub>14</sub>H<sub>16</sub>N<sub>2</sub>O<sub>4</sub>S: C, 54.53; H, 5.23; N, 9.09; S, 10.40. Found: C, 54.29; H, 5.14; N, 8.98; S, 10.43. HPLC purity: 98.1%.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Ethyl (<i>Z</i>)-3-(2-(<i>tert</i>-Butoxycarbonylamino)ethylamino)-3-(2,4-dimethoxyphenyl)acrylate (<b>20</b>)</h3><div class="NLM_p last">A solution of ethyl 3-(2,4-dimethoxyphenyl)-3-oxopropanoate (<b>9</b>) (41.91 g, 166 mmol) and <i>tert</i>-butyl (2-aminoethyl)carbamate (<b>15</b>) (54.7 g, 342 mmol) in ethanol (180 mL) was treated with acetic acid (16.14 g, 269 mmol) and heated at reflux. After ∼5 h, the reaction mixture was cooled to ambient temperature and concentrated under reduced pressure. The resulting residue was partitioned between ethyl acetate (300 mL) and a 10% (w/v) aqueous ammonium chloride solution. The organic layer was separated and washed with water, 10% (w/v) aq ammonium chloride (3 mL), and brine (10 mL). The organic layer was then agitated with a saturated aqueous sodium bicarbonate solution, to which brine (6 mL) was added, and the phases were separated. The organic layer was washed with brine and dried (Na<sub>2</sub>SO<sub>4</sub>). Concentration of the organic layer afforded <b>20</b> as a viscous, amber solid (62.3 g, 95%), which was used in the subsequent procedure without further purification. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.65 (br s, 1 H), 7.12 (d, <i>J</i> = 8.3 Hz, 1 H), 6.50 (dd, <i>J</i> = 8.4, 1.8 Hz, 1 H), 6.47 (d, <i>J</i> = 1.7 Hz, 1 H), 4.88 (br s, 1 H), 4.51 (s, 1 H), 4.14 (q, <i>J</i> = 7.1 Hz, 2 H), 3.83 (s, 6 H), 3.03–3.21 (m, 4 H), 1.43 (s, 9 H), 1.27 (t, <i>J</i> = 7.1 Hz, 3 H). LCMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 395.4 [M + H]<sup>+</sup> (100%).</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>tert</i>-Butyl 2-(6-(2,4-Dimethoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)ethylcarbamate (<b>25</b>)</h3><div class="NLM_p last">A solution of ethyl (<i>Z</i>)-3-(2-(<i>tert</i>-butoxycarbonylamino)ethylamino)-3-(2,4-dimethoxyphenyl)acrylate (<b>20</b>) (62.3 g, 158 mmol) in 2-methyltetrahydrofuran (160 mL) was treated with isothiocyanatotrimethylsilane (66 mL, 470 mmol) and heated at reflux under nitrogen. After 15 h, the reaction mixture was cooled to ambient temperature and quenched by cautious addition of a saturated aqueous sodium bicarbonate solution (470 mL). The resulting mixture was extracted with dichloromethane, and the aqueous phase was extracted twice more with dichloromethane. The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure to afford a yellow-amber foam, which was purified by chromatography on silica gel, eluting with 0–80% ethyl acetate in heptanes to afford 49.2 g of a solid. This solid was resuspended in equal parts of ethyl acetate and heptane before being heated at 70 °C for 1 h and then stirred at ambient temperature for 1 h. The resulting solid was collected by vacuum filtration, rinsing the material with additional 1:1 ethyl acetate/heptane, to afford <b>25</b> as a colorless fine powder (38.3 g, 59.5%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, major rotamer) δ 9.58 (br s, 1 H), 7.26 (d, <i>J</i> = 8.4 Hz, 1 H), 6.59 (dd, <i>J</i> = 8.4, 2.1 Hz, 1 H), 6.51 (d, <i>J</i> = 2.2 Hz, 1 H), 5.81 (d, <i>J</i> = 2.2 Hz, 1 H), 4.68–4.81 (m, 2 H), 3.87 (s, 3 H), 3.84 (s, 3 H), 3.74 (dt, <i>J</i> = 14.4, 5.4 Hz, 1 H), 3.23–3.45 (m, 2 H), 1.40 (s, 9 H). LCMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 408.3 [M + H]<sup>+</sup> (100%).</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 1-(2-Aminoethyl)-6-(2,4-dimethoxyphenyl)-2-thioxo-2,3-dihydropyrimidin-4(1<i>H</i>)-one Hydrochloride (<b>4</b>)</h3><div class="NLM_p last">Acetyl chloride (55 mL, 770 mmol) was added slowly over 3 min to a solution of ethanol (50 mL, 860 mmol) in ethyl acetate (390 mL), cooled by stirring in an ice/water bath. After 5 min, the cooling bath was removed, and the solution was stirred for an additional 45 min before being added to <i>tert</i>-butyl 2-(6-(2,4-dimethoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)ethylcarbamate (<b>25</b>) (31.7 g, 77.8 mmol). After stirring for 5 h, the resulting solid was collected by vacuum filtration, rinsing with ethyl acetate. The material collected was dried under vacuum to afford 26.6 g (99.3%) of the desired product <b>4</b> as a colorless solid. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.27 (d, <i>J</i> = 8.3 Hz, 1 H), 6.73 (d, <i>J</i> = 2.2 Hz, 1 H), 6.70 (dd, <i>J</i> = 8.3, 2.2 Hz, 1 H), 5.80 (s, 1 H), 4.82 (ddd, <i>J</i> = 14.0, 7.7, 6.4 Hz, 1 H), 4.14 (ddd, <i>J</i> = 14.0, 7.8, 5.9 Hz, 1 H), 3.89 (s, 3 H), 3.87 (s, 3 H), 3.12 (ddd, <i>J</i> = 12.9, 7.7, 6.4 Hz, 1 H), 3.06 (ddd, <i>J</i> = 12.9, 7.8, 5.9 Hz, 1 H). LCMS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 291.3 [M – NH<sub>3</sub> + H]<sup>+</sup> (100%), 308.3 [M + H]<sup>+</sup> (33%), 615.5 [2M + H]<sup>+</sup> (2.3%). HRMS: <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>18</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 308.1069, found 308.1059. HPLC purity: >95%.</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Methyl (<i>Z</i>)-3-(2,4-Dimethoxyphenyl)-3-((2-isopropoxyethyl)amino)acrylate (<b>21</b>)</h3><div class="NLM_p last">A solution of methyl 3-(2,4-dimethoxyphenyl)-3-oxopropanoate (<b>10</b>) (40.0 g, 168 mmol) and 2-aminoacetamide hydrochloride (<b>16</b>) (49.4 g, 447 mmol) in methanol (160 mL) was agitated with the aid of a mechanical stirrer as it was treated with triethylamine (48 mL, 344 mmol) followed by acetic acid (24 mL, 380 mmol) and then heated in a 80 °C oil bath. After 16 h, the mixture was allowed to cool to ambient temperature, treated with water (200 mL), and stirred for 1 h. The resulting solids were collected by filtration and resuspended in methyl <i>tert</i>-butyl ether (300 mL), filtered, and dried under a flow of nitrogen gas for 16 h to afford <b>21</b> as a flocculent colorless solid (41.2 g, 83%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.77 (t, <i>J</i> = 5.4 Hz, 1 H), 7.13 (d, <i>J</i> = 8.3 Hz, 1 H), 6.47–6.52 (m, 2H), 4.53 (s, 1 H), 3.84 (s, 3 H), 3.82 (s, 3 H), 3.66 (s, 3H), 3.61 (td, <i>J</i> = 5.5, 5.5 Hz, 2 H), 3.15 (td, <i>J</i> = 5.5, 5.5 Hz, 2 H).</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-(6-(2,4-Dimethoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)acetamide (<b>5</b>)</h3><div class="NLM_p last">A suspension of methyl (<i>Z</i>)-3-(2,4-dimethoxyphenyl)-3-((2-isopropoxyethyl)amino)acrylate (<b>21</b>, 41.2 g, 140 mmol) in 2-methyltetrahydrofuran (200 mL) was treated with isothiocyanatotrimethylsilane (95 mL, 630 mmol) and then heated at 80 °C for 16 h before the temperature was increased to 100 °C. After an additional 24 h, the reaction mixture was cooled to ambient temperature, diluted with methyl <i>tert</i>-butyl ether (300 mL), and the resulting solid material was collected by vacuum filtration, rinsing with methyl <i>tert</i>-butyl ether, before drying under a stream of nitrogen gas. The solid was then dissolved in an aqueous 1 N NaOH solution (600 mL) and extracted twice with dichloromethane. The organic phases were discarded, and the aqueous layer was cooled in an ice bath before being acidified with concentrated aqueous HCl. A precipitate began to form at pH ≈ 7 as the solution was acidified further until pH = 2. The resulting solid material was collected by vacuum filtration, rinsing with water, and dried under a stream of nitrogen gas to afford the title compound <b>5</b> as a tan solid (27.8 g, 62%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.75 (s, 1 H), 7.31 (br s, 1 H), 7.08 (d, <i>J</i> = 8.54 Hz, 1 H), 6.98 (br s, 1 H), 6.69 (d, <i>J</i> = 2.20 Hz, 1 H), 6.61 (dd, <i>J</i> = 8.54, 2.20 Hz, 1 H), 5.74 (s, 1 H), 5.38 (br s, 1 H), 3.87 (br s, 1 H), 3.82 (s, 3 H), 3.81 (s, 3 H). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i>: 322.2 [M + H]<sup>+</sup>. HRMS: <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>16</sub>N<sub>3</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 322.0862, found 322.0856. Anal. Calcd for C<sub>14</sub>H<sub>15</sub>N<sub>3</sub>O<sub>4</sub>S: C, 52.33; H, 4.71; N, 13.08; S, 9.98. Found: C, 52.09; H, 4.56; N, 12.86; S, 9.94. HPLC purity: 94.8%.</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Methyl (<i>Z</i>)-3-(2,4-Dimethoxyphenyl)-3-((2-ethoxy-2-oxoethyl)amino)acrylate (<b>22</b>)</h3><div class="NLM_p last">A solution of methyl 3-(2,4-dimethoxyphenyl)-3-oxopropanoate (<b>10</b>) (5.0 g, 21 mmol), glycine methyl ester hydrochloride (<b>17</b>) (10.5 g, 83.9 mmol), acetic acid (1.20 mL, 21 mmol), and triethylamine (8.5 g, 83.9 mmol) in ethanol (30 mL) was heated at 100 °C for 18 h. The reaction mixture was allowed to cool to ambient temperature and partitioned between EtOAc and saturated aqueous ammonium chloride. The organic layer was separated, washed with brine, dried over sodium sulfate, and concentrated under reduced pressure. The residue was dissolved in dichloromethane (10 mL) and eluted through a column of silica gel with a gradient of ethyl acetate in heptanes (15–35%) to afford <b>22</b> as a yellow solid (4.7 g, 69%). The material was used directly in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.95 (br s, 1 H), 7.14 (d, <i>J</i> = 10.57 Hz, 1 H), 6.49 (dd, <i>J</i> = 8.28, 2.07 Hz, 1 H), 6.46 (d, <i>J</i> = 2.07, 1 H), 4.60 (s, 1 H), 4.16 (q, <i>J</i> = 7.80 Hz, 2 H), 3.83 (s, 3 H), 3.80 (s, 3 H), 3.69 (s, 3 H), 1.24 (t, <i>J</i> = 7.80 Hz, 3 H). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i>: 324.3 [M + 1]<sup>+</sup>.</div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Ethyl 2-(6-(2,4-Dimethoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)acetate (<b>26</b>)</h3><div class="NLM_p last">A solution of methyl (<i>Z</i>)-3-(2,4-dimethoxyphenyl)-3-((2-ethoxy-2-oxoethyl)amino)acrylate (<b>22</b>) (4.68 g, 15.1 mmol) in 2-methyltetrahydrofuran (38 mL) was treated with isothiocyanatotrimethylsilane (12.9 mL, 90.8 mmol), and the solution was purged with nitrogen gas and heated at 110 °C. After 18 h, the mixture was allowed to cool to ambient temperature and concentrated under reduced pressure to afford a red solid, which was then suspended in 200 mL of a 25% ethyl acetate in heptanes mixture. After stirring at room temperature for 1 h, the solid was collected by filtration and then triturated with methylene chloride (100 mL), concentrated under reduced pressure, and dried under vacuum to afford <b>26</b> (4.42 g, 87%) as a pink solid. This material was used directly in the next step without further purification. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.91 (br s, 1 H), 7.13 (d, <i>J</i> = 6.12 Hz, 1 H), 6.54 (s, 1 H), 6.51 (d, <i>J</i> = 6.12 Hz, 1 H), 5.86 (s, 1 H), 5.44–5.40 (m, 1 H), 4.25–4.20 (m, 1 H), 4.16–4.06 (m, 2 H), 3.86 (s, 3 H), 3.83 (s, 3 H), 1.20 (t, <i>J</i> = 6.12 Hz, 3 H). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i>: 351.5 [M + H]<sup>+</sup>.</div></div><div id="sec3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2-(6-(2,4-Dimethoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)acetic Acid (<b>27</b>)</h3><div class="NLM_p last">A solution of ethyl 2-(6-(2,4-dimethoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)acetate (<b>26</b>) (6.8 g, 20.3 mmol) in methanol (34 mL) was treated with a 6 N aqueous NaOH solution (16.9 mL), and the solution was heated at 35 °C. After 3 h, the reaction mixture was allowed to cool to ambient temperature and concentrated under reduced pressure. The residue was combined with water (100 mL) and extracted with ethyl acetate (2 × 200 mL), and the aqueous phase was acidified to pH ≈ 2 with concentrated aqueous HCl. The acidic aqueous solution was extracted with ethyl acetate (3 × 200 mL), and the combined organic phases were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure to afford 6.53 g (99%) of <b>27</b> as a colorless solid. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.16 (d, <i>J</i> = 8.86 Hz, 1 H), 6.67 (s, 1 H), 6.64 (d, <i>J</i> = 8.86 Hz, 1 H), 5.79 (s, 1 H), 5.52–5.40 (m, 1 H), 4.34–4.19 (m, 1 H), 3.87 (s, 3 H), 3.86 (s, 3 H). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i>: 323.2 [M + H]<sup>+</sup>.</div></div><div id="sec3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>tert</i>-Butyl (2-(2-(6-(2,4-Dimethoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)acetamido)ethyl)carbamate (<b>28</b>)</h3><div class="NLM_p last">A solution of 2-(6-(2,4-dimethoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)acetic acid (<b>27</b>) (40 g, 124 mmol) in DMF (300 mL) was treated with <i>tert</i>-butyl-(2-aminoethyl)carbamate (40 g, 250 mmol) and pyridine (30 mL) and cooled to 0 °C under nitrogen. A 50% solution of 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphorinane 2,4,6-trioxide in DMF (109 mL) was carefully added with stirring. After 1 h, the cooling bath was removed and the reaction mixture was stirred at ambient temperature. After 4 h, the solution was poured slowly into a stirring 0.5 M aqueous HCl solution (2500 mL). After stirring at ambient temperature for 1 h, the resulting solid was collected by vacuum filtration. The solid was washed with 0.5 M aqueous HCl (500 mL) followed by water (500 mL). The resulting solid was dried in a vacuum oven at 50 °C for 20 h to afford 54.6 g of light beige powder. This solid was suspended in ethyl acetate (500 mL), heated to 70 °C under a stream of nitrogen gas with stirring for 1 h, and then allowed to cool to ambient temperature with stirring. After 18 h, the suspension was cooled to 0 °C, the solid was collected by vacuum filtration, the filter cake washed with cold (0 °C) ethyl acetate (100 mL) and dried in the vacuum oven at 50 °C for 9 h to afford 49.0 g of an off-white solid. This solid was suspended in acetonitrile (300 mL) and stirred at 70 °C under a stream of nitrogen for 18 h. The mixture was cooled to 0 °C, and the resultant solid was collected by vacuum filtration, washed with cold acetonitrile (50 mL), and dried in a vacuum oven at 50 °C for 8 h to give 46.5 g of off-white solid. This solid was suspended in ethyl acetate (350 mL), heated to 70 °C under a stream of nitrogen gas with stirring for 1 h and then at ambient temperature for 18 h before the suspension was cooled down to 0 °C, and the solid was collected by vacuum filtration, the filter cake washed with cold (0 °C) ethyl acetate (50 mL) and dried in the vacuum oven at 50 °C for 9 h to give <b>28</b> (45.4 g, 78.8%) as an off-white powder. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 8.99 (br s, 1 H), 7.16 (d, <i>J</i> = 7.65 Hz, 1 H), 6.65 (s, 1 H), 6.62 (d, <i>J</i> = 7.65 Hz, 1 H), 5.78 (s, 1 H), 5.51–5.41 (m, 1 H), 4.22–4.14 (m, 1 H), 3.87 (s, 3 H), 3.85 (s, 3 H), 3.19–3.11 (m, 2 H), 3.06–3.00 (m, 2 H), 1.42 (s, 9 H). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i>: 465.3 [M + H]<sup>+</sup>.</div></div><div id="sec3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-(2-Aminoethyl)-2-(6-(2,4-dimethoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)acetamide Hydrochloride (<b>6</b>)</h3><div class="NLM_p last">Ethanol (21.5 mL), cooled at 0 °C under nitrogen, was slowly treated with acetyl chloride (1.55 mL) over 5 min, after which the reaction mixture was heated at 50 °C. After 30 min, the reaction mixture was cooled to ambient temperature and <i>tert</i>-butyl-(2-(2-(6-(2,4-dimethoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)acetamido)ethyl)carbamate (<b>28</b>) (1.0 g, 2.15 mmol) was added, followed by heating to 50 °C. After 1 h, the reaction mixture was cooled to ambient temperature and concentrated under reduced pressure. The resulting residue was then suspended in ethanol (10 mL), heated at 75 °C for 20 min before adding ethyl acetate (20 mL). After heating for another 20 min, the reaction mixture was allowed to gradually cool to ambient temperature with stirring. After 18 h, the resulting precipitate was filtered and dried in a vacuum oven at 70 °C for 20 h to afford <b>6</b> (751 mg, 87%) as a colorless solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.81 (br s, 1 H), 8.26 (br s, 1 H), 8.01 (br s, 2 H), 7.08 (d, <i>J</i> = 7.91 Hz, 1 H), 6.70 (s, 1 H), 6.62 (d, <i>J</i> = 7.91 Hz, 1 H), 5.78 (s, 1 H), 5.41–5.35 (m, 1 H), 4.07–4.02 (m, 1 H), 3.84 (s, 3 H), 3.83 (s, 3 H), 3.20–3.16 (m, 2 H), 2.74–2.64 (m, 2 H). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i>: 365.2 [M + H]<sup>+</sup>. HRMS: <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>21</sub>N<sub>4</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 365.1284, found 365.1278. HPLC purity: >95%.</div></div><div id="sec3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Sodium 1-(2,5-Dimethoxyphenyl)-3-ethoxy-3-oxoprop-1-en-1-olate (<b>11</b>)</h3><div class="NLM_p last">A 20 L reaction vessel was charged with magnesium ethoxide (413.5 g, 3.61 mol) and THF (6.6 L), and the resulting mixture was treated with ethyl hydrogen malonate (<b>29</b>) (888.9 mL, 7.23 mol) in THF (20 mL) and heated at 45 °C for 4 h. Meanwhile, a 20 L reactor was charged with 2,5-dimethoxybenzoic acid (<b>30</b>) (600 g, 3.29 mol) and THF (3.6 L). To this mixture was added 1,1′-carbonyldiimidazole (585.98 g, 3.61 mol) in portions to avoid excess foaming. After stirring for 3 h at ambient temperature, the solution of activated acid was added gradually to the ethyl malonate solution and the combined reaction mixture was heated at 45 °C. After 20 h, the mixture was concentrated under reduced pressure followed by the addition of ethyl acetate (6 L) and 2 N HCl (3 L). After mixing, the layers were separated and the organic phase was washed sequentially with 2 N HCl (3 L), saturated sodium bicarbonate (3 L), and water (3 L). The organic phase was concentrated under reduced pressure, the residue taken up in ethyl acetate (6 L) and concentrated again to afford an oil, which was transferred to a 20 L reaction vessel with 5 L of ethyl acetate and treated with a 4.35 M solution of sodium methoxide (793 mL, 3.45 mol) in methanol. After stirring at room temperature for 3 h, an additional 6 L of ethyl acetate was added, the solid was collected by vacuum filtration and dried overnight in a vacuum oven at 40 °C to give 661 g of <b>11</b> (73%) as a solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.92 (d, <i>J</i> = 3.0 Hz, 1 H), 6.84 (d, <i>J</i> = 8.8 Hz, 1 H), 6.73 (dd, <i>J</i> = 8.8, 3.0 Hz, 1 H), 4.67 (s, 1 H), 3.88 (q, <i>J</i> = 7.0 Hz, 2 H), 3.67 (s, 6 H), 1.12 (t, <i>J</i> = 7.0 Hz, 3 H). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i>: 253.1 [M + H]<sup>+</sup>.</div></div><div id="sec3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Ethyl (<i>Z</i>)-3-((2-Amino-2-oxoethyl)amino)-3-(2,5-dimethoxyphenyl)acrylate (<b>23</b>)</h3><div class="NLM_p last">A 5 L reaction vessel was charged with methanol (3.3 L), sodium methoxide (102.4 g, 1.8 mol), and aminoacetamide hydrochloride (<b>16</b>) (202 g, 1.8 mol). The mixture was heated at 65 °C for 1 h before cooling to 50 °C and adding acetic acid (30.88 g, 29.47 mL, 514.25 mmol) and sodium 1-(2,5-dimethoxyphenyl)-3-ethoxy-3-oxoprop-1-en-1-olate (<b>11</b>) (300 g, 1.09 mol). After heating at reflux for 16 h, the reaction mixture was cooled to 10 °C, stirred for 30 min, the resulting solid collected by filtration and dried in a vacuum oven for 14 h to afford <b>23</b> (339.4 g, 100%) as a solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.84 (t, <i>J</i> = 4.7 Hz, 1 H), 7.36 (s, 1 H), 7.09 (s, 1 H), 7.02 (d, <i>J</i> = 8.9 Hz, 1 H), 6.97 (dd, <i>J</i> = 8.9, 2.8 Hz, 1 H), 6.74 (d, <i>J</i> = 2.8 Hz, 1 H), 4.31 (s, 1 H) 4.03 (q, <i>J</i> = 7.1 Hz, 2 H), 3.74 (s, 6 H), 3.58 (br s, 1 H), 3.47 (br s, 1 H), 1.18 (t, <i>J</i> = 7.1 Hz, 3 H). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i>: 309.1 [M + H]<sup>+</sup>.</div></div><div id="sec3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-(6-(2,5-Dimethoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)acetamide (<b>7</b>)</h3><div class="NLM_p last">A 5 L reaction vessel equipped with an efficient stirrer was charged with ethyl (<i>Z</i>)-3-((2-amino-2-oxoethyl)amino)-3-(2,5-dimethoxyphenyl)acrylate (<b>23</b>) (400 g, 1.30 mol), butyl acetate (3.4 L), and isothiocyanatotrimethylsilane (585.67 mL, 544.96 g, 4.15 mol), and the mixture was heated to reflux. After 16 h, the mixture was cooled to 40 °C and treated with a solution of 2 N aqueous NaOH (1.95 L). The organic layer was separated and extracted with another portion of 2 N aqueous NaOH (0.32 L). The combined aqueous phases were filtered, extracted twice with dichloromethane (2 × 1.6 L), and added slowly to a well-stirred 3 N aqueous HCl solution (1.3 L) at room temperature. After stirring for 30 min, the resulting solid was filtered and dissolved in dimethylformamide (2.4 L) at 90 °C and before water (2 L) was added slowly to the solution. The mixture was cooled gradually to room temperature and the resulting solid isolated by vacuum filtration, rinsing with water. This solid was then suspended in 1.25 L of methanol and stirred as 1.25 L of water was added. The mixture was heated with stirring at 50 °C for 2 h and then cooled to 10 °C for 2 h before collecting the solid by vacuum filtration and drying in a vacuum oven to afford <b>7</b> (245 g, 59%) as a solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.80 (s, 1 H), 7.32 (br s, 1 H), 7.06–7.11 (m, 2 H), 7.06 (br s, 1 H), 6.74–6.77 (m, 1 H), 5.82 (d, <i>J</i> = 2.20 Hz, 1 H), 5.37 (br s, 1 H), 3.88 (br s, 1 H), 3.78 (s, 3 H), 3.70 (s, 3 H). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i>: 322.2 [M + H]<sup>+</sup>. HRMS: <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>16</sub>N<sub>3</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 322.0862, found 322.0856. HPLC purity: >95%.</div></div><div id="sec3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Ethyl 3-(5-Chloro-2-methoxyphenyl)-3-oxopropanoate (<b>12</b>)</h3><div class="NLM_p last">A 3 L three-necked round-bottomed flask, flushed with nitrogen, was charged with magnesium ethoxide (67.46 g, 589.51 mmol) and THF (1100 mL), and the resulting mixture was stirred as ethyl hydrogen malonate (<b>29</b>) (162.26 g, 1.18 mol) in THF (100 mL) was added and the mixture was heated at 45 °C for 4 h. Meanwhile, a 2 L three-necked round-bottomed flask, flushed with nitrogen, was charged with 5-chloro-2-methoxybenzoic acid (<b>31</b>) (100 g, 536 mmol) and THF (600 mL). To this mixture was added 1,1′-carbonyldiimidazole (95.59 g, 589.5 mmol) in portions to avoid excess foaming. After stirring for 3 h, the solution of activated acid was added gradually to the ethyl malonate solution, and the resulting reaction mixture was heated at 45 °C. After 20 h, the reaction mixture was concentrated under reduced pressure before adding ethyl acetate (1 L) followed by 2 N HCl (500 mL). After mixing, the layers were separated and the organic phase was washed sequentially with 2 N HCl (500 mL), saturated sodium bicarbonate (500 mL), and water (500 mL). The organic phase was concentrated under reduced pressure to afford <b>12</b> (104.94 g, 76%) as a solid. <sup>1</sup>H NMR showed the desired product as a 7.5:1 keto/enol mixture. For the keto tautomer: <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.85 (d, <i>J</i> = 2.93 Hz, 1 H), 7.45 (dd, <i>J</i> = 8.90, 2.81 Hz, 1 H), 6.92 (d, <i>J</i> = 8.78 Hz, 1 H), 4.18 (q, <i>J</i> = 7.16 Hz, 2 H), 3.95 (s, 2 H), 3.90 (s, 3 H), 1.24 (t, <i>J</i> = 7.07 Hz, 3 H). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i>: 257.2 [M + H]<sup>+</sup>.</div></div><div id="sec3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Ethyl (<i>Z</i>)-3-((2-Amino-2-oxoethyl)amino)-3-(5-chloro-2-methoxyphenyl)acrylate (<b>24</b>)</h3><div class="NLM_p last">A 5 L reaction vessel was charged with methanol (3.3 L), sodium methoxide (102.4 g, 1.8 mol), and aminoacetamide hydrochloride (<b>16</b>) (202 g, 1.8 mol). The mixture was heated at 65 °C for 1 h before cooling to 50 °C and adding acetic acid (514.3 mmol, 30.9 g, 29.5 mL) and ethyl 3-(5-chloro-2-methoxyphenyl)-3-oxopropanoate (<b>12</b>) (300 g, 1.17 mol). After heating at reflux for 16 h, the reaction mixture was stirred as it was cooled to 10 °C. After 30 min the resulting solid was filtered and dried in a vacuum oven (20 mmHg, 65 °C) for 14 h to afford <b>24</b> (339.4 g, 93%) as a solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.80 (t, <i>J</i> = 5.00 Hz, 1 H), 7.47 (dd, <i>J</i> = 8.90, 2.81 Hz, 1 H), 7.27 (br s, 1 H), 7.22 (d, <i>J</i> = 2.68 Hz, 1 H), 7.14 (d, <i>J</i> = 8.78 Hz, 1 H), 7.09 (br s, 1 H), 4.30 (s, 1 H), 4.03 (q, <i>J</i> = 7.07 Hz, 2 H), 3.80 (s, 3 H), 3.56 (br s, 1 H), 3.45 (br s, 1 H), 1.18 (t, <i>J</i> = 7.07 Hz, 3 H). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i>: 313.2 [M + H]<sup>+</sup>.</div></div><div id="sec3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)acetamide (<b>8</b>)</h3><div class="NLM_p last">A reaction vessel equipped with an efficient stirrer was charged with ethyl (<i>Z</i>)-3-((2-amino-2-oxoethyl)amino)-3-(5-chloro-2-methoxyphenyl)acrylate (<b>24</b>) (15 g, 50.2 mmol), butyl acetate (150 mL), and isothiocyanatotrimethylsilane (21.1 g, 22.7 mL, 160.7 mmol), and the mixture was heated to reflux. After 15 h, the mixture was cooled to 30 °C and treated with 1 N aqueous NaOH (112.5 mL). After 30 min, the organic layer was separated and extracted with another portion of 1 N sodium hydroxide (37.5 mL). The combined aqueous phases were extracted twice with dichloromethane (2 × 45 mL), filtered, and treated with 6 N HCl until a pH of 2.5 was achieved. After stirring for 1 h, the resulting solid was collected by vacuum filtration, resuspended in 100 mL of a 1:1 methanol–water solution, heated with stirring at 50 °C for 2 h, and cooled to room temperature before collecting the solid by filtration and drying in a vacuum oven (20 mmHg, 50 °C) for 12 h to afford <b>8</b> (8.7 g, 53%) as a tan solid (mp = 165.3 °C). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.85 (s, 1 H), 7.57 (dd, <i>J</i> = 9.03, 2.68 Hz, 1 H), 7.33 (s, 1 H), 7.17–7.23 (m, 2 H), 7.10 (s, 1 H), 5.89 (d, <i>J</i> = 1.71 Hz, 1 H), 5.41 (br s, 1 H), 3.89 (br s, 1 H), 3.84 (s, 3 H). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i>: 326.0 [M + H]<sup>+</sup>. HRMS: <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>13</sub>ClN<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 326.0366, found 326.0361. Anal. Calcd for C<sub>13</sub>H<sub>12</sub>ClN<sub>3</sub>O<sub>3</sub>S: C, 47.93; H, 3.71; N, 12.90; S, 9.84. Found: C, 47.81; H, 3.70; N, 12.83; S, 9.83. HPLC purity: >95%.</div></div><div id="sec3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Pharmacokinetics</h3><div class="NLM_p last">All experiments involving animals were conducted in our AAALAC-accredited facilities and were reviewed and approved by Pfizer Institutional Animal Care and Use Committee. Male CD-1 mice (25–35 g), jugular vein/carotid artery double cannulated Wistar-Han rats (250 g), obtained from Charles River Laboratories (Wilmington, MA), male beagle dogs (12 kg), and male cynomolgus monkeys (7 kg) were used for these studies. Animals were fasted overnight and fed after dosing (1.0 or 2.0 h), whereas access to water was provided ad libitum. Compounds were administered intravenously (iv) in either saline, 12% sulfobutyl ether β-cyclodextrin with or without 1% DMSO or 30% hydroxypropyl-β-cyclodextrin containing 5% DMSO via the tail vein (mice, <i>n</i> = 3), carotid artery (rats, <i>n</i> = 3), saphenous vein (dogs, <i>n</i> = 3), femoral vein (monkeys, <i>n</i> = 2) at a dose of 1.0 mg/kg in a dosing volume of 5 mL/kg (mice), 2 mL/kg (rats), 0.5 mL/kg (dogs), and 1 mL/kg (monkeys). Serial blood samples were collected before dosing and 0.083, 0.25, 0.5, 1, 2, 4, 7, and 24 h after dosing. Compounds were also administered by po gavage to mice (5 mg/kg at 5 mL/kg in 0.5% methylcellulose), rats (5 mg/kg at 5 mL/kg in 0.5% methylcellulose), dogs (3 mg/kg at 1.5 mL/kg in 0.5% methylcellulose), and monkeys (3 mg/kg at 5 mL/kg in 0.5% methylcellulose). Blood samples were taken prior to po administration, and then serial samples were collected at 0.25, 0.5, 1, 2, 4, 7, and 24 h after dosing. Blood samples from the various pharmacokinetic studies were centrifuged to generate plasma. All plasma samples were kept frozen until analysis. Urine samples (0–7.0 and 7.0–24 h; pooled 0–24 h for mice) were also collected after iv administration to mice, rats, dogs, and monkeys. For mouse samples, aliquots of plasma (10 μL) or urine (2 μL mixed with 8 μL plasma) were extracted using liquid/liquid extraction with methyl <i>tert</i>-butyl ether containing internal standard. For rat, dog, or monkey samples, aliquots of plasma or urine (20–25 μL) were transferred to 96-well blocks and acetonitrile (150–200 μL) containing internal standard was added to each well. Supernatant was dried under nitrogen and reconstituted with 100 μL of acetonitrile/water (1:1 with 0.1% formic acid for mice; 20:80 for dog) or added to 100 μL of water without evaporation (rat, monkey). Following extraction, the samples were then analyzed by LC–MS/MS, and concentrations of analyte in plasma and urine were determined by interpolation from a standard curve as described previously.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div></div><div id="sec3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> In Vitro Metabolism of <i>N</i>1-Substituted-6-arylthiouracils in MPO</h3><div class="NLM_p">Stock solutions of thiouracil derivatives were prepared in DMSO. Compounds (final concentration of 10 μM) were added to an incubation mixture containing 50 mM sodium phosphate buffer, pH 7.4, 150 mM NaCl, 1 mM diethylenetriaminepentacetic acid, 2 μM H<sub>2</sub>O<sub>2</sub>, 30 μM Amplex Red, and 1 mM GSH. Reactions were initiated by the addition of 100 pM MPO, and the final concentration of DMSO was kept at 2% in the incubation (volume of 200 μL). The reaction mixture was incubated at 37 °C for 60 min, terminated by the addition of ice cold acetonitrile (400 μL) and centrifuged (3000<i>g</i>, 15 min). The supernatants were dried under a steady stream of nitrogen, reconstituted with 25% aqueous acetonitrile (250 μL), and analyzed via LC–MS/MS for formation of sulfydryl conjugates. Qualitative assessment of metabolites was conducted using a Thermo Finnegan Surveyor photodiode array plus detector, Thermo Acela pump, and a Thermo Acela autosampler (Thermoscientific, West Palm Beach, FL). Chromatography was performed on a Phenomenex Hydro RP C18 (4.6 mm × 150 mm, 3.5 μm) column (Phenomenex, Torrance, CA). The mobile phase was composed of 5 mM ammonium formate buffer with 0.1% formic acid (pH = 3) (solvent A) and acetonitrile (solvent B) at a flow rate of 1 mL/min. The binary gradient was as follows: solvent A to solvent B ratio was held at 95:5 (v/v) for 3 min and then adjusted to 55:45 (v/v) from 0 to 35 min, 30:70 (v/v) from 35 to 45 min, and 5:95 (v/v) from 45 to 52 min where it was held for 3 min and then returned to 95:5 (v/v) for 6 min before next analytical run. Metabolite identification was performed on a Thermo Orbitrap mass spectrometer operating in positive ion electrospray mode. The spray potential was 4 V, and heated capillary was at 275 °C. Xcalibur software version 2.0 was used to control the HPLC–MS system. Full scan measurements from 50–1000 amu were collected at 15 000 resolution, with two data-dependent acquisition scans of the most intense ion in scan events 1 and 2, respectively. Product ion spectra were acquired at a normalized collision energy of 65 eV with an isolation width of 2 amu.</div><div class="NLM_p last">Liquid chromatography–tandem mass spectrometry (LC–MS/MS) analysis of an incubation of arylthiouracil <b>2</b> (retention time (<i>t</i><sub>R</sub>) = 25.4 min, exact mass (MH<sup>+</sup>) = 351.1367) with human MPO/H<sub>2</sub>O<sub>2</sub>/Cl<sup>–</sup> in the presence of excess glutathione (GSH) (1 mM) indicated the formation of a GSH conjugate (<i>t</i><sub>R</sub> = 15.7 min; MH<sup>+</sup> = 624.2334, <i>m</i>/<i>z</i> (+H<sup>+</sup>) = 495.1906 (loss of pyroglutamate, 129 amu), which can be obtained via oxidation of the thiocarbonyl group in <b>2</b> to the putative sulfonate species followed by nucleophilic displacement in the presence of exogenously added GSH (<a class="ref internalNav" href="#sch1" aria-label="Scheme 2">Scheme 2</a>).</div></div><div id="sec3_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Inhibition of MPO Activity in LPS-Treated Cynomolgus Monkeys by <b>8</b></h3><div class="NLM_p last">All experiments involving animals were conducted in our AAALAC-accredited facilities and were reviewed and approved by Pfizer Institutional Animal Care and Use Committee. Male cynomolgus monkeys (<i>n</i> = 8; >2.5 years old at initiation of dosing) were assigned to dose groups randomized in a crossover manner with 2 weeks between treatments. The treatments were the following: iv LPS (5 μg/kg; Sigma, L3491) in sterile saline followed after 1 h by po administration of vehicle (20 mM Tris, 0.5% [w/v] hydroxypropylmethylcellulose, and 0.5% [w/v] hydroxypropylmethylcellulose acetate succinate high-fine grade) or <b>8</b> in vehicle at 5, 20, or 80 mg/kg. Blood samples were taken just prior to LPS dosing and at 0.5, 2.0, 4.0, 8.0, and 24 h after vehicle or <b>8</b> dosing in sodium heparinized containers. Total MPO and residual MPO activity were determined from plasma samples by antibody capture as described above for the human whole blood assay, and plasma levels of <b>8</b> were measured by liquid chromatography–tandem mass spectrometry.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00963" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23750" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23750" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roger B. Ruggeri</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d183beb6b4a3ff93ff83a4b6b6b4a3b891a1b7b8abb4a3ffb2bebc"><span class="__cf_email__" data-cfemail="e9bb868e8c9bc7abc7bb9c8e8e8c9b80a9998f80938c9bc78a8684">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leonard Buckbinder</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott W. Bagley</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip A. Carpino</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edward L. Conn</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew S. Dowling</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dilinie P. Fernando</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenhua Jiao</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel W. Kung</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suvi T. M. Orr</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yingmei Qi</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin N. Rocke</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aaron Smith</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph S. Warmus</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Zhang</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Bowles</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel W. Widlicka</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heather Eng</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tim Ryder</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raman Sharma</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela Wolford</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carlin Okerberg</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen Walters</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tristan S. Maurer</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yanwei Zhang</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul D. Bonin</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samantha N. Spath</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gang Xing</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Hepworth</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kay Ahn</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amit S. Kalgutkar</span> - <span class="hlFld-Affiliation affiliation">Worldwide Research
and Development, Pfizer,
Inc., Groton, Connecticut 06340, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): All authors are current or former employees of Pfizer, Inc.<br /></br></div></li></ul></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i43" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i43"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i44" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i44"> Abbreviations Used</h2><tr><td class="NLM_term">MPO</td><td class="NLM_def"><p class="first last">myeloperoxidase</p></td></tr><tr><td class="NLM_term">H<sub>2</sub>O<sub>2</sub></td><td class="NLM_def"><p class="first last">hydrogen peroxide</p></td></tr><tr><td class="NLM_term">COPD</td><td class="NLM_def"><p class="first last">chronic obstructive pulmonary disease</p></td></tr><tr><td class="NLM_term">TPO</td><td class="NLM_def"><p class="first last">thyroid peroxidase</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">PF-06282999</td><td class="NLM_def"><p class="first last">2-(6-(5-chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2<i>H</i>)-yl)acetamide</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">oral</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">PTU</td><td class="NLM_def"><p class="first last">propylthiouracil</p></td></tr><tr><td class="NLM_term"><i>k</i><sub>inact</sub></td><td class="NLM_def"><p class="first last">maximal rate of MPO inactivation</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>I</sub></td><td class="NLM_def"><p class="first last">concentration required to achieve half the maximal rate of inactivator</p></td></tr><tr><td class="NLM_term">[I]</td><td class="NLM_def"><p class="first last">inhibitor concentration</p></td></tr><tr><td class="NLM_term">TMSNCS</td><td class="NLM_def"><p class="first last">isothiocyanatotrimethylsilane</p></td></tr><tr><td class="NLM_term">T3P</td><td class="NLM_def"><p class="first last">2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphorinane 2,4,6-trioxide</p></td></tr><tr><td class="NLM_term">LC–MS/MS</td><td class="NLM_def"><p class="first last">liquid chromatography–tandem mass spectrometry</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">HHEP</td><td class="NLM_def"><p class="first last">cryopreserved human hepatocyte</p></td></tr><tr><td class="NLM_term">RRCK</td><td class="NLM_def"><p class="first last">Ralph–Russ canine kidney</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">CL<sub>p</sub></td><td class="NLM_def"><p class="first last">plasma clearance</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>dss</sub></td><td class="NLM_def"><p class="first last">steady state volume of distribution</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">elimination half-life</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>max</sub></td><td class="NLM_def"><p class="first last">time to reach <i>C</i><sub>max</sub></p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24175" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24175" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 63 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hansson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nauseef, W. M.</span><span> </span><span class="NLM_article-title">Biosynthesis, processing, and sorting of human myeloperoxidase</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">445</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span><span class="refDoi"> DOI: 10.1016/j.abb.2005.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1016%2Fj.abb.2005.08.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=445&publication_year=2006&pages=214-224&author=M.+Hanssonauthor=I.+Olssonauthor=W.+M.+Nauseef&title=Biosynthesis%2C+processing%2C+and+sorting+of+human+myeloperoxidase&doi=10.1016%2Fj.abb.2005.08.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2005.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2005.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DHansson%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DI.%26aulast%3DNauseef%26aufirst%3DW.%2BM.%26atitle%3DBiosynthesis%252C%2520processing%252C%2520and%2520sorting%2520of%2520human%2520myeloperoxidase%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2006%26volume%3D445%26spage%3D214%26epage%3D224%26doi%3D10.1016%2Fj.abb.2005.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Kutter, D.</span><span> </span><span class="NLM_article-title">Prevalence of myeloperoxidase deficiency: Population studies using Bayer-Technicon automated hematology</span> <span class="citation_source-journal">J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">675</span><span class="refDoi"> DOI: 10.1007/s001090050266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1007%2Fs001090050266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=9766844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A280%3ADyaK1cvjvVagtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1998&pages=669-675&author=D.+Kutter&title=Prevalence+of+myeloperoxidase+deficiency%3A+Population+studies+using+Bayer-Technicon+automated+hematology&doi=10.1007%2Fs001090050266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Prevalence of myeloperoxidase deficiency: population studies using Bayer-Technicon automated hematology</span></div><div class="casAuthors">Kutter D</div><div class="citationInfo"><span class="NLM_cas:title">Journal of molecular medicine (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">669-75</span>
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    </div><div class="casAbstract">The Bayer-Technicon hematological devices differentiate leukocytes by their peroxidase activity and their volume, displaying them as separate clusters.  Peroxidase deficiencies are manifested by the irregular location of these clusters.  This makes it possible to identify persons totally or partially lacking myeloperoxidase.  The deficiency is quantified by the myeloperoxidase index, which is expressed for every routine analysis and for which normal values were determined.  Values of the myeloperoxidase index confirm varying degrees of deficiency and prevalence.  Family studies using these degrees show that the hereditary pattern must be more complicated than the classical autosomal-recessive mode.  A bigenic mode is suggested.  While about half of the totally deficient individuals detected were free of typical symptoms, in the other half we found infectious complications that were sometimes life-threatening.  The hematological devices allow the identification of persons suffering from eosinoperoxidase deficiency and from MPO deficiency of the monocytes.  The latter symptom seems to indicate immaturity of these cells and may lead to unexpected diagnosis of malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSopF3R1F9CRv69nzq6467DfW6udTcc2eY6yY4X_sOYG7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1cvjvVagtg%253D%253D&md5=a55eed4752a55c0b3f6a390588b7614b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs001090050266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs001090050266%26sid%3Dliteratum%253Aachs%26aulast%3DKutter%26aufirst%3DD.%26atitle%3DPrevalence%2520of%2520myeloperoxidase%2520deficiency%253A%2520Population%2520studies%2520using%2520Bayer-Technicon%2520automated%2520hematology%26jtitle%3DJ.%2520Mol.%2520Med.%26date%3D1998%26volume%3D76%26spage%3D669%26epage%3D675%26doi%3D10.1007%2Fs001090050266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Lekstrom-Himes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallin, J.</span><span> </span><span class="NLM_article-title">Immunodeficiency diseases caused by defects in phagocytes</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">1703</span><span class="NLM_x">–</span> <span class="NLM_lpage">1714</span><span class="refDoi"> DOI: 10.1056/NEJM200012073432307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1056%2FNEJM200012073432307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=11106721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovVGhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2000&pages=1703-1714&author=J.+Lekstrom-Himesauthor=J.+Gallin&title=Immunodeficiency+diseases+caused+by+defects+in+phagocytes&doi=10.1056%2FNEJM200012073432307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Immunodeficiency diseases caused by defects in phagocytes</span></div><div class="casAuthors">Lekstrom-Himes, Julie A.; Gallin, John I.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">1703-1714</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review with 114 refs.  Topics discussed include congenital neutropenias; defects of adhesion; defects of signaling; defects of intracellular killing; and defects in the formation and function of neutrophil granules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCXYN05yco3LVg90H21EOLACvtfcHk0ljh5DZkUu4B1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovVGhu78%253D&md5=8363d004760e5925f63f8f816526bb6c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1056%2FNEJM200012073432307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200012073432307%26sid%3Dliteratum%253Aachs%26aulast%3DLekstrom-Himes%26aufirst%3DJ.%26aulast%3DGallin%26aufirst%3DJ.%26atitle%3DImmunodeficiency%2520diseases%2520caused%2520by%2520defects%2520in%2520phagocytes%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2000%26volume%3D343%26spage%3D1703%26epage%3D1714%26doi%3D10.1056%2FNEJM200012073432307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Churg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sin, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thain, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadogan, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soars, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallinder, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. L.</span><span> </span><span class="NLM_article-title">Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary disease</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span><span class="refDoi"> DOI: 10.1164/rccm.201103-0468OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1164%2Frccm.201103-0468OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=21997333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC38XitF2rsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2012&pages=34-43&author=A.+Churgauthor=C.+V.+Marshallauthor=D.+D.+Sinauthor=S.+Boltonauthor=S.+Zhouauthor=K.+Thainauthor=E.+B.+Cadoganauthor=J.+Maltbyauthor=M.+G.+Soarsauthor=P.+R.+Mallinderauthor=J.+L.+Wright&title=Late+intervention+with+a+myeloperoxidase+inhibitor+stops+progression+of+experimental+chronic+obstructive+pulmonary+disease&doi=10.1164%2Frccm.201103-0468OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary disease</span></div><div class="casAuthors">Churg, Andrew; Marshall, Caroline V.; Sin, Don D.; Bolton, Sarah; Zhou, Steven; Thain, Katherine; Cadogan, Elaine B.; Maltby, Justine; Soars, Matthew G.; Mallinder, Philip R.; Wright, Joanne L.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-43</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Inflammation and oxidative stress are linked to the deleterious effects of cigarette smoke in producing chronic obstructive pulmonary disease (COPD).  Myeloperoxidase (MPO), a neutrophil and macrophage product, is important in bacterial killing, but also drives inflammatory reactions and tissue oxidn.  Objectives: To det. the role of MPO in COPD.  Methods: We treated guinea pigs with a 2-thioxanthine MPO inhibitor, AZ1, in a 6-mo cigarette smoke exposure model, with one group receiving compd. from Smoking Day 1 and another group treated after 3 mo of smoke exposure.  Results: At 6 mo both treatments abolished smoke-induced increases in lavage inflammatory cells, largely ameliorated physiol. changes, and prevented or stopped progression of morphol. emphysema and small airway remodeling.  Cigarette smoke caused a marked increase in immunohistochem. staining for the myeloperoxidase-generated protein oxidn. marker dityrosine, and this effect was considerably decreased with both treatment arms.  Serum 8-isoprostane, another marker of oxidative stress, showed similar trends.  Both treatments also prevented muscularization of the small intrapulmonary arteries, but only partially ameliorated smoke-induced pulmonary hypertension.  Acutely, AZ1 prevented smoke-induced increases in expression of cytokine mediators and nuclear factor-κB binding.  Conclusions: We conclude that an MPO inhibitor is able to stop progression of emphysema and small airway remodeling and to partially protect against pulmonary hypertension, even when treatment starts relatively late in the course of long-term smoke exposure, suggesting that inhibition of MPO may be a novel and useful therapeutic treatment for COPD.  Protection appears to relate to inhibition of oxidative damage and down-regulation of the smoke-induced inflammatory response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm-d4sj2ZP6LVg90H21EOLACvtfcHk0ljh5DZkUu4B1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitF2rsL4%253D&md5=2ed38089e836610c8e067acbac2015ad</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1164%2Frccm.201103-0468OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.201103-0468OC%26sid%3Dliteratum%253Aachs%26aulast%3DChurg%26aufirst%3DA.%26aulast%3DMarshall%26aufirst%3DC.%2BV.%26aulast%3DSin%26aufirst%3DD.%2BD.%26aulast%3DBolton%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DThain%26aufirst%3DK.%26aulast%3DCadogan%26aufirst%3DE.%2BB.%26aulast%3DMaltby%26aufirst%3DJ.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DMallinder%26aufirst%3DP.%2BR.%26aulast%3DWright%26aufirst%3DJ.%2BL.%26atitle%3DLate%2520intervention%2520with%2520a%2520myeloperoxidase%2520inhibitor%2520stops%2520progression%2520of%2520experimental%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2012%26volume%3D185%26spage%3D34%26epage%3D43%26doi%3D10.1164%2Frccm.201103-0468OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Odobasic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muljadi, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Sullivan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morand, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holdsworth, S. R.</span><span> </span><span class="NLM_article-title">Endogenous myeloperoxidase is a mediator of joint inflammation and damage in experimental arthritis</span> <span class="citation_source-journal">Arthritis Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">907</span><span class="NLM_x">–</span> <span class="NLM_lpage">917</span><span class="refDoi"> DOI: 10.1002/art.38299</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1002%2Fart.38299" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=24757143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtl2qtbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2014&pages=907-917&author=D.+Odobasicauthor=Y.+Yangauthor=R.+C.+Muljadiauthor=K.+M.+O%E2%80%99Sullivanauthor=W.+Kaoauthor=M.+Smithauthor=E.+F.+Morandauthor=S.+R.+Holdsworth&title=Endogenous+myeloperoxidase+is+a+mediator+of+joint+inflammation+and+damage+in+experimental+arthritis&doi=10.1002%2Fart.38299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous myeloperoxidase is a mediator of joint inflammation and damage in experimental arthritis</span></div><div class="casAuthors">Odobasic, Dragana; Yang, Yuan; Muljadi, Ruth C. M.; O'Sullivan, Kim M.; Kao, Wenping; Smith, Malcolm; Morand, Eric F.; Holdsworth, Stephen R.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">907-917</span>CODEN:
                <span class="NLM_cas:coden">ARRHBO</span>;
        ISSN:<span class="NLM_cas:issn">2326-5191</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. Myeloperoxidase (MPO) is implicated as a local mediator of tissue damage when released extracellularly in many chronic inflammatory diseases.  The purpose of this study was to explore the role of endogenous MPO in exptl. rheumatoid arthritis (RA).  Methods. K/BxN serum-transfer arthritis was induced in C57BL/6 wild-type (WT) and MPO knockout (MPO-/-) mice, and disease development was assessed.  MPO activity was measured in joint tissues from mice with or without K/BxN arthritis.  Collagen-induced arthritis (CIA) was induced in WT and MPO-/- mice, and disease development and immune responses were examd.  MPO expression was assessed in synovial biopsy samples from patients with active RA, and the effect of MPO on synovial fibroblasts was tested in vitro.  Results. MPO was up-regulated in the joints of mice with K/BxN arthritis, and MPO deficiency attenuated the severity of the disease without affecting circulating cytokine levels.  In CIA, MPO-/- mice had enhanced CD4+ T cell responses and reduced frequency of regulatory T cells in the lymph nodes and spleen, as well as augmented interleukin-17A and diminished interferon-γ secretion by collagen-stimulated splenocytes, without an effect on circulating anticollagen antibody levels.  Despite enhanced adaptive immunity in secondary lymphoid organs, CIA development was attenuated in MPO-/- mice.  Intracellular and extracellular MPO was detected in the synovium of patients with active RA, and human MPO enhanced the proliferation and decreased the apoptosis of synovial fibroblasts in vitro.  Conclusion. MPO contributes to the development of arthritis despite suppressing adaptive immunity in secondary lymphoid organs.  This suggests distinct effects of local MPO on arthritogenic effector responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdntnp3vzKTbVg90H21EOLACvtfcHk0lizcY1opjMblA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtl2qtbbJ&md5=8fdea9781dbe061cf3b681209e3d571d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fart.38299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.38299%26sid%3Dliteratum%253Aachs%26aulast%3DOdobasic%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DMuljadi%26aufirst%3DR.%2BC.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DK.%2BM.%26aulast%3DKao%26aufirst%3DW.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DMorand%26aufirst%3DE.%2BF.%26aulast%3DHoldsworth%26aufirst%3DS.%2BR.%26atitle%3DEndogenous%2520myeloperoxidase%2520is%2520a%2520mediator%2520of%2520joint%2520inflammation%2520and%2520damage%2520in%2520experimental%2520arthritis%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2014%26volume%3D66%26spage%3D907%26epage%3D917%26doi%3D10.1002%2Fart.38299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Odobasic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitching, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semple, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holdsworth, S. R.</span><span> </span><span class="NLM_article-title">Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis</span> <span class="citation_source-journal">J. Am. Soc. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">770</span><span class="refDoi"> DOI: 10.1681/ASN.2006040375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1681%2FASN.2006040375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=17267745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs1Grs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=760-770&author=D.+Odobasicauthor=A.+R.+Kitchingauthor=T.+J.+Sempleauthor=S.+R.+Holdsworth&title=Endogenous+myeloperoxidase+promotes+neutrophil-mediated+renal+injury%2C+but+attenuates+T+cell+immunity+inducing+crescentic+glomerulonephritis&doi=10.1681%2FASN.2006040375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis</span></div><div class="casAuthors">Odobasic, Dragana; Kitching, A. Richard; Semple, Timothy J.; Holdsworth, Stephen R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">760-770</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">Myeloperoxidase (MPO) is an enzyme that is found in neutrophils and monocytes/macrophages.  Intracellularly, it plays a major role in microbial killing, but extracellularly, it may cause host tissue damage.  The role of endogenous MPO was studied during neutrophil-mediated (heterologous) and T helper 1 (Th1)/macrophage-mediated (autologous) phases of crescentic glomerulonephritis.  Glomerulonephritis was induced in C57BL/6 wild-type (WT) and MPO-deficient (MPO-/-) mice by i.v. injection of sheep anti-mouse glomerular basement membrane globulin.  MPO activity was increased in kidneys of WT mice during both the heterologous and autologous phases of glomerulonephritis.  During the heterologous phase of glomerulonephritis, proteinuria was decreased, whereas glomerular neutrophil accumulation and P-selectin expression were enhanced in MPO-/- mice.  In the autologous, crescentic phase of glomerulonephritis, MPO-/- mice had increased accumulation of CD4+ cells and macrophages in glomeruli compared with WT mice.  However, no difference in renal injury (crescent formation, proteinuria, and serum creatinine levels) was obsd.  Neutrophils and macrophages from MPO-/- mice exhibited reduced prodn. of reactive oxygen species.  Assessment of systemic immunity to sheep globulin showed that MPO-/- mice had increased splenic CD4+ cell proliferation, cytokine prodn., and dermal delayed-type hypersensitivity, as well as enhanced levels of circulating IgG, IgG1, and IgG3.  MPO-/- mice also had an augmented Th1:Th2 ratio compared with WT mice (IFN-γ:IL-4 and IgG3:IgG1 ratios).  These results suggest that endogenous MPO locally contributes to glomerular damage during neutrophil-mediated glomerulonephritis, whereas it attenuates initiation of the adaptive immune response inducing crescentic, autologous-phase glomerulonephritis by suppressing T cell proliferation, cytokine prodn., and Th1:Th2 ratio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQi_AsILNfSLVg90H21EOLACvtfcHk0lizcY1opjMblA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs1Grs78%253D&md5=4396b682e831588c6470b20cf1860fb2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1681%2FASN.2006040375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2006040375%26sid%3Dliteratum%253Aachs%26aulast%3DOdobasic%26aufirst%3DD.%26aulast%3DKitching%26aufirst%3DA.%2BR.%26aulast%3DSemple%26aufirst%3DT.%2BJ.%26aulast%3DHoldsworth%26aufirst%3DS.%2BR.%26atitle%3DEndogenous%2520myeloperoxidase%2520promotes%2520neutrophil-mediated%2520renal%2520injury%252C%2520but%2520attenuates%2520T%2520cell%2520immunity%2520inducing%2520crescentic%2520glomerulonephritis%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2007%26volume%3D18%26spage%3D760%26epage%3D770%26doi%3D10.1681%2FASN.2006040375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Choi, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennathur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tieu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teismann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson-Lewis, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vila, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vonsattel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinecke, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przedborski, S.</span><span> </span><span class="NLM_article-title">Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson’s disease in mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">6594</span><span class="NLM_x">–</span> <span class="NLM_lpage">6600</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1523%2FJNEUROSCI.0970-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=16014720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmslCltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=6594-6600&author=D.+K.+Choiauthor=S.+Pennathurauthor=C.+Perierauthor=K.+Tieuauthor=P.+Teismannauthor=D.+C.+Wuauthor=V.+Jackson-Lewisauthor=M.+Vilaauthor=J.+P.+Vonsattelauthor=J.+W.+Heineckeauthor=S.+Przedborski&title=Ablation+of+the+inflammatory+enzyme+myeloperoxidase+mitigates+features+of+Parkinson%E2%80%99s+disease+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice</span></div><div class="casAuthors">Choi, Dong-Kug; Pennathur, Subramaniam; Perier, Celine; Tieu, Kim; Teismann, Peter; Wu, Du-Chu; Jackson-Lewis, Vernice; Vila, Miquel; Vonsattel, Jean-Paul; Heinecke, Jay W.; Przedborski, Serge</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">6594-6600</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) is characterized by a loss of ventral midbrain dopaminergic neurons, which can be modeled by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).  Inflammatory oxidants have emerged as key contributors to PD- and MPTP-related neurodegeneration.  Here, the authors show that myeloperoxidase (MPO), a key oxidant-producing enzyme during inflammation, is upregulated in the ventral midbrain of human PD and MPTP mice.  We also show that ventral midbrain dopaminergic neurons of mutant mice deficient in MPO are more resistant to MPTP-induced cytotoxicity than their wild-type littermates.  Supporting the oxidative damaging role of MPO in this PD model are the demonstrations that MPO-specific biomarkers 3-chlorotyrosine and hypochlorous acid-modified proteins increase in the brains of MPTP-injected mice.  This study demonstrates that MPO participates in the MPTP neurotoxic process and suggests that inhibitors of MPO may provide a protective benefit in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpigWoYeLTtu7Vg90H21EOLACvtfcHk0lizcY1opjMblA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmslCltLc%253D&md5=52e92e299bf03863ce83399e3e209eb4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0970-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0970-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DD.%2BK.%26aulast%3DPennathur%26aufirst%3DS.%26aulast%3DPerier%26aufirst%3DC.%26aulast%3DTieu%26aufirst%3DK.%26aulast%3DTeismann%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DD.%2BC.%26aulast%3DJackson-Lewis%26aufirst%3DV.%26aulast%3DVila%26aufirst%3DM.%26aulast%3DVonsattel%26aufirst%3DJ.%2BP.%26aulast%3DHeinecke%26aufirst%3DJ.%2BW.%26aulast%3DPrzedborski%26aufirst%3DS.%26atitle%3DAblation%2520of%2520the%2520inflammatory%2520enzyme%2520myeloperoxidase%2520mitigates%2520features%2520of%2520Parkinson%25E2%2580%2599s%2520disease%2520in%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D6594%26epage%3D6600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Mayyas, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Jarrah, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alzoubi, K. H.</span><span> </span><span class="NLM_article-title">Level and significance of plasma myeloperoxidase and the neutrophil to lymphocyte ratio in patients with coronary artery disease</span> <span class="citation_source-journal">Exp. Ther. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1951</span><span class="NLM_x">–</span> <span class="NLM_lpage">1957</span><span class="refDoi"> DOI: 10.3892/etm.2014.2034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.3892%2Fetm.2014.2034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=25371762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislGhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=1951-1957&author=F.+A.+Mayyasauthor=M.+I.+Al-Jarrahauthor=K.+S.+Ibrahimauthor=K.+H.+Alzoubi&title=Level+and+significance+of+plasma+myeloperoxidase+and+the+neutrophil+to+lymphocyte+ratio+in+patients+with+coronary+artery+disease&doi=10.3892%2Fetm.2014.2034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Level and significance of plasma myeloperoxidase and the neutrophil to lymphocyte ratio in patients with coronary artery disease</span></div><div class="casAuthors">Mayyas, Fadia A.; Al-Jarrah, Mohammad I.; Ibrahim, Khalid S.; Alzoubi, Karem H.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Therapeutic Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1951-1957</span>CODEN:
                <span class="NLM_cas:coden">ETMXA2</span>;
        ISSN:<span class="NLM_cas:issn">1792-0981</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Inflammation plays a pivotal role in the etiol. of coronary artery disease (CAD).  Myeloperoxidase (MPO) is a potent inflammatory factor and a crit. modulator of coronary inflammation and oxidative stress.  The goal of this study was to det. the impact of the plasma MPO (pMPO) level and neutrophil/lymphocyte ratio on the clin. characteristics and outcomes of patients with CAD.  Blood samples were collected from 210 patients with underlying chest pain or recent myocardial infarction (MI) prior to coronary angiog. in order to measure pMPO levels.  The pMPO levels and neutrophil/lymphocyte ratio were correlated with clin. characteristics and outcomes following catheterization.  The pMPO level and neutrophil/lymphocyte ratio were higher in patients with recent MI than in patients with CAD (coronary occlusion ≥50%) or without CAD (coronary occlusion <50%).  Patients with ST segment elevated MI (STEMI) had a higher neutrophil/lymphocyte ratio relative to patients with non-STEMI.  The pMPO level was identified to correlate with the neutrophil/lymphocyte ratio and the need for coronary artery reperfusion by coronary artery bypass surgery or percutaneous coronary intervention.  Patients who were taking aspirin had lower pMPO levels and neutrophil/lymphocyte ratio compared with those who were not taking aspirin.  The plasma neutrophil/lymphocyte ratio was neg. assocd. with the left ventricular ejection fraction at baseline and the 30-day follow-up, whereas pMPO showed no correlation.  Multivariate anal. indicated that the pMPO level was pos. assocd. with MI, the neutrophil/lymphocyte ratio and coronary intervention.  The preoperative use of aspirin was assocd. with a lower pMPO level and neutrophil/lymphocyte ratio.  In conclusion, pMPO is pos. assocd. with MI, the neutrophil/lymphocyte ratio and coronary intervention.  The preoperative use of aspirin is assocd. with a lower pMPO level and neutrophil/lymphocyte ratio.  PMPO may serve as a predictor of coronary intervention and as a potential therapeutic target for the redn. of inflammation in patients with CAD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlWfDOmazGG7Vg90H21EOLACvtfcHk0ljohLoWiBl-zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislGhsw%253D%253D&md5=4e2e300f31bba5d4caf8b0e3baea3d6b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3892%2Fetm.2014.2034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fetm.2014.2034%26sid%3Dliteratum%253Aachs%26aulast%3DMayyas%26aufirst%3DF.%2BA.%26aulast%3DAl-Jarrah%26aufirst%3DM.%2BI.%26aulast%3DIbrahim%26aufirst%3DK.%2BS.%26aulast%3DAlzoubi%26aufirst%3DK.%2BH.%26atitle%3DLevel%2520and%2520significance%2520of%2520plasma%2520myeloperoxidase%2520and%2520the%2520neutrophil%2520to%2520lymphocyte%2520ratio%2520in%2520patients%2520with%2520coronary%2520artery%2520disease%26jtitle%3DExp.%2520Ther.%2520Med.%26date%3D2014%26volume%3D8%26spage%3D1951%26epage%3D1957%26doi%3D10.3892%2Fetm.2014.2034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, X.</span><span> </span><span class="NLM_article-title">Association between myeloperoxidase levels and risk of coronary artery disease</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">2136</span><span class="NLM_x">–</span> <span class="NLM_lpage">2142</span><span class="refDoi"> DOI: 10.1001/jama.286.17.2136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1001%2Fjama.286.17.2136" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2001&pages=2136-2142&author=R.+Zhangauthor=M.+L.+Brennanauthor=X.+Fu&title=Association+between+myeloperoxidase+levels+and+risk+of+coronary+artery+disease&doi=10.1001%2Fjama.286.17.2136"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1001%2Fjama.286.17.2136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.286.17.2136%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DBrennan%26aufirst%3DM.%2BL.%26aulast%3DFu%26aufirst%3DX.%26atitle%3DAssociation%2520between%2520myeloperoxidase%2520levels%2520and%2520risk%2520of%2520coronary%2520artery%2520disease%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2001%26volume%3D286%26spage%3D2136%26epage%3D2142%26doi%3D10.1001%2Fjama.286.17.2136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Ndrepepa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehilli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Beckerath, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schomig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastrati, A.</span><span> </span><span class="NLM_article-title">Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes</span> <span class="citation_source-journal">Eur. J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span><span class="refDoi"> DOI: 10.1111/j.1365-2362.2007.01908.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1111%2Fj.1365-2362.2007.01908.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=90-96&author=G.+Ndrepepaauthor=S.+Braunauthor=J.+Mehilliauthor=N.+von+Beckerathauthor=A.+Schomigauthor=A.+Kastrati&title=Myeloperoxidase+level+in+patients+with+stable+coronary+artery+disease+and+acute+coronary+syndromes&doi=10.1111%2Fj.1365-2362.2007.01908.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2362.2007.01908.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2362.2007.01908.x%26sid%3Dliteratum%253Aachs%26aulast%3DNdrepepa%26aufirst%3DG.%26aulast%3DBraun%26aufirst%3DS.%26aulast%3DMehilli%26aufirst%3DJ.%26aulast%3Dvon%2BBeckerath%26aufirst%3DN.%26aulast%3DSchomig%26aufirst%3DA.%26aulast%3DKastrati%26aufirst%3DA.%26atitle%3DMyeloperoxidase%2520level%2520in%2520patients%2520with%2520stable%2520coronary%2520artery%2520disease%2520and%2520acute%2520coronary%2520syndromes%26jtitle%3DEur.%2520J.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D38%26spage%3D90%26epage%3D96%26doi%3D10.1111%2Fj.1365-2362.2007.01908.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Heinecke, J. W.</span><span> </span><span class="NLM_article-title">Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis</span> <span class="citation_source-journal">Curr. Opin. Lipidol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span><span class="refDoi"> DOI: 10.1097/00041433-199710000-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1097%2F00041433-199710000-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=9335950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADyaK2sXmslGhur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=268-274&author=J.+W.+Heinecke&title=Mechanisms+of+oxidative+damage+of+low+density+lipoprotein+in+human+atherosclerosis&doi=10.1097%2F00041433-199710000-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis</span></div><div class="casAuthors">Heinecke, Jay W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Lipidology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">268-274</span>CODEN:
                <span class="NLM_cas:coden">COPLEU</span>;
        ISSN:<span class="NLM_cas:issn">0957-9672</span>.
    
            (<span class="NLM_cas:orgname">Rapid Science Publishers</span>)
        </div><div class="casAbstract">A review with 62 refs.  Oxidatively damaged LDL may play a crit. role in the pathogenesis of atherosclerotic vascular disease.  Several pathways promote LDL oxidn. in vitro but the physiol. relevant mechanisms have proven difficult to identify.  Detection of stable compds. that result from specific reaction pathways has provided the first insights into the mechanism of oxidative damage in the human artery wall.  Mass spectrometric anal. of protein oxidn. products isolated from atherosclerotic tissue implicate tyrosyl radical, reactive nitrogen intermediates and hypochlorous acid in LDL oxidn. and lesion formation in vivo.  Hypochlorous acid is only generated by the phagocytic enzyme myeloperoxidase, which can also generate tyrosyl radical and reactive nitrogen intermediates.  Chiral phase high-pressure liq. chromatog. anal. of lipid oxidn. products suggests that cellular lipoxygenases may also play a role at certain stages.  In contrast, LDL isolated from atherosclerotic tissue is not enriched in protein oxidn. products characteristic of free metal ions, which are the most widely studied in vitro model of LDL oxidn.  These observations provide the first direct chem. evidence for reaction pathways that promote LDL oxidn. in human atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjkgnn6gi0ObVg90H21EOLACvtfcHk0ljohLoWiBl-zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslGhur8%253D&md5=40f7d22467fdd48af83e0bdc9e41c995</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1097%2F00041433-199710000-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00041433-199710000-00005%26sid%3Dliteratum%253Aachs%26aulast%3DHeinecke%26aufirst%3DJ.%2BW.%26atitle%3DMechanisms%2520of%2520oxidative%2520damage%2520of%2520low%2520density%2520lipoprotein%2520in%2520human%2520atherosclerosis%26jtitle%3DCurr.%2520Opin.%2520Lipidol.%26date%3D1997%26volume%3D8%26spage%3D268%26epage%3D274%26doi%3D10.1097%2F00041433-199710000-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Smith, J. D.</span><span> </span><span class="NLM_article-title">Myeloperoxidase, inflammation, and dysfunctional HDL</span> <span class="citation_source-journal">J. Clin. Lipidol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span><span class="refDoi"> DOI: 10.1016/j.jacl.2010.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1016%2Fj.jacl.2010.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=21076633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FjsVegsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2010&pages=382-388&author=J.+D.+Smith&title=Myeloperoxidase%2C+inflammation%2C+and+dysfunctional+HDL&doi=10.1016%2Fj.jacl.2010.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein</span></div><div class="casAuthors">Smith Jonathan D</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical lipidology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">382-8</span>
        ISSN:<span class="NLM_cas:issn">1933-2874</span>.
    </div><div class="casAbstract">High-density lipoprotein (HDL) has many protective activities against atherosclerosis, including its role in reverse cholesterol transport, and its antioxidant, anti-inflammatory, and endothelial cell maintenance functions.  However, all HDL is not functionally equivalent.  The authors of recent studies have shown that infection, inflammation, diabetes, and coronary artery disease are associated with dysfunctional HDL.  HDL can lose its protective activities through a variety of mechanisms, including, but not limited to, altered protein composition, oxidative protein modification mediated by the enzyme myeloperoxidase, and lipid modification.  Studies in which the authors used bacterial endotoxin in humans and mice have directly demonstrated changes in HDL composition, loss of HDL's cholesterol acceptor activity, and decreased hepatic processing and secretion of cholesterol.  Although a routine clinical assay for dysfunctional HDL is not currently available, the development of such an assay would be beneficial for a better understanding of the role that dysfunctional HDL plays as a risk factor for coronary artery disease and for the determination of how various drug therapies effect HDL functionality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2jhjOFJQ9zGxpATR2EQURfW6udTcc2eaZXSmUxCSOILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FjsVegsw%253D%253D&md5=09a0c4805609155f65e221f5f41bd6fa</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jacl.2010.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacl.2010.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DJ.%2BD.%26atitle%3DMyeloperoxidase%252C%2520inflammation%252C%2520and%2520dysfunctional%2520HDL%26jtitle%3DJ.%2520Clin.%2520Lipidol.%26date%3D2010%26volume%3D4%26spage%3D382%26epage%3D388%26doi%3D10.1016%2Fj.jacl.2010.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Eiserich, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tousson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lusis, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nauseef, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, B. A.</span><span> </span><span class="NLM_article-title">Myeloperoxidase, a leukocyte-derived vascular NO oxidase</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">2391</span><span class="NLM_x">–</span> <span class="NLM_lpage">2394</span><span class="refDoi"> DOI: 10.1126/science.1106830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1126%2Fscience.1106830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=12089442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD38XltFWlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=2391-2394&author=J.+P.+Eiserichauthor=S.+Baldusauthor=M.+L.+Brennanauthor=W.+Maauthor=C.+Zhangauthor=A.+Toussonauthor=L.+Castroauthor=A.+J.+Lusisauthor=W.+M.+Nauseefauthor=C.+R.+Whiteauthor=B.+A.+Freeman&title=Myeloperoxidase%2C+a+leukocyte-derived+vascular+NO+oxidase&doi=10.1126%2Fscience.1106830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Myeloperoxidase, a leukocyte-derived vascular no oxidase</span></div><div class="casAuthors">Eiserich, Jason P.; Baldus, Stephan; Brennan, Marie-Luise; Ma, Wenxin; Zhang, Chunxiang; Tousson, Albert; Castro, Laura; Lusis, Aldons J.; Nauseef, William M.; White, C. Roger; Freeman, Bruce A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5577</span>),
    <span class="NLM_cas:pages">2391-2394</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Myeloperoxidase (MPO) is an abundant mammalian phagocyte hemoprotein thought to primarily mediate host defense reactions.  Although its microbicidal functions are well established in vitro, humans deficient in MPO are not at unusual risk of infection.  MPO was obsd. herein to modulate the vascular signaling and vasodilatory functions of nitric oxide (NO) during acute inflammation.  After leukocyte degranulation, MPO localized in and around vascular endothelial cells in a rodent model of acute endotoxemia and impaired endothelium-dependent relaxant responses, to which MPO-deficient mice were resistant.  Altered vascular responsiveness was due to catalytic consumption of NO by substrate radicals generated by MPO.  Thus MPO can directly modulate vascular inflammatory responses by regulating NO bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxB0ls1QynlLVg90H21EOLACvtfcHk0lg2r6mr7CVPHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltFWlu7Y%253D&md5=edbc2c97b86f24603ae0f1ab790af4e9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscience.1106830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1106830%26sid%3Dliteratum%253Aachs%26aulast%3DEiserich%26aufirst%3DJ.%2BP.%26aulast%3DBaldus%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DM.%2BL.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DTousson%26aufirst%3DA.%26aulast%3DCastro%26aufirst%3DL.%26aulast%3DLusis%26aufirst%3DA.%2BJ.%26aulast%3DNauseef%26aufirst%3DW.%2BM.%26aulast%3DWhite%26aufirst%3DC.%2BR.%26aulast%3DFreeman%26aufirst%3DB.%2BA.%26atitle%3DMyeloperoxidase%252C%2520a%2520leukocyte-derived%2520vascular%2520NO%2520oxidase%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D2391%26epage%3D2394%26doi%3D10.1126%2Fscience.1106830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Carr, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCall, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frei, B.</span><span> </span><span class="NLM_article-title">Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1716</span><span class="NLM_x">–</span> <span class="NLM_lpage">1723</span><span class="refDoi"> DOI: 10.1161/01.ATV.20.7.1716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1161%2F01.ATV.20.7.1716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10894808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFGnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=1716-1723&author=A.+C.+Carrauthor=M.+R.+McCallauthor=B.+Frei&title=Oxidation+of+LDL+by+myeloperoxidase+and+reactive+nitrogen+species%3A+reaction+pathways+and+antioxidant+protection&doi=10.1161%2F01.ATV.20.7.1716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation of LDL by myeloperoxidase and reactive nitrogen species. Reaction pathways and antioxidant protection</span></div><div class="casAuthors">Carr, Anitra C.; McCall, Mark R.; Frei, Balz</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1716-1723</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review is given with 106 refs. on reaction pathways involved in low d. lipoprotein (LDL) oxidn. by myeloperoxidase and reactive N species and the potential protective effects of the antioxidant vitamins C and E.  Oxidative modification of LDL appears to play an important role in atherogenesis.  Although the precise mechanisms of LDL oxidn. in vivo are unknown, several lines of evidence implicate myeloperoxidase and reactive N species, in addn. to ceruloplasmin and 15-lipoxygenase.  Myeloperoxidase generates a no. of reactive species, including hypochlorous acid, chloramines, tyrosyl radicals, and NO2.  These reactive species oxidize the protein, lipid, and antioxidant components of LDL.  Modification of apolipoprotein B results in enhanced uptake of LDL by macrophages with subsequent formation of lipid-laden foam cells.  NO synthases produce NO and, under certain conditions, superoxide radicals.  Numerous other sources of superoxide radicals were identified in the arterial wall, including NAD(P)H oxidases and xanthine oxidase.  NO and superoxide readily combine to form peroxynitrite, a reactive N species capable of modifying LDL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8srA7BRxfMrVg90H21EOLACvtfcHk0lg2r6mr7CVPHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFGnsb8%253D&md5=79aee0904cbc249ed08a84495f3e7f5c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1161%2F01.ATV.20.7.1716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.ATV.20.7.1716%26sid%3Dliteratum%253Aachs%26aulast%3DCarr%26aufirst%3DA.%2BC.%26aulast%3DMcCall%26aufirst%3DM.%2BR.%26aulast%3DFrei%26aufirst%3DB.%26atitle%3DOxidation%2520of%2520LDL%2520by%2520myeloperoxidase%2520and%2520reactive%2520nitrogen%2520species%253A%2520reaction%2520pathways%2520and%2520antioxidant%2520protection%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2000%26volume%3D20%26spage%3D1716%26epage%3D1723%26doi%3D10.1161%2F01.ATV.20.7.1716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Sepe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, R. A.</span><span> </span><span class="NLM_article-title">Oxidant membrane injury by the neutrophil myeloperoxidase system. II. Injury by stimulated neutrophils and protection by lipid-soluble antioxidants</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">1896</span><span class="NLM_x">–</span> <span class="NLM_lpage">1901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=1985&pages=1896-1901&author=S.+M.+Sepeauthor=R.+A.+Clark&title=Oxidant+membrane+injury+by+the+neutrophil+myeloperoxidase+system.+II.+Injury+by+stimulated+neutrophils+and+protection+by+lipid-soluble+antioxidants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSepe%26aufirst%3DS.%2BM.%26aulast%3DClark%26aufirst%3DR.%2BA.%26atitle%3DOxidant%2520membrane%2520injury%2520by%2520the%2520neutrophil%2520myeloperoxidase%2520system.%2520II.%2520Injury%2520by%2520stimulated%2520neutrophils%2520and%2520protection%2520by%2520lipid-soluble%2520antioxidants%26jtitle%3DJ.%2520Immunol.%26date%3D1985%26volume%3D134%26spage%3D1896%26epage%3D1901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Askari, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinko, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morehead, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topol, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penn, M. S.</span><span> </span><span class="NLM_article-title">Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">197</span><span class="NLM_x">, </span> <span class="NLM_fpage">615</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span><span class="refDoi"> DOI: 10.1084/jem.20021426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1084%2Fjem.20021426" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2003&pages=615-624&author=A.+T.+Askariauthor=M.+L.+Brennanauthor=X.+Zhouauthor=J.+Drinkoauthor=A.+Moreheadauthor=J.+D.+Thomasauthor=E.+J.+Topolauthor=S.+L.+Hazenauthor=M.+S.+Penn&title=Myeloperoxidase+and+plasminogen+activator+inhibitor+1+play+a+central+role+in+ventricular+remodeling+after+myocardial+infarction&doi=10.1084%2Fjem.20021426"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1084%2Fjem.20021426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20021426%26sid%3Dliteratum%253Aachs%26aulast%3DAskari%26aufirst%3DA.%2BT.%26aulast%3DBrennan%26aufirst%3DM.%2BL.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DDrinko%26aufirst%3DJ.%26aulast%3DMorehead%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DJ.%2BD.%26aulast%3DTopol%26aufirst%3DE.%2BJ.%26aulast%3DHazen%26aufirst%3DS.%2BL.%26aulast%3DPenn%26aufirst%3DM.%2BS.%26atitle%3DMyeloperoxidase%2520and%2520plasminogen%2520activator%2520inhibitor%25201%2520play%2520a%2520central%2520role%2520in%2520ventricular%2520remodeling%2520after%2520myocardial%2520infarction%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2003%26volume%3D197%26spage%3D615%26epage%3D624%26doi%3D10.1084%2Fjem.20021426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Penn, M. S.</span><span> </span><span class="NLM_article-title">The role of leukocyte-generated oxidants in left ventricular remodeling</span> <span class="citation_source-journal">Am. J. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">S30</span><span class="NLM_x">–</span> <span class="NLM_lpage">S33</span><span class="refDoi"> DOI: 10.1016/j.amjcard.2008.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1016%2Fj.amjcard.2008.02.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2008&pages=S30-S33&author=M.+S.+Penn&title=The+role+of+leukocyte-generated+oxidants+in+left+ventricular+remodeling&doi=10.1016%2Fj.amjcard.2008.02.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.amjcard.2008.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjcard.2008.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DPenn%26aufirst%3DM.%2BS.%26atitle%3DThe%2520role%2520of%2520leukocyte-generated%2520oxidants%2520in%2520left%2520ventricular%2520remodeling%26jtitle%3DAm.%2520J.%2520Cardiol.%26date%3D2008%26volume%3D101%26spage%3DS30%26epage%3DS33%26doi%3D10.1016%2Fj.amjcard.2008.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span>Openinnovation. AZD-5904. <a href="http://openinnovation.astrazeneca.com/what-we-offer/compound/azd5904/" class="extLink">http://openinnovation.astrazeneca.com/what-we-offer/compound/azd5904/</a> (accessed Aug 19,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Openinnovation.+AZD-5904.+http%3A%2F%2Fopeninnovation.astrazeneca.com%2Fwhat-we-offer%2Fcompound%2Fazd5904%2F+%28accessed+Aug+19%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span>AZD3241 PET MSA Trial, Phase 2, Randomized, 12 Week Safety and Tolerability Trial with PET in MSA Patients. <a href="https://clinicaltrials.gov/ct2/show/NCT02388295" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02388295</a> (accessed Aug 19,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=AZD3241+PET+MSA+Trial%2C+Phase+2%2C+Randomized%2C+12+Week+Safety+and+Tolerability+Trial+with+PET+in+MSA+Patients.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02388295+%28accessed+Aug+19%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Davies, M. J.</span><span> </span><span class="NLM_article-title">Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention</span> <span class="citation_source-journal">J. Clin. Biochem. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span><span class="refDoi"> DOI: 10.3164/jcbn.11-006FR</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.3164%2Fjcbn.11-006FR" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=21297906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltlektL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2011&pages=8-19&author=M.+J.+Davies&title=Myeloperoxidase-derived+oxidation%3A+mechanisms+of+biological+damage+and+its+prevention&doi=10.3164%2Fjcbn.11-006FR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention</span></div><div class="casAuthors">Davies, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Biochemistry and Nutrition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-19</span>CODEN:
                <span class="NLM_cas:coden">JCBNER</span>;
        ISSN:<span class="NLM_cas:issn">0912-0009</span>.
    
            (<span class="NLM_cas:orgname">Society for Free Radical Research Japan</span>)
        </div><div class="casAbstract">A review.  There is considerable interest in the role that mammalian heme peroxidases, primarily myeloperoxidase, eosinophil peroxidase, and lactoperoxidase, may play in a wide range of human pathologies.  This has been sparked by rapid developments in the understanding of the basic biochem. of these enzymes, a greater understanding of the basic chem. and biochem. of the oxidants formed by these species, the development of biomarkers that can be used damage induced by these oxidants in vivo, and the recent identification of a no. of compds. that show promise as inhibitors of these enzymes.  Such compds. offer the possibility of modulating damage in a no. of human pathologies.  Here, the author reviews recent developments in the understanding of the biochem. of myeloperoxidase, the oxidants that this enzyme generates, and the use of inhibitors to inhibit such damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXxA-752ozj7Vg90H21EOLACvtfcHk0ljfYCs9rYjThQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltlektL0%253D&md5=b36621bb16b9c0827d46a68a89b0aeb3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3164%2Fjcbn.11-006FR&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3164%252Fjcbn.11-006FR%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DM.%2BJ.%26atitle%3DMyeloperoxidase-derived%2520oxidation%253A%2520mechanisms%2520of%2520biological%2520damage%2520and%2520its%2520prevention%26jtitle%3DJ.%2520Clin.%2520Biochem.%2520Nutr.%26date%3D2011%26volume%3D48%26spage%3D8%26epage%3D19%26doi%3D10.3164%2Fjcbn.11-006FR" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lobach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uetrecht, J.</span><span> </span><span class="NLM_article-title">Involvement of myeloperoxidase and NADPH oxidase in the covalent binding of amodiaquine and clozapine to neutrophils: implications for drug-induced agranulocytosis</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">709</span><span class="refDoi"> DOI: 10.1021/tx500019u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx500019u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=699-709&author=A.+R.+Lobachauthor=J.+Uetrecht&title=Involvement+of+myeloperoxidase+and+NADPH+oxidase+in+the+covalent+binding+of+amodiaquine+and+clozapine+to+neutrophils%3A+implications+for+drug-induced+agranulocytosis&doi=10.1021%2Ftx500019u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Ftx500019u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx500019u%26sid%3Dliteratum%253Aachs%26aulast%3DLobach%26aufirst%3DA.%2BR.%26aulast%3DUetrecht%26aufirst%3DJ.%26atitle%3DInvolvement%2520of%2520myeloperoxidase%2520and%2520NADPH%2520oxidase%2520in%2520the%2520covalent%2520binding%2520of%2520amodiaquine%2520and%2520clozapine%2520to%2520neutrophils%253A%2520implications%2520for%2520drug-induced%2520agranulocytosis%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2014%26volume%3D27%26spage%3D699%26epage%3D709%26doi%3D10.1021%2Ftx500019u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Svensson, B. E.</span><span> </span><span class="NLM_article-title">Thiols as myeloperoxidase-oxidase substrates</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">253</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1042/bj2530441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1042%2Fbj2530441" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1988&pages=441-449&author=B.+E.+Svensson&title=Thiols+as+myeloperoxidase-oxidase+substrates&doi=10.1042%2Fbj2530441"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1042%2Fbj2530441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2530441%26sid%3Dliteratum%253Aachs%26aulast%3DSvensson%26aufirst%3DB.%2BE.%26atitle%3DThiols%2520as%2520myeloperoxidase-oxidase%2520substrates%26jtitle%3DBiochem.%2520J.%26date%3D1988%26volume%3D253%26spage%3D441%26epage%3D449%26doi%3D10.1042%2Fbj2530441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Malle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furtmuller, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sattler, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obinger, C.</span><span> </span><span class="NLM_article-title">Myeloperoxidase: a target for new drug development?</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">838</span><span class="NLM_x">–</span> <span class="NLM_lpage">854</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0707358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1038%2Fsj.bjp.0707358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=17592500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ynt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2007&pages=838-854&author=E.+Malleauthor=P.+G.+Furtmullerauthor=W.+Sattlerauthor=C.+Obinger&title=Myeloperoxidase%3A+a+target+for+new+drug+development%3F&doi=10.1038%2Fsj.bjp.0707358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Myeloperoxidase: a target for new drug development?</span></div><div class="casAuthors">Malle, E.; Furtmueller, P. G.; Sattler, W.; Obinger, C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">838-854</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Myeloperoxidase (MPO), a member of the haem peroxidase-cyclooxygenase superfamily, is abundantly expressed in neutrophils and to a lesser extent in monocytes and certain type of macrophages.  MPO participates in innate immune defense mechanism through formation of microbicidal reactive oxidants and diffusible radical species.  A unique activity of MPO is its ability to use chloride as a cosubstrate with hydrogen peroxide to generate chlorinating oxidants such as hypochlorous acid, a potent antimicrobial agent.  However, evidence has emerged that MPO-derived oxidants contribute to tissue damage and the initiation and propagation of acute and chronic vascular inflammatory disease.  The fact that circulating levels of MPO have been shown to predict risks for major adverse cardiac events and that levels of MPO-derived chlorinated compds. are specific biomarkers for disease progression, has attracted considerable interest in the development of therapeutically useful MPO inhibitors.  Today, detailed information on the structure of ferric MPO and its complexes with low- and high-spin ligands is available.  This, together with a thorough understanding of reaction mechanisms including redox properties of intermediates, enables a rationale attempt in developing specific MPO inhibitors that still maintain MPO activity during host defense and bacterial killing but interfere with pathophysiol. persistent activation of MPO.  The various approaches to inhibit enzyme activity of MPO and to ameliorate adverse effects of MPO-derived oxidants will be discussed.  Emphasis will be put on mechanism-based inhibitors and high-throughput screening of compds. as well as the discussion of physiol. useful HOCl scavengers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp67Q9sFmtWZrVg90H21EOLACvtfcHk0ljfYCs9rYjThQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ynt7vI&md5=86fa4f96cd7b529e73fd9d6bb8b3a91a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707358%26sid%3Dliteratum%253Aachs%26aulast%3DMalle%26aufirst%3DE.%26aulast%3DFurtmuller%26aufirst%3DP.%2BG.%26aulast%3DSattler%26aufirst%3DW.%26aulast%3DObinger%26aufirst%3DC.%26atitle%3DMyeloperoxidase%253A%2520a%2520target%2520for%2520new%2520drug%2520development%253F%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D152%26spage%3D838%26epage%3D854%26doi%3D10.1038%2Fsj.bjp.0707358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Hsuanyu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunford, H. B.</span><span> </span><span class="NLM_article-title">Oxidation of clozapine and ascorbate by myeloperoxidase</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span><span class="refDoi"> DOI: 10.1006/abbi.1999.1328</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1006%2Fabbi.1999.1328" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=1999&pages=413-420&author=Y.+Hsuanyuauthor=H.+B.+Dunford&title=Oxidation+of+clozapine+and+ascorbate+by+myeloperoxidase&doi=10.1006%2Fabbi.1999.1328"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1999.1328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1999.1328%26sid%3Dliteratum%253Aachs%26aulast%3DHsuanyu%26aufirst%3DY.%26aulast%3DDunford%26aufirst%3DH.%2BB.%26atitle%3DOxidation%2520of%2520clozapine%2520and%2520ascorbate%2520by%2520myeloperoxidase%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1999%26volume%3D368%26spage%3D413%26epage%3D420%26doi%3D10.1006%2Fabbi.1999.1328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Forbes, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furtmuller, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khalilova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettle, A. J.</span><span> </span><span class="NLM_article-title">Isoniazid as a substrate and inhibitor of myeloperoxidase: Identification of amine adducts and the influence of superoxide dismutase on their formation</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span><span class="refDoi"> DOI: 10.1016/j.bcp.2012.07.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1016%2Fj.bcp.2012.07.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=22846601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Sku7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=949-960&author=L.+V.+Forbesauthor=P.+G.+Furtmullerauthor=I.+Khalilovaauthor=R.+Turnerauthor=C.+Obingerauthor=A.+J.+Kettle&title=Isoniazid+as+a+substrate+and+inhibitor+of+myeloperoxidase%3A+Identification+of+amine+adducts+and+the+influence+of+superoxide+dismutase+on+their+formation&doi=10.1016%2Fj.bcp.2012.07.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Isoniazid as a substrate and inhibitor of myeloperoxidase: Identification of amine adducts and the influence of superoxide dismutase on their formation</span></div><div class="casAuthors">Forbes, Louisa V.; Furtmuller, Paul G.; Khalilova, Irada; Turner, Rufus; Obinger, Christian; Kettle, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">949-960</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neutrophils ingest Mycobacteria tuberculosis (Mtb) in the lungs of infected individuals.  During phagocytosis they use myeloperoxidase (MPO) to catalyze prodn. of hypochlorous acid (HOCl), their most potent antimicrobial agent.  Isoniazid (INH), the foremost antibiotic in the treatment of tuberculosis, is oxidized by MPO.  It rapidly reduced compd. I of MPO [k = (1.22 ± 0.05) × 106 M-1 s-1] but reacted less favorably with compd. II [(9.8 ± 0.6) × 102 M-1 s-1].  Oxidn. of INH by MPO and hydrogen peroxide was unaffected by chloride, the physiol. substrate for compd. I, and the enzyme was partially converted to compd. III.  This indicates that INH is oxidized outside the classical peroxidn. cycle.  In combination with superoxide dismutase (SOD), MPO oxidized INH without exogenous hydrogen peroxide.  SOD must favor redn. of oxygen by the INH radical to give superoxide and ultimately hydrogen peroxide.  In both oxidn. systems, an adduct with methionine was formed and it was a major product with MPO and SOD.  We show that it is a conjugate of an acyldiimide with amines.  INH substantially inhibited HOCl prodn. by MPO and neutrophils below pharmacol. concns.  The reversible inhibition is explained by diversion of MPO to its ferrous and compd. III forms during oxidn. of INH.  MPO, along with SOD released by Mtb, will oxidize INH at sites of infection and their interactions are likely to limit the efficacy of the drug, promote adverse drug reactions via formation of protein adducts, and impair a major bacterial killing mechanism of neutrophils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGGVc8OypFGrVg90H21EOLACvtfcHk0ljulgqwct3wWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Sku7zF&md5=6a5ff73a6dd4d0bddca26ecad4cbe0a9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.07.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.07.020%26sid%3Dliteratum%253Aachs%26aulast%3DForbes%26aufirst%3DL.%2BV.%26aulast%3DFurtmuller%26aufirst%3DP.%2BG.%26aulast%3DKhalilova%26aufirst%3DI.%26aulast%3DTurner%26aufirst%3DR.%26aulast%3DObinger%26aufirst%3DC.%26aulast%3DKettle%26aufirst%3DA.%2BJ.%26atitle%3DIsoniazid%2520as%2520a%2520substrate%2520and%2520inhibitor%2520of%2520myeloperoxidase%253A%2520Identification%2520of%2520amine%2520adducts%2520and%2520the%2520influence%2520of%2520superoxide%2520dismutase%2520on%2520their%2520formation%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26spage%3D949%26epage%3D960%26doi%3D10.1016%2Fj.bcp.2012.07.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Kettle, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maroz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodroffe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winterbourn, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, R. F.</span><span> </span><span class="NLM_article-title">Spectral and kinetic evidence for reaction of superoxide with compound I of myeloperoxidase</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2190</span><span class="NLM_x">–</span> <span class="NLM_lpage">2194</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2011.09.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1016%2Fj.freeradbiomed.2011.09.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=22002086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFegu7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=2190-2194&author=A.+J.+Kettleauthor=A.+Marozauthor=G.+Woodroffeauthor=C.+C.+Winterbournauthor=R.+F.+Anderson&title=Spectral+and+kinetic+evidence+for+reaction+of+superoxide+with+compound+I+of+myeloperoxidase&doi=10.1016%2Fj.freeradbiomed.2011.09.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Spectral and kinetic evidence for reaction of superoxide with compound I of myeloperoxidase</span></div><div class="casAuthors">Kettle, Anthony J.; Maroz, Andrej; Woodroffe, Grant; Winterbourn, Christine C.; Anderson, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2190-2194</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Superoxide and myeloperoxidase (MPO) are essential for the oxidative killing of bacteria by neutrophils.  Previously, the authors developed a kinetic model to demonstrate that within the confines of neutrophil phagosomes, superoxide should react exclusively with MPO and be converted to hypochlorous acid (HClO).  The model consists of all known reactions and rate consts. for reactions of superoxide, H2O2, and Cl- with MPO, except for the reaction of superoxide with compd. I, which could only be estd.  Compd. I is a transitory redox intermediate of MPO that is responsible for oxidizing Cl- to HClO.  To tackle the challenge of observing the reaction between the 2 transient species, the authors combined stopped-flow spectrophotometry with pulse radiolysis.  Using this technique, the authors directly obsd. the redn. of compd. I by superoxide.  The rate const. for the reaction was detd. to be 5.6 × 106 M-1 s-1.  This value established superoxide as one of the best substrates for compd. I, and based on this value, the rate const. for the redn. of compd. II by superoxide was detd. to be 1.2 × 106 M-1 s-1.  Within phagosomes, the redn. of compd. I by superoxide will compete with the oxidn. of Cl- so that the relative concns. of these 2 substrates will affect the yield of HClO.  The characterization of this reaction confirmed that superoxide is a physiol. substrate for MPO and that their interactions are central to an important host defense mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWsT0UHv116LVg90H21EOLACvtfcHk0ljulgqwct3wWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFegu7zE&md5=7b8185934ae9830f73a4d2f5b780848b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2011.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2011.09.019%26sid%3Dliteratum%253Aachs%26aulast%3DKettle%26aufirst%3DA.%2BJ.%26aulast%3DMaroz%26aufirst%3DA.%26aulast%3DWoodroffe%26aufirst%3DG.%26aulast%3DWinterbourn%26aufirst%3DC.%2BC.%26aulast%3DAnderson%26aufirst%3DR.%2BF.%26atitle%3DSpectral%2520and%2520kinetic%2520evidence%2520for%2520reaction%2520of%2520superoxide%2520with%2520compound%2520I%2520of%2520myeloperoxidase%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2011%26volume%3D51%26spage%3D2190%26epage%3D2194%26doi%3D10.1016%2Fj.freeradbiomed.2011.09.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Marquez, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunford, H. B.</span><span> </span><span class="NLM_article-title">Kinetics of oxidation of tyrosine and dityrosine by myeloperoxidase compounds I and II. Implications for lipoprotein peroxidation studies</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">30434</span><span class="NLM_x">–</span> <span class="NLM_lpage">30440</span><span class="refDoi"> DOI: 10.1074/jbc.270.51.30434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1074%2Fjbc.270.51.30434" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=30434-30440&author=L.+A.+Marquezauthor=H.+B.+Dunford&title=Kinetics+of+oxidation+of+tyrosine+and+dityrosine+by+myeloperoxidase+compounds+I+and+II.+Implications+for+lipoprotein+peroxidation+studies&doi=10.1074%2Fjbc.270.51.30434"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.51.30434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.51.30434%26sid%3Dliteratum%253Aachs%26aulast%3DMarquez%26aufirst%3DL.%2BA.%26aulast%3DDunford%26aufirst%3DH.%2BB.%26atitle%3DKinetics%2520of%2520oxidation%2520of%2520tyrosine%2520and%2520dityrosine%2520by%2520myeloperoxidase%2520compounds%2520I%2520and%2520II.%2520Implications%2520for%2520lipoprotein%2520peroxidation%2520studies%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D30434%26epage%3D30440%26doi%3D10.1074%2Fjbc.270.51.30434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Meotti, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jameson, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harwood, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettle, A. J.</span><span> </span><span class="NLM_article-title">Urate as a physiological substrate for myeloperoxidase: implications for hyperuricemia and inflammation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">12901</span><span class="NLM_x">–</span> <span class="NLM_lpage">12911</span><span class="refDoi"> DOI: 10.1074/jbc.M110.172460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1074%2Fjbc.M110.172460" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=12901-12911&author=F.+C.+Meottiauthor=G.+N.+Jamesonauthor=R.+Turnerauthor=D.+T.+Harwoodauthor=S.+Stockwellauthor=M.+D.+Reesauthor=S.+R.+Thomasauthor=A.+J.+Kettle&title=Urate+as+a+physiological+substrate+for+myeloperoxidase%3A+implications+for+hyperuricemia+and+inflammation&doi=10.1074%2Fjbc.M110.172460"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.172460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.172460%26sid%3Dliteratum%253Aachs%26aulast%3DMeotti%26aufirst%3DF.%2BC.%26aulast%3DJameson%26aufirst%3DG.%2BN.%26aulast%3DTurner%26aufirst%3DR.%26aulast%3DHarwood%26aufirst%3DD.%2BT.%26aulast%3DStockwell%26aufirst%3DS.%26aulast%3DRees%26aufirst%3DM.%2BD.%26aulast%3DThomas%26aufirst%3DS.%2BR.%26aulast%3DKettle%26aufirst%3DA.%2BJ.%26atitle%3DUrate%2520as%2520a%2520physiological%2520substrate%2520for%2520myeloperoxidase%253A%2520implications%2520for%2520hyperuricemia%2520and%2520inflammation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D12901%26epage%3D12911%26doi%3D10.1074%2Fjbc.M110.172460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Kettle, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedye, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winterbourn, C. C.</span><span> </span><span class="NLM_article-title">Superoxide is an antagonist of anti-inflammatory drugs that inhibit hypochlorous acid production by myeloperoxidase</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2003</span><span class="NLM_x">–</span> <span class="NLM_lpage">2010</span><span class="refDoi"> DOI: 10.1016/0006-2952(93)90010-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1016%2F0006-2952%2893%2990010-T" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1993&pages=2003-2010&author=A.+J.+Kettleauthor=C.+A.+Gedyeauthor=C.+C.+Winterbourn&title=Superoxide+is+an+antagonist+of+anti-inflammatory+drugs+that+inhibit+hypochlorous+acid+production+by+myeloperoxidase&doi=10.1016%2F0006-2952%2893%2990010-T"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2893%2990010-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252893%252990010-T%26sid%3Dliteratum%253Aachs%26aulast%3DKettle%26aufirst%3DA.%2BJ.%26aulast%3DGedye%26aufirst%3DC.%2BA.%26aulast%3DWinterbourn%26aufirst%3DC.%2BC.%26atitle%3DSuperoxide%2520is%2520an%2520antagonist%2520of%2520anti-inflammatory%2520drugs%2520that%2520inhibit%2520hypochlorous%2520acid%2520production%2520by%2520myeloperoxidase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1993%26volume%3D45%26spage%3D2003%26epage%3D2010%26doi%3D10.1016%2F0006-2952%2893%2990010-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Tiden, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjogren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernlind, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senthilmohan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auchere, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markgren, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundquist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magon, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paton, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jameson, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettle, A. J.</span><span> </span><span class="NLM_article-title">2-Thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">37578</span><span class="NLM_x">–</span> <span class="NLM_lpage">37589</span><span class="refDoi"> DOI: 10.1074/jbc.M111.266981</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1074%2Fjbc.M111.266981" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=37578-37589&author=A.+K.+Tidenauthor=T.+Sjogrenauthor=M.+Svenssonauthor=A.+Bernlindauthor=R.+Senthilmohanauthor=F.+Auchereauthor=H.+Normanauthor=P.+O.+Markgrenauthor=S.+Gustavssonauthor=S.+Schmidtauthor=S.+Lundquistauthor=L.+V.+Forbesauthor=N.+J.+Magonauthor=L.+N.+Patonauthor=G.+N.+Jamesonauthor=H.+Erikssonauthor=A.+J.+Kettle&title=2-Thioxanthines+are+mechanism-based+inactivators+of+myeloperoxidase+that+block+oxidative+stress+during+inflammation&doi=10.1074%2Fjbc.M111.266981"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.266981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.266981%26sid%3Dliteratum%253Aachs%26aulast%3DTiden%26aufirst%3DA.%2BK.%26aulast%3DSjogren%26aufirst%3DT.%26aulast%3DSvensson%26aufirst%3DM.%26aulast%3DBernlind%26aufirst%3DA.%26aulast%3DSenthilmohan%26aufirst%3DR.%26aulast%3DAuchere%26aufirst%3DF.%26aulast%3DNorman%26aufirst%3DH.%26aulast%3DMarkgren%26aufirst%3DP.%2BO.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DLundquist%26aufirst%3DS.%26aulast%3DForbes%26aufirst%3DL.%2BV.%26aulast%3DMagon%26aufirst%3DN.%2BJ.%26aulast%3DPaton%26aufirst%3DL.%2BN.%26aulast%3DJameson%26aufirst%3DG.%2BN.%26aulast%3DEriksson%26aufirst%3DH.%26aulast%3DKettle%26aufirst%3DA.%2BJ.%26atitle%3D2-Thioxanthines%2520are%2520mechanism-based%2520inactivators%2520of%2520myeloperoxidase%2520that%2520block%2520oxidative%2520stress%2520during%2520inflammation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D37578%26epage%3D37589%26doi%3D10.1074%2Fjbc.M111.266981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varghese, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessire, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conboy, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spath, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippov, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrad, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpino, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimaraes, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajdos, F. F.</span><span> </span><span class="NLM_article-title">Deconstruction of activity-dependent covalent modification of heme in human neutrophil myeloperoxidase by multistage mass spectrometry (MS(4))</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2065</span><span class="NLM_x">–</span> <span class="NLM_lpage">2077</span><span class="refDoi"> DOI: 10.1021/bi201872j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi201872j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=2065-2077&author=K.+F.+Geogheganauthor=A.+H.+Vargheseauthor=X.+Fengauthor=A.+J.+Bessireauthor=J.+J.+Conboyauthor=R.+B.+Ruggeriauthor=K.+Ahnauthor=S.+N.+Spathauthor=S.+V.+Filippovauthor=S.+J.+Conradauthor=P.+A.+Carpinoauthor=C.+R.+Guimaraesauthor=F.+F.+Vajdos&title=Deconstruction+of+activity-dependent+covalent+modification+of+heme+in+human+neutrophil+myeloperoxidase+by+multistage+mass+spectrometry+%28MS%284%29%29&doi=10.1021%2Fbi201872j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fbi201872j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi201872j%26sid%3Dliteratum%253Aachs%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DVarghese%26aufirst%3DA.%2BH.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DBessire%26aufirst%3DA.%2BJ.%26aulast%3DConboy%26aufirst%3DJ.%2BJ.%26aulast%3DRuggeri%26aufirst%3DR.%2BB.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DSpath%26aufirst%3DS.%2BN.%26aulast%3DFilippov%26aufirst%3DS.%2BV.%26aulast%3DConrad%26aufirst%3DS.%2BJ.%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26aulast%3DGuimaraes%26aufirst%3DC.%2BR.%26aulast%3DVajdos%26aufirst%3DF.%2BF.%26atitle%3DDeconstruction%2520of%2520activity-dependent%2520covalent%2520modification%2520of%2520heme%2520in%2520human%2520neutrophil%2520myeloperoxidase%2520by%2520multistage%2520mass%2520spectrometry%2520%2528MS%25284%2529%2529%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D2065%26epage%3D2077%26doi%3D10.1021%2Fbi201872j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Ward, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spath, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pabst, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpino, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speers, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span> </span><span class="NLM_article-title">Mechanistic characterization of a 2-thioxanthine myeloperoxidase inhibitor and selectivity assessment utilizing click chemistry – activity-based protein profiling</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">9187</span><span class="NLM_x">–</span> <span class="NLM_lpage">9201</span><span class="refDoi"> DOI: 10.1021/bi401354d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi401354d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=9187-9201&author=J.+Wardauthor=S.+N.+Spathauthor=B.+Pabstauthor=P.+A.+Carpinoauthor=R.+B.+Ruggeriauthor=G.+Xingauthor=A.+E.+Speersauthor=B.+F.+Cravattauthor=K.+Ahn&title=Mechanistic+characterization+of+a+2-thioxanthine+myeloperoxidase+inhibitor+and+selectivity+assessment+utilizing+click+chemistry+%E2%80%93+activity-based+protein+profiling&doi=10.1021%2Fbi401354d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fbi401354d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi401354d%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DSpath%26aufirst%3DS.%2BN.%26aulast%3DPabst%26aufirst%3DB.%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26aulast%3DRuggeri%26aufirst%3DR.%2BB.%26aulast%3DXing%26aufirst%3DG.%26aulast%3DSpeers%26aufirst%3DA.%2BE.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DAhn%26aufirst%3DK.%26atitle%3DMechanistic%2520characterization%2520of%2520a%25202-thioxanthine%2520myeloperoxidase%2520inhibitor%2520and%2520selectivity%2520assessment%2520utilizing%2520click%2520chemistry%2520%25E2%2580%2593%2520activity-based%2520protein%2520profiling%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26spage%3D9187%26epage%3D9201%26doi%3D10.1021%2Fbi401354d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Fumarola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dainelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvanese, A.</span><span> </span><span class="NLM_article-title">Medical treatment of hyperthyroidism: state of the art</span> <span class="citation_source-journal">Exp. Clin. Endocrinol. Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">678</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span><span class="refDoi"> DOI: 10.1055/s-0030-1253420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1055%2Fs-0030-1253420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=20496313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1arsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2010&pages=678-684&author=A.+Fumarolaauthor=A.+Di+Fioreauthor=M.+Dainelliauthor=G.+Graniauthor=A.+Calvanese&title=Medical+treatment+of+hyperthyroidism%3A+state+of+the+art&doi=10.1055%2Fs-0030-1253420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Medical treatment of hyperthyroidism: state of the art</span></div><div class="casAuthors">Fumarola, A.; Di Fiore, A.; Dainelli, M.; Grani, G.; Calvanese, A.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Clinical Endocrinology & Diabetes</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">678-684</span>CODEN:
                <span class="NLM_cas:coden">ECEDFQ</span>;
        ISSN:<span class="NLM_cas:issn">0947-7349</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A review.  Methimazole (MMI) and propylthiouracil (PTU) are the main antithyroid drugs used for hyperthyroidism.  They inhibit the synthesis of thyroid hormone at various levels and are used as the primary treatment for hyperthyroidism or as a prepn. before radioiodine therapy or thyroidectomy.  MMI is the drug of choice because of its widespread availability, longer half-life and small no. of severe side effects.  Drugs of second choice are potassium perchlorate, beta blockers, iodine, lithium carbonate and glucocorticoids.  Rituximab, a monoclonal antibody directed against human CD20, was recently proposed as a biol. therapy for cases of Graves' disease unresponsive to traditional drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD3ZlLwabhB7Vg90H21EOLACvtfcHk0lhrSUscHrFX-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1arsbbJ&md5=26802cb6042f3197b2b8c0cd7441d202</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1055%2Fs-0030-1253420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0030-1253420%26sid%3Dliteratum%253Aachs%26aulast%3DFumarola%26aufirst%3DA.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DDainelli%26aufirst%3DM.%26aulast%3DGrani%26aufirst%3DG.%26aulast%3DCalvanese%26aufirst%3DA.%26atitle%3DMedical%2520treatment%2520of%2520hyperthyroidism%253A%2520state%2520of%2520the%2520art%26jtitle%3DExp.%2520Clin.%2520Endocrinol.%2520Diabetes%26date%3D2010%26volume%3D118%26spage%3D678%26epage%3D684%26doi%3D10.1055%2Fs-0030-1253420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Lee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirouchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosokawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kariya, K.</span><span> </span><span class="NLM_article-title">Inactivation of peroxidases of rat bone marrow by repeated administration of propylthiouracil is accompanied by a change in the heme structure</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2151</span><span class="NLM_x">–</span> <span class="NLM_lpage">2153</span><span class="refDoi"> DOI: 10.1016/0006-2952(88)90574-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1016%2F0006-2952%2888%2990574-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1988&pages=2151-2153&author=E.+Leeauthor=M.+Hirouchiauthor=M.+Hosokawaauthor=H.+Sayoauthor=M.+Kohnoauthor=K.+Kariya&title=Inactivation+of+peroxidases+of+rat+bone+marrow+by+repeated+administration+of+propylthiouracil+is+accompanied+by+a+change+in+the+heme+structure&doi=10.1016%2F0006-2952%2888%2990574-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2888%2990574-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252888%252990574-6%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%26aulast%3DHirouchi%26aufirst%3DM.%26aulast%3DHosokawa%26aufirst%3DM.%26aulast%3DSayo%26aufirst%3DH.%26aulast%3DKohno%26aufirst%3DM.%26aulast%3DKariya%26aufirst%3DK.%26atitle%3DInactivation%2520of%2520peroxidases%2520of%2520rat%2520bone%2520marrow%2520by%2520repeated%2520administration%2520of%2520propylthiouracil%2520is%2520accompanied%2520by%2520a%2520change%2520in%2520the%2520heme%2520structure%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1988%26volume%3D37%26spage%3D2151%26epage%3D2153%26doi%3D10.1016%2F0006-2952%2888%2990574-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Lee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsljra, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kariya, K.</span><span> </span><span class="NLM_article-title">Mechanism of inactivation of myeloperoxidase by propylthiouracil</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1467</span><span class="NLM_x">–</span> <span class="NLM_lpage">1471</span><span class="refDoi"> DOI: 10.1016/0006-2952(90)90428-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1016%2F0006-2952%2890%2990428-N" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1990&pages=1467-1471&author=E.+Leeauthor=Y.+Mikiauthor=H.+Katsljraauthor=K.+Kariya&title=Mechanism+of+inactivation+of+myeloperoxidase+by+propylthiouracil&doi=10.1016%2F0006-2952%2890%2990428-N"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2890%2990428-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252890%252990428-N%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%26aulast%3DMiki%26aufirst%3DY.%26aulast%3DKatsljra%26aufirst%3DH.%26aulast%3DKariya%26aufirst%3DK.%26atitle%3DMechanism%2520of%2520inactivation%2520of%2520myeloperoxidase%2520by%2520propylthiouracil%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1990%26volume%3D39%26spage%3D1467%26epage%3D1471%26doi%3D10.1016%2F0006-2952%2890%2990428-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khursigara, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, R. L.</span><span> </span><span class="NLM_article-title">Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">810</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span><span class="refDoi"> DOI: 10.1126/science.7973636</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1126%2Fscience.7973636" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1994&pages=810-813&author=X.+Jiangauthor=G.+Khursigaraauthor=R.+L.+Rubin&title=Transformation+of+lupus-inducing+drugs+to+cytotoxic+products+by+activated+neutrophils&doi=10.1126%2Fscience.7973636"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1126%2Fscience.7973636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.7973636%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DKhursigara%26aufirst%3DG.%26aulast%3DRubin%26aufirst%3DR.%2BL.%26atitle%3DTransformation%2520of%2520lupus-inducing%2520drugs%2520to%2520cytotoxic%2520products%2520by%2520activated%2520neutrophils%26jtitle%3DScience%26date%3D1994%26volume%3D266%26spage%3D810%26epage%3D813%26doi%3D10.1126%2Fscience.7973636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Waldhauser, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uetrecht, J.</span><span> </span><span class="NLM_article-title">Oxidation of propylthiouracil to reactive metabolites by activated neutrophils. Implications for agranulocytosis</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">354</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1991&pages=354-359&author=L.+Waldhauserauthor=J.+Uetrecht&title=Oxidation+of+propylthiouracil+to+reactive+metabolites+by+activated+neutrophils.+Implications+for+agranulocytosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWaldhauser%26aufirst%3DL.%26aulast%3DUetrecht%26aufirst%3DJ.%26atitle%3DOxidation%2520of%2520propylthiouracil%2520to%2520reactive%2520metabolites%2520by%2520activated%2520neutrophils.%2520Implications%2520for%2520agranulocytosis%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1991%26volume%3D19%26spage%3D354%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Copeland, R. A.</span><span> </span><span class="NLM_article-title">Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists</span> <span class="citation_source-journal">Methods Biochem. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=16350889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A280%3ADC%252BD2MnmtlyjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=1-265&author=R.+A.+Copeland&title=Evaluation+of+enzyme+inhibitors+in+drug+discovery.+A+guide+for+medicinal+chemists+and+pharmacologists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists</span></div><div class="casAuthors">Copeland Robert A</div><div class="citationInfo"><span class="NLM_cas:title">Methods of biochemical analysis</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-265</span>
        ISSN:<span class="NLM_cas:issn">0076-6941</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSR7_ubfiC0DK2q3xNe7a7QfW6udTcc2eZllNKPneCIprntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MnmtlyjsA%253D%253D&md5=4bb6759b5155aa6c2b6a462432afda7f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DEvaluation%2520of%2520enzyme%2520inhibitors%2520in%2520drug%2520discovery.%2520A%2520guide%2520for%2520medicinal%2520chemists%2520and%2520pharmacologists%26jtitle%3DMethods%2520Biochem.%2520Anal.%26date%3D2005%26volume%3D46%26spage%3D1%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Zheng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skoura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okerberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobrowski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabe, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coskran, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckbinder, L.</span><span> </span><span class="NLM_article-title">PF-1355, a mechanism-based myeloperoxidase inhibitor, prevents immune-complex vasculitis and anti-glomerular basement membrane glomerulonephritis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span><span class="refDoi"> DOI: 10.1124/jpet.114.221788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1124%2Fjpet.114.221788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=25698787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvVWntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2015&pages=288-298&author=W.+Zhengauthor=R.+Warnerauthor=R.+B.+Ruggeriauthor=C.+Suauthor=C.+Cortesauthor=A.+Skouraauthor=J.+Wardauthor=K.+Ahnauthor=A.+Kalgutkarauthor=D.+Sunauthor=T.+Maurerauthor=P.+Boninauthor=C.+Okerbergauthor=W.+Bobrowskiauthor=T.+T.+Kawabeauthor=Y.+Zhangauthor=T.+M.+Coskranauthor=S.+Bellauthor=B.+Kapoorauthor=K.+Johnsonauthor=L.+Buckbinder&title=PF-1355%2C+a+mechanism-based+myeloperoxidase+inhibitor%2C+prevents+immune-complex+vasculitis+and+anti-glomerular+basement+membrane+glomerulonephritis&doi=10.1124%2Fjpet.114.221788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">PF-1355, a mechanism-based myeloperoxidase inhibitor, prevents immune complex vasculitis and anti-glomerular basement membrane glomerulonephritis</span></div><div class="casAuthors">Zheng, Wei; Warner, Roscoe; Ruggeri, Roger; Su, Chunyan; Cortes, Christian; Skoura, Athanasia; Ward, Jessica; Ahn, Kay; Kalgutkar, Amit; Sun, Dexue; Maurer, Tristan S.; Bonin, Paul D.; Okerberg, Carlin; Bobrowski, Walter; Kawabe, Thomas; Zhang, Yanwei; Coskran, Timothy; Bell, Sammy; Kapoor, Bhupesh; Johnson, Kent; Buckbinder, Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">288-298</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Small vessel vasculitis is a life-threatening condition and patients typically present with renal and pulmonary injury.  Disease pathogenesis is assocd. with neutrophil accumulation, activation, and oxidative damage, the latter being driven in large part by myeloperoxidase (MPO), which generates hypochlorous acid among other oxidants.  MPO has been assocd. with vasculitis, disseminated vascular inflammation typically involving pulmonary and renal microvasculature and often resulting in crit. consequences.  MPO contributes to vascular injury by (1) catabolizing nitric oxide, impairing vasomotor function; (2) causing oxidative damage to lipoproteins and endothelial cells, leading to atherosclerosis; and (3) stimulating formation of neutrophil extracellular traps, resulting in vessel occlusion and thrombosis.  Here we report a selective 2-thiouracil mechanism-based MPO inhibitor (PF-1355 [2-(6-(2,5-dimethoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide]) and demonstrate that MPO is a crit. mediator of vasculitis in mouse disease models.  A pharmacokinetic/pharmacodynamic response model of PF-1355 exposure in relation with MPO activity was derived from mouse peritonitis.  The contribution of MPO activity to vasculitis was then examd. in an immune complexmodel of pulmonary disease.  Oral administration of PF-1355 reduced plasma MPO activity, vascular edema, neutrophil recruitment, and elevated circulating cytokines.  In a model of anti-glomerular basement membrane disease, formerly known as Goodpasture disease, albuminuria and chronic renal dysfunction were completely suppressed by PF-1355 treatment.  This study shows that MPO activity is crit. in driving immune complex vasculitis and provides confidence in testing the hypothesis that MPO inhibition will provide benefit in treating human vasculitic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPRyjPwLB3XbVg90H21EOLACvtfcHk0liQ3GMwDcD_6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvVWntL4%253D&md5=682459ce0d7ea6d2826b6d861db72b39</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.221788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.221788%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DWarner%26aufirst%3DR.%26aulast%3DRuggeri%26aufirst%3DR.%2BB.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DCortes%26aufirst%3DC.%26aulast%3DSkoura%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DKalgutkar%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DMaurer%26aufirst%3DT.%26aulast%3DBonin%26aufirst%3DP.%26aulast%3DOkerberg%26aufirst%3DC.%26aulast%3DBobrowski%26aufirst%3DW.%26aulast%3DKawabe%26aufirst%3DT.%2BT.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCoskran%26aufirst%3DT.%2BM.%26aulast%3DBell%26aufirst%3DS.%26aulast%3DKapoor%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DBuckbinder%26aufirst%3DL.%26atitle%3DPF-1355%252C%2520a%2520mechanism-based%2520myeloperoxidase%2520inhibitor%252C%2520prevents%2520immune-complex%2520vasculitis%2520and%2520anti-glomerular%2520basement%2520membrane%2520glomerulonephritis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D353%26spage%3D288%26epage%3D298%26doi%3D10.1124%2Fjpet.114.221788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Neidlein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menche, G.</span><span> </span><span class="NLM_article-title">Synthese von 3.4-sowie 4-substituierten uracilen und thiouracilen</span> <span class="citation_source-journal">Arch. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">601</span><span class="refDoi"> DOI: 10.1002/ardp.19723050806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1002%2Fardp.19723050806" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADyaE38Xlt1KmtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=1972&pages=596-601&author=R.+Neidleinauthor=G.+Menche&title=Synthese+von+3.4-sowie+4-substituierten+uracilen+und+thiouracilen&doi=10.1002%2Fardp.19723050806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 3,4- and 4-substituted uracils and 2-thiouracils</span></div><div class="casAuthors">Neidlein, R.; Menche, G.</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">596-601</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    </div><div class="casAbstract">The title compds. (I, R = 3- or 4-pyridyl, 2-furyl; R1 = H, Me; X = O, S) (31-49%) were prepd. by reaction of RCOCH2CO2Et with  H2NCXNHR1 4-19 hr at 110-20°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh32pSZydk1LVg90H21EOLACvtfcHk0lixGOQAeokjlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38Xlt1KmtrY%253D&md5=42ee309d1c33cb1d5d06444d361e6a06</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fardp.19723050806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.19723050806%26sid%3Dliteratum%253Aachs%26aulast%3DNeidlein%26aufirst%3DR.%26aulast%3DMenche%26aufirst%3DG.%26atitle%3DSynthese%2520von%25203.4-sowie%25204-substituierten%2520uracilen%2520und%2520thiouracilen%26jtitle%3DArch.%2520Pharm.%26date%3D1972%26volume%3D305%26spage%3D596%26epage%3D601%26doi%3D10.1002%2Fardp.19723050806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Medda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirrie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slawin, A. M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, N. J.</span><span> </span><span class="NLM_article-title">N1-Benzyl substituted cambinol analogues as isozyme selective inhibitors of the sirtuin family of protein deacetylases</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">611</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span><span class="refDoi"> DOI: 10.1039/c1md00023c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1039%2Fc1md00023c" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=611-615&author=F.+Meddaauthor=T.+L.+Josephauthor=L.+Pirrieauthor=M.+Higginsauthor=A.+M.+Z.+Slawinauthor=S.+Lainauthor=C.+Vermaauthor=N.+J.+Westwood&title=N1-Benzyl+substituted+cambinol+analogues+as+isozyme+selective+inhibitors+of+the+sirtuin+family+of+protein+deacetylases&doi=10.1039%2Fc1md00023c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1039%2Fc1md00023c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00023c%26sid%3Dliteratum%253Aachs%26aulast%3DMedda%26aufirst%3DF.%26aulast%3DJoseph%26aufirst%3DT.%2BL.%26aulast%3DPirrie%26aufirst%3DL.%26aulast%3DHiggins%26aufirst%3DM.%26aulast%3DSlawin%26aufirst%3DA.%2BM.%2BZ.%26aulast%3DLain%26aufirst%3DS.%26aulast%3DVerma%26aufirst%3DC.%26aulast%3DWestwood%26aufirst%3DN.%2BJ.%26atitle%3DN1-Benzyl%2520substituted%2520cambinol%2520analogues%2520as%2520isozyme%2520selective%2520inhibitors%2520of%2520the%2520sirtuin%2520family%2520of%2520protein%2520deacetylases%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D611%26epage%3D615%26doi%3D10.1039%2Fc1md00023c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span> </span><span class="NLM_article-title">A comprehensive listing of bioactivation pathways of organic functional groups</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span><span class="refDoi"> DOI: 10.2174/1389200054021799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.2174%2F1389200054021799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=15975040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=161-225&author=A.+S.+Kalgutkarauthor=I.+Gardnerauthor=R.+S.+Obachauthor=C.+L.+Shafferauthor=E.+Callegariauthor=K.+R.+Henneauthor=A.+E.+Mutlibauthor=D.+K.+Dalvieauthor=J.+S.+Leeauthor=Y.+Nakaiauthor=J.+P.+O%E2%80%99Donnellauthor=J.+Boerauthor=S.+P.+Harriman&title=A+comprehensive+listing+of+bioactivation+pathways+of+organic+functional+groups&doi=10.2174%2F1389200054021799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive listing of bioactivation pathways of organic functional groups</span></div><div class="casAuthors">Kalgutkar, Amit S.; Gardner, Iain; Obach, R. Scott; Shaffer, Christopher L.; Callegari, Ernesto; Henne, Kirk R.; Mutlib, Abdul E.; Dalvie, Deepak K.; Lee, Jae S.; Nakai, Yasuhiro; O'Donnell, John P.; Boer, Jason; Harriman, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-225</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The occurrence of idiosyncratic adverse drug reactions during late clin. trials or after a drug has been released can lead to a severe restriction in its use and even in its withdrawal.  Metabolic activation of relatively inert functional groups to reactive electrophilic intermediates is considered to be an obligatory event in the etiol. of many drug-induced adverse reactions.  Therefore, a thorough examn. of the biochem. reactivity of functional groups/structural motifs in all new drug candidates is essential from a safety standpoint.  A major theme attempted in this review is the comprehensive cataloging of all of the known bioactivation pathways of functional groups or structural motifs commonly utilized in drug design efforts.  Potential strategies in the detection of reactive intermediates in biochem. systems are also discussed.  The intention of this review is not to "black list" functional groups or to immediately discard compds. based on their potential to form reactive metabolites, but rather to serve as a resource describing the structural diversity of these functionalities as well as exptl. approaches that could be taken to evaluate whether a "structural alert" in a new drug candidate undergoes bioactivation to reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVj7cmxfwXrVg90H21EOLACvtfcHk0lixGOQAeokjlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D&md5=b16dfc2de97c40a11218ecc3043bed66</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.2174%2F1389200054021799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200054021799%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26atitle%3DA%2520comprehensive%2520listing%2520of%2520bioactivation%2520pathways%2520of%2520organic%2520functional%2520groups%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2005%26volume%3D6%26spage%3D161%26epage%3D225%26doi%3D10.2174%2F1389200054021799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Futcher, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massie, E.</span><span> </span><span class="NLM_article-title">Agranulocytosis due to propylthiouracil</span> <span class="citation_source-journal">Ann. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1950</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="refDoi"> DOI: 10.7326/0003-4819-32-1-137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.7326%2F0003-4819-32-1-137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=15404133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A280%3ADyaG3c%252FhtlOltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1950&pages=137&author=P.+H.+Futcherauthor=E.+Massie&title=Agranulocytosis+due+to+propylthiouracil&doi=10.7326%2F0003-4819-32-1-137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Agranulocytosis due to propylthiouracil</span></div><div class="casAuthors">FUTCHER P H; MASSIE E</div><div class="citationInfo"><span class="NLM_cas:title">Annals of internal medicine</span>
        (<span class="NLM_cas:date">1950</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">137</span>
        ISSN:<span class="NLM_cas:issn">0003-4819</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwmHczcwXobVWTCLT8lX9SfW6udTcc2eZV_fDuzM-wWrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG3c%252FhtlOltw%253D%253D&md5=d2ef257c565752e3ec538cc03abcd645</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-32-1-137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-32-1-137%26sid%3Dliteratum%253Aachs%26aulast%3DFutcher%26aufirst%3DP.%2BH.%26aulast%3DMassie%26aufirst%3DE.%26atitle%3DAgranulocytosis%2520due%2520to%2520propylthiouracil%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D1950%26volume%3D32%26spage%3D137%26doi%3D10.7326%2F0003-4819-32-1-137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Cooper, D. S.</span><span> </span><span class="NLM_article-title">Antithyroid drugs</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">917</span><span class="refDoi"> DOI: 10.1056/NEJMra042972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1056%2FNEJMra042972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=15745981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvFOht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=905-917&author=D.+S.+Cooper&title=Antithyroid+drugs&doi=10.1056%2FNEJMra042972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Antithyroid drugs</span></div><div class="casAuthors">Cooper, David S.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">905-917</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review discusses recent pharmacol. and clin. data related to the use of antithyroid compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLT7VSyN--JLVg90H21EOLACvtfcHk0lhSQLKuTIn3yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvFOht7o%253D&md5=80d6bf43f34b755c25e592b079a5a883</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1056%2FNEJMra042972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra042972%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DD.%2BS.%26atitle%3DAntithyroid%2520drugs%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D905%26epage%3D917%26doi%3D10.1056%2FNEJMra042972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Ichiki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akahoshi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishibashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niho, Y.</span><span> </span><span class="NLM_article-title">Propylthiouracil-induced severe hepatitis: a case report and review of the literature</span> <span class="citation_source-journal">J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">750</span><span class="refDoi"> DOI: 10.1007/s005350050167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1007%2Fs005350050167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=9773944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A280%3ADyaK1cvksV2hug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1998&pages=747-750&author=Y.+Ichikiauthor=M.+Akahoshiauthor=N.+Yamashitaauthor=C.+Moritaauthor=T.+Maruyamaauthor=T.+Horiuchiauthor=K.+Hayashidaauthor=H.+Ishibashiauthor=Y.+Niho&title=Propylthiouracil-induced+severe+hepatitis%3A+a+case+report+and+review+of+the+literature&doi=10.1007%2Fs005350050167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Propylthiouracil-induced severe hepatitis: a case report and review of the literature</span></div><div class="casAuthors">Ichiki Y; Akahoshi M; Yamashita N; Morita C; Maruyama T; Horiuchi T; Hayashida K; Ishibashi H; Niho Y</div><div class="citationInfo"><span class="NLM_cas:title">Journal of gastroenterology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">747-50</span>
        ISSN:<span class="NLM_cas:issn">0944-1174</span>.
    </div><div class="casAbstract">A 21-year-old woman was diagnosed as having Graves' disease in April, 1995.  Thiamazole was administered; about a month later the patient had a skin rash and propylthiouracil (PTU) was given instead.  Two months after commencing PTU, she rapidly developed jaundice, accompanied by severe liver damage.  The drug-induced lymphocyte stimulating test was positive for PTU and she was diagnosed as having severe hepatitis induced by PTU.  After pulse therapy with 500 mg of methylprednisolone was given for 3 days, liver function test results were gradually improved, and became normalized 1 1/2 months after admission.  The pathology findings of the liver biopsy sample taken before administration of corticosteroid showed necrosis of hepatocytes predominantly around the central veins (i.e., zone 3 necrosis), and moderate to severe infiltration of lymphocytes and neutrophils in portal areas and lobules.  Severe hepatic damage due to PTU is rare; 25 cases have been reported so far in the English-language literature.  When we use PTU for patients with hyperthyroidism, we should keep in mind that severe liver damage induced by PTU can be fatal, and we should therefore diagnose it earlier by liver biopsy and lymphocyte stimulating test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6G7CBGsTo2RpyrDyM_m9cfW6udTcc2eaUPj0w1XqX-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1cvksV2hug%253D%253D&md5=2d46552b8ecc7d061107a72207570904</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2Fs005350050167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs005350050167%26sid%3Dliteratum%253Aachs%26aulast%3DIchiki%26aufirst%3DY.%26aulast%3DAkahoshi%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DN.%26aulast%3DMorita%26aufirst%3DC.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DHoriuchi%26aufirst%3DT.%26aulast%3DHayashida%26aufirst%3DK.%26aulast%3DIshibashi%26aufirst%3DH.%26aulast%3DNiho%26aufirst%3DY.%26atitle%3DPropylthiouracil-induced%2520severe%2520hepatitis%253A%2520a%2520case%2520report%2520and%2520review%2520of%2520the%2520literature%26jtitle%3DJ.%2520Gastroenterol.%26date%3D1998%26volume%3D33%26spage%3D747%26epage%3D750%26doi%3D10.1007%2Fs005350050167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Guffy, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goeken, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, C. P.</span><span> </span><span class="NLM_article-title">Granulocytotoxic antibodies in a patient with propylthiouracil-induced agranulocytosis</span> <span class="citation_source-journal">Arch. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">1687</span><span class="NLM_x">–</span> <span class="NLM_lpage">1688</span><span class="refDoi"> DOI: 10.1001/archinte.144.8.1687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1001%2Farchinte.144.8.1687" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=1984&pages=1687-1688&author=M.+M.+Guffyauthor=N.+E.+Goekenauthor=C.+P.+Burns&title=Granulocytotoxic+antibodies+in+a+patient+with+propylthiouracil-induced+agranulocytosis&doi=10.1001%2Farchinte.144.8.1687"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1001%2Farchinte.144.8.1687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchinte.144.8.1687%26sid%3Dliteratum%253Aachs%26aulast%3DGuffy%26aufirst%3DM.%2BM.%26aulast%3DGoeken%26aufirst%3DN.%2BE.%26aulast%3DBurns%26aufirst%3DC.%2BP.%26atitle%3DGranulocytotoxic%2520antibodies%2520in%2520a%2520patient%2520with%2520propylthiouracil-induced%2520agranulocytosis%26jtitle%3DArch.%2520Intern.%2520Med.%26date%3D1984%26volume%3D144%26spage%3D1687%26epage%3D1688%26doi%3D10.1001%2Farchinte.144.8.1687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Fibbe, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claas, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Star-Dijkstra, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaafsma, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyboom, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falkenburg, J. H.</span><span> </span><span class="NLM_article-title">Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span><span class="refDoi"> DOI: 10.1111/j.1365-2141.1986.tb04130.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1111%2Fj.1365-2141.1986.tb04130.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=3778829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A280%3ADyaL2s%252FkvFGguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1986&pages=363-373&author=W.+E.+Fibbeauthor=F.+H.+Claasauthor=W.+Van+der+Star-Dijkstraauthor=M.+R.+Schaafsmaauthor=R.+H.+Meyboomauthor=J.+H.+Falkenburg&title=Agranulocytosis+induced+by+propylthiouracil%3A+evidence+of+a+drug+dependent+antibody+reacting+with+granulocytes%2C+monocytes+and+haematopoietic+progenitor+cells&doi=10.1111%2Fj.1365-2141.1986.tb04130.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells</span></div><div class="casAuthors">Fibbe W E; Claas F H; Van der Star-Dijkstra W; Schaafsma M R; Meyboom R H; Falkenburg J H</div><div class="citationInfo"><span class="NLM_cas:title">British journal of haematology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">363-73</span>
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    </div><div class="casAbstract">A patient with agranulocytosis and myeloid marrow hypoplasia following a second exposure to propylthiouracil (PTU) was studied for antibodies against mature blood cells and bone marrow precursor cells.  During the acute phase of the agranulocytosis, significant growth inhibition of the myeloid committed progenitor cells (CFU-GM) was found following incubation with complement, indicating the presence of in-vivo cell bound cytotoxic antibodies.  Using immunofluorescence and complement dependent cytotoxicity techniques it was demonstrated that acute phase and recovery phase sera contained circulating antibodies, reactive not only with differentiated granulocytes and monocytes but also with myeloid and erythroid (BFU-E/CFU-E) progenitor cells.  Complement dependent lysis of the progenitor cells was facilitated by preincubation with PTU.  These results indicate that the agranulocytosis was mediated by a PTU dependent antibody that affected both mature blood cells and bone precursor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSpaMkNG--B3qe0F5ixvZgXfW6udTcc2eaUPj0w1XqX-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2s%252FkvFGguw%253D%253D&md5=2aa334ab044a03efdeb6f9cb09ab0d7b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.1986.tb04130.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.1986.tb04130.x%26sid%3Dliteratum%253Aachs%26aulast%3DFibbe%26aufirst%3DW.%2BE.%26aulast%3DClaas%26aufirst%3DF.%2BH.%26aulast%3DVan%2Bder%2BStar-Dijkstra%26aufirst%3DW.%26aulast%3DSchaafsma%26aufirst%3DM.%2BR.%26aulast%3DMeyboom%26aufirst%3DR.%2BH.%26aulast%3DFalkenburg%26aufirst%3DJ.%2BH.%26atitle%3DAgranulocytosis%2520induced%2520by%2520propylthiouracil%253A%2520evidence%2520of%2520a%2520drug%2520dependent%2520antibody%2520reacting%2520with%2520granulocytes%252C%2520monocytes%2520and%2520haematopoietic%2520progenitor%2520cells%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D1986%26volume%3D64%26spage%3D363%26epage%3D373%26doi%3D10.1111%2Fj.1365-2141.1986.tb04130.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Bilezikian, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laleli, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsan, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodkinson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ice, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, P. A.</span><span> </span><span class="NLM_article-title">Immunological reactions involving leukocytes: III. Agranulocytosis induced by antithyroid drugs</span> <span class="citation_source-journal">Johns Hopkins Med. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=58084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A280%3ADyaE287psVeiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=1976&pages=124-129&author=S.+B.+Bilezikianauthor=Y.+Laleliauthor=M.+F.+Tsanauthor=B.+A.+Hodkinsonauthor=S.+Iceauthor=P.+A.+McIntyre&title=Immunological+reactions+involving+leukocytes%3A+III.+Agranulocytosis+induced+by+antithyroid+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Immunological: reactions involving leukocytes: III. Agranulocytosis induced by antithyroid drugs</span></div><div class="casAuthors">Bilezikian S B; Laleli Y; Tsan M F; Hodkinson B A; Ice S; McIntyre P A</div><div class="citationInfo"><span class="NLM_cas:title">The Johns Hopkins medical journal</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">124-9</span>
        ISSN:<span class="NLM_cas:issn">0021-7263</span>.
    </div><div class="casAbstract">A method has previously been described which detected xenogeneic and allogeneic antibodies to human granulocytes by their inhibition of the normal phagocytosis-associated hexose monophosphate shunt (HMS) activity.  This method was used to study three patients with acute agranulocytosis secondary to antithyroid drug administration.  Two patients with methimazole and one patient with propylthiouracil induced agranulocytosis were studied.  Serum samples from each of these three patients taken during the acute phase of agranulocytosis had inhibitory effects on phagocytosis-associated HMS activity in leukocytes from both normal donors and the patients after their full recovery from agranulocytosis.  IgM but not IgG prepared from acute sera in two patients was also inhibitory.  Disruption of IgM disulfide bonds by dithiothreitol destroyed its inhibitory activity.  The possibility of drug-dependent immune destruction of leukocytes in these patients is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPyhlNzzGjVbjnyZkbE8yXfW6udTcc2ebCo2axRqn5-bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE287psVeiug%253D%253D&md5=d922f86ad402873073753b3dd3e2f03a</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilezikian%26aufirst%3DS.%2BB.%26aulast%3DLaleli%26aufirst%3DY.%26aulast%3DTsan%26aufirst%3DM.%2BF.%26aulast%3DHodkinson%26aufirst%3DB.%2BA.%26aulast%3DIce%26aufirst%3DS.%26aulast%3DMcIntyre%26aufirst%3DP.%2BA.%26atitle%3DImmunological%2520reactions%2520involving%2520leukocytes%253A%2520III.%2520Agranulocytosis%2520induced%2520by%2520antithyroid%2520drugs%26jtitle%3DJohns%2520Hopkins%2520Med.%2520J.%26date%3D1976%26volume%3D138%26spage%3D124%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Berkman, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlin, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfsdorf, J.</span><span> </span><span class="NLM_article-title">An anti-neutrophil antibody associated with a propylthiouracil-induced lupus-like syndrome</span> <span class="citation_source-journal">Transfusion</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span><span class="refDoi"> DOI: 10.1046/j.1537-2995.1983.23283172851.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1046%2Fj.1537-2995.1983.23283172851.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1983&pages=135-138&author=E.+M.+Berkmanauthor=J.+B.+Orlinauthor=J.+Wolfsdorf&title=An+anti-neutrophil+antibody+associated+with+a+propylthiouracil-induced+lupus-like+syndrome&doi=10.1046%2Fj.1537-2995.1983.23283172851.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1046%2Fj.1537-2995.1983.23283172851.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1537-2995.1983.23283172851.x%26sid%3Dliteratum%253Aachs%26aulast%3DBerkman%26aufirst%3DE.%2BM.%26aulast%3DOrlin%26aufirst%3DJ.%2BB.%26aulast%3DWolfsdorf%26aufirst%3DJ.%26atitle%3DAn%2520anti-neutrophil%2520antibody%2520associated%2520with%2520a%2520propylthiouracil-induced%2520lupus-like%2520syndrome%26jtitle%3DTransfusion%26date%3D1983%26volume%3D23%26spage%3D135%26epage%3D138%26doi%3D10.1046%2Fj.1537-2995.1983.23283172851.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Kitamura, I. R.</span><span> </span><span class="NLM_article-title">The action of hydrogen peroxide on organic sulfur compounds</span> <span class="citation_source-journal">Yakugaku Zasshi</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1934</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1934&pages=1-13&author=I.+R.+Kitamura&title=The+action+of+hydrogen+peroxide+on+organic+sulfur+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DI.%2BR.%26atitle%3DThe%2520action%2520of%2520hydrogen%2520peroxide%2520on%2520organic%2520sulfur%2520compounds%26jtitle%3DYakugaku%2520Zasshi%26date%3D1934%26volume%3D54%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Kalm, M. J.</span><span> </span><span class="NLM_article-title">Peroxide desulfurization of thioureas</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2925</span><span class="NLM_x">–</span> <span class="NLM_lpage">2929</span><span class="refDoi"> DOI: 10.1021/jo01066a072</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01066a072" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1961&pages=2925-2929&author=M.+J.+Kalm&title=Peroxide+desulfurization+of+thioureas&doi=10.1021%2Fjo01066a072"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjo01066a072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01066a072%26sid%3Dliteratum%253Aachs%26aulast%3DKalm%26aufirst%3DM.%2BJ.%26atitle%3DPeroxide%2520desulfurization%2520of%2520thioureas%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1961%26volume%3D26%26spage%3D2925%26epage%3D2929%26doi%3D10.1021%2Fjo01066a072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Henderson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddens, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kedzie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidelbaugh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garst, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. E.</span><span> </span><span class="NLM_article-title">Flavin-containing monooxygenase S-oxygenation of a series of thioureas and thiones</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1016/j.taap.2014.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1016%2Fj.taap.2014.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=24727368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVaqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2014&pages=91-99&author=M.+C.+Hendersonauthor=L.+K.+Siddensauthor=S.+K.+Kruegerauthor=J.+F.+Stevensauthor=K.+Kedzieauthor=W.+K.+Fangauthor=T.+Heidelbaughauthor=P.+Nguyenauthor=K.+Chowauthor=M.+Garstauthor=D.+Gilauthor=D.+E.+Williams&title=Flavin-containing+monooxygenase+S-oxygenation+of+a+series+of+thioureas+and+thiones&doi=10.1016%2Fj.taap.2014.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Flavin-containing monooxygenase S-oxygenation of a series of thioureas and thiones</span></div><div class="casAuthors">Henderson, Marilyn C.; Siddens, Lisbeth K.; Krueger, Sharon K.; Stevens, J. Fred; Kedzie, Karen; Fang, Wenkui K.; Heidelbaugh, Todd; Nguyen, Phong; Chow, Ken; Garst, Michael; Gil, Daniel; Williams, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-99</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Mammalian flavin-contg. monooxygenase (FMO) is active towards many drugs with a heteroatom having the properties of a soft nucleophile.  Thiocarbamides and thiones are S-oxygenated to the sulfenic acid which can either react with glutathione and initiate a redox-cycle or be oxygenated a second time to the unstable sulfinic acid.  In this study, we utilized LC-MS/MS to demonstrate that the oxygenation by hFMO of the thioureas under test terminated at the sulfenic acid.  With thiones, hFMO catalyzed the second reaction and the sulfinic acid rapidly lost sulfite to form the corresponding imidazole.  Thioureas are often pulmonary toxicants in mammals and, as previously reported by our lab., are excellent substrates for hFMO2.  This isoform is expressed at high levels in the lung of most mammals, including non-human primates.  Genotyping to date indicates that individuals of African (up to 49%) or Hispanic (2-7%) ancestry have at least one allele for functional hFMO2 in lung, but not Caucasians nor Asians.  In this study the major metabolite formed by hFMO2 with thioureas from Allergan, Inc. was the sulfenic acid that reacted with glutathione.  The majority of thiones were poor substrates for hFMO3, the major form in adult human liver.  However, hFMO1, the major isoform expressed in infant and neonatal liver and adult kidney and intestine, readily S-oxygenated thiones under test, with Kms ranging from 7 to 160 μM and turnover nos. of 30-40 min- 1.  The product formed was identified by LC-MS/MS as the imidazole.  The activities of the mouse and human FMO1 and FMO3 orthologs were in good agreement with the exception of some thiones for which activity was much greater with hFMO1 than mFMO1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpog_KXJBUA8LVg90H21EOLACvtfcHk0ljt0L7C-Y970Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVaqtLk%253D&md5=134a66894da5023de0955d1ea6d8ab5d</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2014.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2014.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DM.%2BC.%26aulast%3DSiddens%26aufirst%3DL.%2BK.%26aulast%3DKrueger%26aufirst%3DS.%2BK.%26aulast%3DStevens%26aufirst%3DJ.%2BF.%26aulast%3DKedzie%26aufirst%3DK.%26aulast%3DFang%26aufirst%3DW.%2BK.%26aulast%3DHeidelbaugh%26aufirst%3DT.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DChow%26aufirst%3DK.%26aulast%3DGarst%26aufirst%3DM.%26aulast%3DGil%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DD.%2BE.%26atitle%3DFlavin-containing%2520monooxygenase%2520S-oxygenation%2520of%2520a%2520series%2520of%2520thioureas%2520and%2520thiones%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2014%26volume%3D278%26spage%3D91%26epage%3D99%26doi%3D10.1016%2Fj.taap.2014.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Henderson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. E.</span><span> </span><span class="NLM_article-title">Human flavin-containing monooxygenase form 2 S-oxygenation: sulfenic acid formation from thioureas and oxidation of glutathione</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">–</span> <span class="NLM_lpage">640</span><span class="refDoi"> DOI: 10.1021/tx034253s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx034253s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=633-640&author=M.+C.+Hendersonauthor=S.+K.+Kruegerauthor=J.+F.+Stevensauthor=D.+E.+Williams&title=Human+flavin-containing+monooxygenase+form+2+S-oxygenation%3A+sulfenic+acid+formation+from+thioureas+and+oxidation+of+glutathione&doi=10.1021%2Ftx034253s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Ftx034253s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx034253s%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DM.%2BC.%26aulast%3DKrueger%26aufirst%3DS.%2BK.%26aulast%3DStevens%26aufirst%3DJ.%2BF.%26aulast%3DWilliams%26aufirst%3DD.%2BE.%26atitle%3DHuman%2520flavin-containing%2520monooxygenase%2520form%25202%2520S-oxygenation%253A%2520sulfenic%2520acid%2520formation%2520from%2520thioureas%2520and%2520oxidation%2520of%2520glutathione%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2004%26volume%3D17%26spage%3D633%26epage%3D640%26doi%3D10.1021%2Ftx034253s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Mansuy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansette, P. M.</span><span> </span><span class="NLM_article-title">Sulfenic acids as reactive intermediates in xenobiotic metabolism</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">507</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1016/j.abb.2010.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1016%2Fj.abb.2010.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=20869346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFegt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=507&publication_year=2011&pages=174-185&author=D.+Mansuyauthor=P.+M.+Dansette&title=Sulfenic+acids+as+reactive+intermediates+in+xenobiotic+metabolism&doi=10.1016%2Fj.abb.2010.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfenic acids as reactive intermediates in xenobiotic metabolism</span></div><div class="casAuthors">Mansuy, Daniel; Dansette, Patrick M.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">507</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">174-185</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sulfenic acid reactive intermediates are formed during the oxidn. of cysteine residues of proteins and play key roles in enzyme catalysis, redox homeostasis and regulation of cell signalling.  However few data are presently available on the formation and fate of sulfenic acids as reactive intermediates during the metab. of xenobiotics.  This article is a review of the xenobiotic metab. situations in which the intermediate formation of a sulfenic acid has been reported.  Formation of these intermediates has been either proposed on the basis of the isolation of products possibly deriving from sulfenic acids or shown after trapping of the sulfenic acid by specific nucleophiles.  This review indicates the different mechanisms by which a sulfur-contg. xenobiotic can be metabolized with the intermediate formation of a sulfenic acid.  It also indicates the different possible fates of these sulfenic acids that have been reported in the literature.  Finally, it discusses the possible implications of the formation of xenobiotic-derived sulfenic acid reactive metabolites in pharmacol. and toxicol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMGeP-6Njzh7Vg90H21EOLACvtfcHk0lhLa84Ce-9c3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFegt7c%253D&md5=598905063d4325c495e2740c61132a42</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2010.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2010.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DMansuy%26aufirst%3DD.%26aulast%3DDansette%26aufirst%3DP.%2BM.%26atitle%3DSulfenic%2520acids%2520as%2520reactive%2520intermediates%2520in%2520xenobiotic%2520metabolism%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2011%26volume%3D507%26spage%3D174%26epage%3D185%26doi%3D10.1016%2Fj.abb.2010.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Stopher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClean, S.</span><span> </span><span class="NLM_article-title">An improved method for the determination of distribution coefficients</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="refDoi"> DOI: 10.1111/j.2042-7158.1990.tb05373.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1111%2Fj.2042-7158.1990.tb05373.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1972404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADyaK3cXitFSntbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1990&pages=144&author=D.+Stopherauthor=S.+McClean&title=An+improved+method+for+the+determination+of+distribution+coefficients&doi=10.1111%2Fj.2042-7158.1990.tb05373.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">An improved method for the determination of distribution coefficients</span></div><div class="casAuthors">Stopher, David; McClean, Siobhan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    </div><div class="casAbstract">The traditional shake flash method for measuring the distribution coeff. (D) of drugs (Leo et al., 1971) was modified to minimize the amt. of compd. required by employing HPLC to detn. the concn. of the compd. in the octanol and buffer phases.  The HPLC employed a reverse-phase Spherisorb octyl column with a mobile phase of MeOH-ammonium phosphate 0.01 M, pH 7.  The method was validated using drugs with a range of log D values of -2 to 4.  The method is suitable for rapid evaluation of the compds. since it decreases errors due to any impurities present.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodB1AZ9RwrrLVg90H21EOLACvtfcHk0lhLa84Ce-9c3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXitFSntbc%253D&md5=4d4ab2e9a04d54dbb868cb1b212e8e55</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.1990.tb05373.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.1990.tb05373.x%26sid%3Dliteratum%253Aachs%26aulast%3DStopher%26aufirst%3DD.%26aulast%3DMcClean%26aufirst%3DS.%26atitle%3DAn%2520improved%2520method%2520for%2520the%2520determination%2520of%2520distribution%2520coefficients%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D1990%26volume%3D42%26spage%3D144%26doi%3D10.1111%2Fj.2042-7158.1990.tb05373.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Korolev, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakin, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolsky, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirillov, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanenkov, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savchuk, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivashchenko, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolskaya, T.</span><span> </span><span class="NLM_article-title">Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3631</span><span class="NLM_x">–</span> <span class="NLM_lpage">3643</span><span class="refDoi"> DOI: 10.1021/jm030102a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030102a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3631-3643&author=D.+Korolevauthor=K.+V.+Balakinauthor=Y.+Nikolskyauthor=E.+Kirillovauthor=Y.+A.+Ivanenkovauthor=N.+P.+Savchukauthor=A.+A.+Ivashchenkoauthor=T.+Nikolskaya&title=Modeling+of+human+cytochrome+p450-mediated+drug+metabolism+using+unsupervised+machine+learning+approach&doi=10.1021%2Fjm030102a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm030102a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030102a%26sid%3Dliteratum%253Aachs%26aulast%3DKorolev%26aufirst%3DD.%26aulast%3DBalakin%26aufirst%3DK.%2BV.%26aulast%3DNikolsky%26aufirst%3DY.%26aulast%3DKirillov%26aufirst%3DE.%26aulast%3DIvanenkov%26aufirst%3DY.%2BA.%26aulast%3DSavchuk%26aufirst%3DN.%2BP.%26aulast%3DIvashchenko%26aufirst%3DA.%2BA.%26aulast%3DNikolskaya%26aufirst%3DT.%26atitle%3DModeling%2520of%2520human%2520cytochrome%2520p450-mediated%2520drug%2520metabolism%2520using%2520unsupervised%2520machine%2520learning%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3631%26epage%3D3643%26doi%3D10.1021%2Fjm030102a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitney-Pickett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gebhard, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federico, J. J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempshall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kattan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span> </span><span class="NLM_article-title">Development of a new permeability assay using low-efflux MDCKII cells</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4974</span><span class="NLM_x">–</span> <span class="NLM_lpage">4985</span><span class="refDoi"> DOI: 10.1002/jps.22674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1002%2Fjps.22674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=21766308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4974-4985&author=L.+Diauthor=C.+Whitney-Pickettauthor=J.+P.+Umlandauthor=H.+Zhangauthor=X.+Zhangauthor=D.+F.+Gebhardauthor=Y.+Laiauthor=J.+J.+Federicoauthor=R.+E.+Davidsonauthor=R.+Smithauthor=E.+L.+Reynerauthor=C.+Leeauthor=B.+Fengauthor=C.+Rotterauthor=M.+V.+Varmaauthor=S.+Kempshallauthor=K.+Fennerauthor=A.+F.+El-Kattanauthor=T.+E.+Listonauthor=M.+D.+Troutman&title=Development+of+a+new+permeability+assay+using+low-efflux+MDCKII+cells&doi=10.1002%2Fjps.22674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new permeability assay using low-efflux MDCKII cells</span></div><div class="casAuthors">Di, Li; Whitney-Pickett, Carrie; Umland, John P.; Zhang, Hui; Zhang, Xun; Gebhard, David F.; Lai, Yurong; Federico, James J.; Davidson, Ralph E.; Smith, Russ; Reyner, Eric L.; Lee, Caroline; Feng, Bo; Rotter, Charles; Varma, Manthena V.; Kempshall, Sarah; Fenner, Katherine; El-kattan, Ayman F.; Liston, Theodore E.; Troutman, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4974-4985</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Permeability is an important property of drug candidates.  The Madin-Darby canine kidney cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK cells is the presence of endogenous transporters of nonhuman origin.  The canine P-glycoprotein (Pgp) can interfere with permeability and transporter studies, leading to less reliable data.  A new cell line, MDCKII-LE (low efflux), has been developed by selecting a subpopulation of low-efflux cells from MDCKII-WT using an iterative fluorescence-activated cell sorting technique with calcein-AM as a Pgp and efflux substrate.  MDCKII-LE cells are a subpopulation of MDCKII cells with over 200-fold lower canine Pgp mRNA level and fivefold lower protein level than MDCKII-WT.  MDCKII-LE cells showed less functional efflux activity than MDCKII-WT based on efflux ratios.  Notably, MDCKII-MDR1 showed about 1.5-fold decreased expression of endogenous canine Pgp, suggesting that using the net flux ratio might not completely cancel out the background endogenous transporter activities.  MDCKII-LE cells offer clear advantages over the MDCKII-WT by providing less efflux transporter background signals and minimizing interference from canine Pgp.  The MDCKII-LE apparent permeability values well differentiates compds. from high to medium/low human intestinal absorption and can be used for Biopharmaceutical Classification System.  The MDCKII-LE permeability assay (4-in-1 cassette dosing) is high throughput with good precision, reproducibility, robustness, and cost-effective. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVtRmYnbF17Vg90H21EOLACvtfcHk0lhLa84Ce-9c3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D&md5=97f647fc215ea6d04882351ffc912a1e</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fjps.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22674%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DFederico%26aufirst%3DJ.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DReyner%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DRotter%26aufirst%3DC.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DEl-Kattan%26aufirst%3DA.%2BF.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520new%2520permeability%2520assay%2520using%2520low-efflux%2520MDCKII%2520cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4974%26epage%3D4985%26doi%3D10.1002%2Fjps.22674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Banker, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. A.</span><span> </span><span class="NLM_article-title">Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">974</span><span class="refDoi"> DOI: 10.1002/jps.10332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1002%2Fjps.10332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=12712416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1ehsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=967-974&author=M.+J.+Bankerauthor=T.+H.+Clarkauthor=J.+A.+Williams&title=Development+and+validation+of+a+96-well+equilibrium+dialysis+apparatus+for+measuring+plasma+protein+binding&doi=10.1002%2Fjps.10332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding</span></div><div class="casAuthors">Banker, Michael J.; Clark, Tracey H.; Williams, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">967-974</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A 96-well equil. dialysis block was designed and constructed that is compatible with most std. 96-well format lab. supplies and instruments.  The unique design of the dialysis app. allows one to dispense and aspirate from either or both the sample and dialyzate sides from the top of the app., which is not possible with systems currently on the market.  This feature permits the investigator to analyze a large no. of samples, time points, or replicates in the same expt.  The novel alignment of the dialysis membrane vertically in the well maximizes the surface-to-vol. ratio, eliminates problems assocd. with trapped air pockets, and allows one to add or remove samples independently or all at once.  Furthermore, the design of the app. allows both the sample and dialyzate sides of the dialysis well to be accessible by robotic systems, so assays can be readily automated.  Teflon construction is used to minimize nonspecific binding of test samples to the app.  The device is reusable, easily assembled, and can be shaken in controlled temp. environments to decrease the time required to reach equil. as well as facilitate dissoln. of test compds.  Plasma protein binding values obtained for 10 diverse compds. using std. dialysis equipment and the 96-well dialysis block validates this method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp9qyX_9tHHrVg90H21EOLACvtfcHk0lhXadg71UWpXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1ehsrs%253D&md5=0948f0a11373c57be06be9e0d604ad40</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fjps.10332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.10332%26sid%3Dliteratum%253Aachs%26aulast%3DBanker%26aufirst%3DM.%2BJ.%26aulast%3DClark%26aufirst%3DT.%2BH.%26aulast%3DWilliams%26aufirst%3DJ.%2BA.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%252096-well%2520equilibrium%2520dialysis%2520apparatus%2520for%2520measuring%2520plasma%2520protein%2520binding%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D92%26spage%3D967%26epage%3D974%26doi%3D10.1002%2Fjps.10332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Walsky, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Validated assays for human cytochrome P450 activities</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span><span class="refDoi"> DOI: 10.1124/dmd.32.6.647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1124%2Fdmd.32.6.647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=15155557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlOgt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=647-660&author=R.+L.+Walskyauthor=R.+S.+Obach&title=Validated+assays+for+human+cytochrome+P450+activities&doi=10.1124%2Fdmd.32.6.647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Validated assays for human cytochrome P450 activities</span></div><div class="casAuthors">Walsky, Robert L.; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">647-660</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The measurement of the effect of new chem. entities on human cytochrome P 450 marker activities using in vitro experimentation represents an important exptl. approach in drug development.  In vitro drug interaction data can be used in guiding the design of clin. drug interaction studies, or, when no effect is obsd. in vitro, the data can be used in place of an in vivo study to claim that no interaction will occur in vivo.  To make such a claim, it must be assured that the in vitro expts. are performed with abs. confidence in the methods used and data obtained.  To meet this need, 12 semiautomated assays for human P 450 marker substrate activities have been developed and validated using approaches described in the GLP (good lab. practices) as per the code of U.S. Federal Regulations.  The assays that were validated are: phenacetin O-deethylase (CYP1A2), coumarin 7-hydroxylase (CYP2A6), bupropion hydroxylase (CYP2B6), amodiaquine N-deethylase (CYP2C8), diclofenac 4'-hydroxylase and tolbutamide methylhydroxylase (CYP2C9), (S)-mephenytoin 4'-hydroxylase (CYP2C19), dextromethorphan O-demethylase (CYP2D6), chlorzoxazone 6-hydroxylase (CYP2E1), felodipine dehydrogenase, testosterone 6β-hydroxylase, and midazolam 1'-hydroxylase (CYP3A4 and CYP3A5).  High-pressure liq. chromatog.-tandem mass spectrometry, using stable isotope-labeled internal stds., has been applied as the anal. method.  This anal. approach, through its high sensitivity and selectivity, has permitted the use of very low incubation concns. of microsomal protein (0.01-0.2 mg/mL).  Anal. assay accuracy and precision values were excellent.  Enzyme kinetic and inhibition parameters obtained using these methods demonstrated high precision and were within the range of values previously reported in the scientific literature.  These methods should prove useful in the routine assessments of the potential for new drug candidates to elicit pharmacokinetic drug interactions via inhibition of cytochrome P 450 activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwF04TGeyYbbVg90H21EOLACvtfcHk0lhXadg71UWpXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlOgt74%253D&md5=35532b907c15f1053aa8233dab2ec581</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fdmd.32.6.647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.32.6.647%26sid%3Dliteratum%253Aachs%26aulast%3DWalsky%26aufirst%3DR.%2BL.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DValidated%2520assays%2520for%2520human%2520cytochrome%2520P450%2520activities%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26spage%3D647%26epage%3D660%26doi%3D10.1124%2Fdmd.32.6.647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Orr, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripp, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span> </span><span class="NLM_article-title">Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug-drug interaction risks</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4896</span><span class="NLM_x">–</span> <span class="NLM_lpage">4933</span><span class="refDoi"> DOI: 10.1021/jm300065h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300065h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Wlur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4896-4933&author=S.+T.+Orrauthor=S.+L.+Rippauthor=T.+E.+Ballardauthor=J.+L.+Hendersonauthor=D.+O.+Scottauthor=R.+S.+Obachauthor=H.+Sunauthor=A.+S.+Kalgutkar&title=Mechanism-based+inactivation+%28MBI%29+of+cytochrome+P450+enzymes%3A+structure-activity+relationships+and+discovery+strategies+to+mitigate+drug-drug+interaction+risks&doi=10.1021%2Fjm300065h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism-Based Inactivation (MBI) of Cytochrome P450 Enzymes: Structure-Activity Relationships and Discovery Strategies To Mitigate Drug-Drug Interaction Risks</span></div><div class="casAuthors">Orr, Suvi T. M.; Ripp, Sharon L.; Ballard, T. Eric; Henderson, Jaclyn L.; Scott, Dennis O.; Obach, R. Scott; Sun, Hao; Kalgutkar, Amit S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4896-4933</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The importance of mitigating drug-drug interaction (DDI) risks, which arise from inhibition of major human cytochrome P 450 enzymes is a well-established component of the lead optimization process in drug discovery.  More recently, there has been much interest in clin. DDIs potentially arising via time- and concn.-dependent cytochrome P 450 inhibition, a phenomenon consistent with mechanism-based inactivation.  Inactivated P 450 is catalytically incompetent and must be replenished by newly synthesized protein.  Consequently, time-dependent inhibition of P450s presents a greater safety concern compared to reversible inhibition because of the increased propensity for pharmacokinetic interactions upon multiple dosing and the sustained duration of these interactions after discontinuation of the mechanism-based inactivator.  Mechanism-based or time-dependent P 450 inhibitors pose an addnl. risk of idiosyncratic drug toxicity since the mechanism of time-dependency often involves the formation of reactive metabolites, which can react with proteins other than the P 450 isoenzyme responsible for catalysis. in vitro time-dependent inhibition (TDI) of P 450 enzymes is now routinely assessed as part of lead optimization efforts in preclin. drug discovery.  However, identification of an in vitro TDI liability can raise several questions such as: What is the mechanism of TDI.  Does it involve the formation of reactive metabolites.  Is there a 1:1 correlation between P 450 TDI and RM formation (as measured from reactive metabolite trapping studies).  What is the likelihood that a P 450 time-dependent inhibitor will also cause toxicity.  What are the DDI risk mitigation options when dealing with P 450 inactivators in drug discovery - compd. progression or termination.  Several drugs exhibit in vitro TDI of P 450 enzymes, but only a fraction thereof causes clin. DDIs.  Hence, when do we initiate labor-intensive medicinal chem. efforts to design compds. devoid of P 450 TDI liability.  What are the best methods to precisely predict the likelihood of occurrence of clin. DDIs with drug candidates that inactivate P 450 enzymes.  What are (if any) the qualifying considerations for clin. progression of a P 450 time-dependent inactivator with projected clin. DDI risks.  In an effort to address these questions and hopefully provide answers to some of them, we embarked on the present venture wherein we highlight the current state-of-the-art knowledge in this field with a special emphasis on (a) available biochem. and mechanistic approaches in drug discovery to examine TDI of P 450 isoenzymes with new chem. entities, (b) structure-activity relationship studies with marketed drugs assocd. with DDIs via P 450 inactivation, (c) case studies of medicinal chem. tactics to abrogate P 450 inactivation liability, (d) strategies for progression of P 450 TDI-pos. drug candidates, and (e) the utility of in silico methodol., including the use of physiol.-based pharmacokinetic simulators, in drug discovery to predict the magnitude of clin. DDIs risks anticipated with new clin. candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDO60qqRvpS7Vg90H21EOLACvtfcHk0lhXadg71UWpXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Wlur8%253D&md5=aa4aa4f633b3b4f73b3d79917327b0de</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm300065h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300065h%26sid%3Dliteratum%253Aachs%26aulast%3DOrr%26aufirst%3DS.%2BT.%26aulast%3DRipp%26aufirst%3DS.%2BL.%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DHenderson%26aufirst%3DJ.%2BL.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26atitle%3DMechanism-based%2520inactivation%2520%2528MBI%2529%2520of%2520cytochrome%2520P450%2520enzymes%253A%2520structure-activity%2520relationships%2520and%2520discovery%2520strategies%2520to%2520mitigate%2520drug-drug%2520interaction%2520risks%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4896%26epage%3D4933%26doi%3D10.1021%2Fjm300065h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Varma, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chupka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kattan, A.</span><span> </span><span class="NLM_article-title">Physicochemical determinants of human renal clearance</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4844</span><span class="NLM_x">–</span> <span class="NLM_lpage">4852</span><span class="refDoi"> DOI: 10.1021/jm900403j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900403j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvFOnt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4844-4852&author=M.+V.+Varmaauthor=B.+Fengauthor=R.+S.+Obachauthor=M.+D.+Troutmanauthor=J.+Chupkaauthor=H.+R.+Millerauthor=A.+El-Kattan&title=Physicochemical+determinants+of+human+renal+clearance&doi=10.1021%2Fjm900403j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical Determinants of Human Renal Clearance</span></div><div class="casAuthors">Varma, Manthena V. S.; Feng, Bo; Obach, R. Scott; Troutman, Matthew D.; Chupka, Jonathan; Miller, Howard R.; El-Kattan, Ayman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4844-4852</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Kidney plays an important role in the elimination of drugs, esp. with low or negligible hepatic clearance.  An anal. of the interrelation of physicochem. properties and the human renal clearance for a data set of 391 drugs or compds. tested in humans is presented.  The data set indicated that lipophilicity shows a neg. relationship while polar descriptors show a pos. relationship with renal clearance.  Anal. of net secreted and net reabsorbed subsets revealed that hydrophilic ionized compds. are probable compds. to show net secretion and a possible drug-drug interaction due to their likely interaction with uptake transporters and inherent low passive reabsorption.  The physicochem. space and renal clearance were also statistically analyzed by therapeutic area.  In conclusion, ionization state, lipophilicity, and polar descriptors are found to be the physicochem. determinants of renal clearance.  These fundamental properties can be valuable in early prediction of human renal clearance and can aid the chemist in structural modifications to optimize drug disposition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorGLq4kYGi_LVg90H21EOLACvtfcHk0lj3PNrixUqS7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvFOnt7s%253D&md5=a99ccaa1651d04ed7f7c0a49679f55f6</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm900403j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900403j%26sid%3Dliteratum%253Aachs%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DChupka%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DH.%2BR.%26aulast%3DEl-Kattan%26aufirst%3DA.%26atitle%3DPhysicochemical%2520determinants%2520of%2520human%2520renal%2520clearance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4844%26epage%3D4852%26doi%3D10.1021%2Fjm900403j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Taylor, F. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddad, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hack, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peer, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrissey, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinasewitz, G. T.</span><span> </span><span class="NLM_article-title">Two-stage response to endotoxin infusion into normal human subjects: Correlation of blood phagocyte luminescence with clinical and laboratory markers of the inflammatory, hemostatic response</span> <span class="citation_source-journal">Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">326</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span><span class="refDoi"> DOI: 10.1097/00003246-200102000-00020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1097%2F00003246-200102000-00020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=11269245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsleltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=326-334&author=F.+B.+Taylorauthor=P.+A.+Haddadauthor=E.+Hackauthor=A.+C.+Changauthor=G.+T.+Peerauthor=J.+H.+Morrisseyauthor=A.+Liauthor=R.+C.+Allenauthor=H.+Wadaauthor=G.+T.+Kinasewitz&title=Two-stage+response+to+endotoxin+infusion+into+normal+human+subjects%3A+Correlation+of+blood+phagocyte+luminescence+with+clinical+and+laboratory+markers+of+the+inflammatory%2C+hemostatic+response&doi=10.1097%2F00003246-200102000-00020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Two-stage response to endotoxin infusion into normal human subjects: Correlation of blood phagocyte luminescence with clinical and laboratory markers of the inflammatory, hemostatic response</span></div><div class="casAuthors">Taylor, Fletcher B., Jr.; Haddad, Phillip A.; Hack, Erik; Chang, Alvin C.; Peer, Glenn T.; Morrissey, James H.; Li, Anguo; Allen, Robert C.; Wada, Hideo; Kinasewitz, Gary T.</div><div class="citationInfo"><span class="NLM_cas:title">Critical Care Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">326-334</span>CODEN:
                <span class="NLM_cas:coden">CCMDC7</span>;
        ISSN:<span class="NLM_cas:issn">0090-3493</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The present studies characterize the receptor and oxidative enzymic responses of phagocytes in the human model of endotoxemia and correlate them with the responses of mol. markers of hemostatic and inflammatory system activation and endothelial injury.  These observations establish for the first time that the compensated response of human subjects to endotoxin consists of 2 stages: an immediate symptomatic inflammatory stage followed by an asymptomatic stage that is characterized by a recurrence of hemostatic activity, appearance of complement activation products complexed to C-reactive protein, and evidence of endothelial cell injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRB3dD4FzghbVg90H21EOLACvtfcHk0lj3PNrixUqS7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsleltLw%253D&md5=3e3cbc28ac37c329448d74c815b48ef6</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1097%2F00003246-200102000-00020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00003246-200102000-00020%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DF.%2BB.%26aulast%3DHaddad%26aufirst%3DP.%2BA.%26aulast%3DHack%26aufirst%3DE.%26aulast%3DChang%26aufirst%3DA.%2BC.%26aulast%3DPeer%26aufirst%3DG.%2BT.%26aulast%3DMorrissey%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DAllen%26aufirst%3DR.%2BC.%26aulast%3DWada%26aufirst%3DH.%26aulast%3DKinasewitz%26aufirst%3DG.%2BT.%26atitle%3DTwo-stage%2520response%2520to%2520endotoxin%2520infusion%2520into%2520normal%2520human%2520subjects%253A%2520Correlation%2520of%2520blood%2520phagocyte%2520luminescence%2520with%2520clinical%2520and%2520laboratory%2520markers%2520of%2520the%2520inflammatory%252C%2520hemostatic%2520response%26jtitle%3DCrit.%2520Care%2520Med.%26date%3D2001%26volume%3D29%26spage%3D326%26epage%3D334%26doi%3D10.1097%2F00003246-200102000-00020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Predicting clearance in humans from in vitro data</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">334</span><span class="NLM_x">–</span> <span class="NLM_lpage">339</span><span class="refDoi"> DOI: 10.2174/156802611794480873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.2174%2F156802611794480873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=21320062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=334-339&author=R.+S.+Obach&title=Predicting+clearance+in+humans+from+in+vitro+data&doi=10.2174%2F156802611794480873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting clearance in humans from in vitro data</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">334-339</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The use of in vitro metab. in scaling to predict human clearance of new chem. entities has become a commonplace activity in the research and development of new drugs.  The measurement of in vitro lability in human liver microsomes, a rich source of drug metabolizing cytochrome P 450 enzymes, has become a high throughput screen in many research organizations which is a testament to its usefulness in drug design.  In this chapter, the methods used to scale in vitro intrinsic clearance data to predict in vivo clearance are described.  Importantly, the numerous assumptions that are required in order to use in vitro data in this manner are laid out.  These include assumptions regarding the scaling process as well as tech. aspects of the generation of the in vitro data.  Finally, some other drug clearance processes that have been emerging as important are described with regard to ongoing research efforts to develop clearance prediction methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHL7BnSTNtWbVg90H21EOLACvtfcHk0lj3PNrixUqS7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSntbk%253D&md5=38df8707bb77fdc8b6bb6ef2144a79da</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.2174%2F156802611794480873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611794480873%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPredicting%2520clearance%2520in%2520humans%2520from%2520in%2520vitro%2520data%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D334%26epage%3D339%26doi%3D10.2174%2F156802611794480873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 35 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Cuihua Wang, David Cheng, Negin Jalali Motlagh, Enrico G. Kuellenberg, Gregory R. Wojtkiewicz, Stephen P. Schmidt, Roland Stocker, <span class="NLM_string-name hlFld-ContribAuthor">John W. Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Highly Efficient Activatable MRI Probe to Sense Myeloperoxidase Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 5874-5885. <a href="https://doi.org/10.1021/acs.jmedchem.1c00038" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00038%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHighly%252BEfficient%252BActivatable%252BMRI%252BProbe%252Bto%252BSense%252BMyeloperoxidase%252BActivity%26aulast%3DWang%26aufirst%3DCuihua%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D09012021%26date%3D04052021%26volume%3D64%26issue%3D9%26spage%3D5874%26epage%3D5885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Isaac de Araújo Matos, Nivan Bezerra da Costa Júnior, <span class="NLM_string-name hlFld-ContribAuthor">Flavia Carla Meotti</span>. </span><span class="cited-content_cbyCitation_article-title">Integration of an Inhibitor-like Rule and Structure-based Virtual Screening for the Discovery of Novel Myeloperoxidase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (12)
                                     , 6408-6418. <a href="https://doi.org/10.1021/acs.jcim.0c00813" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c00813</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c00813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c00813%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DIntegration%252Bof%252Ban%252BInhibitor-like%252BRule%252Band%252BStructure-based%252BVirtual%252BScreening%252Bfor%252Bthe%252BDiscovery%252Bof%252BNovel%252BMyeloperoxidase%252BInhibitors%26aulast%3DMatos%26aufirst%3DIsaac%2Bde%2BAra%25C3%25BAjo%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17072020%26date%3D03122020%26volume%3D60%26issue%3D12%26spage%3D6408%26epage%3D6418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthew A. Cerny, Amit S. Kalgutkar, R. Scott Obach, Raman Sharma, Douglas K. Spracklin, <span class="NLM_string-name hlFld-ContribAuthor">Gregory S. Walker</span>. </span><span class="cited-content_cbyCitation_article-title">Effective Application of Metabolite Profiling in Drug Design and Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (12)
                                     , 6387-6406. <a href="https://doi.org/10.1021/acs.jmedchem.9b01840" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01840</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01840%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEffective%252BApplication%252Bof%252BMetabolite%252BProfiling%252Bin%252BDrug%252BDesign%252Band%252BDiscovery%26aulast%3DCerny%26aufirst%3DMatthew%2BA.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D06112019%26date%3D06032020%26date%3D25022020%26volume%3D63%26issue%3D12%26spage%3D6387%26epage%3D6406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhenhong Li, John Litchfield, David A. Tess, Anthony A. Carlo, Heather Eng, Christopher Keefer, <span class="NLM_string-name hlFld-ContribAuthor">Tristan S. Maurer</span>. </span><span class="cited-content_cbyCitation_article-title">A Physiologically Based in Silico Tool to Assess the Risk of Drug-Related Crystalluria. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (12)
                                     , 6489-6498. <a href="https://doi.org/10.1021/acs.jmedchem.9b01995" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01995</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01995%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BPhysiologically%252BBased%252Bin%252BSilico%252BTool%252Bto%252BAssess%252Bthe%252BRisk%252Bof%252BDrug-Related%252BCrystalluria%26aulast%3DLi%26aufirst%3DZhenhong%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D30112019%26date%3D13032020%26date%3D04032020%26volume%3D63%26issue%3D12%26spage%3D6489%26epage%3D6498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Huihui Ti, Yang Zhou, Xue Liang, Runfeng Li, Ke Ding, <span class="NLM_string-name hlFld-ContribAuthor">Xin Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (13)
                                     , 5944-5978. <a href="https://doi.org/10.1021/acs.jmedchem.8b01520" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01520%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeted%252BTreatments%252Bfor%252BChronic%252BObstructive%252BPulmonary%252BDisease%252B%252528COPD%252529%252BUsing%252BLow-Molecular-Weight%252BDrugs%252B%252528LMWDs%252529%26aulast%3DTi%26aufirst%3DHuihui%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D30092018%26date%3D12022019%26date%3D25012019%26volume%3D62%26issue%3D13%26spage%3D5944%26epage%3D5978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nicholas R. Wurtz, Andrew Viet, Scott A. Shaw, Andrew Dilger, Meriah N. Valente, Javed A. Khan, Sutjano Jusuf, Rangaraj Narayanan, Gayani Fernando, Fred Lo, Xiaoqin Liu, Gregory A. Locke, Lisa Kopcho, Lynn M. Abell, Paul Sleph, Michael Basso, Lei Zhao, Ruth R. Wexler, Franck Duclos, <span class="NLM_string-name hlFld-ContribAuthor">Ellen K. Kick</span>. </span><span class="cited-content_cbyCitation_article-title">Potent Triazolopyridine Myeloperoxidase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (12)
                                     , 1175-1180. <a href="https://doi.org/10.1021/acsmedchemlett.8b00308" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00308</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00308%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPotent%252BTriazolopyridine%252BMyeloperoxidase%252BInhibitors%26aulast%3DWurtz%26aufirst%3DNicholas%2BR.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D06072018%26date%3D01112018%26date%3D07112018%26date%3D01112018%26volume%3D9%26issue%3D12%26spage%3D1175%26epage%3D1180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jalal  Soubhye</span>, <span class="hlFld-ContribAuthor ">Ibaa  Chikh Alard</span>, <span class="hlFld-ContribAuthor ">Iyas  Aldib</span>, <span class="hlFld-ContribAuthor ">Martine  Prévost</span>, <span class="hlFld-ContribAuthor ">Michel  Gelbcke</span>, <span class="hlFld-ContribAuthor ">Annelise  De Carvalho</span>, <span class="hlFld-ContribAuthor ">Paul G.  Furtmüller</span>, <span class="hlFld-ContribAuthor ">Christian  Obinger</span>, <span class="hlFld-ContribAuthor ">Jörg  Flemmig</span>, <span class="hlFld-ContribAuthor ">Sara  Tadrent</span>, <span class="hlFld-ContribAuthor ">Franck  Meyer</span>, <span class="hlFld-ContribAuthor ">Alexandre  Rousseau</span>, <span class="hlFld-ContribAuthor ">Jean  Nève</span>, <span class="hlFld-ContribAuthor ">Véronique  Mathieu</span>, <span class="hlFld-ContribAuthor ">Karim  Zouaoui Boudjeltia</span>, <span class="hlFld-ContribAuthor ">François  Dufrasne</span>, and <span class="hlFld-ContribAuthor ">Pierre  Van Antwerpen</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors Using Virtual Screening Procedure. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (15)
                                     , 6563-6586. <a href="https://doi.org/10.1021/acs.jmedchem.7b00285" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00285</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00285%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BPotent%252BReversible%252Band%252BIrreversible%252BMyeloperoxidase%252BInhibitors%252BUsing%252BVirtual%252BScreening%252BProcedure%26aulast%3DSoubhye%26aufirst%3DJalal%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D20022017%26date%3D19072017%26date%3D10082017%26date%3D03072017%26volume%3D60%26issue%3D15%26spage%3D6563%26epage%3D6586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carol H.  Hu</span>, <span class="hlFld-ContribAuthor ">Meriah W.  Neissel Valente</span>, <span class="hlFld-ContribAuthor ">O. Scott  Halpern</span>, <span class="hlFld-ContribAuthor ">Sutjano  Jusuf</span>, <span class="hlFld-ContribAuthor ">Javed A.  Khan</span>, <span class="hlFld-ContribAuthor ">Gregory A.  Locke</span>, <span class="hlFld-ContribAuthor ">Gerald J.  Duke</span>, <span class="hlFld-ContribAuthor ">Xiaoqin  Liu</span>, <span class="hlFld-ContribAuthor ">Franck J.  Duclos</span>, <span class="hlFld-ContribAuthor ">Ruth R.  Wexler</span>, <span class="hlFld-ContribAuthor ">Ellen K.  Kick</span>, <span class="hlFld-ContribAuthor ">Joanne M.  Smallheer</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule and macrocyclic pyrazole derived inhibitors of myeloperoxidase (MPO). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>42 </em>, 128010. <a href="https://doi.org/10.1016/j.bmcl.2021.128010" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSmall%252Bmolecule%252Band%252Bmacrocyclic%252Bpyrazole%252Bderived%252Binhibitors%252Bof%252Bmyeloperoxidase%252B%252528MPO%252529%26aulast%3DHu%26aufirst%3DCarol%2BH.%26date%3D2021%26volume%3D42%26spage%3D128010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sophie L.  Maiocchi</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Ku</span>, <span class="hlFld-ContribAuthor ">Thuan  Thai</span>, <span class="hlFld-ContribAuthor ">Enoch  Chan</span>, <span class="hlFld-ContribAuthor ">Martin D.  Rees</span>, <span class="hlFld-ContribAuthor ">Shane R.  Thomas</span>. </span><span class="cited-content_cbyCitation_article-title">Myeloperoxidase: A versatile mediator of endothelial dysfunction and therapeutic target during cardiovascular disease. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2021,</strong> <em>221 </em>, 107711. <a href="https://doi.org/10.1016/j.pharmthera.2020.107711" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2020.107711</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2020.107711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2020.107711%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DMyeloperoxidase%25253A%252BA%252Bversatile%252Bmediator%252Bof%252Bendothelial%252Bdysfunction%252Band%252Btherapeutic%252Btarget%252Bduring%252Bcardiovascular%252Bdisease%26aulast%3DMaiocchi%26aufirst%3DSophie%2BL.%26date%3D2021%26volume%3D221%26spage%3D107711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael J.  Davies</span>. </span><span class="cited-content_cbyCitation_article-title">Myeloperoxidase: Mechanisms, reactions and inhibition as a therapeutic strategy in inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2021,</strong> <em>218 </em>, 107685. <a href="https://doi.org/10.1016/j.pharmthera.2020.107685" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2020.107685</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2020.107685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2020.107685%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DMyeloperoxidase%25253A%252BMechanisms%25252C%252Breactions%252Band%252Binhibition%252Bas%252Ba%252Btherapeutic%252Bstrategy%252Bin%252Binflammatory%252Bdiseases%26aulast%3DDavies%26aufirst%3DMichael%2BJ.%26date%3D2021%26volume%3D218%26spage%3D107685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patricia P.  Yee</span>, <span class="hlFld-ContribAuthor ">Yiju  Wei</span>, <span class="hlFld-ContribAuthor ">Soo-Yeon  Kim</span>, <span class="hlFld-ContribAuthor ">Tong  Lu</span>, <span class="hlFld-ContribAuthor ">Stephen Y.  Chih</span>, <span class="hlFld-ContribAuthor ">Cynthia  Lawson</span>, <span class="hlFld-ContribAuthor ">Miaolu  Tang</span>, <span class="hlFld-ContribAuthor ">Zhijun  Liu</span>, <span class="hlFld-ContribAuthor ">Benjamin  Anderson</span>, <span class="hlFld-ContribAuthor ">Krishnamoorthy  Thamburaj</span>, <span class="hlFld-ContribAuthor ">Megan M.  Young</span>, <span class="hlFld-ContribAuthor ">Dawit G.  Aregawi</span>, <span class="hlFld-ContribAuthor ">Michael J.  Glantz</span>, <span class="hlFld-ContribAuthor ">Brad E.  Zacharia</span>, <span class="hlFld-ContribAuthor ">Charles S.  Specht</span>, <span class="hlFld-ContribAuthor ">Hong-Gang  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-020-19193-y" title="DOI URL">https://doi.org/10.1038/s41467-020-19193-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-020-19193-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-020-19193-y%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DNeutrophil-induced%252Bferroptosis%252Bpromotes%252Btumor%252Bnecrosis%252Bin%252Bglioblastoma%252Bprogression%26aulast%3DYee%26aufirst%3DPatricia%2BP.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mary  El Kazzi</span>, <span class="hlFld-ContribAuthor ">Benjamin Saul  Rayner</span>, <span class="hlFld-ContribAuthor ">Belal  Chami</span>, <span class="hlFld-ContribAuthor ">Joanne Marie  Dennis</span>, <span class="hlFld-ContribAuthor ">Shane Ross  Thomas</span>, <span class="hlFld-ContribAuthor ">Paul Kenneth  Witting</span>. </span><span class="cited-content_cbyCitation_article-title">Neutrophil-Mediated Cardiac Damage After Acute Myocardial Infarction: Significance of Defining a New Target Cell Type for Developing Cardioprotective Drugs. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants & Redox Signaling</span><span> <strong>2020,</strong> <em>33 </em>
                                    (10)
                                     , 689-712. <a href="https://doi.org/10.1089/ars.2019.7928" title="DOI URL">https://doi.org/10.1089/ars.2019.7928</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/ars.2019.7928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fars.2019.7928%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%2520%2526%2520Redox%2520Signaling%26atitle%3DNeutrophil-Mediated%252BCardiac%252BDamage%252BAfter%252BAcute%252BMyocardial%252BInfarction%25253A%252BSignificance%252Bof%252BDefining%252Ba%252BNew%252BTarget%252BCell%252BType%252Bfor%252BDeveloping%252BCardioprotective%252BDrugs%26aulast%3DEl%2BKazzi%26aufirst%3DMary%26date%3D2020%26volume%3D33%26issue%3D10%26spage%3D689%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jalal  Soubhye</span>, <span class="hlFld-ContribAuthor ">Pierre  Van Antwerpen</span>, <span class="hlFld-ContribAuthor ">François  Dufrasne</span>. </span><span class="cited-content_cbyCitation_article-title">A patent review of myeloperoxidase inhibitors for treating chronic inflammatory syndromes (focus on cardiovascular diseases, 2013-2019). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (8)
                                     , 595-608. <a href="https://doi.org/10.1080/13543776.2020.1780210" title="DOI URL">https://doi.org/10.1080/13543776.2020.1780210</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1780210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1780210%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252Bpatent%252Breview%252Bof%252Bmyeloperoxidase%252Binhibitors%252Bfor%252Btreating%252Bchronic%252Binflammatory%252Bsyndromes%252B%252528focus%252Bon%252Bcardiovascular%252Bdiseases%25252C%252B2013-2019%252529%26aulast%3DSoubhye%26aufirst%3DJalal%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D8%26spage%3D595%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thanat  Chaikijurajai</span>, <span class="hlFld-ContribAuthor ">W. H. Wilson  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Myeloperoxidase: a potential therapeutic target for coronary artery disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2020,</strong> <em>24 </em>
                                    (7)
                                     , 695-705. <a href="https://doi.org/10.1080/14728222.2020.1762177" title="DOI URL">https://doi.org/10.1080/14728222.2020.1762177</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2020.1762177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2020.1762177%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DMyeloperoxidase%25253A%252Ba%252Bpotential%252Btherapeutic%252Btarget%252Bfor%252Bcoronary%252Bartery%252Bdisease%26aulast%3DChaikijurajai%26aufirst%3DThanat%26date%3D2020%26date%3D2020%26volume%3D24%26issue%3D7%26spage%3D695%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anup  Patnaik</span>, <span class="hlFld-ContribAuthor ">Laura  Axford</span>, <span class="hlFld-ContribAuthor ">Lin  Deng</span>, <span class="hlFld-ContribAuthor ">Evan  Cohick</span>, <span class="hlFld-ContribAuthor ">Xianglin  Ren</span>, <span class="hlFld-ContribAuthor ">Sally  Loi</span>, <span class="hlFld-ContribAuthor ">Sam  Kecman</span>, <span class="hlFld-ContribAuthor ">Micah  Hollis-Symynkywicz</span>, <span class="hlFld-ContribAuthor ">Tyler J.  Harrison</span>, <span class="hlFld-ContribAuthor ">Julien P.N.  Papillon</span>, <span class="hlFld-ContribAuthor ">Natalie  Dales</span>, <span class="hlFld-ContribAuthor ">Lawrence G.  Hamann</span>, <span class="hlFld-ContribAuthor ">Lac  Lee</span>, <span class="hlFld-ContribAuthor ">Jean B.  Regard</span>, <span class="hlFld-ContribAuthor ">Jovita  Marcinkeviciene</span>, <span class="hlFld-ContribAuthor ">Martin L.  Marro</span>, <span class="hlFld-ContribAuthor ">Andrew W.  Patterson</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a novel indole pharmacophore for the irreversible inhibition of myeloperoxidase (MPO). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (12)
                                     , 115548. <a href="https://doi.org/10.1016/j.bmc.2020.115548" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115548</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115548%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252Bnovel%252Bindole%252Bpharmacophore%252Bfor%252Bthe%252Birreversible%252Binhibition%252Bof%252Bmyeloperoxidase%252B%252528MPO%252529%26aulast%3DPatnaik%26aufirst%3DAnup%26date%3D2020%26volume%3D28%26issue%3D12%26spage%3D115548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jala  Soubhye</span>, <span class="hlFld-ContribAuthor ">Paul G.  Furtmüller</span>, <span class="hlFld-ContribAuthor ">Francois  Dufrasne</span>, <span class="hlFld-ContribAuthor ">Christian  Obinger</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Myeloperoxidase. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 261-285. <a href="https://doi.org/10.1007/164_2020_388" title="DOI URL">https://doi.org/10.1007/164_2020_388</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/164_2020_388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F164_2020_388%26sid%3Dliteratum%253Aachs%26atitle%3DInhibition%252Bof%252BMyeloperoxidase%26aulast%3DSoubhye%26aufirst%3DJala%26date%3D2020%26date%3D2020%26spage%3D261%26epage%3D285%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DReactive%252BOxygen%252BSpecies%26aulast%3DSchmidt%26aufirst%3DHarald%2BH.%2BH.%2BW.%26date%3D2021%26volume%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Inas R  El-Alameey</span>, <span class="hlFld-ContribAuthor ">Hanaa H  Ahmed</span>, <span class="hlFld-ContribAuthor ">Rehab A  Mahmoud</span>, <span class="hlFld-ContribAuthor ">Sahar A.  Kairy</span>, <span class="hlFld-ContribAuthor ">Eman A  Medany</span>. </span><span class="cited-content_cbyCitation_article-title">Significance of Myeloperoxidase in the Onset of Cardiovascular Disease among Obese Children and Adolescents. </span><span class="cited-content_cbyCitation_journal-name">Biomedical and Pharmacology Journal</span><span> <strong>2019,</strong> <em>12 </em>
                                    (04)
                                     , 1647-1659. <a href="https://doi.org/10.13005/bpj/1795" title="DOI URL">https://doi.org/10.13005/bpj/1795</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.13005/bpj/1795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.13005%2Fbpj%2F1795%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedical%2520and%2520Pharmacology%2520Journal%26atitle%3DSignificance%252Bof%252BMyeloperoxidase%252Bin%252Bthe%252BOnset%252Bof%252BCardiovascular%252BDisease%252Bamong%252BObese%252BChildren%252Band%252BAdolescents%26aulast%3DEl-Alameey%26aufirst%3DInas%2BR%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D04%26spage%3D1647%26epage%3D1659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tingting  Li</span>, <span class="hlFld-ContribAuthor ">Sida  Jiang</span>, <span class="hlFld-ContribAuthor ">Bingwei  Ni</span>, <span class="hlFld-ContribAuthor ">Qiuji  Cui</span>, <span class="hlFld-ContribAuthor ">Qinan  Liu</span>, <span class="hlFld-ContribAuthor ">Hongping  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Discontinued Drugs for the Treatment of Cardiovascular Disease from 2016 to 2018. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (18)
                                     , 4513. <a href="https://doi.org/10.3390/ijms20184513" title="DOI URL">https://doi.org/10.3390/ijms20184513</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20184513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20184513%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDiscontinued%252BDrugs%252Bfor%252Bthe%252BTreatment%252Bof%252BCardiovascular%252BDisease%252Bfrom%252B2016%252Bto%252B2018%26aulast%3DLi%26aufirst%3DTingting%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D18%26spage%3D4513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cuihua  Wang</span>, <span class="hlFld-ContribAuthor ">Edmund  Keliher</span>, <span class="hlFld-ContribAuthor ">Matthias W. G.  Zeller</span>, <span class="hlFld-ContribAuthor ">Gregory R.  Wojtkiewicz</span>, <span class="hlFld-ContribAuthor ">Aaron D.  Aguirre</span>, <span class="hlFld-ContribAuthor ">Leonard  Buckbinder</span>, <span class="hlFld-ContribAuthor ">Hye-Yeong  Kim</span>, <span class="hlFld-ContribAuthor ">Jianqing  Chen</span>, <span class="hlFld-ContribAuthor ">Kevin  Maresca</span>, <span class="hlFld-ContribAuthor ">Maaz S.  Ahmed</span>, <span class="hlFld-ContribAuthor ">Negin Jalali  Motlagh</span>, <span class="hlFld-ContribAuthor ">Matthias  Nahrendorf</span>, <span class="hlFld-ContribAuthor ">John W.  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">An activatable PET imaging radioprobe is a dynamic reporter of myeloperoxidase activity in vivo. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2019,</strong> <em>7 </em>, 201818434. <a href="https://doi.org/10.1073/pnas.1818434116" title="DOI URL">https://doi.org/10.1073/pnas.1818434116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1818434116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1818434116%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DAn%252Bactivatable%252BPET%252Bimaging%252Bradioprobe%252Bis%252Ba%252Bdynamic%252Breporter%252Bof%252Bmyeloperoxidase%252Bactivity%252Bin%252Bvivo%26aulast%3DWang%26aufirst%3DCuihua%26date%3D2019%26date%3D2019%26volume%3D7%26spage%3D201818434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachel J.  Roth Flach</span>, <span class="hlFld-ContribAuthor ">Chunyan  Su</span>, <span class="hlFld-ContribAuthor ">Eliza  Bollinger</span>, <span class="hlFld-ContribAuthor ">Christian  Cortes</span>, <span class="hlFld-ContribAuthor ">Andrew W.  Robertson</span>, <span class="hlFld-ContribAuthor ">Alan C.  Opsahl</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Coskran</span>, <span class="hlFld-ContribAuthor ">Kevin P.  Maresca</span>, <span class="hlFld-ContribAuthor ">Edmund J.  Keliher</span>, <span class="hlFld-ContribAuthor ">Phillip D.  Yates</span>, <span class="hlFld-ContribAuthor ">Albert M.  Kim</span>, <span class="hlFld-ContribAuthor ">Amit S.  Kalgutkar</span>, <span class="hlFld-ContribAuthor ">Leonard  Buckbinder</span>, . </span><span class="cited-content_cbyCitation_article-title">Myeloperoxidase inhibition in mice alters atherosclerotic lesion composition. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2019,</strong> <em>14 </em>
                                    (3)
                                     , e0214150. <a href="https://doi.org/10.1371/journal.pone.0214150" title="DOI URL">https://doi.org/10.1371/journal.pone.0214150</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0214150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0214150%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DMyeloperoxidase%252Binhibition%252Bin%252Bmice%252Balters%252Batherosclerotic%252Blesion%252Bcomposition%26aulast%3DRoth%2BFlach%26aufirst%3DRachel%2BJ.%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D3%26spage%3De0214150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin L.  Marro</span>, <span class="hlFld-ContribAuthor ">Andrew W.  Patterson</span>, <span class="hlFld-ContribAuthor ">Lac  Lee</span>, <span class="hlFld-ContribAuthor ">Lin  Deng</span>, <span class="hlFld-ContribAuthor ">Aimee  Reynolds</span>, <span class="hlFld-ContribAuthor ">Xianglin  Ren</span>, <span class="hlFld-ContribAuthor ">Laura  Axford</span>, <span class="hlFld-ContribAuthor ">Anup  Patnaik</span>, <span class="hlFld-ContribAuthor ">Micah  Hollis-Symynkywicz</span>, <span class="hlFld-ContribAuthor ">Nigel  Casson</span>, <span class="hlFld-ContribAuthor ">Dominique  Custeau</span>, <span class="hlFld-ContribAuthor ">Lisa  Ames</span>, <span class="hlFld-ContribAuthor ">Sally  Loi</span>, <span class="hlFld-ContribAuthor ">Lihe  Zhang</span>, <span class="hlFld-ContribAuthor ">Toshiyuki  Honda</span>, <span class="hlFld-ContribAuthor ">Jutta  Blank</span>, <span class="hlFld-ContribAuthor ">Tyler J.  Harrison</span>, <span class="hlFld-ContribAuthor ">Julien P. N.  Papillon</span>, <span class="hlFld-ContribAuthor ">Lawrence G.  Hamann</span>, <span class="hlFld-ContribAuthor ">Jovita  Marcinkeviciene</span>, <span class="hlFld-ContribAuthor ">Jean B.  Regard</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 1-((6-Aminopyridin-3-yl)Methyl)-3-(4-Bromophenyl)Urea as a Potent, Irreversible Myeloperoxidase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2018,</strong> <em>367 </em>
                                    (1)
                                     , 147-154. <a href="https://doi.org/10.1124/jpet.118.248435" title="DOI URL">https://doi.org/10.1124/jpet.118.248435</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.118.248435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.118.248435%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DDiscovery%252Bof%252B1-%252528%2525286-Aminopyridin-3-yl%252529Methyl%252529-3-%2525284-Bromophenyl%252529Urea%252Bas%252Ba%252BPotent%25252C%252BIrreversible%252BMyeloperoxidase%252BInhibitor%26aulast%3DMarro%26aufirst%3DMartin%2BL.%26date%3D2018%26date%3D2018%26volume%3D367%26issue%3D1%26spage%3D147%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jamie E.  Moscovitz</span>, <span class="hlFld-ContribAuthor ">Zhiwu  Lin</span>, <span class="hlFld-ContribAuthor ">Nathaniel  Johnson</span>, <span class="hlFld-ContribAuthor ">Meihua  Tu</span>, <span class="hlFld-ContribAuthor ">Theunis C.  Goosen</span>, <span class="hlFld-ContribAuthor ">Yan  Weng</span>, <span class="hlFld-ContribAuthor ">Amit S.  Kalgutkar</span>. </span><span class="cited-content_cbyCitation_article-title">Induction of human cytochrome P450 3A4 by the irreversible myeloperoxidase inactivator PF-06282999 is mediated by the pregnane X receptor. </span><span class="cited-content_cbyCitation_journal-name">Xenobiotica</span><span> <strong>2018,</strong> <em>48 </em>
                                    (7)
                                     , 647-655. <a href="https://doi.org/10.1080/00498254.2017.1353163" title="DOI URL">https://doi.org/10.1080/00498254.2017.1353163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00498254.2017.1353163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00498254.2017.1353163%26sid%3Dliteratum%253Aachs%26jtitle%3DXenobiotica%26atitle%3DInduction%252Bof%252Bhuman%252Bcytochrome%252BP450%252B3A4%252Bby%252Bthe%252Birreversible%252Bmyeloperoxidase%252Binactivator%252BPF-06282999%252Bis%252Bmediated%252Bby%252Bthe%252Bpregnane%252BX%252Breceptor%26aulast%3DMoscovitz%26aufirst%3DJamie%2BE.%26date%3D2018%26date%3D2017%26volume%3D48%26issue%3D7%26spage%3D647%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jamie E.  Moscovitz</span>, <span class="hlFld-ContribAuthor ">Amit S.  Kalgutkar</span>, <span class="hlFld-ContribAuthor ">Kelly  Nulick</span>, <span class="hlFld-ContribAuthor ">Nathaniel  Johnson</span>, <span class="hlFld-ContribAuthor ">Zhiwu  Lin</span>, <span class="hlFld-ContribAuthor ">Theunis C.  Goosen</span>, <span class="hlFld-ContribAuthor ">Yan  Weng</span>. </span><span class="cited-content_cbyCitation_article-title">Establishing Transcriptional Signatures to Differentiate PXR-, CAR-, and AhR-Mediated Regulation of Drug Metabolism and Transport Genes in Cryopreserved Human Hepatocytes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2018,</strong> <em>365 </em>
                                    (2)
                                     , 262-271. <a href="https://doi.org/10.1124/jpet.117.247296" title="DOI URL">https://doi.org/10.1124/jpet.117.247296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.117.247296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.117.247296%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DEstablishing%252BTranscriptional%252BSignatures%252Bto%252BDifferentiate%252BPXR-%25252C%252BCAR-%25252C%252Band%252BAhR-Mediated%252BRegulation%252Bof%252BDrug%252BMetabolism%252Band%252BTransport%252BGenes%252Bin%252BCryopreserved%252BHuman%252BHepatocytes%26aulast%3DMoscovitz%26aufirst%3DJamie%2BE.%26date%3D2018%26date%3D2018%26volume%3D365%26issue%3D2%26spage%3D262%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Louisa V.  Forbes</span>, <span class="hlFld-ContribAuthor ">Anthony J.  Kettle</span>. </span><span class="cited-content_cbyCitation_article-title">A multi-substrate assay for finding physiologically effective inhibitors of myeloperoxidase. </span><span class="cited-content_cbyCitation_journal-name">Analytical Biochemistry</span><span> <strong>2018,</strong> <em>544 </em>, 13-21. <a href="https://doi.org/10.1016/j.ab.2017.12.022" title="DOI URL">https://doi.org/10.1016/j.ab.2017.12.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ab.2017.12.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ab.2017.12.022%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Biochemistry%26atitle%3DA%252Bmulti-substrate%252Bassay%252Bfor%252Bfinding%252Bphysiologically%252Beffective%252Binhibitors%252Bof%252Bmyeloperoxidase%26aulast%3DForbes%26aufirst%3DLouisa%2BV.%26date%3D2018%26volume%3D544%26spage%3D13%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Guo</span>, <span class="hlFld-ContribAuthor ">Ying  Xie</span>, <span class="hlFld-ContribAuthor ">Qiao-Lei  Wu</span>, <span class="hlFld-ContribAuthor ">Wen-Tian  Zeng</span>, <span class="hlFld-ContribAuthor ">Albert S. C.  Chan</span>, <span class="hlFld-ContribAuthor ">Jiang  Weng</span>, <span class="hlFld-ContribAuthor ">Gui  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-catalyzed aerobic decarboxylative coupling between cyclic α-amino acids and diverse C–H nucleophiles with low catalyst loading. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (29)
                                     , 16202-16206. <a href="https://doi.org/10.1039/C8RA02340A" title="DOI URL">https://doi.org/10.1039/C8RA02340A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA02340A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA02340A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DCopper-catalyzed%252Baerobic%252Bdecarboxylative%252Bcoupling%252Bbetween%252Bcyclic%252B%2525CE%2525B1-amino%252Bacids%252Band%252Bdiverse%252BC%2525E2%252580%252593H%252Bnucleophiles%252Bwith%252Blow%252Bcatalyst%252Bloading%26aulast%3DGuo%26aufirst%3DJing%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D29%26spage%3D16202%26epage%3D16206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luiza de Carvalho  Bertozo</span>, <span class="hlFld-ContribAuthor ">Maria Luiza  Zeraik</span>, <span class="hlFld-ContribAuthor ">Valdecir Farias  Ximenes</span>. </span><span class="cited-content_cbyCitation_article-title">Dansylglycine, a fluorescent probe for specific determination of halogenating activity of myeloperoxidase and eosinophil peroxidase. </span><span class="cited-content_cbyCitation_journal-name">Analytical Biochemistry</span><span> <strong>2017,</strong> <em>532 </em>, 29-37. <a href="https://doi.org/10.1016/j.ab.2017.05.029" title="DOI URL">https://doi.org/10.1016/j.ab.2017.05.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ab.2017.05.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ab.2017.05.029%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Biochemistry%26atitle%3DDansylglycine%25252C%252Ba%252Bfluorescent%252Bprobe%252Bfor%252Bspecific%252Bdetermination%252Bof%252Bhalogenating%252Bactivity%252Bof%252Bmyeloperoxidase%252Band%252Beosinophil%252Bperoxidase%26aulast%3DBertozo%26aufirst%3DLuiza%2Bde%2BCarvalho%26date%3D2017%26volume%3D532%26spage%3D29%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manon  Poret</span>, <span class="hlFld-ContribAuthor ">Thanh  Tran</span>, <span class="hlFld-ContribAuthor ">Marie  Villotte</span>, <span class="hlFld-ContribAuthor ">Oliver  Nüsse</span>. </span><span class="cited-content_cbyCitation_article-title">La myéloperoxydase : un fin stratège face à l’infection par un pathogène. </span><span class="cited-content_cbyCitation_journal-name">médecine/sciences</span><span> <strong>2017,</strong> <em>33 </em>
                                    (8-9)
                                     , 741-743. <a href="https://doi.org/10.1051/medsci/20173308018" title="DOI URL">https://doi.org/10.1051/medsci/20173308018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1051/medsci/20173308018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1051%2Fmedsci%2F20173308018%26sid%3Dliteratum%253Aachs%26jtitle%3Dm%25C3%25A9decine%252Fsciences%26atitle%3DLa%252Bmy%2525C3%2525A9loperoxydase%2525C2%2525A0%25253A%252Bun%252Bfin%252Bstrat%2525C3%2525A8ge%252Bface%252B%2525C3%2525A0%252Bl%2525E2%252580%252599infection%252Bpar%252Bun%252Bpathog%2525C3%2525A8ne%26aulast%3DPoret%26aufirst%3DManon%26date%3D2017%26date%3D2017%26volume%3D33%26issue%3D8-9%26spage%3D741%26epage%3D743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer Q.  Dong</span>, <span class="hlFld-ContribAuthor ">James R.  Gosset</span>, <span class="hlFld-ContribAuthor ">Odette A.  Fahmi</span>, <span class="hlFld-ContribAuthor ">Zhiwu  Lin</span>, <span class="hlFld-ContribAuthor ">Jeffrey R.  Chabot</span>, <span class="hlFld-ContribAuthor ">Steven G.  Terra</span>, <span class="hlFld-ContribAuthor ">Vu  Le</span>, <span class="hlFld-ContribAuthor ">Kristin  Chidsey</span>, <span class="hlFld-ContribAuthor ">Parya  Nouri</span>, <span class="hlFld-ContribAuthor ">Albert  Kim</span>, <span class="hlFld-ContribAuthor ">Leonard  Buckbinder</span>, <span class="hlFld-ContribAuthor ">Amit S.  Kalgutkar</span>. </span><span class="cited-content_cbyCitation_article-title">Examination of the Human Cytochrome P4503A4 Induction Potential of PF-06282999, an Irreversible Myeloperoxidase Inactivator: Integration of Preclinical, In Silico, and Biomarker Methodologies in the Prediction of the Clinical Outcome. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2017,</strong> <em>45 </em>
                                    (5)
                                     , 501-511. <a href="https://doi.org/10.1124/dmd.116.074476" title="DOI URL">https://doi.org/10.1124/dmd.116.074476</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.116.074476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.116.074476%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DExamination%252Bof%252Bthe%252BHuman%252BCytochrome%252BP4503A4%252BInduction%252BPotential%252Bof%252BPF-06282999%25252C%252Ban%252BIrreversible%252BMyeloperoxidase%252BInactivator%25253A%252BIntegration%252Bof%252BPreclinical%25252C%252BIn%252BSilico%25252C%252Band%252BBiomarker%252BMethodologies%252Bin%252Bthe%252BPrediction%252Bof%252Bthe%252BClinical%252BOutcome%26aulast%3DDong%26aufirst%3DJennifer%2BQ.%26date%3D2017%26date%3D2017%26volume%3D45%26issue%3D5%26spage%3D501%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nura  Schürmann</span>, <span class="hlFld-ContribAuthor ">Pascal  Forrer</span>, <span class="hlFld-ContribAuthor ">Olivier  Casse</span>, <span class="hlFld-ContribAuthor ">Jiagui  Li</span>, <span class="hlFld-ContribAuthor ">Boas  Felmy</span>, <span class="hlFld-ContribAuthor ">Anne-Valérie  Burgener</span>, <span class="hlFld-ContribAuthor ">Nikolaus  Ehrenfeuchter</span>, <span class="hlFld-ContribAuthor ">Wolf-Dietrich  Hardt</span>, <span class="hlFld-ContribAuthor ">Mike  Recher</span>, <span class="hlFld-ContribAuthor ">Christoph  Hess</span>, <span class="hlFld-ContribAuthor ">Astrid  Tschan-Plessl</span>, <span class="hlFld-ContribAuthor ">Nina  Khanna</span>, <span class="hlFld-ContribAuthor ">Dirk  Bumann</span>. </span><span class="cited-content_cbyCitation_article-title">Myeloperoxidase targets oxidative host attacks to Salmonella and prevents collateral tissue damage. </span><span class="cited-content_cbyCitation_journal-name">Nature Microbiology</span><span> <strong>2017,</strong> <em>2 </em>
                                    (4)
                                     <a href="https://doi.org/10.1038/nmicrobiol.2016.268" title="DOI URL">https://doi.org/10.1038/nmicrobiol.2016.268</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nmicrobiol.2016.268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnmicrobiol.2016.268%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Microbiology%26atitle%3DMyeloperoxidase%252Btargets%252Boxidative%252Bhost%252Battacks%252Bto%252BSalmonella%252Band%252Bprevents%252Bcollateral%252Btissue%252Bdamage%26aulast%3DSch%25C3%25BCrmann%26aufirst%3DNura%26date%3D2017%26date%3D2017%26volume%3D2%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajagopal  Desikan</span>, <span class="hlFld-ContribAuthor ">Chandrakala Aluganti  Narasimhulu</span>, <span class="hlFld-ContribAuthor ">Bobby  Khan</span>, <span class="hlFld-ContribAuthor ">Sanjay  Rajagopalan</span>, <span class="hlFld-ContribAuthor ">Sampath  Parthasarathy</span>. </span><span class="cited-content_cbyCitation_article-title">Myeloperoxidase (MPO): Do We Need Inhibitors?. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 535-571. <a href="https://doi.org/10.1007/978-3-319-60324-7_24" title="DOI URL">https://doi.org/10.1007/978-3-319-60324-7_24</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-60324-7_24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-60324-7_24%26sid%3Dliteratum%253Aachs%26atitle%3DMyeloperoxidase%252B%252528MPO%252529%25253A%252BDo%252BWe%252BNeed%252BInhibitors%25253F%26aulast%3DDesikan%26aufirst%3DRajagopal%26date%3D2017%26date%3D2017%26spage%3D535%26epage%3D571%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DMechanisms%252Bof%252BVascular%252BDefects%252Bin%252BDiabetes%252BMellitus%26aulast%3DKartha%26aufirst%3DC.C.%26date%3D2017%26volume%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Franck  Duclos</span>, <span class="hlFld-ContribAuthor ">Lynn M.  Abell</span>, <span class="hlFld-ContribAuthor ">David G.  Harden</span>, <span class="hlFld-ContribAuthor ">Kristen  Pike</span>, <span class="hlFld-ContribAuthor ">Kimberly  Nowak</span>, <span class="hlFld-ContribAuthor ">Gregory A.  Locke</span>, <span class="hlFld-ContribAuthor ">Gerald J.  Duke</span>, <span class="hlFld-ContribAuthor ">Xiaoqin  Liu</span>, <span class="hlFld-ContribAuthor ">Gayani  Fernando</span>, <span class="hlFld-ContribAuthor ">Scott A.  Shaw</span>, <span class="hlFld-ContribAuthor ">Benjamin P.  Vokits</span>, <span class="hlFld-ContribAuthor ">Nicholas R.  Wurtz</span>, <span class="hlFld-ContribAuthor ">Andrew  Viet</span>, <span class="hlFld-ContribAuthor ">Meriah N.  Valente</span>, <span class="hlFld-ContribAuthor ">Sylwia  Stachura</span>, <span class="hlFld-ContribAuthor ">Paul  Sleph</span>, <span class="hlFld-ContribAuthor ">Javed A.  Khan</span>, <span class="hlFld-ContribAuthor ">Ji  Gao</span>, <span class="hlFld-ContribAuthor ">Ashok R.  Dongre</span>, <span class="hlFld-ContribAuthor ">Lei  Zhao</span>, <span class="hlFld-ContribAuthor ">Ruth R.  Wexler</span>, <span class="hlFld-ContribAuthor ">David A.  Gordon</span>, <span class="hlFld-ContribAuthor ">Ellen K.  Kick</span>. </span><span class="cited-content_cbyCitation_article-title">Triazolopyrimidines identified as reversible myeloperoxidase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (11)
                                     , 2093-2099. <a href="https://doi.org/10.1039/C7MD00268H" title="DOI URL">https://doi.org/10.1039/C7MD00268H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00268H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00268H%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DTriazolopyrimidines%252Bidentified%252Bas%252Breversible%252Bmyeloperoxidase%252Binhibitors%26aulast%3DDuclos%26aufirst%3DFranck%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D11%26spage%3D2093%26epage%3D2099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad  Ali</span>, <span class="hlFld-ContribAuthor ">Benjamin  Pulli</span>, <span class="hlFld-ContribAuthor ">Gabriel  Courties</span>, <span class="hlFld-ContribAuthor ">Benoit  Tricot</span>, <span class="hlFld-ContribAuthor ">Matthew  Sebas</span>, <span class="hlFld-ContribAuthor ">Yoshiko  Iwamoto</span>, <span class="hlFld-ContribAuthor ">Ingo  Hilgendorf</span>, <span class="hlFld-ContribAuthor ">Stefan  Schob</span>, <span class="hlFld-ContribAuthor ">Anping  Dong</span>, <span class="hlFld-ContribAuthor ">Wei  Zheng</span>, <span class="hlFld-ContribAuthor ">Athanasia  Skoura</span>, <span class="hlFld-ContribAuthor ">Amit  Kalgukar</span>, <span class="hlFld-ContribAuthor ">Christian  Cortes</span>, <span class="hlFld-ContribAuthor ">Roger  Ruggeri</span>, <span class="hlFld-ContribAuthor ">Filip K.  Swirski</span>, <span class="hlFld-ContribAuthor ">Matthias  Nahrendorf</span>, <span class="hlFld-ContribAuthor ">Leonard  Buckbinder</span>, <span class="hlFld-ContribAuthor ">John W.  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Myeloperoxidase Inhibition Improves Ventricular Function and Remodeling After Experimental Myocardial Infarction. </span><span class="cited-content_cbyCitation_journal-name">JACC: Basic to Translational Science</span><span> <strong>2016,</strong> <em>1 </em>
                                    (7)
                                     , 633-643. <a href="https://doi.org/10.1016/j.jacbts.2016.09.004" title="DOI URL">https://doi.org/10.1016/j.jacbts.2016.09.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jacbts.2016.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jacbts.2016.09.004%26sid%3Dliteratum%253Aachs%26jtitle%3DJACC%253A%2520Basic%2520to%2520Translational%2520Science%26atitle%3DMyeloperoxidase%252BInhibition%252BImproves%252BVentricular%252BFunction%252Band%252BRemodeling%252BAfter%2525C2%2525A0Experimental%252BMyocardial%252BInfarction%26aulast%3DAli%26aufirst%3DMuhammad%26date%3D2016%26volume%3D1%26issue%3D7%26spage%3D633%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noémi  Zsíros</span>, <span class="hlFld-ContribAuthor ">Péter  Koncsos</span>, <span class="hlFld-ContribAuthor ">Hajnalka  Lőrincz</span>, <span class="hlFld-ContribAuthor ">Ildikó  Seres</span>, <span class="hlFld-ContribAuthor ">Mónika  Katkó</span>, <span class="hlFld-ContribAuthor ">Anita  Szentpéteri</span>, <span class="hlFld-ContribAuthor ">Viktória E.  Varga</span>, <span class="hlFld-ContribAuthor ">Péter  Fülöp</span>, <span class="hlFld-ContribAuthor ">György  Paragh</span>, <span class="hlFld-ContribAuthor ">Mariann  Harangi</span>. </span><span class="cited-content_cbyCitation_article-title">Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications. </span><span class="cited-content_cbyCitation_journal-name">Clinical Biochemistry</span><span> <strong>2016,</strong> <em>49 </em>
                                    (12)
                                     , 862-867. <a href="https://doi.org/10.1016/j.clinbiochem.2016.03.011" title="DOI URL">https://doi.org/10.1016/j.clinbiochem.2016.03.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.clinbiochem.2016.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.clinbiochem.2016.03.011%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Biochemistry%26atitle%3DParaoxonase-1%252Barylesterase%252Bactivity%252Bis%252Ban%252Bindependent%252Bpredictor%252Bof%252Bmyeloperoxidase%252Blevels%252Bin%252Boverweight%252Bpatients%252Bwith%252Bor%252Bwithout%252Bcardiovascular%252Bcomplications%26aulast%3DZs%25C3%25ADros%26aufirst%3DNo%25C3%25A9mi%26date%3D2016%26volume%3D49%26issue%3D12%26spage%3D862%26epage%3D867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H.  Eng</span>, <span class="hlFld-ContribAuthor ">R.  Sharma</span>, <span class="hlFld-ContribAuthor ">A.  Wolford</span>, <span class="hlFld-ContribAuthor ">L.  Di</span>, <span class="hlFld-ContribAuthor ">R. B.  Ruggeri</span>, <span class="hlFld-ContribAuthor ">L.  Buckbinder</span>, <span class="hlFld-ContribAuthor ">E. L.  Conn</span>, <span class="hlFld-ContribAuthor ">D. K.  Dalvie</span>, <span class="hlFld-ContribAuthor ">A. S.  Kalgutkar</span>. </span><span class="cited-content_cbyCitation_article-title">Species Differences in the Oxidative Desulfurization of a Thiouracil-Based Irreversible Myeloperoxidase Inactivator by Flavin-Containing Monooxygenase Enzymes. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2016,</strong> <em>44 </em>
                                    (8)
                                     , 1262-1269. <a href="https://doi.org/10.1124/dmd.116.070185" title="DOI URL">https://doi.org/10.1124/dmd.116.070185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.116.070185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.116.070185%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DSpecies%252BDifferences%252Bin%252Bthe%252BOxidative%252BDesulfurization%252Bof%252Ba%252BThiouracil-Based%252BIrreversible%252BMyeloperoxidase%252BInactivator%252Bby%252BFlavin-Containing%252BMonooxygenase%252BEnzymes%26aulast%3DEng%26aufirst%3DH.%26date%3D2016%26date%3D2016%26volume%3D44%26issue%3D8%26spage%3D1262%26epage%3D1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J. Q.  Dong</span>, <span class="hlFld-ContribAuthor ">M. V.  Varma</span>, <span class="hlFld-ContribAuthor ">A.  Wolford</span>, <span class="hlFld-ContribAuthor ">T.  Ryder</span>, <span class="hlFld-ContribAuthor ">L.  Di</span>, <span class="hlFld-ContribAuthor ">B.  Feng</span>, <span class="hlFld-ContribAuthor ">S. G.  Terra</span>, <span class="hlFld-ContribAuthor ">K.  Sagawa</span>, <span class="hlFld-ContribAuthor ">A. S.  Kalgutkar</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics and Disposition of the Thiouracil Derivative PF-06282999, an Orally Bioavailable, Irreversible Inactivator of Myeloperoxidase Enzyme, Across Animals and Humans. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2016,</strong> <em>44 </em>
                                    (2)
                                     , 209-219. <a href="https://doi.org/10.1124/dmd.115.067868" title="DOI URL">https://doi.org/10.1124/dmd.115.067868</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.115.067868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.115.067868%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DPharmacokinetics%252Band%252BDisposition%252Bof%252Bthe%252BThiouracil%252BDerivative%252BPF-06282999%25252C%252Ban%252BOrally%252BBioavailable%25252C%252BIrreversible%252BInactivator%252Bof%252BMyeloperoxidase%252BEnzyme%25252C%252BAcross%252BAnimals%252Band%252BHumans%26aulast%3DDong%26aufirst%3DJ.%2BQ.%26date%3D2016%26date%3D2015%26volume%3D44%26issue%3D2%26spage%3D209%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00963&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of previously reported MPO irreversible inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00963&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Enzymatic cycle for myeloperoxidase. Oxidation of native MPO by hydrogen peroxide (reaction 1) gives rise to compound <b>I</b>, the most oxidatively reactive state for MPO. In the halogenation cycle (reaction 2) a substrate, typically chloride, undergoes oxidation to afford a reactive species (e.g., hypochlorous acid) that can contribute to tissue damage under inflammatory conditions. In the peroxidation cycle, compound <b>I</b> reacts with an electron-rich organic substrate (reaction 3) to provide a radical species and compound <b>II</b>. For certain substrates such as those described in this article, the resulting radical species may then react with MPO to form a covalent adduct, rendering it irreversibly inhibited. Compound <b>II</b> may also react with another readily oxidized species (reaction 4) to return to the native state of the enzyme and complete the peroxidation cycle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00963&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of MPO by propylthiouracil. The MPO reactions were performed as described in <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>. Data are averages, and error bars represent the SD from two separate experiments. (A) Progress curves for MPO inhibition by PTU varied at 0.47–30 μM. The <i>k</i><sub>obs</sub> values were obtained by fitting the time course as described in <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>. (B) The <i>k</i><sub>obs</sub> values were fit to <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a> to determine the overall potency <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> ratio. (C) The initial rates from the first linear ∼300 s of each reaction progress curve in (A) were used to calculate percent inhibition. The data were fit to equation, <i>y</i> = 100/[1 + (<i>x</i>/IC<sub>50</sub>)<sup><i>z</i></sup>], where IC<sub>50</sub> is the inhibitor concentration at 50% inhibition and <i>z</i> is the Hill slope.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00963&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Reversibility of MPO inhibition by PTU. MPO was incubated with 24 μM PTU with (▲) or without (●) 2 μM H<sub>2</sub>O<sub>2</sub>, or DMSO for control with (■) or without (◆) 2 μM H<sub>2</sub>O<sub>2</sub>. After 15 min, an aliquot of the preincubation mixture was rapidly diluted 300-fold into the MPO reaction buffer containing 2 μM H<sub>2</sub>O<sub>2</sub> and 30 μM Amplex Red substrates and the MPO activity was immediately monitored.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00963&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Determination of the partition ratio for mechanism-based inactivation of MPO by PTU. MPO was incubated with 2 μM H<sub>2</sub>O<sub>2</sub> and PTU at concentrations varying by 1.5-fold between 0.026 and 12 μM (or DMSO for control). After 15 min, an aliquot of the preincubation mixture was rapidly diluted 300-fold into the assay buffer containing 2 μM H<sub>2</sub>O<sub>2</sub> and 30 μM Amplex Red substrates and the MPO activity was immediately monitored. The initial rate of each progress curve was determined, and the fractional MPO activity of each inhibited reaction was plotted as a function of the ratio of PTU to MPO ([PTU]/[MPO]). Data are averages, and error bars represent the SD from two separate experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00963&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>N</i>1-Substituted-6-arylthiouracil Derivatives Described in This Study<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00963&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Mg ethoxide, CDI; (b) AcOH, 80 °C; (c) TMSNCS; (d) HCl; (e) NaOH; (f) NH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NHBoc, T3P.</p></p></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Oxidative Bioactivation of the Thiouracil Motif in PTU and Compound <b>2</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00963&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. LC–MS/MS analysis of the oxidative metabolism of alcohol <b>4</b> to cyclic ether <b>M1</b> in the presence of H<sub>2</sub>O<sub>2</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00963&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/medium/jm-2015-009634_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Concentration–effect relationship for inhibition of MPO activity by <b>8</b> in a cynomolgous monkey LPS challenge study. Compound <b>8</b> was administered orally (5, 20, and 80 mg/kg) 1 h after iv administration of LPS. After 2 h (the peak in MPO activity) plasma samples were collected and concentrations of <b>8</b> as well as residual MPO activity determined. The plasma concentration of <b>8</b> that correlated with 50% of the maximum MPO inhibition achieved was 3.8 μM, approximately twice the IC<sub>50</sub> observed in the human whole blood assay (1.9 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-21/acs.jmedchem.5b00963/20151106/images/large/jm-2015-009634_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00963&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13711" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13711" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 63 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hansson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nauseef, W. M.</span><span> </span><span class="NLM_article-title">Biosynthesis, processing, and sorting of human myeloperoxidase</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">445</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span><span class="refDoi"> DOI: 10.1016/j.abb.2005.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1016%2Fj.abb.2005.08.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=445&publication_year=2006&pages=214-224&author=M.+Hanssonauthor=I.+Olssonauthor=W.+M.+Nauseef&title=Biosynthesis%2C+processing%2C+and+sorting+of+human+myeloperoxidase&doi=10.1016%2Fj.abb.2005.08.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2005.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2005.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DHansson%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DI.%26aulast%3DNauseef%26aufirst%3DW.%2BM.%26atitle%3DBiosynthesis%252C%2520processing%252C%2520and%2520sorting%2520of%2520human%2520myeloperoxidase%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2006%26volume%3D445%26spage%3D214%26epage%3D224%26doi%3D10.1016%2Fj.abb.2005.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Kutter, D.</span><span> </span><span class="NLM_article-title">Prevalence of myeloperoxidase deficiency: Population studies using Bayer-Technicon automated hematology</span> <span class="citation_source-journal">J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">675</span><span class="refDoi"> DOI: 10.1007/s001090050266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1007%2Fs001090050266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=9766844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A280%3ADyaK1cvjvVagtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1998&pages=669-675&author=D.+Kutter&title=Prevalence+of+myeloperoxidase+deficiency%3A+Population+studies+using+Bayer-Technicon+automated+hematology&doi=10.1007%2Fs001090050266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Prevalence of myeloperoxidase deficiency: population studies using Bayer-Technicon automated hematology</span></div><div class="casAuthors">Kutter D</div><div class="citationInfo"><span class="NLM_cas:title">Journal of molecular medicine (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">669-75</span>
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    </div><div class="casAbstract">The Bayer-Technicon hematological devices differentiate leukocytes by their peroxidase activity and their volume, displaying them as separate clusters.  Peroxidase deficiencies are manifested by the irregular location of these clusters.  This makes it possible to identify persons totally or partially lacking myeloperoxidase.  The deficiency is quantified by the myeloperoxidase index, which is expressed for every routine analysis and for which normal values were determined.  Values of the myeloperoxidase index confirm varying degrees of deficiency and prevalence.  Family studies using these degrees show that the hereditary pattern must be more complicated than the classical autosomal-recessive mode.  A bigenic mode is suggested.  While about half of the totally deficient individuals detected were free of typical symptoms, in the other half we found infectious complications that were sometimes life-threatening.  The hematological devices allow the identification of persons suffering from eosinoperoxidase deficiency and from MPO deficiency of the monocytes.  The latter symptom seems to indicate immaturity of these cells and may lead to unexpected diagnosis of malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSopF3R1F9CRv69nzq6467DfW6udTcc2eaO1F-xjvq5G7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1cvjvVagtg%253D%253D&md5=a55eed4752a55c0b3f6a390588b7614b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs001090050266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs001090050266%26sid%3Dliteratum%253Aachs%26aulast%3DKutter%26aufirst%3DD.%26atitle%3DPrevalence%2520of%2520myeloperoxidase%2520deficiency%253A%2520Population%2520studies%2520using%2520Bayer-Technicon%2520automated%2520hematology%26jtitle%3DJ.%2520Mol.%2520Med.%26date%3D1998%26volume%3D76%26spage%3D669%26epage%3D675%26doi%3D10.1007%2Fs001090050266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Lekstrom-Himes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallin, J.</span><span> </span><span class="NLM_article-title">Immunodeficiency diseases caused by defects in phagocytes</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">1703</span><span class="NLM_x">–</span> <span class="NLM_lpage">1714</span><span class="refDoi"> DOI: 10.1056/NEJM200012073432307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1056%2FNEJM200012073432307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=11106721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovVGhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2000&pages=1703-1714&author=J.+Lekstrom-Himesauthor=J.+Gallin&title=Immunodeficiency+diseases+caused+by+defects+in+phagocytes&doi=10.1056%2FNEJM200012073432307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Immunodeficiency diseases caused by defects in phagocytes</span></div><div class="casAuthors">Lekstrom-Himes, Julie A.; Gallin, John I.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">1703-1714</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review with 114 refs.  Topics discussed include congenital neutropenias; defects of adhesion; defects of signaling; defects of intracellular killing; and defects in the formation and function of neutrophil granules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCXYN05yco3LVg90H21EOLACvtfcHk0libylDS3MZwUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovVGhu78%253D&md5=8363d004760e5925f63f8f816526bb6c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1056%2FNEJM200012073432307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200012073432307%26sid%3Dliteratum%253Aachs%26aulast%3DLekstrom-Himes%26aufirst%3DJ.%26aulast%3DGallin%26aufirst%3DJ.%26atitle%3DImmunodeficiency%2520diseases%2520caused%2520by%2520defects%2520in%2520phagocytes%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2000%26volume%3D343%26spage%3D1703%26epage%3D1714%26doi%3D10.1056%2FNEJM200012073432307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Churg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sin, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thain, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadogan, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soars, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallinder, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. L.</span><span> </span><span class="NLM_article-title">Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary disease</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span><span class="refDoi"> DOI: 10.1164/rccm.201103-0468OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1164%2Frccm.201103-0468OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=21997333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC38XitF2rsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2012&pages=34-43&author=A.+Churgauthor=C.+V.+Marshallauthor=D.+D.+Sinauthor=S.+Boltonauthor=S.+Zhouauthor=K.+Thainauthor=E.+B.+Cadoganauthor=J.+Maltbyauthor=M.+G.+Soarsauthor=P.+R.+Mallinderauthor=J.+L.+Wright&title=Late+intervention+with+a+myeloperoxidase+inhibitor+stops+progression+of+experimental+chronic+obstructive+pulmonary+disease&doi=10.1164%2Frccm.201103-0468OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary disease</span></div><div class="casAuthors">Churg, Andrew; Marshall, Caroline V.; Sin, Don D.; Bolton, Sarah; Zhou, Steven; Thain, Katherine; Cadogan, Elaine B.; Maltby, Justine; Soars, Matthew G.; Mallinder, Philip R.; Wright, Joanne L.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-43</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Inflammation and oxidative stress are linked to the deleterious effects of cigarette smoke in producing chronic obstructive pulmonary disease (COPD).  Myeloperoxidase (MPO), a neutrophil and macrophage product, is important in bacterial killing, but also drives inflammatory reactions and tissue oxidn.  Objectives: To det. the role of MPO in COPD.  Methods: We treated guinea pigs with a 2-thioxanthine MPO inhibitor, AZ1, in a 6-mo cigarette smoke exposure model, with one group receiving compd. from Smoking Day 1 and another group treated after 3 mo of smoke exposure.  Results: At 6 mo both treatments abolished smoke-induced increases in lavage inflammatory cells, largely ameliorated physiol. changes, and prevented or stopped progression of morphol. emphysema and small airway remodeling.  Cigarette smoke caused a marked increase in immunohistochem. staining for the myeloperoxidase-generated protein oxidn. marker dityrosine, and this effect was considerably decreased with both treatment arms.  Serum 8-isoprostane, another marker of oxidative stress, showed similar trends.  Both treatments also prevented muscularization of the small intrapulmonary arteries, but only partially ameliorated smoke-induced pulmonary hypertension.  Acutely, AZ1 prevented smoke-induced increases in expression of cytokine mediators and nuclear factor-κB binding.  Conclusions: We conclude that an MPO inhibitor is able to stop progression of emphysema and small airway remodeling and to partially protect against pulmonary hypertension, even when treatment starts relatively late in the course of long-term smoke exposure, suggesting that inhibition of MPO may be a novel and useful therapeutic treatment for COPD.  Protection appears to relate to inhibition of oxidative damage and down-regulation of the smoke-induced inflammatory response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm-d4sj2ZP6LVg90H21EOLACvtfcHk0libylDS3MZwUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitF2rsL4%253D&md5=2ed38089e836610c8e067acbac2015ad</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1164%2Frccm.201103-0468OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.201103-0468OC%26sid%3Dliteratum%253Aachs%26aulast%3DChurg%26aufirst%3DA.%26aulast%3DMarshall%26aufirst%3DC.%2BV.%26aulast%3DSin%26aufirst%3DD.%2BD.%26aulast%3DBolton%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DThain%26aufirst%3DK.%26aulast%3DCadogan%26aufirst%3DE.%2BB.%26aulast%3DMaltby%26aufirst%3DJ.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DMallinder%26aufirst%3DP.%2BR.%26aulast%3DWright%26aufirst%3DJ.%2BL.%26atitle%3DLate%2520intervention%2520with%2520a%2520myeloperoxidase%2520inhibitor%2520stops%2520progression%2520of%2520experimental%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2012%26volume%3D185%26spage%3D34%26epage%3D43%26doi%3D10.1164%2Frccm.201103-0468OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Odobasic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muljadi, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Sullivan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morand, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holdsworth, S. R.</span><span> </span><span class="NLM_article-title">Endogenous myeloperoxidase is a mediator of joint inflammation and damage in experimental arthritis</span> <span class="citation_source-journal">Arthritis Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">907</span><span class="NLM_x">–</span> <span class="NLM_lpage">917</span><span class="refDoi"> DOI: 10.1002/art.38299</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1002%2Fart.38299" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=24757143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtl2qtbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2014&pages=907-917&author=D.+Odobasicauthor=Y.+Yangauthor=R.+C.+Muljadiauthor=K.+M.+O%E2%80%99Sullivanauthor=W.+Kaoauthor=M.+Smithauthor=E.+F.+Morandauthor=S.+R.+Holdsworth&title=Endogenous+myeloperoxidase+is+a+mediator+of+joint+inflammation+and+damage+in+experimental+arthritis&doi=10.1002%2Fart.38299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous myeloperoxidase is a mediator of joint inflammation and damage in experimental arthritis</span></div><div class="casAuthors">Odobasic, Dragana; Yang, Yuan; Muljadi, Ruth C. M.; O'Sullivan, Kim M.; Kao, Wenping; Smith, Malcolm; Morand, Eric F.; Holdsworth, Stephen R.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">907-917</span>CODEN:
                <span class="NLM_cas:coden">ARRHBO</span>;
        ISSN:<span class="NLM_cas:issn">2326-5191</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. Myeloperoxidase (MPO) is implicated as a local mediator of tissue damage when released extracellularly in many chronic inflammatory diseases.  The purpose of this study was to explore the role of endogenous MPO in exptl. rheumatoid arthritis (RA).  Methods. K/BxN serum-transfer arthritis was induced in C57BL/6 wild-type (WT) and MPO knockout (MPO-/-) mice, and disease development was assessed.  MPO activity was measured in joint tissues from mice with or without K/BxN arthritis.  Collagen-induced arthritis (CIA) was induced in WT and MPO-/- mice, and disease development and immune responses were examd.  MPO expression was assessed in synovial biopsy samples from patients with active RA, and the effect of MPO on synovial fibroblasts was tested in vitro.  Results. MPO was up-regulated in the joints of mice with K/BxN arthritis, and MPO deficiency attenuated the severity of the disease without affecting circulating cytokine levels.  In CIA, MPO-/- mice had enhanced CD4+ T cell responses and reduced frequency of regulatory T cells in the lymph nodes and spleen, as well as augmented interleukin-17A and diminished interferon-γ secretion by collagen-stimulated splenocytes, without an effect on circulating anticollagen antibody levels.  Despite enhanced adaptive immunity in secondary lymphoid organs, CIA development was attenuated in MPO-/- mice.  Intracellular and extracellular MPO was detected in the synovium of patients with active RA, and human MPO enhanced the proliferation and decreased the apoptosis of synovial fibroblasts in vitro.  Conclusion. MPO contributes to the development of arthritis despite suppressing adaptive immunity in secondary lymphoid organs.  This suggests distinct effects of local MPO on arthritogenic effector responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdntnp3vzKTbVg90H21EOLACvtfcHk0libylDS3MZwUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtl2qtbbJ&md5=8fdea9781dbe061cf3b681209e3d571d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fart.38299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.38299%26sid%3Dliteratum%253Aachs%26aulast%3DOdobasic%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DMuljadi%26aufirst%3DR.%2BC.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DK.%2BM.%26aulast%3DKao%26aufirst%3DW.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DMorand%26aufirst%3DE.%2BF.%26aulast%3DHoldsworth%26aufirst%3DS.%2BR.%26atitle%3DEndogenous%2520myeloperoxidase%2520is%2520a%2520mediator%2520of%2520joint%2520inflammation%2520and%2520damage%2520in%2520experimental%2520arthritis%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2014%26volume%3D66%26spage%3D907%26epage%3D917%26doi%3D10.1002%2Fart.38299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Odobasic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitching, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semple, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holdsworth, S. R.</span><span> </span><span class="NLM_article-title">Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis</span> <span class="citation_source-journal">J. Am. Soc. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">770</span><span class="refDoi"> DOI: 10.1681/ASN.2006040375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1681%2FASN.2006040375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=17267745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs1Grs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=760-770&author=D.+Odobasicauthor=A.+R.+Kitchingauthor=T.+J.+Sempleauthor=S.+R.+Holdsworth&title=Endogenous+myeloperoxidase+promotes+neutrophil-mediated+renal+injury%2C+but+attenuates+T+cell+immunity+inducing+crescentic+glomerulonephritis&doi=10.1681%2FASN.2006040375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis</span></div><div class="casAuthors">Odobasic, Dragana; Kitching, A. Richard; Semple, Timothy J.; Holdsworth, Stephen R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">760-770</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">Myeloperoxidase (MPO) is an enzyme that is found in neutrophils and monocytes/macrophages.  Intracellularly, it plays a major role in microbial killing, but extracellularly, it may cause host tissue damage.  The role of endogenous MPO was studied during neutrophil-mediated (heterologous) and T helper 1 (Th1)/macrophage-mediated (autologous) phases of crescentic glomerulonephritis.  Glomerulonephritis was induced in C57BL/6 wild-type (WT) and MPO-deficient (MPO-/-) mice by i.v. injection of sheep anti-mouse glomerular basement membrane globulin.  MPO activity was increased in kidneys of WT mice during both the heterologous and autologous phases of glomerulonephritis.  During the heterologous phase of glomerulonephritis, proteinuria was decreased, whereas glomerular neutrophil accumulation and P-selectin expression were enhanced in MPO-/- mice.  In the autologous, crescentic phase of glomerulonephritis, MPO-/- mice had increased accumulation of CD4+ cells and macrophages in glomeruli compared with WT mice.  However, no difference in renal injury (crescent formation, proteinuria, and serum creatinine levels) was obsd.  Neutrophils and macrophages from MPO-/- mice exhibited reduced prodn. of reactive oxygen species.  Assessment of systemic immunity to sheep globulin showed that MPO-/- mice had increased splenic CD4+ cell proliferation, cytokine prodn., and dermal delayed-type hypersensitivity, as well as enhanced levels of circulating IgG, IgG1, and IgG3.  MPO-/- mice also had an augmented Th1:Th2 ratio compared with WT mice (IFN-γ:IL-4 and IgG3:IgG1 ratios).  These results suggest that endogenous MPO locally contributes to glomerular damage during neutrophil-mediated glomerulonephritis, whereas it attenuates initiation of the adaptive immune response inducing crescentic, autologous-phase glomerulonephritis by suppressing T cell proliferation, cytokine prodn., and Th1:Th2 ratio.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQi_AsILNfSLVg90H21EOLACvtfcHk0ljSj3Otd-_diA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs1Grs78%253D&md5=4396b682e831588c6470b20cf1860fb2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1681%2FASN.2006040375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2006040375%26sid%3Dliteratum%253Aachs%26aulast%3DOdobasic%26aufirst%3DD.%26aulast%3DKitching%26aufirst%3DA.%2BR.%26aulast%3DSemple%26aufirst%3DT.%2BJ.%26aulast%3DHoldsworth%26aufirst%3DS.%2BR.%26atitle%3DEndogenous%2520myeloperoxidase%2520promotes%2520neutrophil-mediated%2520renal%2520injury%252C%2520but%2520attenuates%2520T%2520cell%2520immunity%2520inducing%2520crescentic%2520glomerulonephritis%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2007%26volume%3D18%26spage%3D760%26epage%3D770%26doi%3D10.1681%2FASN.2006040375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Choi, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennathur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tieu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teismann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson-Lewis, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vila, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vonsattel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinecke, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przedborski, S.</span><span> </span><span class="NLM_article-title">Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson’s disease in mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">6594</span><span class="NLM_x">–</span> <span class="NLM_lpage">6600</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1523%2FJNEUROSCI.0970-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=16014720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmslCltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=6594-6600&author=D.+K.+Choiauthor=S.+Pennathurauthor=C.+Perierauthor=K.+Tieuauthor=P.+Teismannauthor=D.+C.+Wuauthor=V.+Jackson-Lewisauthor=M.+Vilaauthor=J.+P.+Vonsattelauthor=J.+W.+Heineckeauthor=S.+Przedborski&title=Ablation+of+the+inflammatory+enzyme+myeloperoxidase+mitigates+features+of+Parkinson%E2%80%99s+disease+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice</span></div><div class="casAuthors">Choi, Dong-Kug; Pennathur, Subramaniam; Perier, Celine; Tieu, Kim; Teismann, Peter; Wu, Du-Chu; Jackson-Lewis, Vernice; Vila, Miquel; Vonsattel, Jean-Paul; Heinecke, Jay W.; Przedborski, Serge</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">6594-6600</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) is characterized by a loss of ventral midbrain dopaminergic neurons, which can be modeled by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).  Inflammatory oxidants have emerged as key contributors to PD- and MPTP-related neurodegeneration.  Here, the authors show that myeloperoxidase (MPO), a key oxidant-producing enzyme during inflammation, is upregulated in the ventral midbrain of human PD and MPTP mice.  We also show that ventral midbrain dopaminergic neurons of mutant mice deficient in MPO are more resistant to MPTP-induced cytotoxicity than their wild-type littermates.  Supporting the oxidative damaging role of MPO in this PD model are the demonstrations that MPO-specific biomarkers 3-chlorotyrosine and hypochlorous acid-modified proteins increase in the brains of MPTP-injected mice.  This study demonstrates that MPO participates in the MPTP neurotoxic process and suggests that inhibitors of MPO may provide a protective benefit in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpigWoYeLTtu7Vg90H21EOLACvtfcHk0ljSj3Otd-_diA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmslCltLc%253D&md5=52e92e299bf03863ce83399e3e209eb4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0970-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0970-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DD.%2BK.%26aulast%3DPennathur%26aufirst%3DS.%26aulast%3DPerier%26aufirst%3DC.%26aulast%3DTieu%26aufirst%3DK.%26aulast%3DTeismann%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DD.%2BC.%26aulast%3DJackson-Lewis%26aufirst%3DV.%26aulast%3DVila%26aufirst%3DM.%26aulast%3DVonsattel%26aufirst%3DJ.%2BP.%26aulast%3DHeinecke%26aufirst%3DJ.%2BW.%26aulast%3DPrzedborski%26aufirst%3DS.%26atitle%3DAblation%2520of%2520the%2520inflammatory%2520enzyme%2520myeloperoxidase%2520mitigates%2520features%2520of%2520Parkinson%25E2%2580%2599s%2520disease%2520in%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D6594%26epage%3D6600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Mayyas, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Jarrah, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alzoubi, K. H.</span><span> </span><span class="NLM_article-title">Level and significance of plasma myeloperoxidase and the neutrophil to lymphocyte ratio in patients with coronary artery disease</span> <span class="citation_source-journal">Exp. Ther. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1951</span><span class="NLM_x">–</span> <span class="NLM_lpage">1957</span><span class="refDoi"> DOI: 10.3892/etm.2014.2034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.3892%2Fetm.2014.2034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=25371762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislGhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=1951-1957&author=F.+A.+Mayyasauthor=M.+I.+Al-Jarrahauthor=K.+S.+Ibrahimauthor=K.+H.+Alzoubi&title=Level+and+significance+of+plasma+myeloperoxidase+and+the+neutrophil+to+lymphocyte+ratio+in+patients+with+coronary+artery+disease&doi=10.3892%2Fetm.2014.2034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Level and significance of plasma myeloperoxidase and the neutrophil to lymphocyte ratio in patients with coronary artery disease</span></div><div class="casAuthors">Mayyas, Fadia A.; Al-Jarrah, Mohammad I.; Ibrahim, Khalid S.; Alzoubi, Karem H.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Therapeutic Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1951-1957</span>CODEN:
                <span class="NLM_cas:coden">ETMXA2</span>;
        ISSN:<span class="NLM_cas:issn">1792-0981</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Inflammation plays a pivotal role in the etiol. of coronary artery disease (CAD).  Myeloperoxidase (MPO) is a potent inflammatory factor and a crit. modulator of coronary inflammation and oxidative stress.  The goal of this study was to det. the impact of the plasma MPO (pMPO) level and neutrophil/lymphocyte ratio on the clin. characteristics and outcomes of patients with CAD.  Blood samples were collected from 210 patients with underlying chest pain or recent myocardial infarction (MI) prior to coronary angiog. in order to measure pMPO levels.  The pMPO levels and neutrophil/lymphocyte ratio were correlated with clin. characteristics and outcomes following catheterization.  The pMPO level and neutrophil/lymphocyte ratio were higher in patients with recent MI than in patients with CAD (coronary occlusion ≥50%) or without CAD (coronary occlusion <50%).  Patients with ST segment elevated MI (STEMI) had a higher neutrophil/lymphocyte ratio relative to patients with non-STEMI.  The pMPO level was identified to correlate with the neutrophil/lymphocyte ratio and the need for coronary artery reperfusion by coronary artery bypass surgery or percutaneous coronary intervention.  Patients who were taking aspirin had lower pMPO levels and neutrophil/lymphocyte ratio compared with those who were not taking aspirin.  The plasma neutrophil/lymphocyte ratio was neg. assocd. with the left ventricular ejection fraction at baseline and the 30-day follow-up, whereas pMPO showed no correlation.  Multivariate anal. indicated that the pMPO level was pos. assocd. with MI, the neutrophil/lymphocyte ratio and coronary intervention.  The preoperative use of aspirin was assocd. with a lower pMPO level and neutrophil/lymphocyte ratio.  In conclusion, pMPO is pos. assocd. with MI, the neutrophil/lymphocyte ratio and coronary intervention.  The preoperative use of aspirin is assocd. with a lower pMPO level and neutrophil/lymphocyte ratio.  PMPO may serve as a predictor of coronary intervention and as a potential therapeutic target for the redn. of inflammation in patients with CAD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlWfDOmazGG7Vg90H21EOLACvtfcHk0lh_-lSBsyhhcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislGhsw%253D%253D&md5=4e2e300f31bba5d4caf8b0e3baea3d6b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3892%2Fetm.2014.2034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fetm.2014.2034%26sid%3Dliteratum%253Aachs%26aulast%3DMayyas%26aufirst%3DF.%2BA.%26aulast%3DAl-Jarrah%26aufirst%3DM.%2BI.%26aulast%3DIbrahim%26aufirst%3DK.%2BS.%26aulast%3DAlzoubi%26aufirst%3DK.%2BH.%26atitle%3DLevel%2520and%2520significance%2520of%2520plasma%2520myeloperoxidase%2520and%2520the%2520neutrophil%2520to%2520lymphocyte%2520ratio%2520in%2520patients%2520with%2520coronary%2520artery%2520disease%26jtitle%3DExp.%2520Ther.%2520Med.%26date%3D2014%26volume%3D8%26spage%3D1951%26epage%3D1957%26doi%3D10.3892%2Fetm.2014.2034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, X.</span><span> </span><span class="NLM_article-title">Association between myeloperoxidase levels and risk of coronary artery disease</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">2136</span><span class="NLM_x">–</span> <span class="NLM_lpage">2142</span><span class="refDoi"> DOI: 10.1001/jama.286.17.2136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1001%2Fjama.286.17.2136" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2001&pages=2136-2142&author=R.+Zhangauthor=M.+L.+Brennanauthor=X.+Fu&title=Association+between+myeloperoxidase+levels+and+risk+of+coronary+artery+disease&doi=10.1001%2Fjama.286.17.2136"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1001%2Fjama.286.17.2136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.286.17.2136%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DBrennan%26aufirst%3DM.%2BL.%26aulast%3DFu%26aufirst%3DX.%26atitle%3DAssociation%2520between%2520myeloperoxidase%2520levels%2520and%2520risk%2520of%2520coronary%2520artery%2520disease%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2001%26volume%3D286%26spage%3D2136%26epage%3D2142%26doi%3D10.1001%2Fjama.286.17.2136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Ndrepepa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehilli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Beckerath, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schomig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastrati, A.</span><span> </span><span class="NLM_article-title">Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes</span> <span class="citation_source-journal">Eur. J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span><span class="refDoi"> DOI: 10.1111/j.1365-2362.2007.01908.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1111%2Fj.1365-2362.2007.01908.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=90-96&author=G.+Ndrepepaauthor=S.+Braunauthor=J.+Mehilliauthor=N.+von+Beckerathauthor=A.+Schomigauthor=A.+Kastrati&title=Myeloperoxidase+level+in+patients+with+stable+coronary+artery+disease+and+acute+coronary+syndromes&doi=10.1111%2Fj.1365-2362.2007.01908.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2362.2007.01908.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2362.2007.01908.x%26sid%3Dliteratum%253Aachs%26aulast%3DNdrepepa%26aufirst%3DG.%26aulast%3DBraun%26aufirst%3DS.%26aulast%3DMehilli%26aufirst%3DJ.%26aulast%3Dvon%2BBeckerath%26aufirst%3DN.%26aulast%3DSchomig%26aufirst%3DA.%26aulast%3DKastrati%26aufirst%3DA.%26atitle%3DMyeloperoxidase%2520level%2520in%2520patients%2520with%2520stable%2520coronary%2520artery%2520disease%2520and%2520acute%2520coronary%2520syndromes%26jtitle%3DEur.%2520J.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D38%26spage%3D90%26epage%3D96%26doi%3D10.1111%2Fj.1365-2362.2007.01908.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Heinecke, J. W.</span><span> </span><span class="NLM_article-title">Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis</span> <span class="citation_source-journal">Curr. Opin. Lipidol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span><span class="refDoi"> DOI: 10.1097/00041433-199710000-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1097%2F00041433-199710000-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=9335950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADyaK2sXmslGhur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=268-274&author=J.+W.+Heinecke&title=Mechanisms+of+oxidative+damage+of+low+density+lipoprotein+in+human+atherosclerosis&doi=10.1097%2F00041433-199710000-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis</span></div><div class="casAuthors">Heinecke, Jay W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Lipidology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">268-274</span>CODEN:
                <span class="NLM_cas:coden">COPLEU</span>;
        ISSN:<span class="NLM_cas:issn">0957-9672</span>.
    
            (<span class="NLM_cas:orgname">Rapid Science Publishers</span>)
        </div><div class="casAbstract">A review with 62 refs.  Oxidatively damaged LDL may play a crit. role in the pathogenesis of atherosclerotic vascular disease.  Several pathways promote LDL oxidn. in vitro but the physiol. relevant mechanisms have proven difficult to identify.  Detection of stable compds. that result from specific reaction pathways has provided the first insights into the mechanism of oxidative damage in the human artery wall.  Mass spectrometric anal. of protein oxidn. products isolated from atherosclerotic tissue implicate tyrosyl radical, reactive nitrogen intermediates and hypochlorous acid in LDL oxidn. and lesion formation in vivo.  Hypochlorous acid is only generated by the phagocytic enzyme myeloperoxidase, which can also generate tyrosyl radical and reactive nitrogen intermediates.  Chiral phase high-pressure liq. chromatog. anal. of lipid oxidn. products suggests that cellular lipoxygenases may also play a role at certain stages.  In contrast, LDL isolated from atherosclerotic tissue is not enriched in protein oxidn. products characteristic of free metal ions, which are the most widely studied in vitro model of LDL oxidn.  These observations provide the first direct chem. evidence for reaction pathways that promote LDL oxidn. in human atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjkgnn6gi0ObVg90H21EOLACvtfcHk0lh_-lSBsyhhcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslGhur8%253D&md5=40f7d22467fdd48af83e0bdc9e41c995</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1097%2F00041433-199710000-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00041433-199710000-00005%26sid%3Dliteratum%253Aachs%26aulast%3DHeinecke%26aufirst%3DJ.%2BW.%26atitle%3DMechanisms%2520of%2520oxidative%2520damage%2520of%2520low%2520density%2520lipoprotein%2520in%2520human%2520atherosclerosis%26jtitle%3DCurr.%2520Opin.%2520Lipidol.%26date%3D1997%26volume%3D8%26spage%3D268%26epage%3D274%26doi%3D10.1097%2F00041433-199710000-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Smith, J. D.</span><span> </span><span class="NLM_article-title">Myeloperoxidase, inflammation, and dysfunctional HDL</span> <span class="citation_source-journal">J. Clin. Lipidol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span><span class="refDoi"> DOI: 10.1016/j.jacl.2010.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1016%2Fj.jacl.2010.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=21076633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FjsVegsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2010&pages=382-388&author=J.+D.+Smith&title=Myeloperoxidase%2C+inflammation%2C+and+dysfunctional+HDL&doi=10.1016%2Fj.jacl.2010.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein</span></div><div class="casAuthors">Smith Jonathan D</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical lipidology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">382-8</span>
        ISSN:<span class="NLM_cas:issn">1933-2874</span>.
    </div><div class="casAbstract">High-density lipoprotein (HDL) has many protective activities against atherosclerosis, including its role in reverse cholesterol transport, and its antioxidant, anti-inflammatory, and endothelial cell maintenance functions.  However, all HDL is not functionally equivalent.  The authors of recent studies have shown that infection, inflammation, diabetes, and coronary artery disease are associated with dysfunctional HDL.  HDL can lose its protective activities through a variety of mechanisms, including, but not limited to, altered protein composition, oxidative protein modification mediated by the enzyme myeloperoxidase, and lipid modification.  Studies in which the authors used bacterial endotoxin in humans and mice have directly demonstrated changes in HDL composition, loss of HDL's cholesterol acceptor activity, and decreased hepatic processing and secretion of cholesterol.  Although a routine clinical assay for dysfunctional HDL is not currently available, the development of such an assay would be beneficial for a better understanding of the role that dysfunctional HDL plays as a risk factor for coronary artery disease and for the determination of how various drug therapies effect HDL functionality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2jhjOFJQ9zGxpATR2EQURfW6udTcc2eakKT3mNL1dMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FjsVegsw%253D%253D&md5=09a0c4805609155f65e221f5f41bd6fa</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jacl.2010.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacl.2010.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DJ.%2BD.%26atitle%3DMyeloperoxidase%252C%2520inflammation%252C%2520and%2520dysfunctional%2520HDL%26jtitle%3DJ.%2520Clin.%2520Lipidol.%26date%3D2010%26volume%3D4%26spage%3D382%26epage%3D388%26doi%3D10.1016%2Fj.jacl.2010.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Eiserich, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tousson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lusis, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nauseef, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, B. A.</span><span> </span><span class="NLM_article-title">Myeloperoxidase, a leukocyte-derived vascular NO oxidase</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">2391</span><span class="NLM_x">–</span> <span class="NLM_lpage">2394</span><span class="refDoi"> DOI: 10.1126/science.1106830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1126%2Fscience.1106830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=12089442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD38XltFWlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=2391-2394&author=J.+P.+Eiserichauthor=S.+Baldusauthor=M.+L.+Brennanauthor=W.+Maauthor=C.+Zhangauthor=A.+Toussonauthor=L.+Castroauthor=A.+J.+Lusisauthor=W.+M.+Nauseefauthor=C.+R.+Whiteauthor=B.+A.+Freeman&title=Myeloperoxidase%2C+a+leukocyte-derived+vascular+NO+oxidase&doi=10.1126%2Fscience.1106830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Myeloperoxidase, a leukocyte-derived vascular no oxidase</span></div><div class="casAuthors">Eiserich, Jason P.; Baldus, Stephan; Brennan, Marie-Luise; Ma, Wenxin; Zhang, Chunxiang; Tousson, Albert; Castro, Laura; Lusis, Aldons J.; Nauseef, William M.; White, C. Roger; Freeman, Bruce A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5577</span>),
    <span class="NLM_cas:pages">2391-2394</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Myeloperoxidase (MPO) is an abundant mammalian phagocyte hemoprotein thought to primarily mediate host defense reactions.  Although its microbicidal functions are well established in vitro, humans deficient in MPO are not at unusual risk of infection.  MPO was obsd. herein to modulate the vascular signaling and vasodilatory functions of nitric oxide (NO) during acute inflammation.  After leukocyte degranulation, MPO localized in and around vascular endothelial cells in a rodent model of acute endotoxemia and impaired endothelium-dependent relaxant responses, to which MPO-deficient mice were resistant.  Altered vascular responsiveness was due to catalytic consumption of NO by substrate radicals generated by MPO.  Thus MPO can directly modulate vascular inflammatory responses by regulating NO bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxB0ls1QynlLVg90H21EOLACvtfcHk0lgsgzh_r9OF2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltFWlu7Y%253D&md5=edbc2c97b86f24603ae0f1ab790af4e9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscience.1106830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1106830%26sid%3Dliteratum%253Aachs%26aulast%3DEiserich%26aufirst%3DJ.%2BP.%26aulast%3DBaldus%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DM.%2BL.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DTousson%26aufirst%3DA.%26aulast%3DCastro%26aufirst%3DL.%26aulast%3DLusis%26aufirst%3DA.%2BJ.%26aulast%3DNauseef%26aufirst%3DW.%2BM.%26aulast%3DWhite%26aufirst%3DC.%2BR.%26aulast%3DFreeman%26aufirst%3DB.%2BA.%26atitle%3DMyeloperoxidase%252C%2520a%2520leukocyte-derived%2520vascular%2520NO%2520oxidase%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D2391%26epage%3D2394%26doi%3D10.1126%2Fscience.1106830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Carr, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCall, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frei, B.</span><span> </span><span class="NLM_article-title">Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1716</span><span class="NLM_x">–</span> <span class="NLM_lpage">1723</span><span class="refDoi"> DOI: 10.1161/01.ATV.20.7.1716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1161%2F01.ATV.20.7.1716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10894808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFGnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=1716-1723&author=A.+C.+Carrauthor=M.+R.+McCallauthor=B.+Frei&title=Oxidation+of+LDL+by+myeloperoxidase+and+reactive+nitrogen+species%3A+reaction+pathways+and+antioxidant+protection&doi=10.1161%2F01.ATV.20.7.1716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation of LDL by myeloperoxidase and reactive nitrogen species. Reaction pathways and antioxidant protection</span></div><div class="casAuthors">Carr, Anitra C.; McCall, Mark R.; Frei, Balz</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1716-1723</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review is given with 106 refs. on reaction pathways involved in low d. lipoprotein (LDL) oxidn. by myeloperoxidase and reactive N species and the potential protective effects of the antioxidant vitamins C and E.  Oxidative modification of LDL appears to play an important role in atherogenesis.  Although the precise mechanisms of LDL oxidn. in vivo are unknown, several lines of evidence implicate myeloperoxidase and reactive N species, in addn. to ceruloplasmin and 15-lipoxygenase.  Myeloperoxidase generates a no. of reactive species, including hypochlorous acid, chloramines, tyrosyl radicals, and NO2.  These reactive species oxidize the protein, lipid, and antioxidant components of LDL.  Modification of apolipoprotein B results in enhanced uptake of LDL by macrophages with subsequent formation of lipid-laden foam cells.  NO synthases produce NO and, under certain conditions, superoxide radicals.  Numerous other sources of superoxide radicals were identified in the arterial wall, including NAD(P)H oxidases and xanthine oxidase.  NO and superoxide readily combine to form peroxynitrite, a reactive N species capable of modifying LDL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8srA7BRxfMrVg90H21EOLACvtfcHk0lgsgzh_r9OF2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFGnsb8%253D&md5=79aee0904cbc249ed08a84495f3e7f5c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1161%2F01.ATV.20.7.1716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.ATV.20.7.1716%26sid%3Dliteratum%253Aachs%26aulast%3DCarr%26aufirst%3DA.%2BC.%26aulast%3DMcCall%26aufirst%3DM.%2BR.%26aulast%3DFrei%26aufirst%3DB.%26atitle%3DOxidation%2520of%2520LDL%2520by%2520myeloperoxidase%2520and%2520reactive%2520nitrogen%2520species%253A%2520reaction%2520pathways%2520and%2520antioxidant%2520protection%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2000%26volume%3D20%26spage%3D1716%26epage%3D1723%26doi%3D10.1161%2F01.ATV.20.7.1716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Sepe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, R. A.</span><span> </span><span class="NLM_article-title">Oxidant membrane injury by the neutrophil myeloperoxidase system. II. Injury by stimulated neutrophils and protection by lipid-soluble antioxidants</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">1896</span><span class="NLM_x">–</span> <span class="NLM_lpage">1901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=1985&pages=1896-1901&author=S.+M.+Sepeauthor=R.+A.+Clark&title=Oxidant+membrane+injury+by+the+neutrophil+myeloperoxidase+system.+II.+Injury+by+stimulated+neutrophils+and+protection+by+lipid-soluble+antioxidants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSepe%26aufirst%3DS.%2BM.%26aulast%3DClark%26aufirst%3DR.%2BA.%26atitle%3DOxidant%2520membrane%2520injury%2520by%2520the%2520neutrophil%2520myeloperoxidase%2520system.%2520II.%2520Injury%2520by%2520stimulated%2520neutrophils%2520and%2520protection%2520by%2520lipid-soluble%2520antioxidants%26jtitle%3DJ.%2520Immunol.%26date%3D1985%26volume%3D134%26spage%3D1896%26epage%3D1901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Askari, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinko, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morehead, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topol, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penn, M. S.</span><span> </span><span class="NLM_article-title">Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">197</span><span class="NLM_x">, </span> <span class="NLM_fpage">615</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span><span class="refDoi"> DOI: 10.1084/jem.20021426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1084%2Fjem.20021426" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2003&pages=615-624&author=A.+T.+Askariauthor=M.+L.+Brennanauthor=X.+Zhouauthor=J.+Drinkoauthor=A.+Moreheadauthor=J.+D.+Thomasauthor=E.+J.+Topolauthor=S.+L.+Hazenauthor=M.+S.+Penn&title=Myeloperoxidase+and+plasminogen+activator+inhibitor+1+play+a+central+role+in+ventricular+remodeling+after+myocardial+infarction&doi=10.1084%2Fjem.20021426"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1084%2Fjem.20021426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20021426%26sid%3Dliteratum%253Aachs%26aulast%3DAskari%26aufirst%3DA.%2BT.%26aulast%3DBrennan%26aufirst%3DM.%2BL.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DDrinko%26aufirst%3DJ.%26aulast%3DMorehead%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DJ.%2BD.%26aulast%3DTopol%26aufirst%3DE.%2BJ.%26aulast%3DHazen%26aufirst%3DS.%2BL.%26aulast%3DPenn%26aufirst%3DM.%2BS.%26atitle%3DMyeloperoxidase%2520and%2520plasminogen%2520activator%2520inhibitor%25201%2520play%2520a%2520central%2520role%2520in%2520ventricular%2520remodeling%2520after%2520myocardial%2520infarction%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2003%26volume%3D197%26spage%3D615%26epage%3D624%26doi%3D10.1084%2Fjem.20021426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Penn, M. S.</span><span> </span><span class="NLM_article-title">The role of leukocyte-generated oxidants in left ventricular remodeling</span> <span class="citation_source-journal">Am. J. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">S30</span><span class="NLM_x">–</span> <span class="NLM_lpage">S33</span><span class="refDoi"> DOI: 10.1016/j.amjcard.2008.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1016%2Fj.amjcard.2008.02.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2008&pages=S30-S33&author=M.+S.+Penn&title=The+role+of+leukocyte-generated+oxidants+in+left+ventricular+remodeling&doi=10.1016%2Fj.amjcard.2008.02.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.amjcard.2008.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjcard.2008.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DPenn%26aufirst%3DM.%2BS.%26atitle%3DThe%2520role%2520of%2520leukocyte-generated%2520oxidants%2520in%2520left%2520ventricular%2520remodeling%26jtitle%3DAm.%2520J.%2520Cardiol.%26date%3D2008%26volume%3D101%26spage%3DS30%26epage%3DS33%26doi%3D10.1016%2Fj.amjcard.2008.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span>Openinnovation. AZD-5904. <a href="http://openinnovation.astrazeneca.com/what-we-offer/compound/azd5904/" class="extLink">http://openinnovation.astrazeneca.com/what-we-offer/compound/azd5904/</a> (accessed Aug 19,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Openinnovation.+AZD-5904.+http%3A%2F%2Fopeninnovation.astrazeneca.com%2Fwhat-we-offer%2Fcompound%2Fazd5904%2F+%28accessed+Aug+19%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span>AZD3241 PET MSA Trial, Phase 2, Randomized, 12 Week Safety and Tolerability Trial with PET in MSA Patients. <a href="https://clinicaltrials.gov/ct2/show/NCT02388295" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02388295</a> (accessed Aug 19,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=AZD3241+PET+MSA+Trial%2C+Phase+2%2C+Randomized%2C+12+Week+Safety+and+Tolerability+Trial+with+PET+in+MSA+Patients.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02388295+%28accessed+Aug+19%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Davies, M. J.</span><span> </span><span class="NLM_article-title">Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention</span> <span class="citation_source-journal">J. Clin. Biochem. Nutr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span><span class="refDoi"> DOI: 10.3164/jcbn.11-006FR</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.3164%2Fjcbn.11-006FR" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=21297906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltlektL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2011&pages=8-19&author=M.+J.+Davies&title=Myeloperoxidase-derived+oxidation%3A+mechanisms+of+biological+damage+and+its+prevention&doi=10.3164%2Fjcbn.11-006FR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention</span></div><div class="casAuthors">Davies, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Biochemistry and Nutrition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-19</span>CODEN:
                <span class="NLM_cas:coden">JCBNER</span>;
        ISSN:<span class="NLM_cas:issn">0912-0009</span>.
    
            (<span class="NLM_cas:orgname">Society for Free Radical Research Japan</span>)
        </div><div class="casAbstract">A review.  There is considerable interest in the role that mammalian heme peroxidases, primarily myeloperoxidase, eosinophil peroxidase, and lactoperoxidase, may play in a wide range of human pathologies.  This has been sparked by rapid developments in the understanding of the basic biochem. of these enzymes, a greater understanding of the basic chem. and biochem. of the oxidants formed by these species, the development of biomarkers that can be used damage induced by these oxidants in vivo, and the recent identification of a no. of compds. that show promise as inhibitors of these enzymes.  Such compds. offer the possibility of modulating damage in a no. of human pathologies.  Here, the author reviews recent developments in the understanding of the biochem. of myeloperoxidase, the oxidants that this enzyme generates, and the use of inhibitors to inhibit such damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXxA-752ozj7Vg90H21EOLACvtfcHk0lgUHHQAHAk4MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltlektL0%253D&md5=b36621bb16b9c0827d46a68a89b0aeb3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3164%2Fjcbn.11-006FR&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3164%252Fjcbn.11-006FR%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DM.%2BJ.%26atitle%3DMyeloperoxidase-derived%2520oxidation%253A%2520mechanisms%2520of%2520biological%2520damage%2520and%2520its%2520prevention%26jtitle%3DJ.%2520Clin.%2520Biochem.%2520Nutr.%26date%3D2011%26volume%3D48%26spage%3D8%26epage%3D19%26doi%3D10.3164%2Fjcbn.11-006FR" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lobach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uetrecht, J.</span><span> </span><span class="NLM_article-title">Involvement of myeloperoxidase and NADPH oxidase in the covalent binding of amodiaquine and clozapine to neutrophils: implications for drug-induced agranulocytosis</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">709</span><span class="refDoi"> DOI: 10.1021/tx500019u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx500019u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=699-709&author=A.+R.+Lobachauthor=J.+Uetrecht&title=Involvement+of+myeloperoxidase+and+NADPH+oxidase+in+the+covalent+binding+of+amodiaquine+and+clozapine+to+neutrophils%3A+implications+for+drug-induced+agranulocytosis&doi=10.1021%2Ftx500019u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Ftx500019u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx500019u%26sid%3Dliteratum%253Aachs%26aulast%3DLobach%26aufirst%3DA.%2BR.%26aulast%3DUetrecht%26aufirst%3DJ.%26atitle%3DInvolvement%2520of%2520myeloperoxidase%2520and%2520NADPH%2520oxidase%2520in%2520the%2520covalent%2520binding%2520of%2520amodiaquine%2520and%2520clozapine%2520to%2520neutrophils%253A%2520implications%2520for%2520drug-induced%2520agranulocytosis%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2014%26volume%3D27%26spage%3D699%26epage%3D709%26doi%3D10.1021%2Ftx500019u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Svensson, B. E.</span><span> </span><span class="NLM_article-title">Thiols as myeloperoxidase-oxidase substrates</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">253</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1042/bj2530441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1042%2Fbj2530441" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1988&pages=441-449&author=B.+E.+Svensson&title=Thiols+as+myeloperoxidase-oxidase+substrates&doi=10.1042%2Fbj2530441"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1042%2Fbj2530441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2530441%26sid%3Dliteratum%253Aachs%26aulast%3DSvensson%26aufirst%3DB.%2BE.%26atitle%3DThiols%2520as%2520myeloperoxidase-oxidase%2520substrates%26jtitle%3DBiochem.%2520J.%26date%3D1988%26volume%3D253%26spage%3D441%26epage%3D449%26doi%3D10.1042%2Fbj2530441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Malle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furtmuller, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sattler, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obinger, C.</span><span> </span><span class="NLM_article-title">Myeloperoxidase: a target for new drug development?</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">838</span><span class="NLM_x">–</span> <span class="NLM_lpage">854</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0707358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1038%2Fsj.bjp.0707358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=17592500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ynt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2007&pages=838-854&author=E.+Malleauthor=P.+G.+Furtmullerauthor=W.+Sattlerauthor=C.+Obinger&title=Myeloperoxidase%3A+a+target+for+new+drug+development%3F&doi=10.1038%2Fsj.bjp.0707358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Myeloperoxidase: a target for new drug development?</span></div><div class="casAuthors">Malle, E.; Furtmueller, P. G.; Sattler, W.; Obinger, C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">838-854</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Myeloperoxidase (MPO), a member of the haem peroxidase-cyclooxygenase superfamily, is abundantly expressed in neutrophils and to a lesser extent in monocytes and certain type of macrophages.  MPO participates in innate immune defense mechanism through formation of microbicidal reactive oxidants and diffusible radical species.  A unique activity of MPO is its ability to use chloride as a cosubstrate with hydrogen peroxide to generate chlorinating oxidants such as hypochlorous acid, a potent antimicrobial agent.  However, evidence has emerged that MPO-derived oxidants contribute to tissue damage and the initiation and propagation of acute and chronic vascular inflammatory disease.  The fact that circulating levels of MPO have been shown to predict risks for major adverse cardiac events and that levels of MPO-derived chlorinated compds. are specific biomarkers for disease progression, has attracted considerable interest in the development of therapeutically useful MPO inhibitors.  Today, detailed information on the structure of ferric MPO and its complexes with low- and high-spin ligands is available.  This, together with a thorough understanding of reaction mechanisms including redox properties of intermediates, enables a rationale attempt in developing specific MPO inhibitors that still maintain MPO activity during host defense and bacterial killing but interfere with pathophysiol. persistent activation of MPO.  The various approaches to inhibit enzyme activity of MPO and to ameliorate adverse effects of MPO-derived oxidants will be discussed.  Emphasis will be put on mechanism-based inhibitors and high-throughput screening of compds. as well as the discussion of physiol. useful HOCl scavengers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp67Q9sFmtWZrVg90H21EOLACvtfcHk0lipFC1KgZ5E7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ynt7vI&md5=86fa4f96cd7b529e73fd9d6bb8b3a91a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707358%26sid%3Dliteratum%253Aachs%26aulast%3DMalle%26aufirst%3DE.%26aulast%3DFurtmuller%26aufirst%3DP.%2BG.%26aulast%3DSattler%26aufirst%3DW.%26aulast%3DObinger%26aufirst%3DC.%26atitle%3DMyeloperoxidase%253A%2520a%2520target%2520for%2520new%2520drug%2520development%253F%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D152%26spage%3D838%26epage%3D854%26doi%3D10.1038%2Fsj.bjp.0707358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Hsuanyu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunford, H. B.</span><span> </span><span class="NLM_article-title">Oxidation of clozapine and ascorbate by myeloperoxidase</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span><span class="refDoi"> DOI: 10.1006/abbi.1999.1328</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1006%2Fabbi.1999.1328" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=1999&pages=413-420&author=Y.+Hsuanyuauthor=H.+B.+Dunford&title=Oxidation+of+clozapine+and+ascorbate+by+myeloperoxidase&doi=10.1006%2Fabbi.1999.1328"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1999.1328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1999.1328%26sid%3Dliteratum%253Aachs%26aulast%3DHsuanyu%26aufirst%3DY.%26aulast%3DDunford%26aufirst%3DH.%2BB.%26atitle%3DOxidation%2520of%2520clozapine%2520and%2520ascorbate%2520by%2520myeloperoxidase%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1999%26volume%3D368%26spage%3D413%26epage%3D420%26doi%3D10.1006%2Fabbi.1999.1328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Forbes, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furtmuller, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khalilova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettle, A. J.</span><span> </span><span class="NLM_article-title">Isoniazid as a substrate and inhibitor of myeloperoxidase: Identification of amine adducts and the influence of superoxide dismutase on their formation</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span><span class="refDoi"> DOI: 10.1016/j.bcp.2012.07.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1016%2Fj.bcp.2012.07.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=22846601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Sku7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=949-960&author=L.+V.+Forbesauthor=P.+G.+Furtmullerauthor=I.+Khalilovaauthor=R.+Turnerauthor=C.+Obingerauthor=A.+J.+Kettle&title=Isoniazid+as+a+substrate+and+inhibitor+of+myeloperoxidase%3A+Identification+of+amine+adducts+and+the+influence+of+superoxide+dismutase+on+their+formation&doi=10.1016%2Fj.bcp.2012.07.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Isoniazid as a substrate and inhibitor of myeloperoxidase: Identification of amine adducts and the influence of superoxide dismutase on their formation</span></div><div class="casAuthors">Forbes, Louisa V.; Furtmuller, Paul G.; Khalilova, Irada; Turner, Rufus; Obinger, Christian; Kettle, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">949-960</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neutrophils ingest Mycobacteria tuberculosis (Mtb) in the lungs of infected individuals.  During phagocytosis they use myeloperoxidase (MPO) to catalyze prodn. of hypochlorous acid (HOCl), their most potent antimicrobial agent.  Isoniazid (INH), the foremost antibiotic in the treatment of tuberculosis, is oxidized by MPO.  It rapidly reduced compd. I of MPO [k = (1.22 ± 0.05) × 106 M-1 s-1] but reacted less favorably with compd. II [(9.8 ± 0.6) × 102 M-1 s-1].  Oxidn. of INH by MPO and hydrogen peroxide was unaffected by chloride, the physiol. substrate for compd. I, and the enzyme was partially converted to compd. III.  This indicates that INH is oxidized outside the classical peroxidn. cycle.  In combination with superoxide dismutase (SOD), MPO oxidized INH without exogenous hydrogen peroxide.  SOD must favor redn. of oxygen by the INH radical to give superoxide and ultimately hydrogen peroxide.  In both oxidn. systems, an adduct with methionine was formed and it was a major product with MPO and SOD.  We show that it is a conjugate of an acyldiimide with amines.  INH substantially inhibited HOCl prodn. by MPO and neutrophils below pharmacol. concns.  The reversible inhibition is explained by diversion of MPO to its ferrous and compd. III forms during oxidn. of INH.  MPO, along with SOD released by Mtb, will oxidize INH at sites of infection and their interactions are likely to limit the efficacy of the drug, promote adverse drug reactions via formation of protein adducts, and impair a major bacterial killing mechanism of neutrophils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGGVc8OypFGrVg90H21EOLACvtfcHk0lipFC1KgZ5E7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Sku7zF&md5=6a5ff73a6dd4d0bddca26ecad4cbe0a9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.07.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.07.020%26sid%3Dliteratum%253Aachs%26aulast%3DForbes%26aufirst%3DL.%2BV.%26aulast%3DFurtmuller%26aufirst%3DP.%2BG.%26aulast%3DKhalilova%26aufirst%3DI.%26aulast%3DTurner%26aufirst%3DR.%26aulast%3DObinger%26aufirst%3DC.%26aulast%3DKettle%26aufirst%3DA.%2BJ.%26atitle%3DIsoniazid%2520as%2520a%2520substrate%2520and%2520inhibitor%2520of%2520myeloperoxidase%253A%2520Identification%2520of%2520amine%2520adducts%2520and%2520the%2520influence%2520of%2520superoxide%2520dismutase%2520on%2520their%2520formation%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26spage%3D949%26epage%3D960%26doi%3D10.1016%2Fj.bcp.2012.07.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Kettle, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maroz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodroffe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winterbourn, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, R. F.</span><span> </span><span class="NLM_article-title">Spectral and kinetic evidence for reaction of superoxide with compound I of myeloperoxidase</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2190</span><span class="NLM_x">–</span> <span class="NLM_lpage">2194</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2011.09.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1016%2Fj.freeradbiomed.2011.09.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=22002086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFegu7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=2190-2194&author=A.+J.+Kettleauthor=A.+Marozauthor=G.+Woodroffeauthor=C.+C.+Winterbournauthor=R.+F.+Anderson&title=Spectral+and+kinetic+evidence+for+reaction+of+superoxide+with+compound+I+of+myeloperoxidase&doi=10.1016%2Fj.freeradbiomed.2011.09.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Spectral and kinetic evidence for reaction of superoxide with compound I of myeloperoxidase</span></div><div class="casAuthors">Kettle, Anthony J.; Maroz, Andrej; Woodroffe, Grant; Winterbourn, Christine C.; Anderson, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2190-2194</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Superoxide and myeloperoxidase (MPO) are essential for the oxidative killing of bacteria by neutrophils.  Previously, the authors developed a kinetic model to demonstrate that within the confines of neutrophil phagosomes, superoxide should react exclusively with MPO and be converted to hypochlorous acid (HClO).  The model consists of all known reactions and rate consts. for reactions of superoxide, H2O2, and Cl- with MPO, except for the reaction of superoxide with compd. I, which could only be estd.  Compd. I is a transitory redox intermediate of MPO that is responsible for oxidizing Cl- to HClO.  To tackle the challenge of observing the reaction between the 2 transient species, the authors combined stopped-flow spectrophotometry with pulse radiolysis.  Using this technique, the authors directly obsd. the redn. of compd. I by superoxide.  The rate const. for the reaction was detd. to be 5.6 × 106 M-1 s-1.  This value established superoxide as one of the best substrates for compd. I, and based on this value, the rate const. for the redn. of compd. II by superoxide was detd. to be 1.2 × 106 M-1 s-1.  Within phagosomes, the redn. of compd. I by superoxide will compete with the oxidn. of Cl- so that the relative concns. of these 2 substrates will affect the yield of HClO.  The characterization of this reaction confirmed that superoxide is a physiol. substrate for MPO and that their interactions are central to an important host defense mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWsT0UHv116LVg90H21EOLACvtfcHk0lipFC1KgZ5E7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFegu7zE&md5=7b8185934ae9830f73a4d2f5b780848b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2011.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2011.09.019%26sid%3Dliteratum%253Aachs%26aulast%3DKettle%26aufirst%3DA.%2BJ.%26aulast%3DMaroz%26aufirst%3DA.%26aulast%3DWoodroffe%26aufirst%3DG.%26aulast%3DWinterbourn%26aufirst%3DC.%2BC.%26aulast%3DAnderson%26aufirst%3DR.%2BF.%26atitle%3DSpectral%2520and%2520kinetic%2520evidence%2520for%2520reaction%2520of%2520superoxide%2520with%2520compound%2520I%2520of%2520myeloperoxidase%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2011%26volume%3D51%26spage%3D2190%26epage%3D2194%26doi%3D10.1016%2Fj.freeradbiomed.2011.09.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Marquez, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunford, H. B.</span><span> </span><span class="NLM_article-title">Kinetics of oxidation of tyrosine and dityrosine by myeloperoxidase compounds I and II. Implications for lipoprotein peroxidation studies</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">30434</span><span class="NLM_x">–</span> <span class="NLM_lpage">30440</span><span class="refDoi"> DOI: 10.1074/jbc.270.51.30434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1074%2Fjbc.270.51.30434" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=30434-30440&author=L.+A.+Marquezauthor=H.+B.+Dunford&title=Kinetics+of+oxidation+of+tyrosine+and+dityrosine+by+myeloperoxidase+compounds+I+and+II.+Implications+for+lipoprotein+peroxidation+studies&doi=10.1074%2Fjbc.270.51.30434"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.51.30434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.51.30434%26sid%3Dliteratum%253Aachs%26aulast%3DMarquez%26aufirst%3DL.%2BA.%26aulast%3DDunford%26aufirst%3DH.%2BB.%26atitle%3DKinetics%2520of%2520oxidation%2520of%2520tyrosine%2520and%2520dityrosine%2520by%2520myeloperoxidase%2520compounds%2520I%2520and%2520II.%2520Implications%2520for%2520lipoprotein%2520peroxidation%2520studies%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D30434%26epage%3D30440%26doi%3D10.1074%2Fjbc.270.51.30434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Meotti, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jameson, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harwood, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettle, A. J.</span><span> </span><span class="NLM_article-title">Urate as a physiological substrate for myeloperoxidase: implications for hyperuricemia and inflammation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">12901</span><span class="NLM_x">–</span> <span class="NLM_lpage">12911</span><span class="refDoi"> DOI: 10.1074/jbc.M110.172460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1074%2Fjbc.M110.172460" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=12901-12911&author=F.+C.+Meottiauthor=G.+N.+Jamesonauthor=R.+Turnerauthor=D.+T.+Harwoodauthor=S.+Stockwellauthor=M.+D.+Reesauthor=S.+R.+Thomasauthor=A.+J.+Kettle&title=Urate+as+a+physiological+substrate+for+myeloperoxidase%3A+implications+for+hyperuricemia+and+inflammation&doi=10.1074%2Fjbc.M110.172460"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.172460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.172460%26sid%3Dliteratum%253Aachs%26aulast%3DMeotti%26aufirst%3DF.%2BC.%26aulast%3DJameson%26aufirst%3DG.%2BN.%26aulast%3DTurner%26aufirst%3DR.%26aulast%3DHarwood%26aufirst%3DD.%2BT.%26aulast%3DStockwell%26aufirst%3DS.%26aulast%3DRees%26aufirst%3DM.%2BD.%26aulast%3DThomas%26aufirst%3DS.%2BR.%26aulast%3DKettle%26aufirst%3DA.%2BJ.%26atitle%3DUrate%2520as%2520a%2520physiological%2520substrate%2520for%2520myeloperoxidase%253A%2520implications%2520for%2520hyperuricemia%2520and%2520inflammation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D12901%26epage%3D12911%26doi%3D10.1074%2Fjbc.M110.172460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Kettle, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedye, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winterbourn, C. C.</span><span> </span><span class="NLM_article-title">Superoxide is an antagonist of anti-inflammatory drugs that inhibit hypochlorous acid production by myeloperoxidase</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2003</span><span class="NLM_x">–</span> <span class="NLM_lpage">2010</span><span class="refDoi"> DOI: 10.1016/0006-2952(93)90010-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1016%2F0006-2952%2893%2990010-T" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1993&pages=2003-2010&author=A.+J.+Kettleauthor=C.+A.+Gedyeauthor=C.+C.+Winterbourn&title=Superoxide+is+an+antagonist+of+anti-inflammatory+drugs+that+inhibit+hypochlorous+acid+production+by+myeloperoxidase&doi=10.1016%2F0006-2952%2893%2990010-T"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2893%2990010-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252893%252990010-T%26sid%3Dliteratum%253Aachs%26aulast%3DKettle%26aufirst%3DA.%2BJ.%26aulast%3DGedye%26aufirst%3DC.%2BA.%26aulast%3DWinterbourn%26aufirst%3DC.%2BC.%26atitle%3DSuperoxide%2520is%2520an%2520antagonist%2520of%2520anti-inflammatory%2520drugs%2520that%2520inhibit%2520hypochlorous%2520acid%2520production%2520by%2520myeloperoxidase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1993%26volume%3D45%26spage%3D2003%26epage%3D2010%26doi%3D10.1016%2F0006-2952%2893%2990010-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Tiden, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjogren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernlind, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senthilmohan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auchere, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markgren, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundquist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magon, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paton, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jameson, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettle, A. J.</span><span> </span><span class="NLM_article-title">2-Thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">37578</span><span class="NLM_x">–</span> <span class="NLM_lpage">37589</span><span class="refDoi"> DOI: 10.1074/jbc.M111.266981</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1074%2Fjbc.M111.266981" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=37578-37589&author=A.+K.+Tidenauthor=T.+Sjogrenauthor=M.+Svenssonauthor=A.+Bernlindauthor=R.+Senthilmohanauthor=F.+Auchereauthor=H.+Normanauthor=P.+O.+Markgrenauthor=S.+Gustavssonauthor=S.+Schmidtauthor=S.+Lundquistauthor=L.+V.+Forbesauthor=N.+J.+Magonauthor=L.+N.+Patonauthor=G.+N.+Jamesonauthor=H.+Erikssonauthor=A.+J.+Kettle&title=2-Thioxanthines+are+mechanism-based+inactivators+of+myeloperoxidase+that+block+oxidative+stress+during+inflammation&doi=10.1074%2Fjbc.M111.266981"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.266981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.266981%26sid%3Dliteratum%253Aachs%26aulast%3DTiden%26aufirst%3DA.%2BK.%26aulast%3DSjogren%26aufirst%3DT.%26aulast%3DSvensson%26aufirst%3DM.%26aulast%3DBernlind%26aufirst%3DA.%26aulast%3DSenthilmohan%26aufirst%3DR.%26aulast%3DAuchere%26aufirst%3DF.%26aulast%3DNorman%26aufirst%3DH.%26aulast%3DMarkgren%26aufirst%3DP.%2BO.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DLundquist%26aufirst%3DS.%26aulast%3DForbes%26aufirst%3DL.%2BV.%26aulast%3DMagon%26aufirst%3DN.%2BJ.%26aulast%3DPaton%26aufirst%3DL.%2BN.%26aulast%3DJameson%26aufirst%3DG.%2BN.%26aulast%3DEriksson%26aufirst%3DH.%26aulast%3DKettle%26aufirst%3DA.%2BJ.%26atitle%3D2-Thioxanthines%2520are%2520mechanism-based%2520inactivators%2520of%2520myeloperoxidase%2520that%2520block%2520oxidative%2520stress%2520during%2520inflammation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D37578%26epage%3D37589%26doi%3D10.1074%2Fjbc.M111.266981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varghese, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessire, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conboy, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spath, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippov, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrad, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpino, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimaraes, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajdos, F. F.</span><span> </span><span class="NLM_article-title">Deconstruction of activity-dependent covalent modification of heme in human neutrophil myeloperoxidase by multistage mass spectrometry (MS(4))</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2065</span><span class="NLM_x">–</span> <span class="NLM_lpage">2077</span><span class="refDoi"> DOI: 10.1021/bi201872j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi201872j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=2065-2077&author=K.+F.+Geogheganauthor=A.+H.+Vargheseauthor=X.+Fengauthor=A.+J.+Bessireauthor=J.+J.+Conboyauthor=R.+B.+Ruggeriauthor=K.+Ahnauthor=S.+N.+Spathauthor=S.+V.+Filippovauthor=S.+J.+Conradauthor=P.+A.+Carpinoauthor=C.+R.+Guimaraesauthor=F.+F.+Vajdos&title=Deconstruction+of+activity-dependent+covalent+modification+of+heme+in+human+neutrophil+myeloperoxidase+by+multistage+mass+spectrometry+%28MS%284%29%29&doi=10.1021%2Fbi201872j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fbi201872j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi201872j%26sid%3Dliteratum%253Aachs%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DVarghese%26aufirst%3DA.%2BH.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DBessire%26aufirst%3DA.%2BJ.%26aulast%3DConboy%26aufirst%3DJ.%2BJ.%26aulast%3DRuggeri%26aufirst%3DR.%2BB.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DSpath%26aufirst%3DS.%2BN.%26aulast%3DFilippov%26aufirst%3DS.%2BV.%26aulast%3DConrad%26aufirst%3DS.%2BJ.%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26aulast%3DGuimaraes%26aufirst%3DC.%2BR.%26aulast%3DVajdos%26aufirst%3DF.%2BF.%26atitle%3DDeconstruction%2520of%2520activity-dependent%2520covalent%2520modification%2520of%2520heme%2520in%2520human%2520neutrophil%2520myeloperoxidase%2520by%2520multistage%2520mass%2520spectrometry%2520%2528MS%25284%2529%2529%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D2065%26epage%3D2077%26doi%3D10.1021%2Fbi201872j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Ward, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spath, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pabst, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpino, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speers, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span> </span><span class="NLM_article-title">Mechanistic characterization of a 2-thioxanthine myeloperoxidase inhibitor and selectivity assessment utilizing click chemistry – activity-based protein profiling</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">9187</span><span class="NLM_x">–</span> <span class="NLM_lpage">9201</span><span class="refDoi"> DOI: 10.1021/bi401354d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi401354d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=9187-9201&author=J.+Wardauthor=S.+N.+Spathauthor=B.+Pabstauthor=P.+A.+Carpinoauthor=R.+B.+Ruggeriauthor=G.+Xingauthor=A.+E.+Speersauthor=B.+F.+Cravattauthor=K.+Ahn&title=Mechanistic+characterization+of+a+2-thioxanthine+myeloperoxidase+inhibitor+and+selectivity+assessment+utilizing+click+chemistry+%E2%80%93+activity-based+protein+profiling&doi=10.1021%2Fbi401354d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fbi401354d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi401354d%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DSpath%26aufirst%3DS.%2BN.%26aulast%3DPabst%26aufirst%3DB.%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26aulast%3DRuggeri%26aufirst%3DR.%2BB.%26aulast%3DXing%26aufirst%3DG.%26aulast%3DSpeers%26aufirst%3DA.%2BE.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DAhn%26aufirst%3DK.%26atitle%3DMechanistic%2520characterization%2520of%2520a%25202-thioxanthine%2520myeloperoxidase%2520inhibitor%2520and%2520selectivity%2520assessment%2520utilizing%2520click%2520chemistry%2520%25E2%2580%2593%2520activity-based%2520protein%2520profiling%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26spage%3D9187%26epage%3D9201%26doi%3D10.1021%2Fbi401354d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Fumarola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dainelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvanese, A.</span><span> </span><span class="NLM_article-title">Medical treatment of hyperthyroidism: state of the art</span> <span class="citation_source-journal">Exp. Clin. Endocrinol. Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">678</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span><span class="refDoi"> DOI: 10.1055/s-0030-1253420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1055%2Fs-0030-1253420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=20496313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1arsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2010&pages=678-684&author=A.+Fumarolaauthor=A.+Di+Fioreauthor=M.+Dainelliauthor=G.+Graniauthor=A.+Calvanese&title=Medical+treatment+of+hyperthyroidism%3A+state+of+the+art&doi=10.1055%2Fs-0030-1253420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Medical treatment of hyperthyroidism: state of the art</span></div><div class="casAuthors">Fumarola, A.; Di Fiore, A.; Dainelli, M.; Grani, G.; Calvanese, A.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Clinical Endocrinology & Diabetes</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">678-684</span>CODEN:
                <span class="NLM_cas:coden">ECEDFQ</span>;
        ISSN:<span class="NLM_cas:issn">0947-7349</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A review.  Methimazole (MMI) and propylthiouracil (PTU) are the main antithyroid drugs used for hyperthyroidism.  They inhibit the synthesis of thyroid hormone at various levels and are used as the primary treatment for hyperthyroidism or as a prepn. before radioiodine therapy or thyroidectomy.  MMI is the drug of choice because of its widespread availability, longer half-life and small no. of severe side effects.  Drugs of second choice are potassium perchlorate, beta blockers, iodine, lithium carbonate and glucocorticoids.  Rituximab, a monoclonal antibody directed against human CD20, was recently proposed as a biol. therapy for cases of Graves' disease unresponsive to traditional drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD3ZlLwabhB7Vg90H21EOLACvtfcHk0lgiFwNhMdqMZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1arsbbJ&md5=26802cb6042f3197b2b8c0cd7441d202</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1055%2Fs-0030-1253420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0030-1253420%26sid%3Dliteratum%253Aachs%26aulast%3DFumarola%26aufirst%3DA.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DDainelli%26aufirst%3DM.%26aulast%3DGrani%26aufirst%3DG.%26aulast%3DCalvanese%26aufirst%3DA.%26atitle%3DMedical%2520treatment%2520of%2520hyperthyroidism%253A%2520state%2520of%2520the%2520art%26jtitle%3DExp.%2520Clin.%2520Endocrinol.%2520Diabetes%26date%3D2010%26volume%3D118%26spage%3D678%26epage%3D684%26doi%3D10.1055%2Fs-0030-1253420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Lee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirouchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosokawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kariya, K.</span><span> </span><span class="NLM_article-title">Inactivation of peroxidases of rat bone marrow by repeated administration of propylthiouracil is accompanied by a change in the heme structure</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2151</span><span class="NLM_x">–</span> <span class="NLM_lpage">2153</span><span class="refDoi"> DOI: 10.1016/0006-2952(88)90574-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1016%2F0006-2952%2888%2990574-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1988&pages=2151-2153&author=E.+Leeauthor=M.+Hirouchiauthor=M.+Hosokawaauthor=H.+Sayoauthor=M.+Kohnoauthor=K.+Kariya&title=Inactivation+of+peroxidases+of+rat+bone+marrow+by+repeated+administration+of+propylthiouracil+is+accompanied+by+a+change+in+the+heme+structure&doi=10.1016%2F0006-2952%2888%2990574-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2888%2990574-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252888%252990574-6%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%26aulast%3DHirouchi%26aufirst%3DM.%26aulast%3DHosokawa%26aufirst%3DM.%26aulast%3DSayo%26aufirst%3DH.%26aulast%3DKohno%26aufirst%3DM.%26aulast%3DKariya%26aufirst%3DK.%26atitle%3DInactivation%2520of%2520peroxidases%2520of%2520rat%2520bone%2520marrow%2520by%2520repeated%2520administration%2520of%2520propylthiouracil%2520is%2520accompanied%2520by%2520a%2520change%2520in%2520the%2520heme%2520structure%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1988%26volume%3D37%26spage%3D2151%26epage%3D2153%26doi%3D10.1016%2F0006-2952%2888%2990574-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Lee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsljra, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kariya, K.</span><span> </span><span class="NLM_article-title">Mechanism of inactivation of myeloperoxidase by propylthiouracil</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1467</span><span class="NLM_x">–</span> <span class="NLM_lpage">1471</span><span class="refDoi"> DOI: 10.1016/0006-2952(90)90428-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1016%2F0006-2952%2890%2990428-N" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1990&pages=1467-1471&author=E.+Leeauthor=Y.+Mikiauthor=H.+Katsljraauthor=K.+Kariya&title=Mechanism+of+inactivation+of+myeloperoxidase+by+propylthiouracil&doi=10.1016%2F0006-2952%2890%2990428-N"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2890%2990428-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252890%252990428-N%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%26aulast%3DMiki%26aufirst%3DY.%26aulast%3DKatsljra%26aufirst%3DH.%26aulast%3DKariya%26aufirst%3DK.%26atitle%3DMechanism%2520of%2520inactivation%2520of%2520myeloperoxidase%2520by%2520propylthiouracil%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1990%26volume%3D39%26spage%3D1467%26epage%3D1471%26doi%3D10.1016%2F0006-2952%2890%2990428-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khursigara, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, R. L.</span><span> </span><span class="NLM_article-title">Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">810</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span><span class="refDoi"> DOI: 10.1126/science.7973636</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1126%2Fscience.7973636" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1994&pages=810-813&author=X.+Jiangauthor=G.+Khursigaraauthor=R.+L.+Rubin&title=Transformation+of+lupus-inducing+drugs+to+cytotoxic+products+by+activated+neutrophils&doi=10.1126%2Fscience.7973636"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1126%2Fscience.7973636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.7973636%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DKhursigara%26aufirst%3DG.%26aulast%3DRubin%26aufirst%3DR.%2BL.%26atitle%3DTransformation%2520of%2520lupus-inducing%2520drugs%2520to%2520cytotoxic%2520products%2520by%2520activated%2520neutrophils%26jtitle%3DScience%26date%3D1994%26volume%3D266%26spage%3D810%26epage%3D813%26doi%3D10.1126%2Fscience.7973636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Waldhauser, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uetrecht, J.</span><span> </span><span class="NLM_article-title">Oxidation of propylthiouracil to reactive metabolites by activated neutrophils. Implications for agranulocytosis</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">354</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1991&pages=354-359&author=L.+Waldhauserauthor=J.+Uetrecht&title=Oxidation+of+propylthiouracil+to+reactive+metabolites+by+activated+neutrophils.+Implications+for+agranulocytosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWaldhauser%26aufirst%3DL.%26aulast%3DUetrecht%26aufirst%3DJ.%26atitle%3DOxidation%2520of%2520propylthiouracil%2520to%2520reactive%2520metabolites%2520by%2520activated%2520neutrophils.%2520Implications%2520for%2520agranulocytosis%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1991%26volume%3D19%26spage%3D354%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Copeland, R. A.</span><span> </span><span class="NLM_article-title">Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists</span> <span class="citation_source-journal">Methods Biochem. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=16350889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A280%3ADC%252BD2MnmtlyjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=1-265&author=R.+A.+Copeland&title=Evaluation+of+enzyme+inhibitors+in+drug+discovery.+A+guide+for+medicinal+chemists+and+pharmacologists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists</span></div><div class="casAuthors">Copeland Robert A</div><div class="citationInfo"><span class="NLM_cas:title">Methods of biochemical analysis</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-265</span>
        ISSN:<span class="NLM_cas:issn">0076-6941</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSR7_ubfiC0DK2q3xNe7a7QfW6udTcc2eZcHPlMs4Yhwrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MnmtlyjsA%253D%253D&md5=4bb6759b5155aa6c2b6a462432afda7f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DEvaluation%2520of%2520enzyme%2520inhibitors%2520in%2520drug%2520discovery.%2520A%2520guide%2520for%2520medicinal%2520chemists%2520and%2520pharmacologists%26jtitle%3DMethods%2520Biochem.%2520Anal.%26date%3D2005%26volume%3D46%26spage%3D1%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Zheng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skoura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okerberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobrowski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabe, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coskran, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckbinder, L.</span><span> </span><span class="NLM_article-title">PF-1355, a mechanism-based myeloperoxidase inhibitor, prevents immune-complex vasculitis and anti-glomerular basement membrane glomerulonephritis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span><span class="refDoi"> DOI: 10.1124/jpet.114.221788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1124%2Fjpet.114.221788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=25698787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvVWntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2015&pages=288-298&author=W.+Zhengauthor=R.+Warnerauthor=R.+B.+Ruggeriauthor=C.+Suauthor=C.+Cortesauthor=A.+Skouraauthor=J.+Wardauthor=K.+Ahnauthor=A.+Kalgutkarauthor=D.+Sunauthor=T.+Maurerauthor=P.+Boninauthor=C.+Okerbergauthor=W.+Bobrowskiauthor=T.+T.+Kawabeauthor=Y.+Zhangauthor=T.+M.+Coskranauthor=S.+Bellauthor=B.+Kapoorauthor=K.+Johnsonauthor=L.+Buckbinder&title=PF-1355%2C+a+mechanism-based+myeloperoxidase+inhibitor%2C+prevents+immune-complex+vasculitis+and+anti-glomerular+basement+membrane+glomerulonephritis&doi=10.1124%2Fjpet.114.221788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">PF-1355, a mechanism-based myeloperoxidase inhibitor, prevents immune complex vasculitis and anti-glomerular basement membrane glomerulonephritis</span></div><div class="casAuthors">Zheng, Wei; Warner, Roscoe; Ruggeri, Roger; Su, Chunyan; Cortes, Christian; Skoura, Athanasia; Ward, Jessica; Ahn, Kay; Kalgutkar, Amit; Sun, Dexue; Maurer, Tristan S.; Bonin, Paul D.; Okerberg, Carlin; Bobrowski, Walter; Kawabe, Thomas; Zhang, Yanwei; Coskran, Timothy; Bell, Sammy; Kapoor, Bhupesh; Johnson, Kent; Buckbinder, Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">288-298</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Small vessel vasculitis is a life-threatening condition and patients typically present with renal and pulmonary injury.  Disease pathogenesis is assocd. with neutrophil accumulation, activation, and oxidative damage, the latter being driven in large part by myeloperoxidase (MPO), which generates hypochlorous acid among other oxidants.  MPO has been assocd. with vasculitis, disseminated vascular inflammation typically involving pulmonary and renal microvasculature and often resulting in crit. consequences.  MPO contributes to vascular injury by (1) catabolizing nitric oxide, impairing vasomotor function; (2) causing oxidative damage to lipoproteins and endothelial cells, leading to atherosclerosis; and (3) stimulating formation of neutrophil extracellular traps, resulting in vessel occlusion and thrombosis.  Here we report a selective 2-thiouracil mechanism-based MPO inhibitor (PF-1355 [2-(6-(2,5-dimethoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide]) and demonstrate that MPO is a crit. mediator of vasculitis in mouse disease models.  A pharmacokinetic/pharmacodynamic response model of PF-1355 exposure in relation with MPO activity was derived from mouse peritonitis.  The contribution of MPO activity to vasculitis was then examd. in an immune complexmodel of pulmonary disease.  Oral administration of PF-1355 reduced plasma MPO activity, vascular edema, neutrophil recruitment, and elevated circulating cytokines.  In a model of anti-glomerular basement membrane disease, formerly known as Goodpasture disease, albuminuria and chronic renal dysfunction were completely suppressed by PF-1355 treatment.  This study shows that MPO activity is crit. in driving immune complex vasculitis and provides confidence in testing the hypothesis that MPO inhibition will provide benefit in treating human vasculitic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPRyjPwLB3XbVg90H21EOLACvtfcHk0ljgyhZJl5yXpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvVWntL4%253D&md5=682459ce0d7ea6d2826b6d861db72b39</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.221788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.221788%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DWarner%26aufirst%3DR.%26aulast%3DRuggeri%26aufirst%3DR.%2BB.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DCortes%26aufirst%3DC.%26aulast%3DSkoura%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DKalgutkar%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DMaurer%26aufirst%3DT.%26aulast%3DBonin%26aufirst%3DP.%26aulast%3DOkerberg%26aufirst%3DC.%26aulast%3DBobrowski%26aufirst%3DW.%26aulast%3DKawabe%26aufirst%3DT.%2BT.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCoskran%26aufirst%3DT.%2BM.%26aulast%3DBell%26aufirst%3DS.%26aulast%3DKapoor%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DBuckbinder%26aufirst%3DL.%26atitle%3DPF-1355%252C%2520a%2520mechanism-based%2520myeloperoxidase%2520inhibitor%252C%2520prevents%2520immune-complex%2520vasculitis%2520and%2520anti-glomerular%2520basement%2520membrane%2520glomerulonephritis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D353%26spage%3D288%26epage%3D298%26doi%3D10.1124%2Fjpet.114.221788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Neidlein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menche, G.</span><span> </span><span class="NLM_article-title">Synthese von 3.4-sowie 4-substituierten uracilen und thiouracilen</span> <span class="citation_source-journal">Arch. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">601</span><span class="refDoi"> DOI: 10.1002/ardp.19723050806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1002%2Fardp.19723050806" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADyaE38Xlt1KmtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=1972&pages=596-601&author=R.+Neidleinauthor=G.+Menche&title=Synthese+von+3.4-sowie+4-substituierten+uracilen+und+thiouracilen&doi=10.1002%2Fardp.19723050806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 3,4- and 4-substituted uracils and 2-thiouracils</span></div><div class="casAuthors">Neidlein, R.; Menche, G.</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">596-601</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    </div><div class="casAbstract">The title compds. (I, R = 3- or 4-pyridyl, 2-furyl; R1 = H, Me; X = O, S) (31-49%) were prepd. by reaction of RCOCH2CO2Et with  H2NCXNHR1 4-19 hr at 110-20°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh32pSZydk1LVg90H21EOLACvtfcHk0ljE0fCbMGTdWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38Xlt1KmtrY%253D&md5=42ee309d1c33cb1d5d06444d361e6a06</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fardp.19723050806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.19723050806%26sid%3Dliteratum%253Aachs%26aulast%3DNeidlein%26aufirst%3DR.%26aulast%3DMenche%26aufirst%3DG.%26atitle%3DSynthese%2520von%25203.4-sowie%25204-substituierten%2520uracilen%2520und%2520thiouracilen%26jtitle%3DArch.%2520Pharm.%26date%3D1972%26volume%3D305%26spage%3D596%26epage%3D601%26doi%3D10.1002%2Fardp.19723050806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Medda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirrie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slawin, A. M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, N. J.</span><span> </span><span class="NLM_article-title">N1-Benzyl substituted cambinol analogues as isozyme selective inhibitors of the sirtuin family of protein deacetylases</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">611</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span><span class="refDoi"> DOI: 10.1039/c1md00023c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1039%2Fc1md00023c" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=611-615&author=F.+Meddaauthor=T.+L.+Josephauthor=L.+Pirrieauthor=M.+Higginsauthor=A.+M.+Z.+Slawinauthor=S.+Lainauthor=C.+Vermaauthor=N.+J.+Westwood&title=N1-Benzyl+substituted+cambinol+analogues+as+isozyme+selective+inhibitors+of+the+sirtuin+family+of+protein+deacetylases&doi=10.1039%2Fc1md00023c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1039%2Fc1md00023c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00023c%26sid%3Dliteratum%253Aachs%26aulast%3DMedda%26aufirst%3DF.%26aulast%3DJoseph%26aufirst%3DT.%2BL.%26aulast%3DPirrie%26aufirst%3DL.%26aulast%3DHiggins%26aufirst%3DM.%26aulast%3DSlawin%26aufirst%3DA.%2BM.%2BZ.%26aulast%3DLain%26aufirst%3DS.%26aulast%3DVerma%26aufirst%3DC.%26aulast%3DWestwood%26aufirst%3DN.%2BJ.%26atitle%3DN1-Benzyl%2520substituted%2520cambinol%2520analogues%2520as%2520isozyme%2520selective%2520inhibitors%2520of%2520the%2520sirtuin%2520family%2520of%2520protein%2520deacetylases%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D611%26epage%3D615%26doi%3D10.1039%2Fc1md00023c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span> </span><span class="NLM_article-title">A comprehensive listing of bioactivation pathways of organic functional groups</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span><span class="refDoi"> DOI: 10.2174/1389200054021799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.2174%2F1389200054021799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=15975040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=161-225&author=A.+S.+Kalgutkarauthor=I.+Gardnerauthor=R.+S.+Obachauthor=C.+L.+Shafferauthor=E.+Callegariauthor=K.+R.+Henneauthor=A.+E.+Mutlibauthor=D.+K.+Dalvieauthor=J.+S.+Leeauthor=Y.+Nakaiauthor=J.+P.+O%E2%80%99Donnellauthor=J.+Boerauthor=S.+P.+Harriman&title=A+comprehensive+listing+of+bioactivation+pathways+of+organic+functional+groups&doi=10.2174%2F1389200054021799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive listing of bioactivation pathways of organic functional groups</span></div><div class="casAuthors">Kalgutkar, Amit S.; Gardner, Iain; Obach, R. Scott; Shaffer, Christopher L.; Callegari, Ernesto; Henne, Kirk R.; Mutlib, Abdul E.; Dalvie, Deepak K.; Lee, Jae S.; Nakai, Yasuhiro; O'Donnell, John P.; Boer, Jason; Harriman, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-225</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The occurrence of idiosyncratic adverse drug reactions during late clin. trials or after a drug has been released can lead to a severe restriction in its use and even in its withdrawal.  Metabolic activation of relatively inert functional groups to reactive electrophilic intermediates is considered to be an obligatory event in the etiol. of many drug-induced adverse reactions.  Therefore, a thorough examn. of the biochem. reactivity of functional groups/structural motifs in all new drug candidates is essential from a safety standpoint.  A major theme attempted in this review is the comprehensive cataloging of all of the known bioactivation pathways of functional groups or structural motifs commonly utilized in drug design efforts.  Potential strategies in the detection of reactive intermediates in biochem. systems are also discussed.  The intention of this review is not to "black list" functional groups or to immediately discard compds. based on their potential to form reactive metabolites, but rather to serve as a resource describing the structural diversity of these functionalities as well as exptl. approaches that could be taken to evaluate whether a "structural alert" in a new drug candidate undergoes bioactivation to reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVj7cmxfwXrVg90H21EOLACvtfcHk0ljE0fCbMGTdWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D&md5=b16dfc2de97c40a11218ecc3043bed66</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.2174%2F1389200054021799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200054021799%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26atitle%3DA%2520comprehensive%2520listing%2520of%2520bioactivation%2520pathways%2520of%2520organic%2520functional%2520groups%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2005%26volume%3D6%26spage%3D161%26epage%3D225%26doi%3D10.2174%2F1389200054021799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Futcher, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massie, E.</span><span> </span><span class="NLM_article-title">Agranulocytosis due to propylthiouracil</span> <span class="citation_source-journal">Ann. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1950</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="refDoi"> DOI: 10.7326/0003-4819-32-1-137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.7326%2F0003-4819-32-1-137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=15404133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A280%3ADyaG3c%252FhtlOltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1950&pages=137&author=P.+H.+Futcherauthor=E.+Massie&title=Agranulocytosis+due+to+propylthiouracil&doi=10.7326%2F0003-4819-32-1-137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Agranulocytosis due to propylthiouracil</span></div><div class="casAuthors">FUTCHER P H; MASSIE E</div><div class="citationInfo"><span class="NLM_cas:title">Annals of internal medicine</span>
        (<span class="NLM_cas:date">1950</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">137</span>
        ISSN:<span class="NLM_cas:issn">0003-4819</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwmHczcwXobVWTCLT8lX9SfW6udTcc2eb7t96izWOGh7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaG3c%252FhtlOltw%253D%253D&md5=d2ef257c565752e3ec538cc03abcd645</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-32-1-137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-32-1-137%26sid%3Dliteratum%253Aachs%26aulast%3DFutcher%26aufirst%3DP.%2BH.%26aulast%3DMassie%26aufirst%3DE.%26atitle%3DAgranulocytosis%2520due%2520to%2520propylthiouracil%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D1950%26volume%3D32%26spage%3D137%26doi%3D10.7326%2F0003-4819-32-1-137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Cooper, D. S.</span><span> </span><span class="NLM_article-title">Antithyroid drugs</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">917</span><span class="refDoi"> DOI: 10.1056/NEJMra042972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1056%2FNEJMra042972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=15745981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvFOht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=905-917&author=D.+S.+Cooper&title=Antithyroid+drugs&doi=10.1056%2FNEJMra042972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Antithyroid drugs</span></div><div class="casAuthors">Cooper, David S.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">905-917</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review discusses recent pharmacol. and clin. data related to the use of antithyroid compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLT7VSyN--JLVg90H21EOLACvtfcHk0lj-ar14a_yhag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvFOht7o%253D&md5=80d6bf43f34b755c25e592b079a5a883</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1056%2FNEJMra042972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra042972%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DD.%2BS.%26atitle%3DAntithyroid%2520drugs%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D905%26epage%3D917%26doi%3D10.1056%2FNEJMra042972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Ichiki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akahoshi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishibashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niho, Y.</span><span> </span><span class="NLM_article-title">Propylthiouracil-induced severe hepatitis: a case report and review of the literature</span> <span class="citation_source-journal">J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">750</span><span class="refDoi"> DOI: 10.1007/s005350050167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1007%2Fs005350050167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=9773944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A280%3ADyaK1cvksV2hug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1998&pages=747-750&author=Y.+Ichikiauthor=M.+Akahoshiauthor=N.+Yamashitaauthor=C.+Moritaauthor=T.+Maruyamaauthor=T.+Horiuchiauthor=K.+Hayashidaauthor=H.+Ishibashiauthor=Y.+Niho&title=Propylthiouracil-induced+severe+hepatitis%3A+a+case+report+and+review+of+the+literature&doi=10.1007%2Fs005350050167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Propylthiouracil-induced severe hepatitis: a case report and review of the literature</span></div><div class="casAuthors">Ichiki Y; Akahoshi M; Yamashita N; Morita C; Maruyama T; Horiuchi T; Hayashida K; Ishibashi H; Niho Y</div><div class="citationInfo"><span class="NLM_cas:title">Journal of gastroenterology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">747-50</span>
        ISSN:<span class="NLM_cas:issn">0944-1174</span>.
    </div><div class="casAbstract">A 21-year-old woman was diagnosed as having Graves' disease in April, 1995.  Thiamazole was administered; about a month later the patient had a skin rash and propylthiouracil (PTU) was given instead.  Two months after commencing PTU, she rapidly developed jaundice, accompanied by severe liver damage.  The drug-induced lymphocyte stimulating test was positive for PTU and she was diagnosed as having severe hepatitis induced by PTU.  After pulse therapy with 500 mg of methylprednisolone was given for 3 days, liver function test results were gradually improved, and became normalized 1 1/2 months after admission.  The pathology findings of the liver biopsy sample taken before administration of corticosteroid showed necrosis of hepatocytes predominantly around the central veins (i.e., zone 3 necrosis), and moderate to severe infiltration of lymphocytes and neutrophils in portal areas and lobules.  Severe hepatic damage due to PTU is rare; 25 cases have been reported so far in the English-language literature.  When we use PTU for patients with hyperthyroidism, we should keep in mind that severe liver damage induced by PTU can be fatal, and we should therefore diagnose it earlier by liver biopsy and lymphocyte stimulating test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6G7CBGsTo2RpyrDyM_m9cfW6udTcc2eZQ79r9EhEDqLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1cvksV2hug%253D%253D&md5=2d46552b8ecc7d061107a72207570904</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2Fs005350050167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs005350050167%26sid%3Dliteratum%253Aachs%26aulast%3DIchiki%26aufirst%3DY.%26aulast%3DAkahoshi%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DN.%26aulast%3DMorita%26aufirst%3DC.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DHoriuchi%26aufirst%3DT.%26aulast%3DHayashida%26aufirst%3DK.%26aulast%3DIshibashi%26aufirst%3DH.%26aulast%3DNiho%26aufirst%3DY.%26atitle%3DPropylthiouracil-induced%2520severe%2520hepatitis%253A%2520a%2520case%2520report%2520and%2520review%2520of%2520the%2520literature%26jtitle%3DJ.%2520Gastroenterol.%26date%3D1998%26volume%3D33%26spage%3D747%26epage%3D750%26doi%3D10.1007%2Fs005350050167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Guffy, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goeken, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, C. P.</span><span> </span><span class="NLM_article-title">Granulocytotoxic antibodies in a patient with propylthiouracil-induced agranulocytosis</span> <span class="citation_source-journal">Arch. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">1687</span><span class="NLM_x">–</span> <span class="NLM_lpage">1688</span><span class="refDoi"> DOI: 10.1001/archinte.144.8.1687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1001%2Farchinte.144.8.1687" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=1984&pages=1687-1688&author=M.+M.+Guffyauthor=N.+E.+Goekenauthor=C.+P.+Burns&title=Granulocytotoxic+antibodies+in+a+patient+with+propylthiouracil-induced+agranulocytosis&doi=10.1001%2Farchinte.144.8.1687"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1001%2Farchinte.144.8.1687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchinte.144.8.1687%26sid%3Dliteratum%253Aachs%26aulast%3DGuffy%26aufirst%3DM.%2BM.%26aulast%3DGoeken%26aufirst%3DN.%2BE.%26aulast%3DBurns%26aufirst%3DC.%2BP.%26atitle%3DGranulocytotoxic%2520antibodies%2520in%2520a%2520patient%2520with%2520propylthiouracil-induced%2520agranulocytosis%26jtitle%3DArch.%2520Intern.%2520Med.%26date%3D1984%26volume%3D144%26spage%3D1687%26epage%3D1688%26doi%3D10.1001%2Farchinte.144.8.1687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Fibbe, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claas, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Star-Dijkstra, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaafsma, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyboom, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falkenburg, J. H.</span><span> </span><span class="NLM_article-title">Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells</span> <span class="citation_source-journal">Br. J. Haematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span><span class="refDoi"> DOI: 10.1111/j.1365-2141.1986.tb04130.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1111%2Fj.1365-2141.1986.tb04130.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=3778829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A280%3ADyaL2s%252FkvFGguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1986&pages=363-373&author=W.+E.+Fibbeauthor=F.+H.+Claasauthor=W.+Van+der+Star-Dijkstraauthor=M.+R.+Schaafsmaauthor=R.+H.+Meyboomauthor=J.+H.+Falkenburg&title=Agranulocytosis+induced+by+propylthiouracil%3A+evidence+of+a+drug+dependent+antibody+reacting+with+granulocytes%2C+monocytes+and+haematopoietic+progenitor+cells&doi=10.1111%2Fj.1365-2141.1986.tb04130.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells</span></div><div class="casAuthors">Fibbe W E; Claas F H; Van der Star-Dijkstra W; Schaafsma M R; Meyboom R H; Falkenburg J H</div><div class="citationInfo"><span class="NLM_cas:title">British journal of haematology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">363-73</span>
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    </div><div class="casAbstract">A patient with agranulocytosis and myeloid marrow hypoplasia following a second exposure to propylthiouracil (PTU) was studied for antibodies against mature blood cells and bone marrow precursor cells.  During the acute phase of the agranulocytosis, significant growth inhibition of the myeloid committed progenitor cells (CFU-GM) was found following incubation with complement, indicating the presence of in-vivo cell bound cytotoxic antibodies.  Using immunofluorescence and complement dependent cytotoxicity techniques it was demonstrated that acute phase and recovery phase sera contained circulating antibodies, reactive not only with differentiated granulocytes and monocytes but also with myeloid and erythroid (BFU-E/CFU-E) progenitor cells.  Complement dependent lysis of the progenitor cells was facilitated by preincubation with PTU.  These results indicate that the agranulocytosis was mediated by a PTU dependent antibody that affected both mature blood cells and bone precursor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSpaMkNG--B3qe0F5ixvZgXfW6udTcc2eZQ79r9EhEDqLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2s%252FkvFGguw%253D%253D&md5=2aa334ab044a03efdeb6f9cb09ab0d7b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.1986.tb04130.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.1986.tb04130.x%26sid%3Dliteratum%253Aachs%26aulast%3DFibbe%26aufirst%3DW.%2BE.%26aulast%3DClaas%26aufirst%3DF.%2BH.%26aulast%3DVan%2Bder%2BStar-Dijkstra%26aufirst%3DW.%26aulast%3DSchaafsma%26aufirst%3DM.%2BR.%26aulast%3DMeyboom%26aufirst%3DR.%2BH.%26aulast%3DFalkenburg%26aufirst%3DJ.%2BH.%26atitle%3DAgranulocytosis%2520induced%2520by%2520propylthiouracil%253A%2520evidence%2520of%2520a%2520drug%2520dependent%2520antibody%2520reacting%2520with%2520granulocytes%252C%2520monocytes%2520and%2520haematopoietic%2520progenitor%2520cells%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D1986%26volume%3D64%26spage%3D363%26epage%3D373%26doi%3D10.1111%2Fj.1365-2141.1986.tb04130.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Bilezikian, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laleli, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsan, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodkinson, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ice, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, P. A.</span><span> </span><span class="NLM_article-title">Immunological reactions involving leukocytes: III. Agranulocytosis induced by antithyroid drugs</span> <span class="citation_source-journal">Johns Hopkins Med. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=58084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A280%3ADyaE287psVeiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=1976&pages=124-129&author=S.+B.+Bilezikianauthor=Y.+Laleliauthor=M.+F.+Tsanauthor=B.+A.+Hodkinsonauthor=S.+Iceauthor=P.+A.+McIntyre&title=Immunological+reactions+involving+leukocytes%3A+III.+Agranulocytosis+induced+by+antithyroid+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Immunological: reactions involving leukocytes: III. Agranulocytosis induced by antithyroid drugs</span></div><div class="casAuthors">Bilezikian S B; Laleli Y; Tsan M F; Hodkinson B A; Ice S; McIntyre P A</div><div class="citationInfo"><span class="NLM_cas:title">The Johns Hopkins medical journal</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">124-9</span>
        ISSN:<span class="NLM_cas:issn">0021-7263</span>.
    </div><div class="casAbstract">A method has previously been described which detected xenogeneic and allogeneic antibodies to human granulocytes by their inhibition of the normal phagocytosis-associated hexose monophosphate shunt (HMS) activity.  This method was used to study three patients with acute agranulocytosis secondary to antithyroid drug administration.  Two patients with methimazole and one patient with propylthiouracil induced agranulocytosis were studied.  Serum samples from each of these three patients taken during the acute phase of agranulocytosis had inhibitory effects on phagocytosis-associated HMS activity in leukocytes from both normal donors and the patients after their full recovery from agranulocytosis.  IgM but not IgG prepared from acute sera in two patients was also inhibitory.  Disruption of IgM disulfide bonds by dithiothreitol destroyed its inhibitory activity.  The possibility of drug-dependent immune destruction of leukocytes in these patients is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPyhlNzzGjVbjnyZkbE8yXfW6udTcc2ea-toLk82imkbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE287psVeiug%253D%253D&md5=d922f86ad402873073753b3dd3e2f03a</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilezikian%26aufirst%3DS.%2BB.%26aulast%3DLaleli%26aufirst%3DY.%26aulast%3DTsan%26aufirst%3DM.%2BF.%26aulast%3DHodkinson%26aufirst%3DB.%2BA.%26aulast%3DIce%26aufirst%3DS.%26aulast%3DMcIntyre%26aufirst%3DP.%2BA.%26atitle%3DImmunological%2520reactions%2520involving%2520leukocytes%253A%2520III.%2520Agranulocytosis%2520induced%2520by%2520antithyroid%2520drugs%26jtitle%3DJohns%2520Hopkins%2520Med.%2520J.%26date%3D1976%26volume%3D138%26spage%3D124%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Berkman, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlin, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfsdorf, J.</span><span> </span><span class="NLM_article-title">An anti-neutrophil antibody associated with a propylthiouracil-induced lupus-like syndrome</span> <span class="citation_source-journal">Transfusion</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span><span class="refDoi"> DOI: 10.1046/j.1537-2995.1983.23283172851.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1046%2Fj.1537-2995.1983.23283172851.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1983&pages=135-138&author=E.+M.+Berkmanauthor=J.+B.+Orlinauthor=J.+Wolfsdorf&title=An+anti-neutrophil+antibody+associated+with+a+propylthiouracil-induced+lupus-like+syndrome&doi=10.1046%2Fj.1537-2995.1983.23283172851.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1046%2Fj.1537-2995.1983.23283172851.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1537-2995.1983.23283172851.x%26sid%3Dliteratum%253Aachs%26aulast%3DBerkman%26aufirst%3DE.%2BM.%26aulast%3DOrlin%26aufirst%3DJ.%2BB.%26aulast%3DWolfsdorf%26aufirst%3DJ.%26atitle%3DAn%2520anti-neutrophil%2520antibody%2520associated%2520with%2520a%2520propylthiouracil-induced%2520lupus-like%2520syndrome%26jtitle%3DTransfusion%26date%3D1983%26volume%3D23%26spage%3D135%26epage%3D138%26doi%3D10.1046%2Fj.1537-2995.1983.23283172851.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Kitamura, I. R.</span><span> </span><span class="NLM_article-title">The action of hydrogen peroxide on organic sulfur compounds</span> <span class="citation_source-journal">Yakugaku Zasshi</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1934</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1934&pages=1-13&author=I.+R.+Kitamura&title=The+action+of+hydrogen+peroxide+on+organic+sulfur+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DI.%2BR.%26atitle%3DThe%2520action%2520of%2520hydrogen%2520peroxide%2520on%2520organic%2520sulfur%2520compounds%26jtitle%3DYakugaku%2520Zasshi%26date%3D1934%26volume%3D54%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Kalm, M. J.</span><span> </span><span class="NLM_article-title">Peroxide desulfurization of thioureas</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2925</span><span class="NLM_x">–</span> <span class="NLM_lpage">2929</span><span class="refDoi"> DOI: 10.1021/jo01066a072</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01066a072" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1961&pages=2925-2929&author=M.+J.+Kalm&title=Peroxide+desulfurization+of+thioureas&doi=10.1021%2Fjo01066a072"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjo01066a072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01066a072%26sid%3Dliteratum%253Aachs%26aulast%3DKalm%26aufirst%3DM.%2BJ.%26atitle%3DPeroxide%2520desulfurization%2520of%2520thioureas%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1961%26volume%3D26%26spage%3D2925%26epage%3D2929%26doi%3D10.1021%2Fjo01066a072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Henderson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddens, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kedzie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidelbaugh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garst, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. E.</span><span> </span><span class="NLM_article-title">Flavin-containing monooxygenase S-oxygenation of a series of thioureas and thiones</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1016/j.taap.2014.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1016%2Fj.taap.2014.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=24727368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVaqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2014&pages=91-99&author=M.+C.+Hendersonauthor=L.+K.+Siddensauthor=S.+K.+Kruegerauthor=J.+F.+Stevensauthor=K.+Kedzieauthor=W.+K.+Fangauthor=T.+Heidelbaughauthor=P.+Nguyenauthor=K.+Chowauthor=M.+Garstauthor=D.+Gilauthor=D.+E.+Williams&title=Flavin-containing+monooxygenase+S-oxygenation+of+a+series+of+thioureas+and+thiones&doi=10.1016%2Fj.taap.2014.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Flavin-containing monooxygenase S-oxygenation of a series of thioureas and thiones</span></div><div class="casAuthors">Henderson, Marilyn C.; Siddens, Lisbeth K.; Krueger, Sharon K.; Stevens, J. Fred; Kedzie, Karen; Fang, Wenkui K.; Heidelbaugh, Todd; Nguyen, Phong; Chow, Ken; Garst, Michael; Gil, Daniel; Williams, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-99</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Mammalian flavin-contg. monooxygenase (FMO) is active towards many drugs with a heteroatom having the properties of a soft nucleophile.  Thiocarbamides and thiones are S-oxygenated to the sulfenic acid which can either react with glutathione and initiate a redox-cycle or be oxygenated a second time to the unstable sulfinic acid.  In this study, we utilized LC-MS/MS to demonstrate that the oxygenation by hFMO of the thioureas under test terminated at the sulfenic acid.  With thiones, hFMO catalyzed the second reaction and the sulfinic acid rapidly lost sulfite to form the corresponding imidazole.  Thioureas are often pulmonary toxicants in mammals and, as previously reported by our lab., are excellent substrates for hFMO2.  This isoform is expressed at high levels in the lung of most mammals, including non-human primates.  Genotyping to date indicates that individuals of African (up to 49%) or Hispanic (2-7%) ancestry have at least one allele for functional hFMO2 in lung, but not Caucasians nor Asians.  In this study the major metabolite formed by hFMO2 with thioureas from Allergan, Inc. was the sulfenic acid that reacted with glutathione.  The majority of thiones were poor substrates for hFMO3, the major form in adult human liver.  However, hFMO1, the major isoform expressed in infant and neonatal liver and adult kidney and intestine, readily S-oxygenated thiones under test, with Kms ranging from 7 to 160 μM and turnover nos. of 30-40 min- 1.  The product formed was identified by LC-MS/MS as the imidazole.  The activities of the mouse and human FMO1 and FMO3 orthologs were in good agreement with the exception of some thiones for which activity was much greater with hFMO1 than mFMO1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpog_KXJBUA8LVg90H21EOLACvtfcHk0lhI6qn9sca6jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVaqtLk%253D&md5=134a66894da5023de0955d1ea6d8ab5d</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2014.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2014.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DM.%2BC.%26aulast%3DSiddens%26aufirst%3DL.%2BK.%26aulast%3DKrueger%26aufirst%3DS.%2BK.%26aulast%3DStevens%26aufirst%3DJ.%2BF.%26aulast%3DKedzie%26aufirst%3DK.%26aulast%3DFang%26aufirst%3DW.%2BK.%26aulast%3DHeidelbaugh%26aufirst%3DT.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DChow%26aufirst%3DK.%26aulast%3DGarst%26aufirst%3DM.%26aulast%3DGil%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DD.%2BE.%26atitle%3DFlavin-containing%2520monooxygenase%2520S-oxygenation%2520of%2520a%2520series%2520of%2520thioureas%2520and%2520thiones%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2014%26volume%3D278%26spage%3D91%26epage%3D99%26doi%3D10.1016%2Fj.taap.2014.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Henderson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. E.</span><span> </span><span class="NLM_article-title">Human flavin-containing monooxygenase form 2 S-oxygenation: sulfenic acid formation from thioureas and oxidation of glutathione</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">–</span> <span class="NLM_lpage">640</span><span class="refDoi"> DOI: 10.1021/tx034253s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx034253s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=633-640&author=M.+C.+Hendersonauthor=S.+K.+Kruegerauthor=J.+F.+Stevensauthor=D.+E.+Williams&title=Human+flavin-containing+monooxygenase+form+2+S-oxygenation%3A+sulfenic+acid+formation+from+thioureas+and+oxidation+of+glutathione&doi=10.1021%2Ftx034253s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Ftx034253s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx034253s%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DM.%2BC.%26aulast%3DKrueger%26aufirst%3DS.%2BK.%26aulast%3DStevens%26aufirst%3DJ.%2BF.%26aulast%3DWilliams%26aufirst%3DD.%2BE.%26atitle%3DHuman%2520flavin-containing%2520monooxygenase%2520form%25202%2520S-oxygenation%253A%2520sulfenic%2520acid%2520formation%2520from%2520thioureas%2520and%2520oxidation%2520of%2520glutathione%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2004%26volume%3D17%26spage%3D633%26epage%3D640%26doi%3D10.1021%2Ftx034253s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Mansuy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansette, P. M.</span><span> </span><span class="NLM_article-title">Sulfenic acids as reactive intermediates in xenobiotic metabolism</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">507</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1016/j.abb.2010.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1016%2Fj.abb.2010.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=20869346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFegt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=507&publication_year=2011&pages=174-185&author=D.+Mansuyauthor=P.+M.+Dansette&title=Sulfenic+acids+as+reactive+intermediates+in+xenobiotic+metabolism&doi=10.1016%2Fj.abb.2010.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfenic acids as reactive intermediates in xenobiotic metabolism</span></div><div class="casAuthors">Mansuy, Daniel; Dansette, Patrick M.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">507</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">174-185</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sulfenic acid reactive intermediates are formed during the oxidn. of cysteine residues of proteins and play key roles in enzyme catalysis, redox homeostasis and regulation of cell signalling.  However few data are presently available on the formation and fate of sulfenic acids as reactive intermediates during the metab. of xenobiotics.  This article is a review of the xenobiotic metab. situations in which the intermediate formation of a sulfenic acid has been reported.  Formation of these intermediates has been either proposed on the basis of the isolation of products possibly deriving from sulfenic acids or shown after trapping of the sulfenic acid by specific nucleophiles.  This review indicates the different mechanisms by which a sulfur-contg. xenobiotic can be metabolized with the intermediate formation of a sulfenic acid.  It also indicates the different possible fates of these sulfenic acids that have been reported in the literature.  Finally, it discusses the possible implications of the formation of xenobiotic-derived sulfenic acid reactive metabolites in pharmacol. and toxicol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMGeP-6Njzh7Vg90H21EOLACvtfcHk0liy_xnhWMeOmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFegt7c%253D&md5=598905063d4325c495e2740c61132a42</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2010.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2010.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DMansuy%26aufirst%3DD.%26aulast%3DDansette%26aufirst%3DP.%2BM.%26atitle%3DSulfenic%2520acids%2520as%2520reactive%2520intermediates%2520in%2520xenobiotic%2520metabolism%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2011%26volume%3D507%26spage%3D174%26epage%3D185%26doi%3D10.1016%2Fj.abb.2010.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Stopher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClean, S.</span><span> </span><span class="NLM_article-title">An improved method for the determination of distribution coefficients</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="refDoi"> DOI: 10.1111/j.2042-7158.1990.tb05373.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1111%2Fj.2042-7158.1990.tb05373.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1972404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADyaK3cXitFSntbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1990&pages=144&author=D.+Stopherauthor=S.+McClean&title=An+improved+method+for+the+determination+of+distribution+coefficients&doi=10.1111%2Fj.2042-7158.1990.tb05373.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">An improved method for the determination of distribution coefficients</span></div><div class="casAuthors">Stopher, David; McClean, Siobhan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    </div><div class="casAbstract">The traditional shake flash method for measuring the distribution coeff. (D) of drugs (Leo et al., 1971) was modified to minimize the amt. of compd. required by employing HPLC to detn. the concn. of the compd. in the octanol and buffer phases.  The HPLC employed a reverse-phase Spherisorb octyl column with a mobile phase of MeOH-ammonium phosphate 0.01 M, pH 7.  The method was validated using drugs with a range of log D values of -2 to 4.  The method is suitable for rapid evaluation of the compds. since it decreases errors due to any impurities present.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodB1AZ9RwrrLVg90H21EOLACvtfcHk0liy_xnhWMeOmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXitFSntbc%253D&md5=4d4ab2e9a04d54dbb868cb1b212e8e55</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.1990.tb05373.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.1990.tb05373.x%26sid%3Dliteratum%253Aachs%26aulast%3DStopher%26aufirst%3DD.%26aulast%3DMcClean%26aufirst%3DS.%26atitle%3DAn%2520improved%2520method%2520for%2520the%2520determination%2520of%2520distribution%2520coefficients%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D1990%26volume%3D42%26spage%3D144%26doi%3D10.1111%2Fj.2042-7158.1990.tb05373.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Korolev, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakin, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolsky, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirillov, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanenkov, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savchuk, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivashchenko, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolskaya, T.</span><span> </span><span class="NLM_article-title">Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3631</span><span class="NLM_x">–</span> <span class="NLM_lpage">3643</span><span class="refDoi"> DOI: 10.1021/jm030102a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030102a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3631-3643&author=D.+Korolevauthor=K.+V.+Balakinauthor=Y.+Nikolskyauthor=E.+Kirillovauthor=Y.+A.+Ivanenkovauthor=N.+P.+Savchukauthor=A.+A.+Ivashchenkoauthor=T.+Nikolskaya&title=Modeling+of+human+cytochrome+p450-mediated+drug+metabolism+using+unsupervised+machine+learning+approach&doi=10.1021%2Fjm030102a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm030102a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030102a%26sid%3Dliteratum%253Aachs%26aulast%3DKorolev%26aufirst%3DD.%26aulast%3DBalakin%26aufirst%3DK.%2BV.%26aulast%3DNikolsky%26aufirst%3DY.%26aulast%3DKirillov%26aufirst%3DE.%26aulast%3DIvanenkov%26aufirst%3DY.%2BA.%26aulast%3DSavchuk%26aufirst%3DN.%2BP.%26aulast%3DIvashchenko%26aufirst%3DA.%2BA.%26aulast%3DNikolskaya%26aufirst%3DT.%26atitle%3DModeling%2520of%2520human%2520cytochrome%2520p450-mediated%2520drug%2520metabolism%2520using%2520unsupervised%2520machine%2520learning%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3631%26epage%3D3643%26doi%3D10.1021%2Fjm030102a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitney-Pickett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gebhard, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federico, J. J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempshall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kattan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span> </span><span class="NLM_article-title">Development of a new permeability assay using low-efflux MDCKII cells</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4974</span><span class="NLM_x">–</span> <span class="NLM_lpage">4985</span><span class="refDoi"> DOI: 10.1002/jps.22674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1002%2Fjps.22674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=21766308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4974-4985&author=L.+Diauthor=C.+Whitney-Pickettauthor=J.+P.+Umlandauthor=H.+Zhangauthor=X.+Zhangauthor=D.+F.+Gebhardauthor=Y.+Laiauthor=J.+J.+Federicoauthor=R.+E.+Davidsonauthor=R.+Smithauthor=E.+L.+Reynerauthor=C.+Leeauthor=B.+Fengauthor=C.+Rotterauthor=M.+V.+Varmaauthor=S.+Kempshallauthor=K.+Fennerauthor=A.+F.+El-Kattanauthor=T.+E.+Listonauthor=M.+D.+Troutman&title=Development+of+a+new+permeability+assay+using+low-efflux+MDCKII+cells&doi=10.1002%2Fjps.22674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new permeability assay using low-efflux MDCKII cells</span></div><div class="casAuthors">Di, Li; Whitney-Pickett, Carrie; Umland, John P.; Zhang, Hui; Zhang, Xun; Gebhard, David F.; Lai, Yurong; Federico, James J.; Davidson, Ralph E.; Smith, Russ; Reyner, Eric L.; Lee, Caroline; Feng, Bo; Rotter, Charles; Varma, Manthena V.; Kempshall, Sarah; Fenner, Katherine; El-kattan, Ayman F.; Liston, Theodore E.; Troutman, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4974-4985</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Permeability is an important property of drug candidates.  The Madin-Darby canine kidney cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK cells is the presence of endogenous transporters of nonhuman origin.  The canine P-glycoprotein (Pgp) can interfere with permeability and transporter studies, leading to less reliable data.  A new cell line, MDCKII-LE (low efflux), has been developed by selecting a subpopulation of low-efflux cells from MDCKII-WT using an iterative fluorescence-activated cell sorting technique with calcein-AM as a Pgp and efflux substrate.  MDCKII-LE cells are a subpopulation of MDCKII cells with over 200-fold lower canine Pgp mRNA level and fivefold lower protein level than MDCKII-WT.  MDCKII-LE cells showed less functional efflux activity than MDCKII-WT based on efflux ratios.  Notably, MDCKII-MDR1 showed about 1.5-fold decreased expression of endogenous canine Pgp, suggesting that using the net flux ratio might not completely cancel out the background endogenous transporter activities.  MDCKII-LE cells offer clear advantages over the MDCKII-WT by providing less efflux transporter background signals and minimizing interference from canine Pgp.  The MDCKII-LE apparent permeability values well differentiates compds. from high to medium/low human intestinal absorption and can be used for Biopharmaceutical Classification System.  The MDCKII-LE permeability assay (4-in-1 cassette dosing) is high throughput with good precision, reproducibility, robustness, and cost-effective. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVtRmYnbF17Vg90H21EOLACvtfcHk0liy_xnhWMeOmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D&md5=97f647fc215ea6d04882351ffc912a1e</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fjps.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22674%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DFederico%26aufirst%3DJ.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DReyner%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DRotter%26aufirst%3DC.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DEl-Kattan%26aufirst%3DA.%2BF.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520new%2520permeability%2520assay%2520using%2520low-efflux%2520MDCKII%2520cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4974%26epage%3D4985%26doi%3D10.1002%2Fjps.22674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Banker, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. A.</span><span> </span><span class="NLM_article-title">Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">974</span><span class="refDoi"> DOI: 10.1002/jps.10332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1002%2Fjps.10332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=12712416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1ehsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=967-974&author=M.+J.+Bankerauthor=T.+H.+Clarkauthor=J.+A.+Williams&title=Development+and+validation+of+a+96-well+equilibrium+dialysis+apparatus+for+measuring+plasma+protein+binding&doi=10.1002%2Fjps.10332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding</span></div><div class="casAuthors">Banker, Michael J.; Clark, Tracey H.; Williams, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">967-974</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A 96-well equil. dialysis block was designed and constructed that is compatible with most std. 96-well format lab. supplies and instruments.  The unique design of the dialysis app. allows one to dispense and aspirate from either or both the sample and dialyzate sides from the top of the app., which is not possible with systems currently on the market.  This feature permits the investigator to analyze a large no. of samples, time points, or replicates in the same expt.  The novel alignment of the dialysis membrane vertically in the well maximizes the surface-to-vol. ratio, eliminates problems assocd. with trapped air pockets, and allows one to add or remove samples independently or all at once.  Furthermore, the design of the app. allows both the sample and dialyzate sides of the dialysis well to be accessible by robotic systems, so assays can be readily automated.  Teflon construction is used to minimize nonspecific binding of test samples to the app.  The device is reusable, easily assembled, and can be shaken in controlled temp. environments to decrease the time required to reach equil. as well as facilitate dissoln. of test compds.  Plasma protein binding values obtained for 10 diverse compds. using std. dialysis equipment and the 96-well dialysis block validates this method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp9qyX_9tHHrVg90H21EOLACvtfcHk0lgSBbyo3GG5cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1ehsrs%253D&md5=0948f0a11373c57be06be9e0d604ad40</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fjps.10332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.10332%26sid%3Dliteratum%253Aachs%26aulast%3DBanker%26aufirst%3DM.%2BJ.%26aulast%3DClark%26aufirst%3DT.%2BH.%26aulast%3DWilliams%26aufirst%3DJ.%2BA.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%252096-well%2520equilibrium%2520dialysis%2520apparatus%2520for%2520measuring%2520plasma%2520protein%2520binding%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D92%26spage%3D967%26epage%3D974%26doi%3D10.1002%2Fjps.10332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Walsky, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Validated assays for human cytochrome P450 activities</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span><span class="refDoi"> DOI: 10.1124/dmd.32.6.647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1124%2Fdmd.32.6.647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=15155557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlOgt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=647-660&author=R.+L.+Walskyauthor=R.+S.+Obach&title=Validated+assays+for+human+cytochrome+P450+activities&doi=10.1124%2Fdmd.32.6.647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Validated assays for human cytochrome P450 activities</span></div><div class="casAuthors">Walsky, Robert L.; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">647-660</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The measurement of the effect of new chem. entities on human cytochrome P 450 marker activities using in vitro experimentation represents an important exptl. approach in drug development.  In vitro drug interaction data can be used in guiding the design of clin. drug interaction studies, or, when no effect is obsd. in vitro, the data can be used in place of an in vivo study to claim that no interaction will occur in vivo.  To make such a claim, it must be assured that the in vitro expts. are performed with abs. confidence in the methods used and data obtained.  To meet this need, 12 semiautomated assays for human P 450 marker substrate activities have been developed and validated using approaches described in the GLP (good lab. practices) as per the code of U.S. Federal Regulations.  The assays that were validated are: phenacetin O-deethylase (CYP1A2), coumarin 7-hydroxylase (CYP2A6), bupropion hydroxylase (CYP2B6), amodiaquine N-deethylase (CYP2C8), diclofenac 4'-hydroxylase and tolbutamide methylhydroxylase (CYP2C9), (S)-mephenytoin 4'-hydroxylase (CYP2C19), dextromethorphan O-demethylase (CYP2D6), chlorzoxazone 6-hydroxylase (CYP2E1), felodipine dehydrogenase, testosterone 6β-hydroxylase, and midazolam 1'-hydroxylase (CYP3A4 and CYP3A5).  High-pressure liq. chromatog.-tandem mass spectrometry, using stable isotope-labeled internal stds., has been applied as the anal. method.  This anal. approach, through its high sensitivity and selectivity, has permitted the use of very low incubation concns. of microsomal protein (0.01-0.2 mg/mL).  Anal. assay accuracy and precision values were excellent.  Enzyme kinetic and inhibition parameters obtained using these methods demonstrated high precision and were within the range of values previously reported in the scientific literature.  These methods should prove useful in the routine assessments of the potential for new drug candidates to elicit pharmacokinetic drug interactions via inhibition of cytochrome P 450 activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwF04TGeyYbbVg90H21EOLACvtfcHk0lgSBbyo3GG5cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlOgt74%253D&md5=35532b907c15f1053aa8233dab2ec581</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fdmd.32.6.647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.32.6.647%26sid%3Dliteratum%253Aachs%26aulast%3DWalsky%26aufirst%3DR.%2BL.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DValidated%2520assays%2520for%2520human%2520cytochrome%2520P450%2520activities%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26spage%3D647%26epage%3D660%26doi%3D10.1124%2Fdmd.32.6.647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Orr, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripp, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span> </span><span class="NLM_article-title">Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug-drug interaction risks</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4896</span><span class="NLM_x">–</span> <span class="NLM_lpage">4933</span><span class="refDoi"> DOI: 10.1021/jm300065h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300065h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Wlur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4896-4933&author=S.+T.+Orrauthor=S.+L.+Rippauthor=T.+E.+Ballardauthor=J.+L.+Hendersonauthor=D.+O.+Scottauthor=R.+S.+Obachauthor=H.+Sunauthor=A.+S.+Kalgutkar&title=Mechanism-based+inactivation+%28MBI%29+of+cytochrome+P450+enzymes%3A+structure-activity+relationships+and+discovery+strategies+to+mitigate+drug-drug+interaction+risks&doi=10.1021%2Fjm300065h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism-Based Inactivation (MBI) of Cytochrome P450 Enzymes: Structure-Activity Relationships and Discovery Strategies To Mitigate Drug-Drug Interaction Risks</span></div><div class="casAuthors">Orr, Suvi T. M.; Ripp, Sharon L.; Ballard, T. Eric; Henderson, Jaclyn L.; Scott, Dennis O.; Obach, R. Scott; Sun, Hao; Kalgutkar, Amit S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4896-4933</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The importance of mitigating drug-drug interaction (DDI) risks, which arise from inhibition of major human cytochrome P 450 enzymes is a well-established component of the lead optimization process in drug discovery.  More recently, there has been much interest in clin. DDIs potentially arising via time- and concn.-dependent cytochrome P 450 inhibition, a phenomenon consistent with mechanism-based inactivation.  Inactivated P 450 is catalytically incompetent and must be replenished by newly synthesized protein.  Consequently, time-dependent inhibition of P450s presents a greater safety concern compared to reversible inhibition because of the increased propensity for pharmacokinetic interactions upon multiple dosing and the sustained duration of these interactions after discontinuation of the mechanism-based inactivator.  Mechanism-based or time-dependent P 450 inhibitors pose an addnl. risk of idiosyncratic drug toxicity since the mechanism of time-dependency often involves the formation of reactive metabolites, which can react with proteins other than the P 450 isoenzyme responsible for catalysis. in vitro time-dependent inhibition (TDI) of P 450 enzymes is now routinely assessed as part of lead optimization efforts in preclin. drug discovery.  However, identification of an in vitro TDI liability can raise several questions such as: What is the mechanism of TDI.  Does it involve the formation of reactive metabolites.  Is there a 1:1 correlation between P 450 TDI and RM formation (as measured from reactive metabolite trapping studies).  What is the likelihood that a P 450 time-dependent inhibitor will also cause toxicity.  What are the DDI risk mitigation options when dealing with P 450 inactivators in drug discovery - compd. progression or termination.  Several drugs exhibit in vitro TDI of P 450 enzymes, but only a fraction thereof causes clin. DDIs.  Hence, when do we initiate labor-intensive medicinal chem. efforts to design compds. devoid of P 450 TDI liability.  What are the best methods to precisely predict the likelihood of occurrence of clin. DDIs with drug candidates that inactivate P 450 enzymes.  What are (if any) the qualifying considerations for clin. progression of a P 450 time-dependent inactivator with projected clin. DDI risks.  In an effort to address these questions and hopefully provide answers to some of them, we embarked on the present venture wherein we highlight the current state-of-the-art knowledge in this field with a special emphasis on (a) available biochem. and mechanistic approaches in drug discovery to examine TDI of P 450 isoenzymes with new chem. entities, (b) structure-activity relationship studies with marketed drugs assocd. with DDIs via P 450 inactivation, (c) case studies of medicinal chem. tactics to abrogate P 450 inactivation liability, (d) strategies for progression of P 450 TDI-pos. drug candidates, and (e) the utility of in silico methodol., including the use of physiol.-based pharmacokinetic simulators, in drug discovery to predict the magnitude of clin. DDIs risks anticipated with new clin. candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDO60qqRvpS7Vg90H21EOLACvtfcHk0lgSBbyo3GG5cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Wlur8%253D&md5=aa4aa4f633b3b4f73b3d79917327b0de</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm300065h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300065h%26sid%3Dliteratum%253Aachs%26aulast%3DOrr%26aufirst%3DS.%2BT.%26aulast%3DRipp%26aufirst%3DS.%2BL.%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DHenderson%26aufirst%3DJ.%2BL.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26atitle%3DMechanism-based%2520inactivation%2520%2528MBI%2529%2520of%2520cytochrome%2520P450%2520enzymes%253A%2520structure-activity%2520relationships%2520and%2520discovery%2520strategies%2520to%2520mitigate%2520drug-drug%2520interaction%2520risks%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4896%26epage%3D4933%26doi%3D10.1021%2Fjm300065h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Varma, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chupka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kattan, A.</span><span> </span><span class="NLM_article-title">Physicochemical determinants of human renal clearance</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4844</span><span class="NLM_x">–</span> <span class="NLM_lpage">4852</span><span class="refDoi"> DOI: 10.1021/jm900403j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900403j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvFOnt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4844-4852&author=M.+V.+Varmaauthor=B.+Fengauthor=R.+S.+Obachauthor=M.+D.+Troutmanauthor=J.+Chupkaauthor=H.+R.+Millerauthor=A.+El-Kattan&title=Physicochemical+determinants+of+human+renal+clearance&doi=10.1021%2Fjm900403j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical Determinants of Human Renal Clearance</span></div><div class="casAuthors">Varma, Manthena V. S.; Feng, Bo; Obach, R. Scott; Troutman, Matthew D.; Chupka, Jonathan; Miller, Howard R.; El-Kattan, Ayman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4844-4852</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Kidney plays an important role in the elimination of drugs, esp. with low or negligible hepatic clearance.  An anal. of the interrelation of physicochem. properties and the human renal clearance for a data set of 391 drugs or compds. tested in humans is presented.  The data set indicated that lipophilicity shows a neg. relationship while polar descriptors show a pos. relationship with renal clearance.  Anal. of net secreted and net reabsorbed subsets revealed that hydrophilic ionized compds. are probable compds. to show net secretion and a possible drug-drug interaction due to their likely interaction with uptake transporters and inherent low passive reabsorption.  The physicochem. space and renal clearance were also statistically analyzed by therapeutic area.  In conclusion, ionization state, lipophilicity, and polar descriptors are found to be the physicochem. determinants of renal clearance.  These fundamental properties can be valuable in early prediction of human renal clearance and can aid the chemist in structural modifications to optimize drug disposition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorGLq4kYGi_LVg90H21EOLACvtfcHk0ljRIH5SJHc0IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvFOnt7s%253D&md5=a99ccaa1651d04ed7f7c0a49679f55f6</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm900403j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900403j%26sid%3Dliteratum%253Aachs%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DChupka%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DH.%2BR.%26aulast%3DEl-Kattan%26aufirst%3DA.%26atitle%3DPhysicochemical%2520determinants%2520of%2520human%2520renal%2520clearance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4844%26epage%3D4852%26doi%3D10.1021%2Fjm900403j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Taylor, F. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddad, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hack, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peer, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrissey, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinasewitz, G. T.</span><span> </span><span class="NLM_article-title">Two-stage response to endotoxin infusion into normal human subjects: Correlation of blood phagocyte luminescence with clinical and laboratory markers of the inflammatory, hemostatic response</span> <span class="citation_source-journal">Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">326</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span><span class="refDoi"> DOI: 10.1097/00003246-200102000-00020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.1097%2F00003246-200102000-00020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=11269245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsleltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=326-334&author=F.+B.+Taylorauthor=P.+A.+Haddadauthor=E.+Hackauthor=A.+C.+Changauthor=G.+T.+Peerauthor=J.+H.+Morrisseyauthor=A.+Liauthor=R.+C.+Allenauthor=H.+Wadaauthor=G.+T.+Kinasewitz&title=Two-stage+response+to+endotoxin+infusion+into+normal+human+subjects%3A+Correlation+of+blood+phagocyte+luminescence+with+clinical+and+laboratory+markers+of+the+inflammatory%2C+hemostatic+response&doi=10.1097%2F00003246-200102000-00020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Two-stage response to endotoxin infusion into normal human subjects: Correlation of blood phagocyte luminescence with clinical and laboratory markers of the inflammatory, hemostatic response</span></div><div class="casAuthors">Taylor, Fletcher B., Jr.; Haddad, Phillip A.; Hack, Erik; Chang, Alvin C.; Peer, Glenn T.; Morrissey, James H.; Li, Anguo; Allen, Robert C.; Wada, Hideo; Kinasewitz, Gary T.</div><div class="citationInfo"><span class="NLM_cas:title">Critical Care Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">326-334</span>CODEN:
                <span class="NLM_cas:coden">CCMDC7</span>;
        ISSN:<span class="NLM_cas:issn">0090-3493</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The present studies characterize the receptor and oxidative enzymic responses of phagocytes in the human model of endotoxemia and correlate them with the responses of mol. markers of hemostatic and inflammatory system activation and endothelial injury.  These observations establish for the first time that the compensated response of human subjects to endotoxin consists of 2 stages: an immediate symptomatic inflammatory stage followed by an asymptomatic stage that is characterized by a recurrence of hemostatic activity, appearance of complement activation products complexed to C-reactive protein, and evidence of endothelial cell injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRB3dD4FzghbVg90H21EOLACvtfcHk0ljRIH5SJHc0IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsleltLw%253D&md5=3e3cbc28ac37c329448d74c815b48ef6</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1097%2F00003246-200102000-00020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00003246-200102000-00020%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DF.%2BB.%26aulast%3DHaddad%26aufirst%3DP.%2BA.%26aulast%3DHack%26aufirst%3DE.%26aulast%3DChang%26aufirst%3DA.%2BC.%26aulast%3DPeer%26aufirst%3DG.%2BT.%26aulast%3DMorrissey%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DAllen%26aufirst%3DR.%2BC.%26aulast%3DWada%26aufirst%3DH.%26aulast%3DKinasewitz%26aufirst%3DG.%2BT.%26atitle%3DTwo-stage%2520response%2520to%2520endotoxin%2520infusion%2520into%2520normal%2520human%2520subjects%253A%2520Correlation%2520of%2520blood%2520phagocyte%2520luminescence%2520with%2520clinical%2520and%2520laboratory%2520markers%2520of%2520the%2520inflammatory%252C%2520hemostatic%2520response%26jtitle%3DCrit.%2520Care%2520Med.%26date%3D2001%26volume%3D29%26spage%3D326%26epage%3D334%26doi%3D10.1097%2F00003246-200102000-00020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Predicting clearance in humans from in vitro data</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">334</span><span class="NLM_x">–</span> <span class="NLM_lpage">339</span><span class="refDoi"> DOI: 10.2174/156802611794480873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=10.2174%2F156802611794480873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=21320062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=334-339&author=R.+S.+Obach&title=Predicting+clearance+in+humans+from+in+vitro+data&doi=10.2174%2F156802611794480873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting clearance in humans from in vitro data</span></div><div class="casAuthors">Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">334-339</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The use of in vitro metab. in scaling to predict human clearance of new chem. entities has become a commonplace activity in the research and development of new drugs.  The measurement of in vitro lability in human liver microsomes, a rich source of drug metabolizing cytochrome P 450 enzymes, has become a high throughput screen in many research organizations which is a testament to its usefulness in drug design.  In this chapter, the methods used to scale in vitro intrinsic clearance data to predict in vivo clearance are described.  Importantly, the numerous assumptions that are required in order to use in vitro data in this manner are laid out.  These include assumptions regarding the scaling process as well as tech. aspects of the generation of the in vitro data.  Finally, some other drug clearance processes that have been emerging as important are described with regard to ongoing research efforts to develop clearance prediction methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHL7BnSTNtWbVg90H21EOLACvtfcHk0ljRIH5SJHc0IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSntbk%253D&md5=38df8707bb77fdc8b6bb6ef2144a79da</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.2174%2F156802611794480873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611794480873%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DPredicting%2520clearance%2520in%2520humans%2520from%2520in%2520vitro%2520data%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D334%26epage%3D339%26doi%3D10.2174%2F156802611794480873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00963&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-21%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00963" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00963" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996a7db86d25a5","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
